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Abstract    
 This thesis presents a detailed study into the thermodynamic stability and dehydration 
kinetics of a model pharmaceutical channel hydrate: carbamazepine dihydrate. The model 
compound of different crystal habits and particle size distributions was prepared via solvent-
mediated crystallisation technique and agitated hydration method. The causal relationship 
between key drying process parameters (i.e. temperature, pressure, relative humidity and 
organic solvent partial pressure) and dehydration behaviour of this model compound was 
established using Dynamic Vapour Sorption instruments. Solid state phase transformation 
mechanisms under these drying conditions were elucidated through the evolution of crystal 
structural determined by X-ray Powder Diffraction technique. 
 
 Dehydration kinetics of carbamazepine dihydrate were found to be markedly influenced 
by increasing temperature, reducing pressure, low humidity and higher organic solvent partial 
pressure, providing that the drying environment stays below the critical humidity and partial 
pressure for the dihydrate and acetone solvate formations. Activation energy determined from 
the kinetic study allows differentiation between the physically bound water in the bulk and 
water of crystallisation. Agglomerated dihydrate however possessed a high free water retention 
capacity when it exceeded a certain particle size distribution. This type of agglomerate 
exhibited distinct closed structure characteristics, leading to a relatively more stable form of 
carbamazepine dihydrate, than those without inclusion of unbound water. The agglomeration 
effect can thus be potentially controlled and exploited to expand the environmental stability 
envelope of the desired hydrated forms during manufacturing processes. 
 
 Subtle changes in the drying environment were able to induce polymorphic anhydrates 
of different stabilities. The solid state phase transformation pathway of carbamazepine 
dihydrate to the four polymorphic anhydrates and an amorphous form was strongly correlated 
to types of dehydration mechanism, and specifically to the accessibility of and interaction with 
surrounding solvent vapours (i.e. hydrogen bonding propensity). Alkanol solvent vapour-
mediated dehydration process was found to facilitate the formation of the thermodynamically 
stable anhydrate, without any loss in product crystallinity. Dipolar aprotic solvents however 
induced the (intermediate) formation of least metastable anhydrate, depending on the local 
chemical environment of solute-solvent system.  
 
 In conclusion, the surrounding solvent vapour plays a crucial role in drying strategies 
for a channel type hydrate, as it provides potential to predict and tailor the polymorphism of 
the desired forms which could have profound implications on the quality and performance of 
the final product. 
 7
Publications  
The following journal papers have been prepared as a result of this thesis. 
 
1. Ji Yi Khoo, Jerry Y.Y. Heng and Daryl R. Williams, Agglomeration effects on the drying 
and dehydration stability of pharmaceutical acicular hydrate: Carbamazepine dihydrate. 
Industrial & Engineering Chemistry Research, 2010. 49(1): p. 422-427. 
 
2. Ji Yi Khoo, Daryl R. Williams and Jerry Y.Y. Heng, Dehydration kinetics of 
pharmaceutical hydrate: Effects of environmental conditions and crystal forms. Drying 
Technology, 2010 (Accepted). 
 
3. Ji Yi Khoo, Michael M. Roberts, Daryl R. Williams and Jerry Y.Y. Heng, Process-
induced phase transformation of carbamazepine dihydrate to its polymorphic anhydrates. 
Crystal Growth & Design, 2010 (Submitted). 
 
4. Ji Yi Khoo, Daryl R. Williams and Jerry Y.Y. Heng, Role of organic solvent vapour in 
dehydration stability of channel hydrate. Industrial & Engineering Chemistry Research, 
2010 (In preparation). 
 
 
 
 8
Conferences  
The following refereed national/international conferences and meetings have been attended as 
a result of this thesis. 
 
1. Ji Yi Khoo, Jerry Y.Y. Heng and Daryl R. Williams, “Pharmaceutical channel hydrate: 
Elucidation of its thermodynamic stability and solid state phase transformation to 
polymorphic anhydrates.” 2009 American Association of Pharmaceutical Scientists 
(AAPS) Annual Meeting & Exposition, Los Angeles, CA, USA, 8-12 November 2009 
(Oral contribution). 
 
2. Ji Yi Khoo, Jerry Y.Y. Heng and Daryl R. Williams, “Dehydration kinetics of 
pharmaceutical hydrate: Effect of crystal properties.” 4th Inter-American Drying 
Conference. In: 8th World Congress of Chemical Engineering (WCCE8), Montreal, 
Canada, 23-27 August 2009 (Oral contribution). 
 
3. Ji Yi Khoo, Jerry Y.Y. Heng and Daryl R. Williams, “Dehydration of pharmaceutical 
channel hydrate: Elucidation of its solid state polymorphic transformation.” IChemE 10th 
UK Particle Technology Forum, University of Birmingham, Birmingham, 1-2 July 2009 
(Oral contribution).  
 
4. Ji Yi Khoo and Daryl R. Williams, “Characterisation of particulate solids using DVS at 
the extremes.” Academy of Pharmaceutical Sciences (APS) Extreme Characterisation 
Seminar, University of Loughborough, Loughborough, 26 June 2008 (Oral contribution). 
 
5. Ji Yi Khoo, Jerry Y.Y. Heng and Daryl R. Williams, “The dehydration stability of 
carbamazepine dihydrate: Influences of crystal properties and operating variables.” 6th 
World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 
Barcelona, Spain, 7-10 April 2008. 
 
6. Ji Yi Khoo, Jerry Y.Y. Heng and Daryl R. Williams, “The effects of temperature and 
humidity on the dehydration behaviour of a model channel hydrate: carbamazepine 
dihydrate.” 2007 American Association of Pharmaceutical Scientists (AAPS) Annual 
Meeting & Exposition, San Diego, CA, USA, 11-15 November 2007. 
 
7. Ji Yi Khoo, Jerry Y.Y. Heng and Daryl R. Williams, “The stability of pharmaceutical 
channel hydrate upon drying/dehydration process.” IChemE 8th UK Particle Technology 
Forum, University of Cambridge, Cambridge, 26-27 September 2007. 
 9
Contents 
 
Copyright ..........................................................................................................................3 
Preface ..........................................................................................................................4 
Declaration ..........................................................................................................................5 
Abstract ..........................................................................................................................6 
Publications ..........................................................................................................................7 
Conferences ..........................................................................................................................8 
Contents ..........................................................................................................................9 
List of Tables ........................................................................................................................13 
List of Figures ........................................................................................................................14 
Nomenclature ........................................................................................................................22 
Abbreviation ........................................................................................................................27 
CHAPTER 1 INTRODUCTION........................................................................................29 
1.1 Background ................................................................................................................29 
1.2 Aims and Objectives ..................................................................................................33 
CHAPTER 2 PROPERTIES OF PHARMACEUTICAL SOLIDS................................35 
2.1 Introduction ................................................................................................................35 
2.2 Crystallography ..........................................................................................................36 
2.2.1 Classification for Crystal System.......................................................................37 
2.2.2 Miller Indices .....................................................................................................39 
2.3 Crystalline Solids in the Pharmaceutical Industry .....................................................40 
2.4 Polymorphs.................................................................................................................41 
2.4.1 Thermodynamic Basis of Polymorphism...........................................................43 
2.4.2 Enantiotropic and Monotropic Systems .............................................................46 
2.4.3 Kinetic Factors of Polymorphism ......................................................................48 
2.4.4 Inconsistency in Polymorph Nomenclature .......................................................49 
2.5 Solvate........................................................................................................................51 
2.6 Hydrate .......................................................................................................................52 
2.6.1 Classification of Hydrates ..................................................................................54 
2.7 Amorphous Solids ......................................................................................................59 
 10
CHAPTER 3 WATER VAPOUR UPTAKE IN PHARMACEUTICAL SOLIDS........62 
3.1 Introduction ................................................................................................................62 
3.2 Water Molecule and Hydrogen Bonds .......................................................................64 
3.3 States of Water in Crystalline Solids..........................................................................67 
3.4 Water Sorption Mechanism........................................................................................70 
3.4.1 Surface Adsorption.............................................................................................70 
3.4.2 Condensation in Tunnels or Pores......................................................................71 
3.4.3 Bulk Sorption of Amorphous Materials .............................................................72 
3.5 Moisture Adsorption Isotherms..................................................................................72 
3.5.1 Models for Moisture Adsorption Isotherm.........................................................76 
3.5.2 Hysteresis of Moisture Sorption Isotherms........................................................79 
3.6 Hydration in Pharmaceutical Solids...........................................................................82 
3.6.1 Young-Nelson Model for Moisture Sorption Isotherm......................................85 
CHAPTER 4 DRYING AND DEHYDRATION OF CRYSTALLINE SOLIDS ..........87 
4.1 Introduction ................................................................................................................87 
4.2 Types of Industrial Dryers..........................................................................................88 
4.3 Drying of Crystalline Solids.......................................................................................92 
4.3.1 Transport Phenomena of Moisture.....................................................................93 
4.3.2 Convective Drying .............................................................................................95 
4.3.3 Migration of Moisture in Solids .........................................................................97 
4.3.4 Moisture Removal in Vacuum .........................................................................107 
4.4 Dehydration of Crystalline Hydrates........................................................................111 
4.4.1 Dehydration Mechanisms of Hydrate ..............................................................111 
4.4.2 Dependence of Dehydration Rate on Solid State Reactions ............................115 
4.4.3 Dependence of Dehydration Rate on Structural Factors..................................119 
4.4.4 Dependence of Dehydration Rate on Particle Size and Morphology...............125 
4.5 Dehydration Kinetics................................................................................................128 
4.5.1 Kinetic Models for Solid State Reactions ........................................................129 
4.5.2 Dehydration Kinetic Parameters ......................................................................132 
CHAPTER 5 MATERIAL AND PREPARATION........................................................134 
5.1 Carbamazepine (CBZ)..............................................................................................134 
5.1.1 Carbamazepine Anhydrate Polymorphs...........................................................135 
5.1.2 Naming system of carbamazepine polymorphs ...............................................137 
5.1.3 Metastability of Carbamazepine Polymorphic Anhydrates .............................138 
5.1.4 Preparation of Carbamazepine Anhydrates......................................................139 
5.1.5 Experimental Section for Preparation of Carbamazepine Anhydrates.............141 
5.2 Carbamazepine Dihydrate ........................................................................................142 
5.2.1 Stability of Carbamazepine Dihydrate .............................................................144 
5.2.2 Crystallisation of Carbamazepine Dihydrate ...................................................146 
5.2.3 Experimental Section for Preparation of Carbamazepine Dihydrate ...............147 
5.3 Carbamazepine Acetone Solvate..............................................................................150 
5.3.1 Stability of Carbamazepine Acetone Solvate...................................................151 
5.3.2 Experimental Section for Preparation of Carbamazepine Acetone Solvate.....152 
5.4 Conclusions ..............................................................................................................153 
 11
CHAPTER 6 EXPERIMENTAL DETERMINATION OF DEHYDRATION 
STABILITY 154 
6.1 Introduction to Instrumentation................................................................................154 
6.2 Gravimetric Technique for Dehydration Studies .....................................................158 
6.2.1 Dynamic Vapour Sorption (DVS)....................................................................159 
6.3 Thermoanalytical Technique for Sample Characterisation......................................163 
6.3.1 Thermogravimetric Analysis (TGA)................................................................163 
6.3.2 Differential Scanning Calorimetry (DSC)........................................................164 
6.3.3 Hot Stage Microscopy (HSM)..........................................................................169 
6.4 Spectroscopy Techniques for Pharmaceutical Hydrates ..........................................171 
6.4.1 Raman Spectroscopy Coupled with DVS System............................................173 
6.5 X-ray Powder Diffraction (XRPD) ..........................................................................179 
6.5.1 Theoretical Consideration of X-ray Diffraction...............................................179 
6.5.2 Bragg's Law......................................................................................................181 
6.5.3 Features of XRPD ............................................................................................182 
6.5.4 Limitations of XRPD .......................................................................................187 
6.6 Mercury Porosimetry................................................................................................192 
6.6.1 Theoretical Consideration for Mercury Porosimetry .......................................193 
6.6.2 Washburn Equation ..........................................................................................194 
6.6.3 Features of Mercury Porosimetry.....................................................................195 
6.6.4 Limitations of Mercury Porosimetry................................................................201 
CHAPTER 7 CRYSTAL PROPERTIES ON DEHYDRATION BEHAVIOUR ........203 
7.1 Introduction ..............................................................................................................203 
7.2 Experimental Section for Preparation and Characterisation of Carbamazepine 
Dihydrate..............................................................................................................................204 
7.3 Crystal Habit ............................................................................................................206 
7.3.1 Crystal Growth Mechanism .............................................................................208 
7.3.2 Influence of Crystal Habit on XRPD Pattern ...................................................210 
7.3.3 Effect of Crystal Habit on Dehydration Kinetics .............................................214 
7.4 Spherical Agglomeration..........................................................................................215 
7.4.1 Binding Mechanism and Solvent Inclusion in Agglomerates..........................216 
7.4.2 Bound and Unbound Water in Agglomerates ..................................................219 
7.4.3 Pore Size Distribution of Agglomerates...........................................................220 
7.4.4 Particle Packing Morphology of Agglomerates ...............................................224 
7.4.5 Retention Mechanism of Unbound Water in Agglomerates. ...........................226 
7.4.6 Role of Unbound Water in Agglomerates........................................................228 
7.5 Conclusions ..............................................................................................................231 
CHAPTER 8 KINETIC ANALYSIS OF DRYING AND DEHYDRATION OF 
CARBAMAZEPINE DIHYDRATE.....................................................................................232 
8.1 Introduction ..............................................................................................................232 
8.2 Effects of Temperature on Drying and Dehydration Behaviour ..............................233 
8.2.1 Carbamazepine Dihydrate Crystals ..................................................................233 
8.2.2 Carbamazepine Dihydrate Agglomerates.........................................................235 
8.3 Effects of Vacuum Pressure on Drying and Dehydration Behaviour ......................239 
 12
8.3.1 Carbamazepine Dihydrate Crystals Under Vacuum ........................................239 
8.3.2 Carbamazepine Dihydrate Agglomerates Under Vacuum...............................241 
8.4 Effects of Drying Air Flow Rates on Dehydration Behaviour.................................242 
8.4.1 Conversion of Localised Volumetric Air Flow Rate .......................................244 
8.4.2 Determination of Mass Transfer Coefficient ...................................................246 
8.4.3 Air Velocity Transition Regimes .....................................................................248 
8.5 Effects of Relative Humidity on Dehydration Behaviour........................................249 
8.6 Dehydration Kinetic Analysis ..................................................................................252 
8.7 Conclusions ..............................................................................................................255 
CHAPTER 9 SOLID STATE PHASE TRANSFORMATION DURING 
DEHYDRATION PROCESS................................................................................................257 
9.1 Introduction to Phase Transformation......................................................................257 
9.2 Phase Transformation of Carbamazepine Dihydrate ...............................................259 
9.3 Phase Transformation under Vacuum Pressure .......................................................263 
9.3.1 Effect of Temperature on Nucleation Phenomena ...........................................267 
9.3.2 Effect of Induced Air Flow on Nucleation.......................................................269 
9.4 Water Vapour-mediated Phase Transformation.......................................................271 
9.5 Organic Solvent Vapour-mediated Phase Transformation.......................................273 
9.6 Dehydration-induced Phase Transformation Mechanism........................................274 
9.7 Surface Induced Nucleation by Organic Solvent Vapours.......................................276 
9.8 Transitions between Polymorphic Anhydrates ........................................................279 
9.9 Conclusions ..............................................................................................................281 
CHAPTER 10 SOLUTE-SOLVENT INTERACTION DURING DEHYDRATION AND 
DESOLVATION PROCESSES............................................................................................282 
10.1 Introduction ..............................................................................................................282 
10.2 Role of Solvent Vapour on Dehydration Behaviour ................................................283 
10.2.1 Dehydration Kinetics........................................................................................284 
10.2.2 Solvent Vapour-mediated Phase Transformation of Carbamazepine Dihydrate
 290 
10.2.3 Solvent-solute Interaction ................................................................................295 
10.3 Role of Water Vapour on Desolvation Behaviour ...................................................300 
10.3.1 Kinetics Analysis..............................................................................................300 
10.3.2 Avrami-Erofe’ev Kinetic Model ......................................................................303 
10.4 Conclusions ..............................................................................................................307 
CHAPTER 11 CONCLUSIONS AND FUTURE WORK ...............................................308 
11.1 Overall Summary .....................................................................................................308 
11.2 Future Work .............................................................................................................312 
References ......................................................................................................................316 
 
 13
 
List of Tables 
 
Table 2-1: Bravais crystal system for crystalline materials .....................................................................38 
Table 2-2: Solid state properties ..............................................................................................................41 
Table 2-3: Thermodynamic rules for polymorphic transitions of enantiotropy and monotropy 
systems .................................................................................................................................47 
Table 3-1: Classification of moisture retention in solids .........................................................................69 
Table 4-1: Typical effects of particle size on equipment design parameters. ........................................126 
Table 4-2: Common kinetic equations for solid state reactions .............................................................131 
Table 5-1: Crystallographic data for carbamazepine polymorphs .........................................................136 
Table 5-2: Summary of polymorph nomenclature system employed in literature.................................137 
Table 5-3: Crystallographic data for dihydrate forms of carbamazepine...............................................144 
Table 5-4: Preparation methods for carbamazepine dihydrate adopted in this work. ............................148 
Table 5-5: Crystallographic data for carbamazepine acetone solvate....................................................150 
Table 6-1: Analytical techniques to investigate and characterise the solid state forms .........................154 
Table 6-2: Summary of DVS equipments used in this work..................................................................159 
Table 6-3: Constants of each solvent vapour for the extended modified Antoine equation ..................161 
Table 6-4: Assignment of Raman bands to molecular vibrations for carbamazepine anhydrate, 
dihydrate and acetone solvate.............................................................................................175 
Table 6-5: Comparative data for X-ray diffraction, near infra-red spectroscopy and differential 
scanning calorimetry ..........................................................................................................188 
Table 7-1: Mercury porosimetry analysis for carbamazepine dihydrate agglomerates .........................221 
Table 8-1: Kinetic analysis for dehydration of carbamazepine dihydrate at atmospheric and vacuum 
conditions ...........................................................................................................................254 
Table 10-1: Property parameters of organic solvents at 25ºC................................................................297 
 
 14
 
List of Figures 
Figure 1-1 Schematic diagram of a general route of manufacturing process for a pharmaceutical 
product............................................................................................................................. 31 
Figure 1-2 Schematic diagram of the research objectives of this work, comprising the investigations 
of the kinetic and thermodynamic aspects of the dehydration process. .......................... 33 
Figure 2-1 Schematic depiction of various types of pharmaceutical solids. ..................................... 36 
Figure 2-2 An example of a three-dimensional lattice with lattice point (in dark blue circles) at each 
corner of a unit cell.......................................................................................................... 37 
Figure 2-3 Schematic diagram of a single unit cell with cell dimensions defined by vectors ( ar , b
r
, 
cr ) and angles (α, β, γ)..................................................................................................... 37 
Figure 2-4 Converting intercept coordinate to Miller index. ............................................................ 39 
Figure 2-5 The orientation and interplanar spacing of a crystal structure, defined by the Miller 
indices.............................................................................................................................. 40 
Figure 2-6 Relationship of thermodynamic potentials for the description of non-cyclic processes. 
Source: [34] ..................................................................................................................... 44 
Figure 2-7 Plot of Gibbs free energy G and enthalpy H at constant pressure against the absolute 
temperature T, with S as entropy. Source: [35]............................................................... 45 
Figure 2-8 Free energy vs temperature plots for polymorph pairs exhibiting (a) monotropy, (b) 
enantiotropy relation. Source: [35].................................................................................. 46 
Figure 2-9 Pressure vs temperature plots for polymorph pairs exhibiting (a) monotropy, (b) 
enantiotropy relation. Source: [8].................................................................................... 47 
Figure 2-10 Solubility curves for polymorph pairs exhibiting (a) monotropy, (b) enantiotropy and (c) 
enantiotropy with metastable phases. Source: [40] ......................................................... 48 
Figure 2-11 Schematic diagram of the reaction coordinate for crystallisation in a polymorphic system.
......................................................................................................................................... 49 
Figure 2-12 Donor/acceptor ratios (d/a) analysed for 411 hydrates. Source: [58].............................. 53 
Figure 2-13 Occurrence of crystalline hydrate stoichiometries, compiled from Cambridge Structures 
Database. Source: [59]..................................................................................................... 54 
Figure 2-14 Packing diagram from single-crystal data for cephradine dihydrate Source: [60] .......... 55 
Figure 2-15 Packing diagram from single-crystal data for ampicillin trihydrate Source: [60] ........... 56 
Figure 2-16 Hydrogen-bond network of carbamazepine dihydrate. Source: [70]............................... 58 
Figure 2-17 Packing diagram from single-crystal data for calcium calteridol tetradihydrate. Source: 
[60] .................................................................................................................................. 59 
Figure 2-18 Methods in which amorphous form is being induced in a pharmaceutical system. Source: 
[71-73] ............................................................................................................................. 60 
Figure 2-19 Schematic diagram of variation of enthalpy (or specific volume) with temperature for a 
solid substance in amorphous and crystalline states. Source: [71].................................. 61 
Figure 3-1 Water vapour adsorption and deliquescence of a water soluble solid particle. Source: [79]
......................................................................................................................................... 64 
Figure 3-2  Interaction (hydrogen bonding) between the water molecules. Source: [81] ................. 65 
Figure 3-3 Hydrophobic interaction between hydrophobic (nonpolar) molecules and water 
molecules......................................................................................................................... 66 
 15
Figure 3-4 State of water in crystalline solids................................................................................... 68 
Figure 3-5 Vapour adsorption mechanism in a function of surface coverage and surrounding 
humidity........................................................................................................................... 70 
Figure 3-6 Schematic diagram of adsorption mechanisms, based on the Brunauer, Deming, Deming 
and Teller (BDDT)’s isotherms....................................................................................... 73 
Figure 3-7 Classification of gas adsorption isotherms. Source: [98; 100] ........................................ 74 
Figure 3-8 Determination of hysteresis from gravimetric sorption experiment................................ 80 
Figure 3-9 Schematic diagrams of moisture sorption isotherms (a) without hysteresis; and with (b) 
closed loop; and (c) open loop hysteresis. ....................................................................... 81 
Figure 3-10 Dependence of adsorption hysteresis on pore length and interaction energy. Source: [100; 
118].................................................................................................................................. 82 
Figure 3-11 Moisture sorption behaviours for pharmaceutical solids................................................. 84 
Figure 3-12 Schematic interpretation of sorption and desorption mechanisms considered in Young-
Nelson model................................................................................................................... 85 
Figure 4-1: Stages of a typical pharmaceutical process and their effect on key parameters. Adapted 
from [126]........................................................................................................................ 88 
Figure 4-2 Decision tree for selection of batch dryer. Sources: [128; 130] ...................................... 90 
Figure 4-3 Schematic diagram of tray dryer ..................................................................................... 90 
Figure 4-4 Typical vacuum tray dryer for laboratory and small-scale pilot work. ........................... 91 
Figure 4-5 Types of agitated contact dryer commonly employed in the pharmaceutical industry. .. 92 
Figure 4-6 Schematic diagram of drying stages of solids, depicted in drying rate against (a) time, 
and (b) solvent content. ................................................................................................... 94 
Figure 4-7: Heat and mass transfer near a wet surface. Adapted from [141]..................................... 96 
Figure 4-8 Moisture movement in a porous material during drying process. Adapted from [93]. ... 97 
Figure 4-9 Water vapour transport based on (a) surface diffusion; (b) liquid diffusion; and (c) 
Knudsen diffusion mechanisms. Adapted from [146]..................................................... 99 
Figure 4-10 Relationship between diffusivity and moisture content of solid. Adapted from [93]...... 99 
Figure 4-11 Energy barrier to the movement of an adsorbed molecule across (a) a uniform surface; (b) 
a more complicated but still uniform surface; and (c) a heterogeneous surface. Adapted 
from [149]...................................................................................................................... 101 
Figure 4-12 Proposed moisture transfer mechanisms in a porous medium....................................... 104 
Figure 4-13 Objects at rest on an equal arm balance in a vacuum condition.................................... 109 
Figure 4-14 Variation in buoyancy effect with varying air density. Source: National Physical 
Laboratory [170]............................................................................................................ 110 
Figure 4-15 Schematic representation of interface structure for general dehydration reactions. Source: 
[175] .............................................................................................................................. 112 
Figure 4-16 Schematic diagram of formation of new polymorphs following different dehydration 
chemistry. Source: [16; 99] ........................................................................................... 114 
Figure 4-17 Properties and rate determining steps of dehydration. Adapted from [16].................... 115 
Figure 4-18 Smith-Topley effect: schematic diagram of variation in dehydration rate with prevailing 
water vapour pressure and the corresponding mechanism. Adapted from [176]. ......... 118 
Figure 4-19 Schematic representation of surface texture changes on crystals without active 
imperfection during low water vapour pressure condition. Adapted from [171; 185]. . 119 
Figure 4-20 Ball model of atomic configurations on a FCC (100) surface. Adapted from [189]. .... 121 
 16
Figure 4-21 Schematic representation of surface texture changes on crystals with active imperfections 
during vacuum dehydration process. Adapted from [171; 185]. ................................... 122 
Figure 4-22 Crystal structure of (a) theophylline monohydrate and (b) caffeine 4/5 hydrate. Adapted 
from [67]........................................................................................................................ 125 
Figure 4-23 Effect of hydration on the physical and pharmaceutical properties of a drug. Adapted 
from [193]...................................................................................................................... 127 
Figure 4-24 Reduced time plots for thermal decomposition reactions of solids, as (a) sigmoid rate; (b) 
acceleratory rate; (c) deceleratory rate; and (d) shorter induction period with defected 
surface. Source: [176; 197]............................................................................................ 130 
Figure 5-1 Synthesis routes of Carbamazepine............................................................................... 134 
Figure 5-2 Molecular arrangement of carbamazepine polymorphs (white, red, purple and grey sticks 
denote hydrogen, oxygen, nitrogen and carbon respectively). Source: [210; 211; 216; 
217]................................................................................................................................ 136 
Figure 5-3 Solubility of carbamazepine in methanol and ethanol solvent. Determined from [249].
....................................................................................................................................... 140 
Figure 5-4 Microscopy images of (a) commercial carbamazepine anhydrate, (b) and (c) as the re-
crystallised anhydrates (P-monoclinic) of different facets. ........................................... 142 
Figure 5-5 SEM micrographs of (a) mixture of trigonal and P-monoclinic crystals, and (b) trigonal 
crystal. ........................................................................................................................... 142 
Figure 5-6 Molecular structure of carbamazepine dihydrate (white, red, purple and grey sticks 
denote hydrogen, oxygen, nitrogen and carbon respectively). ...................................... 143 
Figure 5-7 Visualised channel of hydrate water, along the stacking of the carbamazepine molecules.
....................................................................................................................................... 143 
Figure 5-8 Transition points of carbamazepine anhydrate and dihydrate in ethanol-water mixture. 
Adapted from [257]. ...................................................................................................... 145 
Figure 5-9 Microscopy images of carbamazepine dihydrate crystals of (a) plate, and (b) needle 
habits. ............................................................................................................................ 148 
Figure 5-10 Microscopy images of carbamazepine dihydrate agglomerates of different sieve fractions: 
(a) 75-180μm, (b) 180-250μm, (c) 250-500μm, (d) 500-710μm, and (e) 710-1400μm. 149 
Figure 5-12 Molecular structure of carbamazepine mono-acetone solvate (white, red, purple and grey 
sticks denote hydrogen, oxygen, nitrogen and carbon respectively). ............................ 150 
Figure 5-13 Acetone vapour sorption and desorption isotherms on amorphous carbamazepine at 25ºC. 
Adapted from [268]. ...................................................................................................... 151 
Figure 5-14 Solubility curves of carbamazepine in acetone solvent. Adapted from [248]. .............. 152 
Figure 5-15 Microscopy images of carbamazepine mono-acetone solvate crystals. ........................ 152 
Figure 6-1 “Decision tree” for characterising pharmaceutical hydrates. Adapted from [193]........ 158 
Figure 6-2 Schematic diagram of DVS Advantage instrument (also applicable to DVS-1000). .... 160 
Figure 6-3 Schematic diagram of (a) DVS Vacuum instrument and (b) operating modes of the flow 
controller. ...................................................................................................................... 162 
Figure 6-5 TGA profile of carbamazepine dihydrate and solvate samples at heating rate of 10ºC/min; 
revealing the mass loss of bound water (a, c), bound solvent (b), and both bound and 
unbound water (d) ......................................................................................................... 164 
Figure 6-6 Schematic diagram of heat flux differential scanning calorimetry. Adapted from [273].
....................................................................................................................................... 165 
Figure 6-7 Differential scanning calorimetry scan of a drug substance (endothermic transitions 
downward). Adapted from [273]. .................................................................................. 166 
 17
Figure 6-8 DSC profile of carbamazepine anhydrate (P-monoclinic form) prepared in this work. 167 
Figure 6-9 DSC profiles of carbamazepine dihydrate in crystal form and agglomerated form, 
prepared in this work. .................................................................................................... 168 
Figure 6-10 DSC profiles of carbamazepine acetone solvate and the desolvated form. ................... 169 
Figure 6-11 Optical microscopy images showing the evolution of a carbamazepine P-monoclinic 
anhydrate crystal to the triclinic anhydrate upon heating, with transition temperatures 
between 160.5ºC and 162ºC. ......................................................................................... 170 
Figure 6-12 Optical microscopy images showing the evolution of a carbamazepine dihydrate crystal 
losing its water of crystallisation. .................................................................................. 171 
Figure 6-13 Categories for types of spectroscopy technique at different wavelength and frequency.
....................................................................................................................................... 172 
Figure 6-14 Vibrational modes (a) symmetric stretch; (b) asymmetric stretch; (c) bending, and 
librational modes (d) wag; (e) twist; (f) rock for water molecule. ................................ 172 
Figure 6-15 Experimental set-up of Raman spectroscopy coupled with DVS system...................... 174 
Figure 6-16 Molecular arrangements of (a) carbamazepine dihydrate and (b) acetone solvate........ 175 
Figure 6-17 Raman spectra for dehydration of carbamazepine dihydrate crystal from this work, at 0 
%RH, 200 sccm and 40ºC. ............................................................................................ 177 
Figure 6-18 Raman spectra for desolvation of carbamazepine acetone powder from this work, at 30 
%RH, 200 sccm and 30ºC. ............................................................................................ 178 
Figure 6-19 X-ray scattering from a crystal lattice, with case (b) having a higher wavelength (λ), 
longer spacing (dB) and larger scattering angle (2θB).................................................... 180 
Figure 6-20 Derivation of Bragg's Law ............................................................................................ 182 
Figure 6-21 Schematic diagram of an X-ray generator. .................................................................... 184 
Figure 6-22 X-ray spectra produced by three different accelerating voltages (8kV, 25kV and 50 kV) 
from a Cu anode. Source: [287]. ................................................................................... 185 
Figure 6-23 Schematic diagram of a diffractometer slit system in a Bragg Brentano theta-theta setup.
....................................................................................................................................... 186 
Figure 6-24 Schematic diagram explaining the differences between point, line and area detectors, 
used in powder diffractometry....................................................................................... 186 
Figure 6-25 Schematic diagram of data collection using Real Time Multiple Strip (RTMS) detector.
....................................................................................................................................... 187 
Figure 6-26 Calculated penetration depths of the Cu K-α beam on carbamazepine samples. .......... 189 
Figure 6-27 XRPD patterns of the dehydration of carbamazepine dihydrate into a mixture of 
polymorphic anhydrates. ............................................................................................... 190 
Figure 6-28 Penetration depth effect on unevenly distributed carbamazepine mixtures. ................. 190 
Figure 6-29 Crystal statistic effect (a) good statistics, reflecting true pattern of the sample, and (b) 
poor statistics, referring to false pattern. ....................................................................... 191 
Figure 6-30 Pore size detection limits of gas adsorption and mercury porosimetry. ........................ 192 
Figure 6-31 Schematic representation of pores. Adapted from [296]. .............................................. 193 
Figure 6-32 A pore with irregular shape (1) and the same pore determined from the mercury 
porosimetry (2). ............................................................................................................. 194 
Figure 6-33 Capillary action of a wetting and non-wetting liquid relative to the walls of capillary. 195 
Figure 6-34 Typical intrusion-extrusion curve of mercury porosimetry........................................... 196 
Figure 6-35 Cross section of a penetrometer with 50% of the stem capacity has been used. ........... 197 
Figure 6-36 Mercury intrusion mechanism of agglomerates from this work.................................... 199 
 18
Figure 7-1 Plot of mean particle size through a process for alternative process route. Adapted from 
[192]. ............................................................................................................................. 204 
Figure 7-2: Schematic diagram of the six basic crystal shapes. ....................................................... 207 
Figure 7-3 Development of a spiral growth starting from a single screw dislocation. Adapted from 
[18]. ............................................................................................................................... 208 
Figure 7-4: Growth mechanisms for a flat (F) face, as a function of supersaturation...................... 209 
Figure 7-5 Carbamazepine dihydrate crystal lattice (a) viewed down the c-axis and (b) viewed down 
the a-axis........................................................................................................................ 210 
Figure 7-6 Three major types of whisker growth mechanism: (a) thickened base (b) growth from 
hollows on surface and (c) along surface of mother crystal. ......................................... 210 
Figure 7-7 Preferred orientation effects on plate shape carbamazepine dihydrate from this work. 211 
Figure 7-8 XRPD patterns of (a) carbamazepine dihydrate crystals, and (b) carbamazepine dihydrate 
agglomerates prepared in this work............................................................................... 212 
Figure 7-9 SEM image of carbamazepine dihydrate agglomerate, showing a variation of size and 
number of crystallites. ................................................................................................... 212 
Figure 7-10 Twin plane (100) of carbamazepine dihydrate monoclinic system, with the mirror planes 
parallel to one another. .................................................................................................. 213 
Figure 7-11 Projection of the twinning plane (1 0 0) on the molecular packing of carbamazepine 
dihydrate. ....................................................................................................................... 213 
Figure 7-12 Effect of crystal habit variation on dehydration profile of carbamazepine dihydrate 
prepared in this work, at 20ºC and 0%RH..................................................................... 214 
Figure 7-13 Scanning electron microscopy images of carbamazepine dihydrate crystal (habit 1). .. 215 
Figure 7-14 Size change mechanisms in agglomeration processes................................................... 216 
Figure 7-15 Pictorial representation of the binding mechanisms of agglomeration. ........................ 218 
Figure 7-16 Dehydration profile of carbamazepine dihydrate agglomerates of different particle sizes 
at 0 %RH and 30ºC........................................................................................................ 219 
Figure 7-17 Pore size distribution obtained from Hg porosimetry for carbamazepine dihydrate 
agglomerates of different particle size distributions...................................................... 222 
Figure 7-18 Hysteresis between intrusion and extrusion pore volume of carbamazepine agglomerate 
of particle size above 1400μm....................................................................................... 223 
Figure 7-19 Hysteresis between intrusion and extrusion pore volume of carbamazepine agglomerate 
of particle size 180-250μm............................................................................................ 223 
Figure 7-20 Morphology of carbamazepine dihydrate agglomerates of different particle size: (a-b) 
>1400μm and (c-d) 75-180μm. ..................................................................................... 224 
Figure 7-21 Development of crystallising solvent inclusion by the interaction of growth layers. 
Adapted from [335]. ...................................................................................................... 226 
Figure 7-22 Proposed moisture-induced packing transition stages of agglomerated acicular 
carbamazepine dihydrate crystals in particle size 1400-~1800μm................................ 227 
Figure 7-23 Dehydration profile of carbamazepine dihydrate agglomerates (>1400μm) under 
different levels of humidity at 30ºC. Only the removal of unbound water was observed 
for drying conditions above 30 %RH, while removal of both unbound and bound water.
....................................................................................................................................... 229 
Figure 7-24 Critical absolute humidity values for agglomerated carbamazepine dihydrate with 
unbound water (>1400 μm) and without unbound water (< 710 μm). .......................... 230 
Figure 8-1 Effect of temperature variation on dehydration of carbamazepine dihydrate crystals. . 234 
Figure 8-2 Krischer curve for carbamazepine dihydrate crystals at different temperatures. .......... 235 
 19
Figure 8-3 Effect of particle size on dehydration profile of carbamazepine dihydrate agglomerates at 
0 %RH. .......................................................................................................................... 237 
Figure 8-4 Effect of particle size on drying and dehydration profiles of carbamazepine dihydrate 
agglomerates at 0 %RH. ................................................................................................ 238 
Figure 8-5 Krischer curve for carbamazepine dihydrate agglomerates of different particle sizes at 
30ºC. .............................................................................................................................. 239 
Figure 8-6 Effect of vacuum pressure and temperature variation on dehydration of carbamazepine 
dihydrate crystals........................................................................................................... 240 
Figure 8-7 Krischer curve of vacuum dehydration of carbamazepine dihydrate crystals. .............. 240 
Figure 8-8 Effect of vacuum pressure on dehydration of carbamazepine dihydrate agglomerates at 
30ºC. .............................................................................................................................. 241 
Figure 8-9 Krischer curve of vacuum dehydration of carbamazepine dihydrate agglomerates at 100 
Torr and 30ºC. ............................................................................................................... 242 
Figure 8-10  Effects of volumetric air flow rates on dehydration of carbamazepine dihydrate crystals 
at 30ºC. .......................................................................................................................... 243 
Figure 8-11 Effects of volumetric air flow rates on dehydration of carbamazepine dihydrate 
agglomerates (250-500 μm) at 30ºC.............................................................................. 244 
Figure 8-12 Determination of Reynolds number for mass transfer calculation and the representation 
of tangential convective drying in DVS Advantage. ..................................................... 245 
Figure 8-13 Calculated transport parameters of DVS system over a range of operating temperature 
(20ºC-60ºC). .................................................................................................................. 247 
Figure 8-14 Air velocity transition regimes for flow across the DVS sample pan. Adapted from [142].
....................................................................................................................................... 248 
Figure 8-15 Effect of flow regimes transition on dehydration rate of carbamazepine dihydrate...... 249 
Figure 8-16 Effect of water vapour pressures (%RH) on dehydration of carbamazepine dihydrate 
crystals at 40ºC. ............................................................................................................. 250 
Figure 8-17 Effect of water vapour pressures (%RH) on dehydration of carbamazepine dihydrate 
agglomerates (particle size 250-500 µm) at 40ºC. ........................................................ 251 
Figure 8-18 Dehydration rate constants of carbamazepine dihydrate under varying relative humidity.
....................................................................................................................................... 251 
Figure 8-19 Kinetic analysis for dehydration reaction...................................................................... 253 
Figure 9-1 Relation between stable, unstable and metastable states, represented by a rectangular 
block in a series of positions. Source: [348; 349].......................................................... 258 
Figure 9-2 Summary of the dehydration-induced phase transformation of carbamazepine dihydrate 
in this work.................................................................................................................... 261 
Figure 9-3 X-ray powder diffraction profiles of (a) carbamazepine dihydrate; (b) anhydrate trigonal; 
(c) triclinic; (d) C-monoclinic; and (e) P-monoclinic. .................................................. 262 
Figure 9-4 Crystal structure of carbamazepine dihydrate (space group of P21/c), observed along the 
c-axis. (Harris et al., 2005)............................................................................................ 263 
Figure 9-5 X-ray powder diffraction patterns of vacuum pressure dehydration of carbamazepine 
dihydrate crystals, conducted at 40ºC and 10-3 Torr...................................................... 264 
Figure 9-6 SEM images of (a) channel-like defects on plane (100) of carbamazepine dihydrate 
during dehydration and (b) formation of needle-like crystals after reduced pressure 
dehydration. ................................................................................................................... 265 
Figure 9-7 X-ray powder diffraction patterns of vacuum pressure dehydration of carbamazepine 
dihydrate agglomerates, conducted at 40ºC and 10-3 Torr............................................. 266 
 20
Figure 9-8 SEM images of carbamazepine dihydrate agglomerate (>1400 μm) (a) before 
dehydration and (b) after dehydration. .......................................................................... 266 
Figure 9-9 X-ray powder diffraction patterns of low pressure dehydration of carbamazepine 
dihydrate crystals, conducted at 20ºC and 10-3 Torr...................................................... 268 
Figure 9-10 Comparison of X-ray powder diffraction patterns between (a) carbamazepine C-
monoclinic (ICDD reference pattern [211]) and (b) dehydrated sample after 12 days of 
vacuum drying. .............................................................................................................. 269 
Figure 9-11 X-ray powder diffraction patterns of low pressure dehydration of carbamazepine 
dihydrate crystals, conducted at 40ºC and 100 Torr with air flow 50 sccm. ................. 270 
Figure 9-12 X-ray powder diffraction patterns of low pressure dehydration of carbamazepine 
dihydrate crystals at 40ºC and (a) 10-3 Torr; (b) 100 Torr at 200 sccm; (c) 100 Torr at 50 
sccm............................................................................................................................... 270 
Figure 9-13 X-ray powder diffraction patterns of atmospheric dehydration of carbamazepine 
dihydrate crystals, conducted at 40ºC and 40 %RH. ..................................................... 272 
Figure 9-14 X-ray powder diffraction patterns of atmospheric dehydration of carbamazepine 
dihydrate agglomerates, conducted at 40ºC and 40 %RH. ............................................ 273 
Figure 9-15 X-ray powder diffraction patterns of organic solvent vapour-mediated dehydration of 
carbamazepine dihydrate crystals, conducted at 20ºC and 90% P/P0 MeOH................ 274 
Figure 9-16 Phase transformation from carbamazepine dihydrate to the polymorphic anhydrate forms.
....................................................................................................................................... 275 
Figure 9-17 Processing-induced nucleation on surface defects of plane (100) of carbamazepine 
dihydrate crystals........................................................................................................... 278 
Figure 9-18 Solvent vapour uptake at 90 %P/P0 ethanol partial pressure. ........................................ 279 
Figure 10-1 Dehydration profile of carbamazepine dihydrate crystals under acetone partial pressures 
(10 %-50 %P/P0) at 30ºC............................................................................................... 285 
Figure 10-2 Dehydration profile of carbamazepine dihydrate crystals under elevated acetone partial 
pressures at 30ºC. .......................................................................................................... 286 
Figure 10-3 Dehydration of carbamazepine dihydrate crystals under ethyl acetate partial pressures at 
30ºC. .............................................................................................................................. 287 
Figure 10-4 Dehydration of carbamazepine dihydrate crystals under ethanol partial pressures at 30ºC.
....................................................................................................................................... 288 
Figure 10-5 Dehydration of carbamazepine dihydrate crystals under methanol partial pressures at 
30ºC. .............................................................................................................................. 289 
Figure 10-6 Acetone vapour-mediated dehydration of carbamazepine dihydrate crystals at 30ºC, with 
X-ray diffraction profiles at (a) 80 %P/P0 and (b) 60 %P/P0......................................... 291 
Figure 10-7 X-ray powder diffraction patterns of carbamazepine (a) trigonal form; (b) acetone 
solvate; (c) after 5 hours at 80 %P/P0 (denoted as ‘4’ in Figure 10-8). ......................... 292 
Figure 10-8 Ethyl acetate vapour-mediated dehydration of carbamazepine dihydrate crystals at 30ºC, 
with X-ray diffraction profile at 80 %P/P0. ................................................................... 293 
Figure 10-9 Ethanol vapour-mediated dehydration of carbamazepine dihydrate crystals at 30ºC, with 
X-ray diffraction profile at 80 %P/P0. ........................................................................... 294 
Figure 10-10 Methanol vapour-mediated dehydration of carbamazepine dihydrate crystals at 30ºC, 
with X-ray diffraction profile at 80 %P/P0. ................................................................... 295 
Figure 10-11 Schematic representating of the carbamazepine supersaturation-time profile and solid 
phase composition in hydrogen-bond accepting (HBA) solvent. Adapted from [394]. 298 
Figure 10-12 XRPD profile of carbamazepine anhydrate obtained at the end of dehydration under 
varying ethyl acetate partial pressures at 30ºC. ............................................................. 299 
 21
Figure 10-13 Desolvation of carbamazepine acetone solvate crystals under different relative 
humidities. ..................................................................................................................... 302 
Figure 10-14 Kinetic analysis for desolvation reaction....................................................................... 304 
Figure 10-15 Activation energy of desolvation for carbamazepine acetone solvate crystals at different 
relative humidities. ........................................................................................................ 305 
Figure 10-16 Water vapour-mediated phase transformation of carbamazepine acetone solvate at 20 
%RH and 30ºC. ............................................................................................................. 306 
Figure 11-1 Polymorphic interconversion observed in this work. .................................................... 313 
Figure 11-2 Optical profilometry images of carbamazepine crystal surfaces (a) before dehydration, 
and (b) after vacuum dehydration at 40ºC..................................................................... 315 
 
 22
Nomenclature  
 
a Activity 
a Volumetric air content 
aw Water activity 
ar , b
r
, cr  Vectors referring to the three axes of a unit cell 
A Helmholtz free energy 
A Pre-exponential factor 
A Surface area 
b Constant in Langmuir equation 
BC Buoyancy correction 
c Concentration 
C Curvature of meniscus 
C Heat capacity 
CB BET constant 
CG GAB constant 
Cp Heat capacity (constant pressure) 
Cs Solubility of solid 
d Diameter 
d Thickness of material 
dM Molecular diameter 
d-spacing Spacing between planes in atomic lattice 
D Molecular diffusivity 
DAB Binary diffusion coefficient 
Deff Diffusion coefficient 
Dk Knudsen diffusivity 
Dl Liquid diffusivity in solid 
Dv Vapour diffusivity 
Ea Energy of activation 
FDiffusional Diffusional force 
FBinding Binding force 
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g gravity vector 
G Gibbs free energy 
Gº Gibbs free energy for a fluid phase system at datum 
ΔG Gibbs free energy change 
h Planck’s constant 
h Heat transfer coefficient 
(hkl) Miller indices 
H Absolute humidity 
H Enthalpy 
ΔH Enthalpy change 
H1 Heat of adsorption of the first solute molecule adsorbed 
HL Heat of condensation of the bulk solute 
Hm Heat of adsorption of vapour adsorbed in the intermediate layer 
Hº Enthalpy for a fluid phase system at datum 
ΔHfusion Enthalpy change of fusion 
J Intrinsic dissolution rate 
Jv Vapour flux 
k Boltzmann constant 
k Drying rate constant 
k Thermal conductivity 
Ky Mass transfer coefficient 
l length 
L Characteristic length 
m Hancock-Sharp constant 
m Solute content 
mm Monolayer capacity 
m&  Mass flow rate 
evm&  Rate of evaporation inside a solid 
stdm&  Standard molar flow rate 
Ms Moisture content in sorption process (dry basis) 
Md Moisture content in desorption process (dry basis) 
MW Molecular weight 
MWa Molecular weight of water 
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n Number of molecules 
N Rate of effusion 
Na Mass flux of water vapour 
NA Avogadro’s constant 
Nu Nusselt number 
p Partial pressure 
ps Vapour pressure at dry bulb temperature 
P Pressure 
ΔP Applied pressure 
Pr Prandtl number 
P0 , p Vapour pressure of adsorbate 
r Radius 
R Universal gas constant 
R2 Coefficient of determination 
Re Reynolds number 
RH Relative humidity 
RHC Critical relative humidity 
S Entropy 
Sº Entropy for a fluid phase system at datum 
ΔS Entropy change 
Sc Schmidt number 
Sh Sherwood number 
ΔSfusion Entropy change of fusion 
t Time 
T Temperature 
Tg Glass transition temperature 
TK Kauzmann temperature 
Tm Melting temperature 
Tw Wet bulb temperature 
u Velocity 
U Internal energy 
v Mass average velocity 
v&  Volumetric flow rate 
stdv&  Standard volumetric flow rate 
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V Volume 
Vb Volume of absorbed water 
Vc Calculated volume of a unit cell 
Vd Volume of adsorbed water 
VL Molar volume of liquid 
Vm Amount of monolayer adsorbate 
evq&  Rate of latent heat 
q1 Heat of adsorption 
qL Heat of condensation 
Wm Mass of dry material 
W Conventional mass 
x Spatial dimension 
x0 Incremental forward distance for unit reaction 
X Moisture content in the bulk 
X0 Initial moisture content in solid 
XA Moisture content of solid (dry basis) 
Xw Moisture content on the surface 
Z Molecules per unit cell 
α Fractional dehydration/desolvation 
α, β, γ Angles between the axes of a unit cell 
β Total moisture adsorbed in a multi-layer 
Δ Surface area of separation 
Δ0 Initial surface area (radiation in vacuum) 
δ Reaction rate 
εa Molecular interaction energy 
ε Porosity 
η Viscosity 
Γ Flux of molecule 
γ Surface tension of liquid 
λ Heat of reaction 
λ Wavelength 
λw Latent heat of vapourisation 
μ Dynamic fluid viscosity 
μ Chemical potential 
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ν Frequency 
ν Kinematic fluid viscosity 
ν~  Wavenumber 
φ  Molecular thickness 
Φ Source or sink of electromagnetic energy 
ρ Density 
ρl Density of liquid 
ρv Density of vapour 
ρw Density of water vapour 
τ Tortuosity 
θ Angle between incident ray and scattering plane 
θ Contact angle 
θ Surface coverage 
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Abbreviation 
 
AED Antiepileptic drug 
AFM Atomic force microscopy 
API Active pharmaceutical ingredient 
ASTM American Society for Testing and Materials 
CBZ Carbamazepine 
CCD Charge coupled device 
CNS Central nervous system 
CNT Classical nucleation theory 
CSD Cambridge Structural Database 
DRIFT Diffuse reflectance infrared fourier transform 
DMA N,N-dimethyl acetamide 
DMF N,N-dimethyl formamide 
DMSO Dimethyl sulfoxide 
DPP Deliquescence partial pressure 
DSC Differential scanning calorimetry 
DVS Dynamic Vapour Sorption 
FDA Food and Drug Administration 
FT-IR Fourier transform infrared 
GI Gastrointestinal 
HBA Hydrogen bond acceptor 
HBD Hydrogen bond donor 
HSM Hot stage microscopy 
ICDD International Centre for Diffraction Data 
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IR Infrared 
IUCr International Union of Crystallography 
IUPAC International Union of Pure and Applied Chemistry 
IPD Image plate device 
KF Karl Fischer 
LSER Linear solvation energy relationship 
MAC Mass absorption calculator 
NIR Near infrared 
OP Optical profilometry 
PSD Position sensitive device 
QCM Quartz crystal microbalance 
RTMS Real time multiple strip 
SEM Scanning electron microscopy 
SSCI Solid State Chemical Information 
ssNMR Solid state nuclear magnetic resonance 
TGA Thermogravimetric analysis 
TPS Terahertz pulsed spectroscopy 
XRPD X-ray powder diffraction 
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CHAPTER 1 INTRODUCTION 
 
1.1 Background 
 
“And so it begins…” 
Kosh, Babylon 5. 
 
 
 Most drug products are marketed as solid dosage forms (i.e. tablets, capsules, dry 
powder inhalers and dusting powders [1]), due to the ease of bulk production, handling, 
transportation and packaging as well as the actual ease of administration of the drug products. 
Since solid state drug substances can exist in many crystalline forms (i.e. polymorphs and 
pseudopolymorphs), the solid state form selected depends upon a wide range of factors 
including the particular delivery system to be employed. The selection process is usually a 
compromise between physical, chemical, pharmaceutical and biopharmaceutical properties and 
performance. Traditionally, the most thermodynamically stable crystal form is favoured over 
other forms because of its lower tendency to undergo solid phase transformations. Metastable 
crystalline forms or amorphous forms are sometimes deliberately chosen for better solubility 
and hence bioavailability [2].  
 
 In the formulation development and manufacturing stages, drug substances are 
produced by consecutive batch processes, and these bulk solids are often exposed to variable 
environmental conditions (e.g. temperature, pressure, humidity, solvent vapour). During 
production as well as other purification and separation processes, water or solvent molecules 
might become incorporated into the crystal lattices, leading to the formation of hydrates or 
solvates especially during the crystallisation of the active pharmaceutical ingredient (API). The 
formation of hydrates and solvates is a widespread phenomenon in the pharmaceutical industry. 
It has been shown that about 33% of organic compounds crystallise as hydrates and about 10% 
as solvates [3]. 
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 It is not an uncommon practise for a hydrated solid state crystal form to be intentionally 
chosen for development to avoid unplanned hydrate formation during the downstream 
processing operations [4]. Due to the small molecular size and its multidirectional hydrogen 
bonding capability, water molecules are the highest solvate-forming solvent [5]. The crystal 
structure of a hydrate is able to stabilise the lattice via intermolecular hydrogen bonding, 
resulting in the hydrate being the stable form even in aqueous surroundings (below dehydration 
temperature). Therefore, not surprisingly, 50% of those hydrate-forming APIs are used in a 
crystalline hydrate form [6]. Nonetheless, the reasons of why some compounds form hydrates 
whilst others apparently do not is a fundamentally important industrial question yet to be 
solved.  
 
 The production of a hydrated solid state dosage form carries with it one critical 
technical risk. That is the risk of dehydration at some stage during the production cycle, where 
the hydrate looses its water of crystallisation. Some hydrated drug substances have the 
tendency to dehydrate even when exposed to certain ambient conditions for only a short time 
period. The formation of hydrates and their potential to transform into other solid state forms 
such as a crystalline form with a lower hydration states, polymorphic anhydrate, an inherently 
unstable amorphous form or a mixture of these phases [7], can dramatically affect a whole 
range of pharmaceutically important physicochemical properties and their processing 
behaviours. These undesirable phase transformations may consequently hinder the rational 
prediction and significantly impair the performances of the final dosage form, e.g. product 
quality, stability and also its therapeutic effects [8-11]. 
 
 With so many possible crystalline forms that can appear during the making of the drug 
product, the identification and control of different crystal polymorphs is still a growing area of 
science and business [12]. It is essential to determine possible phase changes during 
pharmaceutical formulation development, and take precautions to control them, in part due to 
legal and commercial implications [13]. 
 
 Drying is one of the key industrial operations in many sectors, such as food/agriculture, 
chemicals, textile, paper, timber and pharmaceuticals. The energy consumption for drying in 
the UK industry amounts to about 12% of the total energy used in the manufacturing processes, 
however higher percentages (up to 25%) of energy usage are reported in other European 
countries and the USA [14]. The drying process is also an important practical facet to both 
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primary and secondary pharmaceutical manufacture, as shown in Figure 1-1. In the 
pharmaceutical industry, drying of particulate solids aims at producing consistent, stable, free-
flowing materials suitable for subsequent formulation, packaging, storage and transport. The 
choice of drying method will be associated mainly with the economics of drying and the 
intended route of final product administration (e.g. spray-dried powders for administration via 
inhalation).  
 
 
Figure 1-1 Schematic diagram of a general route of manufacturing process for a pharmaceutical 
product. 
 
 As with most operations, drying is best viewed as part of an integrated process which 
includes particle formation (e.g. crystallisation, wet granulation) and the isolation steps, such 
as filtration and washing. Therefore, any changes in these operations can affect the 
crystal/particle size distribution, crystal properties and moisture content, and most importantly 
this will pose a significant impact on the drying efficiency. It is crucial to render the residual 
moisture level in the final product below the permitted limit from the regulatory authority and 
low enough to prevent subsequent product deterioration which would affect the processing 
ability and performance.    
 
 Yet, the drying of pharmaceutical hydrates is not as simple as just removing all the 
water or solvent. The relationship between percent moisture or solvent content and product 
performance is not straightforward as one might presume. Moreover, there is a huge variation 
of critical moisture content that have to achieve in a drying process (typically 5 %w/w for 500 
μm inorganics and 80 %w/w or more for 30 μm API)1. Apart from the frequently occurring 
problems such as caking, agglomeration and decrease in purity due to solvent inclusion, a 
                                                 
1 Personal communication with Dr. Alan Collier, Chemical Development Strategic Technologies group, 
GlaxoSmithKline R&D, Tonbridge, UK (2 April 2008). Now at Prosonix Ltd., Oxford, UK. 
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failure in the pharmaceutical drying process can often lead to the questioning of the drug 
product quality including concerns such as polymorphism.  
 
 A knowledge of drying kinetics and the influence of the drying process parameters are 
required for dryer design and process control. Likewise, dependencies between material 
temperature and drying time, and moisture content of the material give very important 
information for conducting of the drying of thermolabile materials [15] and are key to the 
eventual development of the drying models/theories. Much of the earlier work reported on 
drying has dealt with macroscopic phenomena, hence our understanding of drying at the 
microscopic level is still rudimentary, and unfortunately product quality often depends on the 
microlevel transport of moisture. Furthermore, current approaches to classify the drying 
behaviours of solids provide only a limited view to the intermediate hydrate formation in 
pharmaceutical solids [16]. In addition, the amount of water (ad)sorbed and removed need to 
be taken into consideration along with the kinetics and operating conditions of the process. As 
a result, any advanced analytical tools and/or methodologies which allow differentiation 
between the states of water/solvent (within the lattice, in the bulk or onto the surface) may be 
instrumental in the unambiguous characterisation of hydrates and polymorphs, and their 
resultant drying performance. 
 
 As the dehydration-induced polymorphism is still an unfolding research topic, this 
thesis seeks to understand the dehydration behaviour of a channel-type hydrate, from both the 
thermodynamic and kinetic perspectives. The work presented here aims to gain a quantitative 
insight into both the external and internal influences (i.e. drying condition and 
crystal/molecular properties) on the dehydration phenomena investigated. For example, by 
understanding variations in thermal history or stresses imposed on a hydrate due to a drying 
method, we can tailor the product property for optimal drug dosage regimen design. 
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1.2 Aims and Objectives 
 
 This project aims to investigate the role of hydrate water on important solid state 
properties and instabilities of solid state drugs, with particular interest on a model channel 
hydrate. In order to understand the underlying principles of the dehydration process and to 
predict the processing behaviour of hydrate, thermodynamic stability and dehydration kinetics 
(Figure 1-2) are of critical importance. 
 
 
Note: DS refers to design space, while OS denotes operating space of drying process. 
Figure 1-2 Schematic diagram of the research objectives of this work, comprising the 
investigations of the kinetic and thermodynamic aspects of the dehydration process. 
 
Technical objectives of the project are: 
 
a) To quantitatively explore the causal relationship between drying operating variables 
(temperature, reduced pressure, % relative humidity and % partial pressure of organic 
solvent vapour), crystal properties (i.e. habit, size and packing structure) and the 
dehydration behaviours of a channel type hydrate. 
b) To perform kinetic analysis on the dehydration of the model compound under the 
influence of key operating variables (temperature, reduced pressure and % relative 
humidity).  
c) To differentiate the state of bound water (hydrate water) and unbound water (physically 
adsorbed water) within the model hydrate, using gravimetric and other experimental 
methods. 
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d) To elucidate the solid state polymorphic transformation mechanisms, and their 
associated key drying operating variables and sample preparation methods. 
e) To clarify the role of the surrounding vapour environment on the nature of the solid 
state phase transformation. 
 
 This project hopes to develop a methodological strategy for mapping out the hydrate 
stability envelope and design space, within the selected key operating parameters. Following 
that, mechanistic interpretations of the physical and chemical transformation associated to 
drying and dehydration behaviours for other types of hydrates can be predicted. 
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CHAPTER 2 PROPERTIES OF PHARMACEUTICAL SOLIDS 
 
2.1 Introduction 
 
Nothing is, everything is becoming. 
Heraclitus (c.535 BC - 475 BC)2 
 
 Pharmaceutical solids primarily exist as crystalline, amorphous or a mixture of both 
materials, typically generated from crystal defects during the processing of pharmaceutical 
solids (e.g. milling, spray drying, tablet compaction, wet granulation and lyophilisation) [17]. 
 
 Amorphous or glassy solid state materials exhibit only short ranged molecular order 
apart from the randomness in molecular conformation. Generally prepared by rapid solution or 
melt cooling, the molecules are unable to pack into a more thermodynamically favourable 
crystalline state, leading to the inherent chemical and physical instabilities of the amorphous 
state. Nonetheless at such higher free energy state materials, amorphous materials could 
provide important benefits such as improved solubility and compressibility. Conversely, the 
more stable crystalline solids are structured with long-range order, which imparts a unique 
symmetry to the crystal. This symmetry feature also dictates the directional dependence of the 
crystal’s physical properties and thermodynamic properties.  
 
 Besides single-component polymorphic forms, APIs can also be created as salts and 
other multi-component crystalline phases (Figure 2-1). For example, solvates and hydrates may 
contain an active pharmaceutical ingredient as the host and either solvent or water molecules, 
respectively, as guests. Analogously, when the guest compound is a solid at room temperature, 
the resulting form is often called a cocrystal. Salts, solvates, hydrates, and cocrystals may all 
exhibit polymorphism as well. 
                                                 
2 Nothing in this world is permanent, but everything is constantly becoming something else or going out of 
existence. In from Diogenes Laertius, Lives of Eminent Philosopher. 
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Figure 2-1 Schematic depiction of various types of pharmaceutical solids. 
 
 
2.2 Crystallography 
 
 Crystals, from the Greek word Krystallos or Kryos – meaning ice cold are defined by 
arrangement of atoms, ions or molecules in a periodic and three-dimensional array, known as a 
lattice (Figure 2-2). Each volume or unit cell that makes up the lattice is surrounded by 
identical objects, leading to the characteristic shape of the crystal. The volume of the unit cell 
is hence defined by an elementary vector analysis (Equation 2-1), consisting of three vectors 
( ar , b
r
, cr ). The angles of the three axes are named according to the opposite vectors, i.e. 
vector ar  for angle α, b
r
for β, and cr for γ (Figure 2-3). 
 
cbaVc
rrr ××=          Equation 2-1 
 
 Based on different values of the vectors and angles, seven different types of unit cells 
can be obtained. Subsequently, fourteen point lattices are possible by placing the lattice points 
at specific locations (or corners) of a unit cell, referring to as the Bravais lattices. 
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Unit cell
 
Figure 2-2 An example of a three-dimensional lattice with lattice point (in dark blue circles) at 
each corner of a unit cell.  
 
 
Figure 2-3 Schematic diagram of a single unit cell with cell dimensions defined by vectors ( ar , b
r
, 
cr ) and angles (α, β, γ).  
 
 
2.2.1 Classification for Crystal System 
 
 The Bravais lattices are the most widely accepted classification system for organic 
crystalline materials. It was first developed by Moritz Ludwig Frankenheim in 1842, and 
subsequently in 1848, Frenchman Auguste Bravais rectified it to the current fourteen crystal 
lattices [18]. 
 
 Table 2-1 summarises the fourteen Bravais lattices, associated from the seven unique 
crystal axial systems and four lattices centrings (primitive, body, face and base). The primitive 
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unit cell is most commonly found, containing precisely one lattice point which translates 
through all the vectors, R (in directions of a, b, c) without overlapping or leaving voids.  
 
Table 2-1: Bravais crystal system for crystalline materials 
Triclinic 
 
 
 
α ≠ β ≠ γ ≠ 90º  
a ≠ b ≠ c 
 
Monoclinic 
 
 
 
(P-) 
α, γ = 90º ≠ β 
a ≠ b ≠ c 
 
 
(C-) 
α, γ = 90º ≠ β 
a ≠ b ≠ c 
 
Orthorhombic 
 
(P-) 
α, β, γ = 90º  
a ≠ b ≠ c 
 
 
(C-) 
α, β, γ = 90º  
a ≠ b ≠ c 
 
 
(I-) 
α, β, γ = 90º  
a ≠ b ≠ c 
 
 
(F-) 
α, β, γ = 90º  
a ≠ b ≠ c 
 
Trigonal / 
Rhombohedral 
 
 
 
i. α, β = 90º, γ = 120º (Most cases) 
a = b ≠ c 
ii. α = β = γ ≠ 90º 
a = b = c 
Cubic 
 
(P-) 
α, β, γ = 90º  
a = b = c 
 
(I-) 
α, β, γ = 90º  
a = b = c 
 
(F-) 
α, β, γ = 90º  
a = b = c 
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Hexagonal 
 
 
c axis perpendicular to a, b & u (inclined at 60º)  
α, β = 90º, γ = 120º 
a = b = u ≠ c 
Tetragonal 
 
 
 
(P-) 
α, β, γ = 90º  
a = b ≠ c 
 
 
 
(I-) 
α, β, γ = 90º  
a = b ≠ c 
 
P: Primitive centred;   I: Body centred;   F: Face centred;    C: Base centred 
Source: [18] 
 
 
2.2.2 Miller Indices 
 
 Miller indices, introduced in 1839 by the British mineralogist William Hallowes Miller 
[19], are a notation system in crystallography for planes and directions in Bravais lattices. It is 
a method of describing the orientation (lattice distance) of a plane in relation to the unit cell, 
where intercept distance of these planes are defined by the three integers nh, nk, nl where n is a 
positive or negative [20]. A zero indicates that the planes are parallel to the corresponding axis. 
For example in Figure 2-4, the (112) plane is parallel to a-axis and b-axis, but cuts the c-axis in 
half. 
 
 
Figure 2-4 Converting intercept coordinate to Miller index. 
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Figure 2-5 The orientation and interplanar spacing of a crystal structure, defined by the Miller 
indices. 
 
 In addition to the internal properties of homogeneity and anisotropy a crystalline 
substance also exits in one or more macroscopic crystal shape: the crystal habit. The final 
crystal habit (or shape) is determined by the relative growth rate of each facet during the 
crystallisation. This topic including the effect of crystal habit on drying processes will be 
discussed in Chapter 8. 
 
 
2.3 Crystalline Solids in the Pharmaceutical Industry 
 
 The solid forms of a given API can have significantly different physicochemical 
properties, as summarised in Table 2-2. According to European Pharmacopoeia, 57% of all 
drug substances exist in more than one solid form; polymorphs, hydrates and/or solvates. The 
occurrence of hydrates is relatively high due to the fact that drugs commonly have hydrophilic 
properties. The solvent-forming propensities of organic compounds from Cambridge Structural 
Database (CSD) entries were analysed in year 2000. It was concluded that water is the highest 
solvate-forming solvent, having >11,000 hits, followed by methanol, benzene, 
dichloromethane, ethanol and acetone. From another analysis by SSCI (Solid State Chemical 
Information), a division of Aptuit Inc., polymorphism screens of 245 API compounds revealed 
that about 90% of them exhibited multiple solid forms. In general, half the compounds were 
polymorphic, often having one to three forms. About one-third of the compounds formed 
hydrates, and also one-third of them were capable of forming solvates [21]. 
 41
 
Table 2-2: Solid state properties 
Packing or related properties Molar volume, density, refractive index, conductivity, electrical, 
thermal, hygroscopicity. 
Thermodynamic properties Melting point, sublimation point, internal energy (i.e. structural energy), 
enthalpy (i.e. heat content), entropy, heat capacity, free energy and 
chemical potential, solubility, vapour pressure. 
Spectroscopic properties Electronic transitions (UV–visible spectra) 
Vibrational transitions (IR and Raman spectra) 
Rotational transitions (Far-IR or microwave spectra) 
Nuclear spin transitions (Nuclear resonance spectra). 
Kinetic properties Dissolution rate, rates of solid state reactions, stability. 
Surface properties Surface free energy, interfacial tensions, crystal habit, adhesion on 
other surfaces. 
Mechanical properties Hardness, cleavage, tensile strength, compactibility, tableting, 
handling, flow of bulk solids, wear. 
Source: [22; 23] 
 
 
2.4 Polymorphs 
 
"Take two aspirin and call me in the morning."  
As paraphrased from the medical adage. 
 
 To most people, this adage means simply taking two tablets of aspirin. From 1899 until 
2005, the entire aspirin industry was built on a single crystalline form of this API, form I. 
However, a second polymorph (form II) was reported by a team of researchers of University of 
South Florida later in that year [24]. Even though the discovery of form II aspirin was not 
expected to have any practical implications, it underscored the importance of identifying, 
making and controlling the polymorphic crystal forms of pharmaceuticals. 
 
 Polymorphism originates from the Greek words; ‘poly’ = many and ‘morph’ = form. 
First discovered in 1821 by the German chemist Eilhard Mitscherlich [25], this is a term used 
 42
in many disciplines, specifying the diversity of nature. Polymorphs exist in more than one 
crystalline form with the same covalent chemical structure, but different internal structure-
molecular packing [26], as exemplified by the ability of carbon to form as diamond, graphite 
and C60. Polymorphism is a widespread phenomenon in dyes, pigments, high energy materials 
(i.e. explosives), agrichemicals and solid state drugs. The solid state structural differences as 
well as changes in their lattice energies and entropies lead to different physicochemical 
properties for the different polymorphs. In industrial terms, these differences have financial 
and considerable practical importance; influencing product quality, patentability, 
manufacturing and processing properties, compressibility, shelf life, solubility, etc. [21; 27].  
 
 In the pharmaceutical industry, approximately 80% of marketed drugs exhibit 
polymorphism under experimentally accessible conditions [28]. Moreover, recent experiments 
have shown that even a seeded polymorph may not appear exclusively in the final 
crystallisation product [29]. With the advent of combinatorial chemistry, drugs are more likely 
to be larger in molecular weight and contain more functional groups, allowing them to 
crystallise in many more polymorphic forms, mainly through different ways of arranging 
hydrogen bonds between the neighbouring molecules in crystal lattices. Most importantly, 
these structural changes result in variations in solubility, dissolution profile in the 
gastrointestinal (GI) tract, and therapeutic drug bioavailability3. Subsequently, the knowledge 
of the parameters which influence the formation of the desired polymorphs is also a question of 
increasing industrial importance [30].  
 
 Under a defined set of conditions (e.g. temperature, pressure and composition) except 
at the transition points, only one polymorph has the lowest free energy. This solid phase is 
thermodynamically the most stable available and all other polymorphs appearing under similar 
conditions will be the metastable phases [31]. These differences however disappear in the 
liquid and vapour phases. The most stable polymorph is the obvious API of choice for a 
pharmaceutical company to take into further development, however a metastable form may 
have higher solubility, hence better dissolution properties which subsequently improves the 
bioavailability. Once the desired polymorph has been identified, the next step is to learn how to 
obtain it reliably and how to inhibit the formation of the less desired forms during the 
crystallisation, manufacturing stages, storage and even on the shelf. 
                                                 
3 Bioavailability: The rate and extent of the physiological absorption of an active drug substance are decisive 
factors in its overall efficacy. 
 43
 
 Even though polymorphism is a major challenge for the pharmaceutical industry, it 
does have its positive side, as these various polymorphs are patentable. Drug companies 
typically would file patents on all the different forms of an API during development. Thus, 
when initial patents on the compound itself expire, they can conceivably extend a product's life 
by moving to another form – a process famously known as ‘ever-greening’ or life cycle 
extension. Nonetheless, in recent years, due to stricter regulatory legislation, the extension of 
patent protection using other polymorphs is not as easy as it used to be, unless the newer 
crystal form is proven to have substantial increase in therapeutic values, compared to the 
existing drug product. 
 
 In turn, generic drug makers will target unprotected forms to avoid patent infringement. 
Nevertheless, the issue of ownership, identification and characterisation of pharmaceutical 
polymorphs has led to several high-profile lawsuits. For examples: Glaxo (now 
GlaxoSmithKline)'s anti-ulcer drug Zantac® and anti-depressant drug Paxil® and Bristol-Myers 
(now Bristol-Myers Squibb)'s Duricef® [21; 25].  
 
 
2.4.1 Thermodynamic Basis of Polymorphism 
 
 From a thermodynamic standpoint, the key questions regarding a polymorphic system 
are the relative mutual stability of those modifications and the changes in their thermodynamic 
relationships accompanying phase transformations occurred under different domains of 
conditions (i.e. temperature, pressure etc.) [8]. The relative stability of polymorphs is closely 
linked to their free energy; the more stable polymorph having the lower free energy at a 
specific temperature and vice versa [28; 32]. Because of this energy relationship, those less 
stable forms will be energetically driven to transform into the most stable form, although 
kinetics factors may hinder the rate of this transformation. Faced with so much variety, 
pharmaceutical companies choose their solid state dosage forms carefully, and always prefer to 
develop the most thermodynamically stable form as the final drug product [21]. However, the 
selection process is not as straightforward as that, as the pharmaceutical industry sometimes 
struggles to understand or even to predict the complex thermodynamic relationship among the 
various polymorph forms indentified to exist [33].  
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 The mnemonic diagram of the four thermodynamic potentials4  [34] is depicted in 
Figure 2-6. As the volume and pressure changes with energy (displacement/expansion work) 
are negligible in solids, the free energy of a solid phase therefore may be represented by either 
the Helmholz or Gibbs relationship using the entropy term. Both free energies here are 
referring to the maximum amount of work obtainable from a thermodynamic process.  
 
 At absolute zero condition, the entropy term, TS (denoting temperature and entropy) 
disappears and the Helmholtz free energy A and Gibbs free energy G should equal to the 
internal energy U and enthalpy H respectively. Therefore, the most stable modification at 
absolute temperature have the lowest internal or enthalpy energy.  Plots of Gibbs free energy, 
as illustrated in Figure 2-7, are more commonly employed than those with Helmholtz free 
energy, as the data required to produce the former type is experimentally more accessible. 
Gibbs free energy is essentially more widely used for the characterisation of polymorphic 
systems and the phase relationships among many different modifications. 
 
 
* Pressure P, volume V, temperature T and entropy S. 
Figure 2-6 Relationship of thermodynamic potentials for the description of non-cyclic processes. 
Source: [34] 
 
 Based on the relation of Gibbs free energy in Figure 2-7, once above absolute zero, the 
entropy term dictates the free energy state of a system and it differs for various polymorphs.  
 
                                                 
4 Thermodynamic potential/property: quantifiable macroscopic characteristics of a system, whose values define 
the thermodynamic state of the system. 
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Figure 2-7 Plot of Gibbs free energy G and enthalpy H at constant pressure against the absolute 
temperature T, with S as entropy. Source: [35] 
 
Gibbs free energy equation for polymorph i (i.e. polymorph A): 
iii TSHG −=          Equation 2-2 
 
For a fluid phase system (e.g. pure hypothetical supercooled liquid or gas or vapour phase), an 
arbitrary datum is taken as the standard state of a solid and independent of crystalline form: 
000 TSHG −=         Equation 2-3 
 
Subtraction of the standard state from energy state of polymorph i at constant temperature:  
( )iiii aRTSTHG ln000 =Δ−Δ=Δ       Equation 2-4 
 
where a is the activity. Following that, comparison between two polymorphs (A and B) is 
made from Equation 2-4 and simplified as: 
⎟⎠
⎞⎜⎝
⎛=−
A
B
AB a
aRTGG ln        Equation 2-5 
 
which GB > GA denotes aB > aA, hence the concentration, cB > cA since activity and 
concentration are associated by the assumption that the activity coefficients for both 
polymorphs are identical.  
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2.4.2 Enantiotropic and Monotropic Systems 
 
 Figure 2-8 and Figure 2-9 illustrate the thermodynamic phase diagrams of polymorphs, 
according to their stability relationship; enantiotropic or monotropic system. The stability 
relationship is often being determined exclusively by their free energy differences at different 
temperatures [23]. For a monotropic system (Figure 2-8a), polymorph A having the lower free 
energy is stable and will not transform into polymorph B before the melting temperature.  
 
 As for the enantiotropic system (Figure 2-8b), polymorph A is thermodynamically 
more stable than polymorph B below the transition temperature5 (denoted in dotted line) while 
polymorph B prevails above the transition temperature. In this system, the melting point of 
polymorph A is lower than that of polymorph B, even though the melting point of polymorph 
A may not be accessible due to the facile solid state transition at lower temperature. At the 
transition point, a reversible transformation between the two polymorphs happens. Another 
representative phase diagram of pressure and temperature can be used to illustrate the stability 
relationship of polymorphs (Figure 2-9). 
 
 
Figure 2-8 Free energy vs temperature plots for polymorph pairs exhibiting (a) monotropy, (b) 
enantiotropy relation. Source: [35] 
 
                                                 
5 Transition temperature: temperature at which the two polymorphs have equal stability. 
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Figure 2-9 Pressure vs temperature plots for polymorph pairs exhibiting (a) monotropy, (b) 
enantiotropy relation. Source: [8] 
 
 In order to identify the polymorphic systems, a number of thermodynamic ‘rules’ are 
considered to characterise, understand and predict the behaviour of polymorphic systems; heat 
of transition rule, heat of fusion rule, infrared rule and density rule (Table 2-3). These rules are 
originally developed by Tammann [36], then expanded by Burger and Ramberger [37; 38] and 
followed by Grunenberg et al. [39]. The heat of transition rule is observed in at least 99% of all 
cases examined [38]. The infrared rule and density rule however are less reliable, and are thus 
not frequently used.  
 
Table 2-3: Thermodynamic rules for polymorphic transitions of enantiotropy and monotropy systems 
System Enantiotropism Monotropism 
Transition < melting I Transition > melting I 
I stable > transition I always stable 
II stable < transition II not stable at any temperature 
Transition reversible Transition irreversible 
Heat of transition rule 
Transition II Æ I is endothermic Transition II Æ I is exothermic 
Solubility rule Solubility I higher < transition Solubility I always < II 
Heat of fusion rule ΔHfusion I < ΔHfusion II ΔHfusion I > ΔHfusion II 
Entropy of fusion rule ΔSfusion I < ΔSfusion II ΔSfusion I > ΔSfusion II 
Heat capacity rule C I > C II C I < C II 
Infrared rule IR peak I before IR peak II IR peak I after IR peak II 
Density rule Density I < II Density I > II 
Note: Polymorph I being the higher melting form; ΔHfusion = Tfusion + ΔSfusion  . Source: [35; 37] 
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2.4.3 Kinetic Factors of Polymorphism 
 
 Crystallisation is complicated by the nature of the activated state which relates to a 
collection of self-assembled molecules having not only a precise packing arrangement but also 
existing as a new separate solid phase. However, if all the polymorphs have the same rates of 
nucleation, the appearance probability would therefore be dominated by the relative free 
energies of the possible crystal structure. Illustrated in Figure 2-10c, when crystallisation 
commences from the initial concentration X in the solubility curve, the metastable polymorph 
A crystals would come out first in the solution. This can be explained using the reaction 
coordinate diagram in Figure 2-11, representing the free energy of a solute in a supersaturated 
solution, transforming into one of the two crystalline products; polymorph A and B, by 
crystallisation. 
 
 
Figure 2-10 Solubility curves for polymorph pairs exhibiting (a) monotropy, (b) enantiotropy and (c) 
enantiotropy with metastable phases. Source: [40] 
 
 Each reaction pathway shown in Figure 2-11 is a transition state (G*A and G*B), having 
the activation energy which implies the relative rates of formation of the two crystal structures. 
The enthalpy of reaction ΔH with respect to polymorph B (G0-GB) is smaller than that for 
polymorph A (G0-GA). In addition, the activation energy for nucleation to polymorph B is 
lower. Therefore, kinetics will favour the formation of polymorph B and ultimately it will have 
to transform to polymorph A – the more stable form. 
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 The transformation process is governed by Ostwald’s law of stages6 or “Stufenregel” 
(step rule in German) [41]. The Ostwald step rule involves an inter-twined collection of 
thermodynamic and kinetic arguments. The thermodynamic argument is that the system visits a 
series of metastable phases on its way down to the most stable phase, decreasing its free energy 
by a series of small steps rather than one big leap. This stepwise progression is kinetically 
favoured and relies on the assumption that structural rearrangements involving smaller changes 
in free energy occur faster, and are rate-determining.  
 
 
Figure 2-11 Schematic diagram of the reaction coordinate for crystallisation in a polymorphic 
system. 
 
 
2.4.4 Inconsistency in Polymorph Nomenclature 
 
 In many cases, there are difficulties in searching and interpreting the polymorph forms 
in the literature as a result of the inconsistent naming system adopted. The discrepancy is due 
to the lack of an accepted standard notation, and perhaps also due to the authors’ unawareness 
of previous work, or lack of attempts to reconcile their own work with the earlier studies [8]. 
Though many polymorphic inorganic compounds are assigned with different names (e.g. rutile, 
                                                 
6 Ostwald’s law of stages: “At a sufficiently high supersaturation the first form that crystallises is the most soluble 
(the least stable by which the smallest loss of free energy) form. This transient state then transforms to the more 
stable form through a process of dissolution and crystallisation.” Ostwald (1897) Zeitschrift für Physikalische 
Chemie. 
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brookite and anatase for titanium dioxide), unfortunately no convention has been universally 
adopted for organic crystals.  
 
 Organic crystals are often labelled with Arabic (1, 2, 3, …) or Roman (I, II, III, …) 
numeral systems, lower or upper case Latin (a, b, c, … or A, B, C, …) or Greek (α, β, γ, …) 
letters. This problem can be exemplified by examining the history of the polymorphism of 
carbamazepine, a central nervous system (CNS) drug. Since the first polymorph nomenclature 
being reported by Kuhnert-Brandstätter in 1968 [42], there have been the Greek letter system 
(Form α, β and γ), the Roman numeral system (Form I, II, III and IV) and others: Form C1, C2, 
C3, according to the sequence of reported crystal structures, sequence of cell parameters being 
determined, or their descending melting points. Previous authors [43] have commented that 
arbitrary systems for naming the polymorphs should be discouraged, and also for those systems 
which have a different order of relative stability and melting points [8], as they do not allow for 
discovery of forms with intermediate values.  
 
 In the cases of carbamazepine, a crystal structure based system (triclinic, trigonol, P-
monoclinic and C-monoclinic) has been chosen in order to avoid any confusion and for clarity 
purpose. However, this is still not the best solution when it comes to a system which has more 
than one polymorph with the same crystal system. For instance: D-mannitol – widely used 
excipient in pharmaceutical formulation, has three modifications but two (β form and α form) 
of which both are arranged in an orthorhombic system [44].  
 
 It has been proposed using Roman numerals for modifications in the order of their 
discovery, based on the order of stability from Ostwald’s rule of stages. The Roman numeral 
was then followed by the melting point of that modification in parentheses [45; 46]. In view of 
the International Union of Crystallography (IUCr) Working Group’s report on phase transition 
nomenclature [47] and the earlier suggestion by McCrone [46], a more solid nomenclature for 
convenient designation has been proposed [33] and discussed [48]. Polymorphs of a compound 
are designated according to their thermodynamic relationship: enantiotropic or monotropic 
system. They are listed as I, II, III, … in order of increasing temperature stability ranges, 
follow by the regions of temperature stability (<T1, T1-T2,…). Other information can be 
included, such as former designations, number of molecules in unit cell, space group etc. 
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2.5 Solvate 
 
 “Any stabilizing interaction of a solute (or solute moiety) and the solvent or a similar 
interaction of solvent with groups of an insoluble material (i.e. the ionic groups of an ion-
exchange resin). Such interactions generally involve electrostatic forces and van der Waals 
forces, as well as chemically more specific effects such as hydrogen bond formation.” 
 
Definition of ‘solvation’ 
International Union of Pure and Applied Chemistry (IUPAC) [49]. 
 
 Solvates and hydrates exhibit pseudopolymorphism7, with molecules of solvent or 
water regularly incorporated into a unique structure in either stoichiometric or non-
stoichiometric proportions. However, solvate formation is also inevitably linked to a 
significant change in the material properties, hence results in various problems in the 
development of industrial products.  
 
 Brittain [50] introduced the term ‘solvatomorphism’ for inclusion of one or more 
molecules of solvent. Each unique structure also portrays different physicochemical properties. 
Therefore, maintaining the pseudopolymorph (or even polymorph) has to be accomplished 
through cautious evaluation of both the thermodynamic8 and the kinetic9 parameters during 
formulation and manufacturing processes.  
 
 Solvent crystallisation often yields highly unstable solvates which are immediately 
desolvated upon harvesting. Therefore, polymorphs may have formed from the desolvation of 
unstable solvates during the isolation procedure, especially the drying process in the final stage. 
As the associated solvates might desolvate under mild condition, hence a comprehensive 
characterisation of solvates under non-ambient conditions, such as dry atmosphere, certain 
partial pressure conditions, low and high temperatures is required.  
 
                                                 
7 A phenomenon by which the same substance exhibits different crystal packing arrangement (polymorph), and 
possesses different molecular composition (e.g. solvates and hydrates). 
8 Tendency toward the formation of more stable crystal forms. 
9 Tendency toward the formation of metastable forms. 
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2.6 Hydrate  
 
 Water represents the smallest molecule found within solvates. Owning to this feature 
and its unique ability to form hydrogen bonds, water is unrivalled as a solvate former. Hydrates 
are known as crystals of drug molecules, with different numbers of water molecules being 
incorporated into the crystal lattice. Nearly half of those drug substances which are capable of 
forming hydrates are manufactured in a crystalline hydrate form [6], for example: the world's 
best-selling medicine is in form of hydrate: Atorvastatin hemi-calcium trihydrate – Pfizer’s 
Lipitor®.  Other active pharmaceutical ingredients (APIs), such as the antibiotics ampicillin [51] 
and erythromycin [52], and vitamin B12 [53] and a number of pharmaceutical excipients (i.e. 
magnesium stearate, lactose, glucose) are marketed in a hydrate form, as they are the more 
stable form at ambient temperature and humidity.  
 
 However, if the hydrate is formed already under low humidity, i.e. ≤ 65 %RH, the 
selection of the preferred form becomes more difficult [54]. This is the case for carbamazepine, 
where formation of the dihydrate form is reported during storage under humid conditions [55]. 
As the presence of water can rarely be avoided during experimental work, unless specific 
measures are undertaken, very stable hydrates may mask the existence of other forms and may 
crystallise even with traces of water in a solvent or uptake from atmospheric moisture. 
Hydrates are typically the most stable forms in aqueous solutions and under high humidity 
conditions [5]. However, there have been cases where the hydrated form immediately 
converted to the anhydrate, when suspended in water (LY334370 HCl dihydrate to anhydrous 
form), or upon exposure to moisture (Mannitol anhydrous form) [56].  
 
 The presence of water molecules modifies the crystal structure of the initial anhydrate 
or lower hydrate, including the dimension, shape, symmetry and capacity of the unit cell. The 
water molecules occupy definite positions within the crystal lattice by forming hydrogen 
bond(s) and/or coordinate covalent bond(s) with the host – drug molecules. These 
intermolecular interactions and associated bonding within the solid causes changes in the 
internal energy and enthalpy, subsequently leading to changes in free energy. The strength of 
the water-solid interaction depends on the level of hydrogen bonding possible within the lattice 
[57]. Hydrates therefore normally contain chemical groups capable of participating in 
hydrogen bonding; proton donors and acceptors. A histogram of the number of hydrated 
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structures as a function of the donor : acceptor ratio (d/a) is shown in Figure 2-12. Not 
surprisingly, there are hardly any structures with a d/a is greater than unity. The vast majority 
of hydrogen bonded compounds have d/a ratios in the range 0.5-1.0, with almost 65% of the 
hydrated structures have d/a <0.5. 
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Figure 2-12 Donor/acceptor ratios (d/a) analysed for 411 hydrates. Source: [58] 
  
 Cambridge Structures Database (1996) showed that approximately 11% of all the 
reported crystal structures contain a water molecule, which represents over 16,000 compounds. 
Since crystalline compounds like organic molecules commonly form multiple hydration states, 
the breakdown of hydration numbers in Figure 2-13 demonstrates that monohydrates are the 
most frequently encountered, whereas the frequency of occurance of hydrate decreases almost 
exponentially as the hydration number increases.  
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Figure 2-13 Occurrence of crystalline hydrate stoichiometries, compiled from Cambridge Structures 
Database. Source: [59] 
 
 
2.6.1 Classification of Hydrates 
 
 Pharmaceutical hydrates are usually classified by a structural approach, allowing the 
prediction of a hydrate’s thermodynamic behaviour based on the crystal structure, or 
conversely facilitating some insight into the structure of hydrate through thermodynamic 
analysis. Various models of hydrates have been published by Morris [59]; water evolution type 
(WET)  [16], “Route 96 model”, Gal’s, Kuhnert-Brandstatter and Grimm’s [35]. The structural 
classification developed by Morris [59] is widely used, whereby there are three major types of  
hydrates: 
 
1. Isolated lattice sites 
2. Lattice channels 
a. Expanded channels 
b. Lattice planes 
c. Dehydrated hydrates 
3. Metal-ion coordinated water 
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 All of these hydrate systems are associated with a stoichiometric amount of water, 
except for the expanded channel, also known as non-stoichiometric channel hydrate. 
 
2.6.1.1 Isolated site hydrates 
 
 Isolated site hydrates are known to have structures with water molecules isolated from 
direct contact with other water molecules by intervening drug molecules. The water molecules 
play an essential role in stabilising these structures through the hydrogen bonding. For instance 
in nitrofurantoin monohydrate, each water molecule in the monohydrate II links with two 
nitrofurantoin molecules via hydrogen bonding. Others, like cephradine dihydrate (Figure 2-14) 
collapses to very unstable amorphous state upon dehydration, due to the ‘hole’ within the 
structure of dehydrated cephradine molecule, which does not allow other water molecules to 
access.  
 
 
Figure 2-14 Packing diagram from single-crystal data for cephradine dihydrate Source: [60] 
 
2.6.1.2 Channel hydrates 
 
 A channel hydrate, a term that derives from visualisation of its crystal structure, is a 
material where water molecules are closely associated in sub-nanometre (generally 5–10 Å 
diameter) hydrophilic tunnels or channels. The drug molecule serves as a host, whilst the 
channels accommodate water or solvents molecules, which lie next to one another of adjoining 
unit cells along an axis of the lattice. These hydrates are also widely referred to as variable 
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hydrates, non-stoichiometric hydrates, and isomorphic desolvates [61]. For example, 
crystalline theophylline monohydrate, known to exist also as the anhydrate, has relatively large 
channels filled with water molecules [5]. In contrast, ampicillin trihydrate is characterised by 
3.5 Å diameter channel, highlighted in blue colour in Figure 2-15.  
 
 By virtue of such unique molecular arrangements, most channel hydrates are able to 
reversibly dehydrate and hydrate with variations in temperature and humidity while retaining 
the same basic crystalline structure. The dehydration process generally begins from ends of the 
channels, exposed to the surface of crystals, and followed by departure of the remaining 
hydrate water along the channel. Characterisation of channel hydrate by thermoanalytical 
techniques shows an early onset temperature of dehydration and a broad dehydration peak. 
Hence, the shape, size and number of the water tunnels, and the number and strength of 
hydrogen bonds (between the water and the host molecule) play vital roles in preventing water 
molecules from escaping within the crystals.  
 
 
Figure 2-15 Packing diagram from single-crystal data for ampicillin trihydrate Source: [60] 
 
 The channel hydrates can be divided into two subcategories: expanded-channel (non-
stoichiometric) hydrates and planar (stoichiometric) hydrates.  
 
Non-stoichiometric hydrates 
 
 Non-stoichiometric hydrates pose a special challenge in dosage form development due 
to the unpredictable water content in the crystals. The structural voids present enable the 
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water/solvent to penetrate easily into the vacant or spacious tunnels. At times, even oxygen 
molecules are able to diffuse and react with the host molecules [62].  
 
 Water in this type of hydrate exists as either tightly bound water or as a disordered or 
free water phase, though differentiating between these two extremes is difficult. At higher 
moisture content, Thiel and Madey [63] reported that the water molecules form clusters and 
begin forming ‘solvent-like’ water, similar to the clusters occurring on crystalline surfaces via 
multilayer adsorption. Following the inclusion of disordered water within the crystal channel, 
this would also allow maximum participation of hydrogen bonding hence leading to severe 
imbalance between the number of acceptor and donor groups and stability of the crystal [64].  
 
 Oksanen and Zografi [65] concluded that the interpretation of water sorption isotherms, 
in terms of ‘tightly-bound’ and solvent-like’ states of water is misleading and inadequate in 
providing a basis for understanding the molecular process involved during water vapour 
adsorption. Authelin [66] however proposed a correlation for the sorption isotherm shape of 
non-stoichiometric hydrates with the degree of order in the crystal.  Apart from the state of 
water, structural features of the crystal are equally important. Ahlqvist and Taylor [67] 
observed that the strength of the hydrogen bonds between drug molecule and water has no 
impact upon the rate and extent of hydrogen/deuterium (H/D) exchange. The experiment thus 
enables the interpretation of structural and energetic information for channel hydrates. 
 
 The expanded lattice channel hydrate may take up additional disordered water 
molecules (apart from the localised water) into the interstitial voids when exposed to high 
humidity. Hence, the crystal lattice may expand or contract to host more or less water 
molecules as the humidity is altered [60]. For instance, the flexible 2-hydroxypropane chain, 
linking two cyclic moieties of cromolyn sodium (an antiasthmatic drug) allows the crystal to 
accommodate non-stoichiometric amounts of water. Chen et al. [68] also discovered that there 
is no fixed coordination site for the one of the sodium ions whilst another two sodium sites are 
unoccupied. Inasmuch the greater free volume for enhancement of solid state reactivity, non-
stoichiometric channel hydrates are reported as physically unstable [62]. Other examples 
include tartarate (muscarinic agonist) and L-lysine monohydrochloride (a nutritional 
substance), have been discussed comprehensively elsewhere [69].  
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Stoichiometric hydrates 
 
 The second subcategory refers to localised water molecule in a two-dimensional order, 
or plane within the crystal lattice (also recognised as a planar hydrate). The water molecules 
commonly occupy structural cavities resulting from the inability of the host molecules to form 
closest packed structures under the given crystallisation conditions. For instance sodium 
ibuprofen at the a–c plane of lattice and carbamazepine dihydrate with four water molecules in 
channel, parallel to axis c (Figure 2-16). These hydrates mostly retain their three-dimensional 
packing arrangements at varies hydration states [62] and exhibit reversible dehydration 
behaviour.  
 
 
Figure 2-16 Hydrogen-bond network of carbamazepine dihydrate. Source: [70] 
 
2.6.1.3 Metal ion associated hydrates 
 
 Hydrates associated with solubility, dissolution or handling problems are often 
recrystallised as salts of sodium, calcium, magnesium, or potassium. Hence, some metal ions 
tend to bond with water molecules due to the structure of the crystal lattice. The strong metal-
water interaction (e.g. Mg(H2O)62+ cation) results in a material exhibiting very high 
dehydration temperatures, which in turn favours the drying process of hydrates [59]. Examples 
include calteridol calcium (Figure 2-17) and disodium uridine diphosphoglucose dihydrate. 
 
a 
b 
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Figure 2-17 Packing diagram from single-crystal data for calcium calteridol tetradihydrate. Source: 
[60]  
 
 All of these classifications focus more or less exclusively on the location and self-
association of the water molecules in the crystal lattice (isolated, channels, planes, ion-
coordinated) and thus require a detailed knowledge of the crystal structure. An ideal 
classification of solvates should consider their stability (e.g. behaviour under different 
conditions) and their thermodynamic features.  Therefore, the ideal classification of solvates 
requires comprehensive understanding of molecular interactions and recognition principles, 
which consist of reliable thermodynamic data, phase diagrams, vapour-solid interaction 
behaviour, kinetics etc. [6]. 
 
 
2.7 Amorphous Solids 
  
 Amorphous solids exist in a non-equilibrium state. By which they lack a three-
dimensional long ranged order and the translational symmetry of crystalline form, nevertheless 
they do display short ranged order. They are often referred to as supercooled liquids, glassy 
solids and non-crystalline solids too. At times, the description given can be temperature 
dependent, with low temperature amorphous materials being described as ‘glassy’, and high 
temperature amorphous materials as exhibiting ‘rubbery’ behaviour.  
 
 Figure 2-18 depicts the standard pharmaceutical processes which are capable of 
forming an amorphous phase from solid, solution and vapour states of a drug substance. These 
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include condensation from the vapour state, quench cooling of the melt, rapid precipitation 
from solution (e.g. freeze-drying and spray drying), mechanical activation of a crystalline mass 
(e.g. milling, granulation and solid dispersion) and recently, dehydration and desolvation of the 
hydrated/solvated forms [71; 72]. Dehydration of a channel type hydrate (carbamazepine 
dihydrate) under zero humidity flow has been shown to be capable of forming the disordered 
amorphous phase following the rapid departure of its water of crystallisation [73]. 
 
Condensation
Spray drying
Freeze drying
Precipitation
Milling
Wet granulation
Solid dispersion
Solution
Hydrate/Solvate Polymorph
Melt
Amorphous state
Vapour
Dehydration
Desolvation
Quench cooling
 
Figure 2-18 Methods in which amorphous form is being induced in a pharmaceutical system. 
Source: [71-73] 
 
 Figure 2-19 describes the variation of enthalpy (H) or specific volume (V) of a solid 
substance as a function of its temperature. For a crystalline solid, there is only a small 
increment in H and V at very low temperatures. Until it reaches the melting temperature (Tm), 
the discontinuity in both H and V correspond to the first-order phase transition into the liquid 
state. Meanwhile, the properties of a glassy amorphous solid are in a non-equilibrium state 
(denoted as the red line), having higher values of H and V than the crystalline solid. Further 
heating allows a change in slope into the rubbery state at the glass transition10 temperature (Tg), 
prior to the melting point to liquid state [71]. 
 
                                                 
10 Glass transition is a second-order transition in which a supercooled melt yields, on cooling, a glassy structure. 
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Note: TK = Kauzmann temperature11; Tg = glass transition temperature; Tm = melting temperature. 
Figure 2-19 Schematic diagram of variation of enthalpy (or specific volume) with temperature for a 
solid substance in amorphous and crystalline states. Source: [71] 
 
 The amorphous states (both glassy and rubbery solids) clearly have favourable 
thermodynamic properties (i.e. higher solubility), greater chemical reactivity and greater 
molecular motion, compared to their purely crystalline counterparts. On the other hand, 
amorphous form is less thermodynamically stable than the purely crystalline form, and may 
spontaneously convert back to the crystalline state during processing or storage [4; 71]. 
 
 From a pharmaceutical perspective, the reality is that many drug candidates which are 
thermodynamically stable are so poorly soluble that the pharmaceutical companies could either 
discard them or produce a form – an amorphous form, that can improve dissolution and allow 
some kind of bioavailability [12]. The classic example of utilising the high solubility of a 
partially crystalline or amorphous drug is the formulation of insulin consisting of a mixture of 
amorphous and crystalline forms of insulin which is able to achieve short, intermediate, and 
long acting therapeutic effects [74]. Others include the orally applied drug – GlaxoSmithKline 
Ceftin®, an antibiotic used to treat a wide variety of bacterial infections. 
                                                 
11 Kauzmann temperature is the critical temperature that marks the lower limit of the experimental glass transition 
(Tg) and is the point at which the configurational entropy of the system reaches zero. 
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CHAPTER 3 WATER VAPOUR UPTAKE IN PHARMACEUTICAL 
SOLIDS 
 
3.1 Introduction 
 
“… the humid air of the night is attracted by light earth or penetrates self-acting into the pores 
in which it may easily condense to wetness.” 
Leon Battistata Alberti (1404–1472) 
1st accurate description of water adsorption in L’architettura  
 
 Water is of fundamental importance for the formation, stability and properties of 
practically all naturally occurring and many synthetic materials. The physicochemical 
properties of solids are critically dependent upon the presence of moisture in their surroundings. 
The modes of interaction as well as the thermodynamic and kinetic states of water in contact 
with various solids are often complex. The term ‘adsorption’ was first introduced by Kayser in 
1881. In 1909, McBain proposed the term ‘sorption’ to cover surface adsorption, absorption by 
penetrating into the crystal lattice/non-crystalline regions and capillary condensation within the 
pores [75]. 
 
 The amount of water adsorbed on/sorbed into a solid is a function of the chemical 
affinity between the surface and water molecules, temperature and relative humidity (RH). The 
interactions between moisture and solids have been described in different ways, as the surface 
properties of the solid determine the degree of chemical interaction between both. Most of all, 
it is the hygroscopicity12 of the solid where the adsorption process occurs with the water 
molecules forming hydrogen bonds with the hydrophilic sites on the solid [76]. Those solids 
which are not affected by the surrounding water vapour are termed as non-hygroscopic 
                                                 
12 Hygroscopicity refers to the ability of a material to interact (in a dynamic equilibrium) with moisture from the 
surrounding atmosphere. 
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materials. Callahan et al. [77] categorised the degree of hygroscopicity into four different 
classes, based on the surrounding water vapour and the water content13 adsorbed/sorbed: 
 
a) Non-hygroscopic solids:  
No increase in water content below 90 %RH, and less than 20 %w/w increment after 
one week storage at above 90 %RH. 
b) Slightly hygroscopic solids:  
No moisture increase below 80 %RH and less than 40 %w/w increment after one-week 
storage at above 80 %RH. 
c) Moderately hygroscopic solids:  
Moisture increase less than 5 %w/w after storage at below 60 %RH, and is less than 50 
%w/w of moisture uptake after storage for one-week at above 80 %RH.  
d) Very hygroscopic solids:  
Moisture increase may occur at 40-50 %RH and may exceed 30 %w/w after one-week 
storage at above 90 %RH. 
 
 Crystalline solids only take up extremely low amounts of water vapour (e.g. <0.5 
%w/w at ambient conditions) under atmospheric pressure, as long as it is below their critical 
relative humidity (RHC)14. These water molecules form an adsorbed monomolecular layer, and 
are subjected to both surface binding and diffusional forces (Figure 3-1a). As the surrounding 
water vapour concentration increases, the excess of a monolayer may cause ‘surface 
dissolution’ (Figure 3-1b). From a thermodynamic perspective, the dissolution of a water-
soluble solid commences once the chemical potential of the water is equal to that of a saturated 
solution. Subsequently, the solid will deliquesce above its RHC [78].  
 
 Apart from that, some common excipient materials, such as sugars undergo significant 
morphological change, such as swelling at elevated humidities [79]. On the other hand, for 
non-hydrating materials, diffusional forces would exceed the binding forces as more water 
molecules adhere to the surfaces. These water molecules would eventually transfer into the 
bulk and be present as condensed moisture within the pores and capillary spaces of the material 
[80]. 
                                                 
13 Water content is the percentage of the total mass of a material constituted by water. 
14 Critical relative humidity (CRH) refers to the relative humidity of the surrounding atmosphere (at a given 
temperature) at which the water-soluble material begins to undergo dissolution from the excess water uptake. 
Below the CRH, there is no significant sorption of atmospheric moisture. 
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Figure 3-1 Water vapour adsorption and deliquescence of a water soluble solid particle. Source: 
[79] 
 
 However, pharmaceutical solids commonly contain various defects and at times, 
various degrees of disorder (amorphous region). Water molecules are therefore preferentially 
absorbed into these amorphous regions, a process known as bulk sorption. Significantly, 
increasing the molecular mobility of the amorphous phase can then lead to partial 
crystallisation. Hence, the amount of water that is usually observed with bulk pharmaceuticals 
and formulations is about a few percent, and at times up to 80 %w/w or more for some active 
pharmaceutical ingredients (APIs) of 30 µm in size. API with smaller particle size tends to 
have higher moisture uptake due to the larger surface area per volume as (ad)sorption sites.  
 
 
3.2 Water Molecule and Hydrogen Bonds 
 
 Water molecules (molecular weight: 18.016 g/mol; molecule cross sectional area: 0.125 
nm2) exhibits unique properties due to its dipolar nature and its ability to form hydrogen bonds 
(Figure 3-2). Water molecules can act as both hydrogen bond acceptors and donors. Since it 
has two hydrogen atoms and two lone pairs on the oxygen atom, it can participate in a 
maximum of four hydrogen bonds in a tetrahedral arrangement. The hydrogen bonds – 
intermolecular forces which hold molecules together – are also known as the electrostatic 
attraction between the molecules. These electrostatic forces play important roles in determining 
the physical properties of a material, and the hydrogen bonds of water molecules account for 
some of the unique properties of water.  
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Figure 3-2  Interaction (hydrogen bonding) between the water molecules. Source: [81] 
 
Although hydrogen bonds are weaker than covalent bonds, they are ubiquitous, 
directional and strong, being reinforced by additional polarisation effects and the resonant 
intermolecular transfer of OH- vibrational energy [82]. Therefore, any reorientation of one 
molecule induces the corresponding motions in the neighbours, at distances of several 
nanometers from each other and extending to tens of nanometers with surfaces.  
 
Water molecules in a hydrate generally form well defined clusters stabilised by 
hydrogen-bonding to the inner surface of the cavity created by the host [83]. The number of the 
hydrogen-bond acceptors and donors in a hydrate may differ significantly from the anhydrous 
counterpart since H-bond contributes to the total lattice energy [64]. The strength of hydrogen-
bond depends on its length and angle. When a large number of hydrogen bonds act in unison, 
they have strong contributory effect [81], and small deviations from linearity in the bond angle 
(up to 20°) possibly have a relatively minor effect. Hydrogen bonds can keep water as a liquid 
over a wider range of temperature than is found for any other molecules of its size [57]. 
However, the dependency of bond strength on the bond length is very important and the bond 
strength has been shown to exponentially decay with distance [82; 84]. Some researchers 
consider the hydrogen bond to be broken if the bond length is greater than 3.10 Å or the bond 
angle less than 146° [85].  
(a) 
(b) 
-ve
+ve
+ve
θ = 104.27º
L = 0.96 Å 
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 In addition, water molecules are also being recognised as a plasticiser for semi-
crystalline materials since they are readily deform from the ideal hydrogen bond geometry [64], 
increases the molecular mobility of the reactants. Water molecules can also act as a reactant, 
participating in chemical reactions, e.g. hydrolytic reactions. There are two types of attractive 
forces, namely cohesive and adhesive forces. For instance, the cohesive forces that prevail 
during wet granulation process are primary due to the liquid bridges between the solid particles, 
however weak intermolecular attractive forces, e.g. van der Waals forces and electrostatic 
forces also play an essential role [86].  
 
 Both hydrogen bonds and the hydrophobic effect are relevant to the interactions of 
water molecules. Forces of attraction between nonpolar atoms (hydrophobic substances) and 
molecules in water are termed as hydrophobic interactions (Figure 3-3). The concept of 
hydrophobic interaction was first identified as the primary source for protein stability in 
solution [87] and it relates to the entropy-driven intermolecular interactions which plays a key 
role in explaining various process related to the effective attraction of nonpolar atoms and 
molecules in water. This is due to the fact that, the stronger interaction of hydrogen-bonding 
network between the water molecules themselves is much more in favour, contributing towards 
the intermolecular aggregation of  the hydrophobic substances, i.e. oil droplets in water [88]. 
All this amounts to a low solubility of carbamazepine in water 
 
 
Figure 3-3 Hydrophobic interaction between hydrophobic (nonpolar) molecules and water 
molecules. 
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3.3 States of Water in Crystalline Solids 
 
 Drug substances are often exposed to water during the manufacturing and processing 
stages; crystallisation, wet granulation, aqueous film coating etc. [89]. The water will be held 
in different degrees of intermolecular attraction (Figure 3-4). For those water molecules that 
are incorporated in a specific position within the crystal lattice, are known as the water of 
crystallisation, or hydrate water, or bound water.  
 
 Hydrate water can be incorporated in a crystal lattice as two different states; as tightly 
bound stoichiometric water or as loosely bound non-stoichiometric water.  ‘Bound’, ‘unbound’ 
and free water are poorly defined, as there are variations in the definitions of these terms. Some 
might also refer to as unhindered and hindered mobility state of water, whilst Authelin [66] 
used the labels of localised and non-localised water. Febles et al. [83] also reported that water 
can either actively assemble in the crystal structure or simply filling the voids left by the host. 
In lyophilisation, ‘confined’ or ‘interfacial water’ is used to represent water attached to the 
surfaces of substrates or filling the small cavities in porous media [90]. A more comprehensive 
but general classification of water retention in solids is summarised in Table 3-1. All in all, due 
to the complexities and interactions of the binding forces involved, no universal definition of 
bound and unbound water has been agreed and adopted thus far. 
 
 Bound water is directly associated with the host and has poor lability for any physical 
and/or chemical interactions. It exhibits the characteristics of high binding energy as measured 
during dehydration, reduced mobility as observed by nuclear magnetic resonance, 
unfreezability at low temperature, and unavailability as a solvent. There is also bound water 
which is moderately or loosely bound within the lattice channel and possessing the 
characteristic of reversible and exothermic upon removal [91]. Conversely, unbound and free 
water is loosely adsorbed either on the surface of the material and behaves as pure water; or 
within the voids of granules/inter-particles. Such physically bound water can facilitate and 
participate in physical and chemical transformations [92].  
 
 68
 
Figure 3-4 State of water in crystalline solids. 
 
 The many different states of water (e.g. bound, loosely bound or free water) may be 
partially predicted from a moisture sorption desorption isotherm. A combination of other 
characterisation techniques is therefore needed to fully differentiate the differing states of 
water, for example: thermogravimetric analysis (TGA), where unbound water is usually 
released at temperatures below 80ºC, while the water of hydration is not removed until higher 
temperatures (120ºC and above) are reached [93]. 
 
 Moreover, the accurate and reliable quantification of bound and loosely bound water is 
currently unattainable. Nuclear magnetic resonance has been used to determine the bound 
water via binding dynamics, which refers to the dissociation activation energy. Chaplin [94] 
however acknowledged the thermodynamics of the water molecules, involving free energy 
changes is the vital link to bound water determination. The states of water are also influenced 
by the surface free energy, exhibiting either hydrophilic or hydrophobic interaction, which can 
be determined via contact angle measurement. For instance, sorbitol – sugar substitute used in 
diet foods [91]. Another factor which influences the state and dynamic properties of water is 
geometrical confinement [90]. 
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Table 3-1: Classification of moisture retention in solids 
Item Bound water Physically adsorbed moisture* Mechanically adsorbed moisture* 
Ionic Molecular Adsorptive Osmotic Structural Microcapillary Macrocapillary Unbound Order of bond energy 
(kJ/mol)  5 3   ≥ 0.1 ≤ 0.1 0 
Water uptake process Hydration Crystallisation 
Hydrogen-
bonding / 
solvation 
Physiochemical adsorption 
Osmotic 
imbibition 
Dissolution 
in gels 
Capillary condensation 
Surface 
condensation 
Electrostatic field Molecular-force field 
Reason of constitution Between 
ions 
Between 
molecules 
All 
molecules 
Outer/inner 
surface 
Inner 
surface 
Osmotic 
pressure 
Moisture 
inclusion on 
gelling 
Meniscus in capillary 
Surface 
adhesion 
Water removal 
process 
Chemical 
reaction 
Dehydration Evaporation Desorption 
More 
concentrated 
ambient 
solution 
Evaporation 
or 
mechanical 
dewatering 
Evaporation from capillaries 
Surface 
evaporation 
Changes in solid 
skeleton and 
associated moisture 
New 
compound 
is formed 
New crystals 
are formed 
Moisture as 
solvate 
Moisture 
held in 
intermicellar 
pores 
Moisture 
held in 
molecular 
layers 
Changes in physical 
appearance and properties, 
e.g. cohesive strength 
Small changes in moisture properties and nearly no 
changes in solid skeleton 
Capillary-porous bodies 
Examples 
Hydrate of 
lime 
Inorganic 
crystals 
Ionic/ 
molecular 
materials 
Hydrophilic 
materials 
Hydrophobic 
materials 
Plant cells 
with 
aqueous 
solutions 
Gels with 
about 1% 
solid 
r ≤ 10-7 m r > 10-7 m 
Non-porous 
hydrophilic 
materials 
* Unbound water 
Source: [93] 
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3.4 Water Sorption Mechanism 
 
 The water vapour sorption phenomena (i.e. surface adsorption, condensation in 
pores/tunnels and bulk sorption) often overlap and complicate the interpretation of the moisture 
sorption studies. Moreover, the surface of a solid material is heterogeneous/ anisotropic; 
therefore one might encounter several sorption mechanisms in the same material concurrently. 
 
 
Figure 3-5 Vapour adsorption mechanism in a function of surface coverage and surrounding 
humidity.  
 
3.4.1 Surface Adsorption  
 
 There are two principal modes of vapour adsorption on surfaces namely, physisorption 
and chemisorption [95], which are distinct by the nature of the intermolecular attractions 
between the molecule and the surface. Generally, the vapour (or gas) taken up on surface is 
termed as the adsorbate, while the solid providing the adsorption sites is termed as the 
adsorbent or sorbent. As mentioned earlier, the tendency for an adsorption to occur is strongly 
dependent on the vapour pressure, temperature, and magnitude of the interfacial intermolecular 
interactions [57].  
 
 Surface adsorption exhibits relatively fast kinetics in the gas phase. Physisorption (or 
physical adsorption) involves weak van der Waals forces. There is no significant redistribution 
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of electron density in either the molecule or at the substrate surface, resulting in the association 
of water molecules together in a quasi-liquid layer on the surface. Physisorption is therefore 
reversible and desorption can be induced by simply increasing the temperature and/or reducing 
the vapour pressure. Physisorption is also a non-dissociative adsorption mode, capable of 
accommodating multilayer molecules. However, physisorption information is important, as it 
provides information about the material, from which surface area, pore size and pore size 
distribution can be derived. 
 
 On the other hand, chemisorption is associated with chemical valence forces – the 
stronger chemical interactions formed between the adsorbate and substrate. Chemisorbed 
molecules are linked to reactive parts of the surface and the adsorption process. There is 
substantial rearrangement of electron density, thus it is often dissociative and possibly an 
irreversible phenomena. Chemisorption is necessarily confined to merely a monolayer [96], 
therefore it is useful for the characterisation of catalyst surfaces, and is also the key mechanism 
of heterogeneous catalysis of chemical reactions. 
 
 Surface adsorption models, such as Langmuir [97], BET [98], and GAB (after 
Anderson in 1946; de Boer in 1953; Guggenheim in 1966) [99] were initially developed for 
monolayer and multilayer gas adsorption. These models hence have to be modified and 
complemented with bulk sorption models for amorphous materials, by which the water 
molecules might diffuse and incorporate into the structures.  
 
3.4.2 Condensation in Tunnels or Pores 
 
 Categories of pores have been proposed by the International Union of Pure and Applied 
Chemistry (IUPAC) [100], based on the internal width of pore: micropores (between 0.8 and 2 
nm), mesopores (between 2 and 50 nm) and macropores (greater than 50 nm). Amongst the 
three groups, micropores and mesopores are most important in moisture sorption.  
 
 In capillary condensation the residual pore space (after multilayer adsorption) will be 
filled with condensate, separated from the gas phase by a meniscus – curvature of the liquid 
surface in the capillary [100]. The mechanism starts with adsorption of water onto the surface 
of the pore wall, followed by condensation of water, and eventually the condensed water will 
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fill up the core of the pore [101]. However, there is a lower limit to the range of pore widths at 
which the occurrence of capillary condensation is conceivable. Capillary condensation is 
normally associated with a decrease in the surface energy at the interface between the pore 
walls and the sorbate [96], which is explained by the Kelvin equation.  
 
3.4.3 Bulk Sorption of Amorphous Materials 
 
 Absorption or bulk sorption infers the binding or incorporation of diffused water 
molecules into a solid. This mechanism is frequently encountered within the amorphous 
materials which absorb considerable amount of water (up to 50%v/v) but at much slower 
kinetics (many hours or days) [65]. The processes depend on the surrounding temperature, 
humidity, as well as the chemistry of the material. The sorption mechanisms normally involve 
diffusion, extensive clustering and multilayer formation, following the Zimm’s clustering [102] 
and Flory-Huggins’s polymer solution theories [103; 104].  
 
 
3.5 Moisture Adsorption Isotherms 
 
 The term ‘adsorption isotherm’ appears to have been introduced by Ostwald in 1885 
[105]. The water sorption-desorption isotherm refers to the amount of water molecules 
adsorbed/desorbed as a function of the partial vapour pressure of the water (relative humidity) 
above the solid, at constant temperature and pressure. The amount of water associated with the 
solid at a specific relative humidity and temperature therefore relies upon the type of solid 
(adsorbent), its chemical affinity for the solid and number of sites available for interaction. 
Knowledge of these water sorption properties is vital to predict the physical state of materials 
at various conditions, as most structural transformations and phase transitions are greatly 
affected by the presence of water [99].  
 
 Figure 3-6 depicts the five major types of physical adsorption mechanisms [98; 100] 
based on the classification of adsorption isotherms by Brunauer, Deming, Deming and Teller 
(BDDT) in 1940 [106]. The BDDT (also known as Brunauer’s) classification has since become 
the core of the modern IUPAC classification of adsorption isotherms though they were 
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developed to describe gas adsorption rather than water adsorption. The monolayer capacity, 
from an energetic point of view [107], is defined as the amount of adsorbed molecules at the 
maximum of surface area interaction with the adsorbent. Authelin [66] has also proposed a 
theoretical link between localisation of the water molecules, structure of the hydrates and shape 
of the isotherm.  
 
Condensation in 
pores/tunnels
Type I Langmuir
Type III BET
Type IV StepType V Sigmoidal
Monolayer
Multilayer
Type II BET
 
Figure 3-6 Schematic diagram of adsorption mechanisms, based on the Brunauer, Deming, 
Deming and Teller (BDDT)’s isotherms.  
 
Type I isotherm BDDT classification (Figure 3-7a) is the Langmuir isotherm. This type 
portrays a rapid rise which approaches a maximum value asymptotically as the vapour pressure 
increases, indicating the completion of monolayer adsorption. The limit of the uptake is 
governed by the accessible micropore volume instead of the internal surface area. It is 
therefore primarily for adsorption on microporous solids with relatively small external surfaces, 
for instance; activated carbon, salts of heteropolyacids, molecular sieve zeolites and several 
porous oxides [75; 100]. 
  
 Solutions with high polymeric concentration often lead to high affinity adsorption 
isotherms, when in contact with an adsorbent. This type of isotherm corresponds to the 
Langmuir equation (Type I) with a very high binding constant, shown as dotted grey line in 
Figure 3-7a. Due to the very strong adsorption interactions, high affinity type isotherm is often 
‘irreversible’, or with a rather very slow desorption kinetics [108]. 
 74
A
m
ou
nt
 A
ds
or
be
d
P0 P0
Partial Pressure
P0
Vm
Vm
(b) Type II (c) Type III(a) Type I
(f) Type VI(e) Type V
Vm
(d) Type IV
 
Vm : amount of monolayered adsorbate 
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Figure 3-7 Classification of gas adsorption isotherms. Source: [98; 100] 
 
Type II isotherm The sigmoid-shaped isotherm (Figure 3-7b) refers to reversible and 
unrestricted multilayer physical adsorption on non-porous (e.g. metal; alumina) or 
macroporous solids. Similar to Type I, there is a build up of an equivalent monolayer where the 
molecules are very strongly attracted to the surface. After the monolayer adsorption, further 
increase in partial pressure result in extensive adsorption and followed by multilayer coverage. 
The post-monolayer molecules may be mobile (free water or solvent), regarded as being 
analogous to condensation. Brunauer-Emmett-Teller (BET) equation [98] extends Type I to 
accommodate both limited and unlimited multilayer sorption.  
 
Type III isotherm The isotherm is characterised by the convexity towards the partial 
pressure axis, starting at the origin. It occurs in situations where interaction between the 
adsorbate molecules is greater than that between adsorbate and adsorbent. Therefore it is 
necessary to have significant partial pressure of adsorbate before the adsorption process 
commences. Having the surface covered with adsorbate, the favourable adsorbated-adsorbate 
interaction would then lead to a very rapid adsorption process, as the partial pressure increases 
(Figure 3-7c). Though rarely found with gaseous isotherms (e.g. nitrogen gas on polyethylene) 
but it is the typical water sorption for hydrophobic crystalline solids and crystalline solids 
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which have low initial uptake until it deliquesces (e.g. sugar). Clustering of the adsorbate onto 
the surface also results in this type of isotherm [100]. 
 
Type IV isotherm Figure 3-7d is analogous to Type II isotherm, having an inflection (or 
knee) as the monolayer formation. This isotherm is commonly exhibited by many mesoporous 
industrial adsorbents and inorganic oxide xerogels [75], of which the monolayered surface 
coverage of the pore walls is followed by capillary condensation or pore filling. The adsorption 
ceases, once all the pores are completely filled. 
 
Type V isotherm The initial pathway of this isotherm is similar as in Type III. In this 
instance, the adsorbate preferentially interacts with the monolayer than the adsorbent surface, 
due to the lower heat of adsorption compared to the heat of liquefaction.  
 
Type VI isotherm A stepwise isotherm (anomalous isotherm) on a uniform non-porous 
surface, associated with formation of complete monolayer before each subsequent multilayer 
commences. Having weak hydrogen bond linking between the solid and water molecules, 
surface water generally does not result in more than one to three molecular layers [60]. This is 
an ideal and visualised isotherm, which seldom occurs, except for argon or krypton onto 
graphitised carbon blacks at liquid nitrogen temperature [100].  
 
 Isotherms are useful for predicting the water sorption properties (e.g. water adsorption 
potential and water retention capacity), however no equation thus far could provide results that 
are accurate throughout the entire range of water activities. Moreover, the BDDT and IUPAC 
classifications have a few deficiencies, as they give the inaccurate impression that adsorption 
isotherms are always monotonic functions of pressure, and they only consider adsorption at 
subcritical temperatures. 
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3.5.1 Models for Moisture Adsorption Isotherm 
 
Langmuir model 
 
 Langmuir [97] developed the theory of adsorption and derived the celebrated isotherm 
equation for adsorption in a monomolecular layer in 1915. The equation assumes that the 
molecules of gases are adsorbed on the active sites of the solid and form only one monolayer. 
At equilibrium, the rate of adsorption and desorption are equal, regardless the occupancy of the 
neighbouring position. Every molecule coming from the gas phase to the first layer of 
molecule is elastically reflected. Therefore due to the negligible forces of attraction of the 
adsorbed molecules, multiple-layered molecule adsorption is not possible.  
 
bp
bpVV m+= 1          Equation 3-1 
V volume adsorbed (m3) 
Vm volume of monolayer capacity (m3) 
p vapour pressure of gas (Pa) 
b constant varying with gas and temperature, but independent of surface coverage [ ] 
 
 Langmuir's isotherm decribes the interesting technical applications involving low 
concentration exceedingly well, therefore it remains one of the most frequently used models. 
At very low partial pressure, the adsorption however is linear and correspondes to the Henry’s 
law isotherm. 
 
 
Brunauer-Emmett-Teller (BET) model 
 
 The BET sorption model [98] was actually derived for multimolecular adsorption of 
inert gases and the rate of adsorption and desorption are equal in each layer. The equation 
hence yields a sigmodal type isotherm, however it is only best fit for data obtained from 
conditions up to 50% P/P0, as the prediction reaches infinity rapidly above 50% P/P0.  
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The BET equation 
( ) ( )( )wBw
wBm
aCa
aCm
m
111 −+−=        Equation 3-2 
 
where 
RT
HHkC LB
−⋅= 1exp        Equation 3-3 
m solute content (g/100g adsorbent) 
mm monolayer of solute or monolayer capacity (g/100g adsorbent) 
aw water activity (0-0.5) [ ] 
CB energy constant, associated to enthalpy of adsorption of the first adsorbed layer [ ] 
H1 heat of adsorption of the first solute molecule adsorbed (kJ/mol) 
HL heat of condensation of the bulk solute (kJ/mol) 
T absolute temperature (K) 
R gas constant (8.31447 J/K.mol) 
k constant [ ] 
 
 The BET monolayer value has been suggested to be optimal water content for stability 
of low-moisture materials and sorption occurs in two distinct thermodynamic states: a tightly 
bound monolayer portion and a multilayer equivalent region with the properties of bulk free 
water [109]. The BET model is still widely used to determine the monolayer and specific area 
values in various physicochemical areas. It is a standard evaluation of monolayer values for 
sorbate activity of between 0.05 and 0.30 [110]. This is mainly due to its simplicity and also 
the approval of IUPAC [98]. 
 
 
Guggenheim-Anderson-de Boer (GAB) model 
 
 The GAB model (after Anderson in 1946; de Boer in 1953; Guggenheim in 1966) [99] 
represents a refinement over the BET model and shares with it the two original BET constants 
(mm, the monolayer capacity and CB, the energy constant). It owes its major versatility to the 
introduction of a third constant (K). The GAB sorption model introduces an intermediate state 
to the tightly bound and free state of absorbate. Though GAB model is commonly used for 
food products [111], it offers considerable practical utility in fitting isotherms for 
pharmaceutical materials for comparison and prediction of their behaviour over the entire RH 
range [109]. 
 
 78
The GAB equation 
( ) ( )[ ]wGw
wGm
KaCKa
KaCm
m
111 −+−=       Equation 3-4 
 
where  
RT
HH
DC mG
−⋅= 1exp        Equation 3-5 
 KCC GB =         Equation 3-6 
and  
RT
HH
BK mL
−⋅= exp        Equation 3-7 
CG, K constants related to excess enthalpy of sorption [ ] 
aw water activity [ ] 
HL heat of condensation of bulk adsorbate (kJ/mol) 
Hm heat of adsorption of vapour adsorbed in the intermediate layer (kJ/mol) 
H1 heat of adsorption of the first vapour molecule (kJ/mol) 
T absolute temperature (K) 
R gas constant (8.31447 J/K.mol) 
D, B constants [ ] 
 
 The distinct differences between the GAB and BET models are noteworthy [110]. The 
improved GAB covers wider range of activity (0.05 to 0.8/0.9), with higher monolayer 
capacity (mm(BET) < 15% mm(GAB)) and extremely lower energy constant (35-40% or more 
CB(BET) > CG(GAB)). It also can characterise the state of the sorbed molecules beyond the first 
monolayer, allowing the explanation of the upswing systematically found in the BET plots 
after the initial linear range. 
 
 
Kelvin’s model 
 
 Kelvin’s equation found its major application in capillary condensation, by which 
undersaturated vapour (adsorbate) will condense in channels of sufficiently small dimensions. 
The equation relates the equilibrium adsorbate vapour pressure to the curvature of the liquid-
vapour interface. However, Kelvin's equation underestimates the calculated pore size of a 
material at range of 2 to 4 nm. Hence, it is best suited for organic liquid with meniscus radii as 
low as 4 nm. Moreover, this equation is applicable for first order phase transition but restricted 
to high partial pressure [112]. On the other hand, macroscopic condensation theory has been 
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used in both Barrett-Joyner-Halenda (BJH) method [113] and Dollimore-Heal (DH) method 
[114]. 
 
θγ cos2ln
0 rRT
V
p
p L−=         Equation 3-8 
p equilibrium vapour pressure of a liquid in a pore of radius r (Pa) 
p0 equilibrium pressure of the same liquid on the plane surface (Pa) 
γ surface tension of the liquid (mN/m) 
VL molar volume of the liquid (m3/mol) 
θ contact angle with which the liquid meets the pore wall (º) 
T absolute temperature (K) 
R gas constant (8.31447 J/K.mol) 
 
3.5.2 Hysteresis of Moisture Sorption Isotherms 
 
 Hysteresis prevails when there is a difference between the adsorption and desorption 
curves. The hysteresis profile, associated to equilibrium moisture sorbed and desorbed can thus 
be obtained at different RH, as illustrated in Figure 3-8.  
 
 Arnell & McDermot [115] and Kapsalis [116] classified hysteresis into three major 
types: hysteresis on porous solids, which is based on capillary condensation; hysteresis on non-
porous solids (crystalline materials) attributed to partial chemisorption, surface impurities, or 
phase changes; lastly hysteresis on non-rigid solids which relies on structural changes. Figure 
3-9 illustrates the three general shapes of an isotherm, associated with the reversibility of 
moisture sorption. The size and shape of hysteresis loop is ascribed to the mode of interaction 
between the solid and water vapour. It can therefore become a way of identification of 
predominant pore-filling or pore-emptying mechanisms.  
 
 Hysteresis loops at high RH are common in highly porous materials whilst at low RH 
are often associated with swelling or interaction between the sorbate and sorbent within the 
bulk [100]. Transition from a glassy to rubbery state and supersaturation of compound during 
desorption, for instance isotherm of sugars may also have a hysteresis. The closed loop 
hysteresis in Figure 3-9b signifies that the material desorbs to its initial mass, nonetheless it is 
not necessary the same material as polymorphic phase changes might occur under certain 
humidities.  
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 Open hysteresis loop in Figure 3-9c is attributed to the binding and physical fit of water 
in bottle-neck pores within the crystal lattice, following the conversion of the amorphous into 
the crystalline form [117]. Formation of thermodynamically stable and higher hydrate or 
desorption to stable intermediate hydrate can also lead to an open looped hysteresis, by which 
water molecules are not readily released unless energy (e.g. heat) is provided. Such sorption-
desorption process is hence irreversible. 
 
 
MS & MD: Equilibrium mass(%) at RHA for sorption and desorption profiles, respectively. 
Figure 3-8 Determination of hysteresis from gravimetric sorption experiment.  
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Figure 3-9 Schematic diagrams of moisture sorption isotherms (a) without hysteresis; and with (b) 
closed loop; and (c) open loop hysteresis. 
 
 International Union of Pure and Applied Chemistry (IUPAC) has also categorised the 
hysteresis loops based on the geometry and texture of the mesoporous adsorbent [100], as 
depicted in Figure 3-10. The shape of sorption hysteresis loops is dependent on temperature 
and pore diameter, of which increasing temperature will often produce smaller hysteresis loop. 
Donohue [118] reproduce the hysteresis isotherm classification, using lattice density functional 
theory (DFT), based on molecular calculation. H1 and H4 represent the extreme types, where 
the former has sorption and desorption curves almost vertical and parallel, whilst the latter type 
is nearly horizontal and parallel. H2 and H3 however may be regarded as the intermediate ones. 
A fifth class of hysteresis loop (H5) with steps at the sorption and desorption branches was 
found, and experimentally proven by Bordere et al. [119]. Figure 3-10 demonstrates the 
dependence of hysteresis loop class on the pore length (unit in nanometre) and molecule-wall 
interaction energy, εa (unit in kT)15, which is useful for the design of industrial adsorption 
processes.  
 
                                                 
15 kT refers as the product of the Boltzmann constant, k and temperature, T. It is the amount of heat required to 
increase the thermodynamic entropy of a system. 
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Figure 3-10 Dependence of adsorption hysteresis on pore length and interaction energy. Source: 
[100; 118] 
 
 
3.6 Hydration in Pharmaceutical Solids 
 
 Since hydrate water is thermodynamically distinct from bulk water, any redistribution 
of water molecules in the bulk and the hydration phases would have a significant impact on the 
net energy of a molecular event [120]. The stability of a hydrate relative to the anhydrate or its 
intermediate hydrate depends upon the activity of water in the vapour phase. This 
straightforward thermodynamic description of hydrate equilibria is the key to understanding 
not only the stability of hydrated forms but also the inherent differences between hydrates and 
polymorphs [6]. 
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 Moisture sorption and desorption isotherms can provide insights into the potential 
phase transformation of the materials and are able to reflect their kinetic stabilities. However 
there are several additional factors which can significantly alter the moisture sorption 
behaviour such as crystallinity, presence of impurities, crystal defects and the presence of 
disordered regions (amorphous state) within the solids. Figure 3-11 shows a variety of moisture 
sorption characteristics of many different types of pharmaceutical solids.  
 
 For amorphous materials (Figure 3-11b), substantial water sorption is commonly 
observed, at times causing the material to crystallise at higher humidities. Similar high bulk 
sorption ability is also observed for deliquescent materials (Figure 3-11c). On the other hand, 
highly crystalline materials typically exhibit very low levels of surface adsorbed water (Figure 
3-11d). In some cases, formation of stoichiometric hydrates occur in stepwise (Figure 3-11e), 
while non-stoichiometric hydrates (Figure 3-11f) experience gradual and continuous 
incorporation of water as the partial pressure increases.  
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Figure 3-11 Moisture sorption behaviours for pharmaceutical solids 
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3.6.1 Young-Nelson Model for Moisture Sorption Isotherm 
 
 The Young-Nelson model [121; 122] comprises three water sorption mechanisms: 
tightly bound surface monolayer, surface multilayer and internally absorbed water molecule. 
Young and Nelson first developed this model for biological materials and food (e.g. wheat).  
 
 Figure 3-12 depicts the sorption and desorption mechanisms of the Young-Nelson 
model. Two types of forces exist in these processes, long range van der Waals which adhere 
the adsorbed water molecules to the surface of material, and between each layers of water 
molecules; diffusional forces for the water molecules to move inwardly and internally. As the 
surrounding partial pressure decreases, the water molecules within the material will only 
diffuse outwardly when all the surface adsorbed water has been removed.  
 
 
Figure 3-12 Schematic interpretation of sorption and desorption mechanisms considered in Young-
Nelson model. 
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 The model hence expresses in the fractions of surface covered by monomolecular layer 
(θ) and those covered by a layer of two or more molecules thick (φ ).  
( )RHRH
RH
−+= 1θ         Equation 3-9 
θφ RH=          Equation 3-10 
 
 The total moisture content within the material during both sorption and desorption is 
the summation of the three states of water held at the two processes: monolayer (Aθ); 
multilayer (βθ); and internally absorbed (Bφ  or Bθ.RHmax).  
 
Sorption: ( ) φβθ BAM s ++=       Equation 3-11 
 
Desorption: ( ) maxRHBAM d ⋅++= θβθ      Equation 3-12 
 
( ) ( ) ( )RHE
E
RHEE
E
E
RHEE
ERH −⋅+−⎥⎦
⎤⎢⎣
⎡ −−⋅−+−−−= 1ln1
1ln
1)1(
2
β  Equation 3-13 
where, ⎥⎦
⎤⎢⎣
⎡ −−=
kT
qqE L1exp ;   
m
dw
W
V
A
ρ=  ;   
m
bw
W
V
B
ρ=   Equation 3-14; 3-15; 3-16 
 
θ surface coverage (number of molecule /m2) 
Φ molecular thickness (number of molecule) 
RH relative humidity [ ] 
β total moisture adsorbed in a multi-layer (kg) 
Ms moisture content in sorption process (dry basis) (kg/kg) 
Md moisture content in desorption process (dry basis) (kg/kg) 
A, B, E parameters unique to each material 
q1 heat of adsorption of water bound to surface (kJ/mol) 
qL normal heat of condensation of water for the second and higher layers (kJ/mol) 
k Boltzmann’s constant (1.38065 x10-23 J/K) 
T absolute temperature (K) 
Vd volume of the adsorbed water (m3) 
Vb volume of the absorbed water (m3) 
ρw density of water (kg/m3) 
Wm mass of dry material (kg) 
Adapted from [91; 121; 122] 
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CHAPTER 4 DRYING AND DEHYDRATION OF CRYSTALLINE 
SOLIDS 
 
4.1 Introduction 
 
“For hot, cold, moist and dry, four champions fierce, strive here for mastery.” 
Paradise Lost by John Milton (1608-1674) 
 
 In the past, most pharmaceutical companies have focused on new drug discovery, or 
mere advertising, at the expense of technology research on materials processing or materials 
fundamentals. Since much less effort is being devoted to the technology used to manufacture 
drug products, and largely as a consequence of poor predictive understanding of these systems, 
pharmaceutical products and processes are often and still being designed empirically and 
monitored qualitatively [123]. Thus, the inherent reliability of pharmaceutical manufacturing is 
still problematic in some areas, and is likely to be increasingly challenged in the near future by 
the Food and Drug Administration (FDA) as they push pharmaceutical companies to obtain an 
improved fundamental understanding of the manufacturing processes. Moreover, such 
uncertainties sometimes lead industry to adopt overly conservative dosage strategies, reducing 
the efficacy and therapeutic range of new drugs. 
 
“Drying is a commonly practised art, but a neglected science”, as described 80 years 
ago by Prof. Thomas Kilgore Sherwood [124]. Considering the high value of pharmaceutical 
products, energy savings are usually a secondary consideration when a drying process is 
selected. Drying process in fact consumes 5 to 10 times the amount of energy per kilogram of 
solvent than in a distillation operation [125]. Thus, demands for product quality and cost 
effectiveness have to be reconciled.  
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Figure 4-1: Stages of a typical pharmaceutical process and their effect on key parameters. Adapted 
from [126]. 
 
As with most unit manufacturing operations, drying is best viewed as part of an 
integrated process that includes the wetting of solids (e.g. crystallisation) and isolation steps, as 
illustrated in Figure 4-1. Therefore, any changes in these operations can affect the 
crystal/particle size distribution, crystal properties and moisture content, and most importantly 
this will pose a significant impact on the drying efficiency. As the crystals become smaller, the 
increasingly important issue of the future drugs development is how to effectively dry the ever-
smaller particles. Due to their higher surface area, as well as smaller interparticle pore sizes, 
they will have a much greater affinity to moisture and thus exhibit a much enhanced tendency 
to agglomerate upon drying [123].  
 
 In addition, a knowledge of drying kinetics and the influence of the process parameters 
on it is required for dryer design and process control. Likewise, the dependence between 
material temperature and drying time, and moisture content of material that is dried, gives very 
important information for conducting of drying processes on thermolabile materials [15]. 
 
 
4.2 Types of Industrial Dryers 
 
 Over 99% of the industrial drying applications involve the removal of water. However, 
the selection of a suitable optimum dryer is likely to be an iterative search or traditionally 
known as a “black art” [127]. The dryers are commonly selected on the basis of the scale of 
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production required and the physicochemical properties of the material to be dried [128]. 
Nonetheless, there are a large number of dryer types available and within each type there are 
various options to be considered. The choice is rarely straightforward and frequently there are 
several dryers which can dry the material acceptably in many different ways. There have been 
several attempts to provide guidelines for dryer selection.  
 
 For example, earlier work by Sazhin and Shadrina [129] in 1979 distinguished 
dispersive methods of drying for four different material groups of solid based on their critical 
pore diameter (below 2 nm and up to 200 nm). Simpler decision trees for batch (Figure 4-2) 
and continuous dryers have been proposed by van’t Land in 1984 [130]. This work includes the 
special requirements, such as heat sensitive materials, material toxicity or propensity of the 
material to oxidatise. Strumillo and Kudra in 1986 [131] considered the key properties that 
determine a dryer selection. These properties are particle structure (i.e. crystalline or colloidal), 
states of moisture (i.e. superficial or bound), thermal resistant and polydispersity of the 
material. Yet, these procedures are largely qualitative, merely cover a few broad types of 
dryers and some require a large amount of input data. Moreover, it is often difficult to deduce 
where novel types of dryer design might be successfully employed. Separation Process Service 
(SPS, UK) [127; 132] has further developed a more comprehensive and rigorous classification 
system based on three major and five minor criteria. The SPS algorithm was incorporated into 
an expert system and had been proven in practice, even though there are still exceptions to the 
rules.  
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Figure 4-2 Decision tree for selection of batch dryer. Sources: [128; 130] 
 
 The three most common drying methods for pharmaceutical solids, are tray drying, 
vacuum drying and agitated contact drying [133-135]. The dryer typically used for laboratory 
and small-scale pilot work is the tray dryer (Figure 4-3). It is employed in industries where 
heating and drying are essential parts of its manufacturing process, for instance: chemicals, dye 
stuff, pharmaceutical and food products. It can be scaled up to moderate size, however its 
limitation in space and efficiency make further scale-up impractical. Though it is reliable and 
has no moving parts, operational and cleaning processes are labour intensive. In addition, 
solvent wicking often induces crust formation on the cake, hence necessitating other post-
drying treatment, e.g. milling, screening, and blending to ensure product homogeneity. 
 
 
Figure 4-3 Schematic diagram of tray dryer 
 91
 A vacuum tray dryer (Figure 4-4) meanwhile is primarily used for drying of high grade, 
temperature and oxygen sensitive products. This technique is particularly effective for drying 
of hygroscopic substances, which can be dried to a very low residual moisture content level. 
Moreover it is safer for the drying of toxic and high-potency substances as well as those 
containing flammable solvents. The smaller units of vacuum dryer are usually heated 
electrically, nonetheless, due to safety reasons in the larger units, steam or other heat transfer 
fluid (HTF) are circulated through the system instead. However, crust formation and caking 
problems occurred in tray dryer also happen in vacuum dryers. These problems nonetheless 
can be avoided by agitation in dryer, which is the major advantage of cone, paddle, tumble and 
fluidised bed dryers (Figure 4-5).  
 
Agitation is necessary especially when the drying process is scaled-up to the plant in 
alternative equipment due to the decreasing surface area exposed to heat transfer surfaces per 
unit volume in the new equipment. Agitation during drying promotes homogeneity of the dried 
product. On the other hand, incorporating agitation in the scale-up of a drying process can lead 
to changes in a material's physical properties, as the solids can break into smaller particles, 
particles then agglomerate into larger clusters, or granulate into new shapes and sizes. 
 
 
Figure 4-4 Typical vacuum tray dryer for laboratory and small-scale pilot work. 
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Figure 4-5 Types of agitated contact dryer commonly employed in the pharmaceutical industry. 
 
 
4.3 Drying of Crystalline Solids 
 
 Drying process is an important operation for the production of consistent, stable, free-
flowing materials for formulation, packaging, storage and transport. The drying step however 
can manifest itself as a production limiting operation within the overall manufacturing process 
from either a product quality or process time cycle perspective, especially for hydrate types of 
drug substances.  
 
 It is a great challenge to maintain an intermediate hydrate form of a drug substance. For 
example, drying a common excipient such as lactose monohydrate illustrates the potential 
problems of hydrate drying. Modifications of  spray dried α-lactose monohydrate observed 
include partial crystallisation of β-lactose, partial solidification of amorphous lactose and 
partial dehydration of α-lactose monohydrate [136]. Moreover, partial drying might produce a 
metastable intermediate hydrate, in which its free water can be released during storage and 
subsequently affect the chemical and physical stability of the drug substances [89]. Even at a 
smaller laboratory scale, needle-like APIs that are fed to the process dryers typically contain 
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55–75 %w/w of moisture. A problematic feature of starting the drying process at higher 
moisture contents in the conical dryer was that a hard layer of product formed against the drier 
wall when the wet cake was agitated with a moisture content greater than 50 %w/w. 
 
 Process control, especially inline monitoring of drying processes is therefore required 
to assist the development, optimisation of the drying process and the final production of quality 
bulk drug substances. Zhou et al. [137] has emphasised that the accurate switch-over period for 
using a humidified nitrogen supply, at which it can preserve the desired form of the compound 
by offering constant agitation which would in turn reduce the shear-induced dehydration at low 
water levels. 
 
 
4.3.1 Transport Phenomena of Moisture 
 
 Drying is essentially a process of simultaneous heat and mass transfer, where by the 
heat from surroundings is transferred to the particle surfaces initially by convection and later 
by conduction into the bulk particle. As the conditions in the dryer approach the boiling point 
of the solvent (or moisture), the free and unbound water on the particle surfaces will firstly be 
removed and evaporated into the surroundings by convection, at a constant rate limited 
primarily by the heat transfer rate, until the particle surfaces are no longer saturated. Once all 
the unbound water on the surfaces is removed, the removal of water trapped in the interstitial 
spaces and micro-capillaries within the crystals commences. Evaporation of this type of water 
is relatively slower compared with those water on the surfaces due to the additional energy 
required to overcome the capillary-attractive forces which bind the water to the particle. 
Subsequently, the drying rate is controlled by diffusion of moisture from internal spaces to the 
external surface and then transfer from the surface into the moving air [138]. Nonetheless, in 
most cases, this tightly bound water and also the hydrate water will not be completely removed.  
 
4.3.1.1 Drying phases 
 
The solvent content versus time data can be plotted directly, but it is often more useful 
to be plotted as drying rate versus time, or as drying rate versus solvent content (Figure 4-6). 
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The various stages of the drying process can be observed and clearly divided into three distinct 
phases: an initial heating rate period, a constant rate period, and a falling rate period [138; 139].  
 
 
Figure 4-6 Schematic diagram of drying stages of solids, depicted in drying rate against (a) time, 
and (b) solvent content. 
 
 The heating phase is considerably short and immediately followed by the constant rate 
period where the moisture is removed from a completely wetted surface. The diffusion rate of 
water from the internal void spaces to the surface via capillary force is larger than the rate of 
water evaporation from surface to the bulk [138]. The constant rate period continues until the 
moisture content in the solid becomes too low to maintained a saturated surface and hence the 
surface starts to dry out. The solvent content at this sharp inflexion point is known as the 
critical moisture content (Figure 4-6), and marked as the transition point between the constant 
rate period and falling rate period.  
 
 The falling rate period is characterised by a continuously changinng drying rate, due to 
the remaining solvent from the unsaturated surface and other components of the internal 
solvent. The rate limiting factor is the diffusion of moisture through the surface of the solid 
particles, which presents a formidable resistance to mass transfer. Therefore the falling rate 
period often dominates the drying cycle. It is an example of a case of diminishing returns, 
which is why a practical drying specification is so important. Eventually, the solid’s moisture 
content of solid reaches a thermodynamic equilibrium with the surrounding air and its relative 
humidity.  
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 Nonetheless, many actual drying curves may not appear to fit the model curves 
illustrated in Figure 4-6 well. Wet cakes with moisture content below the critical value may 
have come out of the isolation steps e.g. filtration unit, and consequently the entire drying 
cycle will consist of merely the falling-rate drying. In other cases, a short period of rapid 
solvent removal may occur, followed by a settling into the falling-rate period. This behaviour 
is most likely to occur if a product cake is placed in a preheated dryer and then a vacuum 
applied. The vast variations in the observed drying rates is one reason why it is valuable to 
know the critical moisture content of the system of interest.  
 
 Apart from that important use, results from laboratory drying studies are able to provide 
valuable information, including diagnostic data which can inform on the types of dryer that 
should be used industrially. For instance, if the constant rate period predominates in the 
laboratory test, it will then be more likely to predominate at larger scale too. In this case, 
agitated dryers may offer the shortest drying times by increasing the effective surface area 
exposed for both heating and drying. If the diffusion-limited falling rate period dominates, 
agitated dryers such as the orbiting screw cones or combination of filter dryers may increase 
the surface area exposed for diffusion by particle attrition [127; 132]. 
 
 
4.3.2 Convective Drying 
 
 Heat and mass transfer by convection, the combination of diffusion mass/heat transfer 
and bulk fluid motion, is generally used to describe the transport between a surface and a 
moving fluid. The flow can be forced or natural, internal or external and laminar or turbulent. 
Examples include; drying of materials under heated air flow, evaporation of water in cooling 
tower, blood oxygenation in lungs etc. [140]. Assuming only mass transfer from a wetted 
surface to the hot air and heat transfer to the solid surface by convection from the hot air 
(Figure 4-7), the transport between these two states can be expressed as: 
 
)( wTThAq −=         Equation 4-1 
 
)( XXKN wya −=         Equation 4-2 
 
 The heat required to vapourise the water on the surface can therefore be arranged into: 
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AMWNq waa λ=         Equation 4-3 
 
h heat transfer coefficient (W/m2.K) 
A exposed area (m2) 
T air temperature (K) 
Tw wet bulb temperature (K) 
Na flux of water vapour (kg/m2.s) 
Ky mass transfer coefficient (m/s) 
X moisture content in the bulk air (kg/kg) 
Xw moisture content on the surface (kg/kg) 
MWa molecular weight of water (kg/kmol) 
λw latent heat of vapourisation at Tw (kJ/kg) 
 
 
Figure 4-7: Heat and mass transfer near a wet surface. Adapted from [141]. 
 
The concept of a low mass transfer rate could provide a simple analogy between heat 
transfer and mass transfer, which can be efficiently exploited in engineering problems [142]. 
The boundary layer analogy relates the heat and moisture convection coefficients, using the 
dimensionless transport criteria; Nusselt (Nu) and Prandtl numbers (Pr), Sherwood (Sh) and 
Schmidt numbers (Sc) respectively [128]. 
 
( )Re*,
Pr
xfNun =         Equation 4-4 
 
( )Re*,xf
Sc
Sh
n =         Equation 4-5 
Where 
k
hLNu =  for heat transfer on a slab, and 
D
LK
Sh y=  for mass transfer of laminar flow 
parallel to a flat plate [141; 143]. 
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Hence, n
y
n Sc
D
LK
k
hL
=
Pr
       Equation 4-6 
n is a positive exponent less than 1, however for most applications it is assumed to be 1/3. 
Re Reynolds number [] 
L characteristic length (m) 
k thermal conductivity (W/m.K) 
D molecular diffusivity of an air-water mixture (m2/s) 
 
 
4.3.3 Migration of Moisture in Solids 
 
 
Figure 4-8 Moisture movement in a porous material during drying process. Adapted from [93]. 
 
As drying progresses in a porous solid (Figure 4-8), the moisture in the pore first flows 
as liquid under a hydraulic gradient, and then gradually migrates by successive evaporation and 
condensation between the liquid bridges as the air pockets appear. Further drying will 
eventually evaporate these liquid bridges, leaving only the absorbed moisture behind. The 
drying process will cease when all the absorbed moisture is removed by vapour diffusion. It is 
obvious that moisture can migrate in either the liquid or vapour phase, and since the physical 
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structure of the drying solid is subjected to changes during drying, the mechanisms of moisture 
transfer may also alter with elapsed time of drying [144; 145].  
 
Migration of moisture within the solid therefore may occur by any one or more of the 
following mechanisms given below [93; 128; 145]. Nevertheless, no one mechanism is likely 
to be dominant over the entire range of interest in a drying process. 
• Vapour diffusion due to partial vapour pressure, if the liquid vapourises within the 
material; 
• Liquid diffusion due to concentration gradient or gravity, if the wet solid is at a 
temperature below the boiling point of the liquid; 
• Knudsen flow or effusion, if drying takes place at very low temperatures and 
pressures, e.g., in freeze drying; 
• Surface diffusion; 
• Hydrostatic pressure differences, when internal vapourisation rates exceed the rate 
of vapour transport through the solid to the surroundings; 
• Combinations of the above mechanisms. 
 
 
4.3.3.1 Diffusion of moisture 
 
Diffusion takes place within the fine structure of the solid; and within capillaries, pores 
and small voids filled with vapour. As the diffusion theory does not consider the occurrence of 
shrinkage, case hardening or even sorption isotherm, the diffusion coefficient (Deff) is merely 
dependent on the temperature and concentration, which in this case, is the moisture content. 
Since the temperature gradient within a wet solid is negligible [93], the Fick’s law of diffusion, 
applied to a one-dimensional system (Figure 4-9a) can thus be expressed as: 
 
2
2
x
XD
t
X
eff ∂
∂=∂
∂
        Equation 4-7 
X free moisture content (kg/kg) 
t time (s) 
Deff diffusion coefficient (m2/s) 
x spatial dimension (m) 
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Figure 4-9 Water vapour transport based on (a) surface diffusion; (b) liquid diffusion; and (c) 
Knudsen diffusion mechanisms. Adapted from [146]. 
 
 
Figure 4-10 Relationship between diffusivity and moisture content of solid. Adapted from [93]. 
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 Relationship between diffusivity and moisture content is described by Keey [93] and 
illustrated in Figure 4-10. When less than a complete monolayer is present, the surface 
diffusion coefficient will reduce with the decreasing coverage, given that vapour phase 
diffusion is due to the loosely bound molecules and the remaining molecules would be those 
adsorbed at the higher energy sites. In addition, at low surface concentrations, the mechanism 
of diffusion involves the moisture adsorbed on the surface hopping (or slipping) from one side 
to another through the interactions between the surface and water molecules – known as 
‘random hopping model’ [147; 148] (or ‘random walk mechanism’ [149]). 
 
A diagrammatic attempt to represent these various energy relationships was first made 
by Carman and Raal in 1950 [148], and followed by Dacey in 1965 [149]. The top horizontal 
line in Figure 4-11a represents the energy in the vapour or gaseous phase, the second line 
refers to the energy level for diffusion; and the bottom line is for the energy level of the 
adsorbed molecules. The corresponding energies required for desorption are given by E, E1 and 
E2. However for diffusion, the molecules merely need a sufficient energy of activation, refered 
to as Ea, Ea1 and Ea2 to bring them up to the second horizontal line. In real cases, the surface is 
often heterogeneous (Figure 4-11c) where sites of many different energy levels exist.  
 
In the case of multilayer desorption, the moisture travels in the liquid phase, as the 
liquid diffusion movement in Figure 4-9b, the water vapour flux (Na) is therefore a function of 
the water concentration gradient within the solid. 
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Figure 4-11 Energy barrier to the movement of an adsorbed molecule across (a) a uniform surface; 
(b) a more complicated but still uniform surface; and (c) a heterogeneous surface. Adapted from [149]. 
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On the other hand, when the molecular mean free path16 is considerably larger than to 
the diameter (between 2 nm and 5 nm) of the pore or channel in which the diffusing molecules 
reside, the water molecules collide more frequently with the pore wall, rather than colliding 
with each other [145; 150]. In this instance (Figure 4-9c), the Knudsen number is more than 
5.0 and each molecule diffuses independently. The water vapour flux therefore is a function of 
the vapour density and vapour diffusivity within the solid. The Knudsen number (Kn) is a 
measure of the probability of the molecule-molecule collision compared to that for the 
molecule-matrix surface collision, of which Knudsen flow exists when Kn ≥ 1 [151]. The 
Knudsen diffusivity (Dk) can be presented by the following mathematical expression. 
 
5.0
2
3
2
⎟⎟⎠
⎞
⎜⎜⎝
⎛=
a
k MW
RTdD π         Equation 4-8 
 
Meanwhile for Knudsen diffusion in porous solids, 
( ) τ
ε k
k
D
porousD =         Equation 4-9 
d pore diameter (m) 
R gas constant (8.31447 J/K.mol) 
T absolute temperature (K) 
MWa molecular weight of water (kg/kmol) 
ε porosity (0-1) [ ] 
τ tortuosity [ ] 
 
 
4.3.3.2 Capillary flow in porous materials 
 
Capillarity refers to the flow of a liquid through the interstices and to the surface of a 
solid based on the molecular attraction between the liquid and solid. Real porous solids often 
contain many capillaries of different sizes, therefore at moderate pressure these micropores 
may be filled with liquid while the larger ones are not even covered by a monolayer [149]. In 
the early theoretical studies conducted within the period of 1927 to 1937, the effect of heat 
                                                 
16 The average length of a path covered by a molecule before colliding with another. The mean free path is gas 
density dependent and if the temperature is constant, it is also pressure dependent.  
Source: O'Hanlon, J.F., A User's Guide to Vacuum Technology. 2nd. edition 1989, New York: John Wiley & Sons, 
Inc.  
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transfer was neglected entirely and moisture transport was assumed to be either by diffusion 
[124; 152-155] or by capillary action [156-158] only. This oversimplication has led to 
misinterpretation of experimental results and also wrong predictions in general situations. Not 
until 1938, when Krischer’s model [159] considered some combination effects of capillary 
flow of liquid and diffusion of vapour in the internal moisture transfer during drying process. 
Capillary flow has been accepted as one of the key mechanisms of drying for porous materials 
[145], and the theories presented below take into account the heat and mass transfers in porous 
material. 
 
 
Evaporation-Condensation Theory  
 
This theory takes into account the simultaneous diffusion of heat and mass, which 
assumes that the rate of condensation of water vapour is equal to the rate of evaporation at the 
surface of the solid (Figure 4-12). For that reason, the theory allows no accumulation of water 
in the pores near the surface and these pores are a continuous network of spaces within the 
solid [160]. The heat and mass transfer phenomena thus considers the vapour concentration 
and volume fraction of air in the pores, tortuosity of the diffusion path and solid properties (i.e. 
skeleton density, specific heat) [146; 160]. 
 
 
The Luikov Theory 
 
The discovery of moisture thermal diffusion phenomena was made in 1934 [161], when 
the direct relationship between liquid and heat transfer in a capillary-porous body was 
determined. This interrelation is attributed to the fact that liquid movement is not only under 
the influence of the liquid concentration gradient, but also under that of a temperature. And if 
the liquid evaporates inside the porous body, the vapour movement within the capillary-porous 
body has to be considered too [162].  
 
 The principles of irreversible thermodynamics were employed in the development of 
Luikov’s Theory, which accounts for the interdependancies between two concurrent driving 
forces (i.e. concentration and temperature gradients) and enables the combination of the heat, 
mass and momentum transfers to be analysed [163]. The approach postulated that the 
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corresponding equilibrium values of the dependent variables, at the surface of the drying 
material, were reached instantly during a drying process – later known as the surface boundary 
condition. Shrinkage, contraction and deformation are not considered in these equations. Most 
importantly, the Luikov Theory assumed isotropy (i.e. constant ‘moisture diffusivity’ and 
‘specific moisture capacity’) [164], which leads to an apparent mathematical paradox if the 
model is extended to describe non-isothermal drying conditions. 
 
 
 
Figure 4-12 Proposed moisture transfer mechanisms in a porous medium. 
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The Philip and De Vries Theory 
 
Philip and De Vries developed a set of equations to describe the heat and mass transfer 
in porous materials under moisture and temperature gradients [165]. A vapour flux (Jv) results 
in the condensation at side A, and evaporation at side B, which subsequently decreases the 
curvature at A, and increases the curvature at B (Figure 4-12). In this case, the capillary flow 
equals to the rate of condensation and the rate of evaporation and the vapour flux can be 
expressed as: 
 
( ) wwv PP
PaDJ ρτ ∇⎟⎟⎠
⎞
⎜⎜⎝
⎛
−−=        Equation 4-10 
where ( )cTfw ,=∇ρ  
 Jv vapour flux (kg/m
2.s) 
 τ tortuosity [ ] 
a volumetric air content within solid (m3) 
D molecular diffusivity of water vapour in air (m2/s) 
P total pressure (Pa) 
Pw partial pressure of water (Pa) 
ρw water vapour density (kg/m
3) 
T temperature (K) 
c concentration (kg) 
 
 
The Berger and Pei Theory 
 
 A mathematical model of drying was presented by Berger and Pei in 1973 [164], based 
on Krischer’s theory, in which the dynamic drying behaviour of a solid can be predicted once 
the basic physical parameters of the system are known. They have demonstrated that the 
characteristics of the drying behaviour during the falling rate period, to a large extent, are 
controlled by the sorption isotherm of the system.  
 
The Berger and Pei theory was based the assumptions that; liquid movement due to 
capillary flow and concentration gradients, vapour movement on the other hand due to vapour 
pressure gradient, and heat transfer by conduction mode through the solid. The moisture 
content, partial vapour pressure and temperature are in equilibrium at any location within the 
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material. Figure 4-12 shows a sketch illustrating the theoretical model, where the liquid and 
vapour fluxes are presented as: 
 
 
x
XDJ lll ∂
∂−= ρ         Equation 4-11 
( )
x
XDJ vvv ∂
∂−−= ρε         Equation 4-12 
Dl liquid diffusivity in solid (m2/s) 
Dv vapour diffusivity (m2/s) 
ρl,v density of liquid and vapour, respectively (kg/m3) 
X moisture content (kg/kg) 
x space coordinate for heat and mass transfer (m) 
ε porosity [ ] 
evq&  rate of latent heat required for / liberated by phase changes (Figure 4-12) (kJ/kg.s) 
evm&  rate of evaporation inside the solid (Figure 4-12) (kg/s) 
 
 
The Whitaker Theory 
 
 Whitaker and his associates [166; 167] have constructed a simplified theory which 
describes the transport of heat, mass and momentum in a granular porous media using the 
microscopic transport equations for continuous media by the volume averaging method. The 
basic assumptions made are that there is no influence of gas phase motion on the liquid flow, 
and the capillary pressure is merely a function of temperature and saturation. 
 
Shown in Figure 4-12 is the multiphase system where σ-phase is the rigid and inert 
solid phase; β-phase represents the liquid which may be continuous or discontinuous; and 
finally the γ-phase refers to the vapour (and air) which is a single inert species. Using the 
following three equations from the laws of continuum physics, the boundary conditions at 
these three phase interfaces (solid, liquid and vapour) were derived into six primary transport 
equations, as explained in [167]. 
 
Continuity equation: ( ) 0=⋅∇+∂
∂
ii
i v
t
ρρ      Equation 4-13 
Momentum energy: 02 =∇++∇− vgp ηρ     Equation 4-14 
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Thermal energy: Φ+∇=∂
∂ T
t
TC p
2λρ      Equation 4-15 
ρ total density (kg/m3) 
ρi individual density (i = liquid or vapour) (kg/m3) 
v mass average velocity (m/s) 
vi individual mass velocity (i = liquid or vapour) (m/s) 
t time (s) 
p pressure (Pa) 
g gravity vector (9.81287 m/s2) 
η viscosity (kg/s.m) 
Cp heat capacity (J/K) 
T temperature (K) 
λ latent heat (kJ/kg) 
Φ source or sink of electromagnetic energy (kJ) 
 
 
4.3.4 Moisture Removal in Vacuum 
 
 By using a vacuum and/or reduced pressure drying, the increased pressure gradient 
between the material and surrounding atmosphere accelerates mass transport [168], as moisture 
boils within the material at a much lower temperature. Hence, lower reduced pressures can 
achieve an elevated mass transport due to the higher pressure gradient.  
 
 
4.3.4.1 Mechanisms of vapour evolution from solid 
 
Vapours released from the surface of a solid are often a result of vapourisation, 
desorption and diffusion. Vapourisation refers to the event of the thermally stimulated 
molecules entering into the vapour phase. In a dynamic equilibrium, the pressure of the vapour 
over a surface is known as the vapour pressure of the solid, provided that the solid and the 
vapour are at the same temperature. Hence, the maximum rate of evaporation Г [169] of a solid 
can be determined from its vapour pressure P, temperature T, surface area A and molecular 
weight of the solid MW: 
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( ) ( ) 21
241063.2/
TMW
PAsmolecule
⋅
×=Γ      Equation 4-16
  
 Thermal desorption on the other hand is a surface phenomenon describing the transition 
between separate phases. The rate of desorption is a function of the molecular binding energy, 
temperature of the surface and the number of monolayers of surface coverage. In vacuum 
conditions, physisorbed molecules are removed quickly even at ambient temperature, while 
chemisorbed molecules desorb slowly unless the surface is heated. The average residence time 
of a chemisorbed water molecules (H2O-H2O with desorption energy of 40.6 MJ/kmol) is 10-5 
seconds at 22ºC and reduces to 10-9 seconds at 450ºC [169].  
 
When water molecules are transported from the inner areas (i.e. intra-granule or voids 
within solids) of initially higher moisture concentration to the relatively dry surface, the 
movement is of a diffusive nature with the water concentration gradient as the driving force. 
Diffusion proceeds at a much slower rate than desorption, therefore the rate of transport 
through the bulk to the surface ( m& , kg/s) governs the rate of release into the vacuum, which 
can be represented as: 
 
( ) ⎥⎦
⎤⎢⎣
⎡
⎟⎟⎠
⎞
⎜⎜⎝
⎛ −−+⎟⎠
⎞⎜⎝
⎛= ∑∞
0
222
1
0 exp121 Dt
dn
t
DXm n&      Equation 4-17 
X0 initial moisture content (kg/kg) 
D diffusivity (m2/s) 
t time (s) 
d thickness of material (m) 
n number of molecules 
 
If a vacuum is applied to a porous solid, as in a freeze dried solution, the water vapour 
can no longer travel by diffusion as the molecular mean free path is of a similar order to the 
pore diameter. The Graham’s law of effusion prevails and the rate of effusion (N) is inversely 
proportional to the square root of the molecular weight (MW) of the vapour or gas, as long as 
the temperature and pressure are held constant. 
 
j
n
j
j MW
N 1
1
∑
=
=         Equation 4-18 
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4.3.4.2 Buoyancy effects under vacuum conditions 
 
 Buoyancy is the upward force exerted on an object when it is immersed, partially or 
fully, in a fluid and strictly where the fluid is subjected to a gravitational force but is not in free 
fall. All objects that are surrounded by fluids (i.e. air, water) on the surface of the Earth 
experience buoyancy to some degree. Although buoyancy cannot affect the intrinsic mass17 
and weight of an object, buoyancy however can and does alter the perception of both mass and 
weight by affecting the measurement processes. The effects of buoyancy forces therefore have 
to be taken into account when measuring the weight of a sample, especially when the 
surrounding environment transitions from atmospheric to vacuum conditions. When measuring 
sample mass update data using gravimetric methods such as Dynamic Vapour Sorption (DVS), 
bouyancy forces may well need to be taken account of. 
 
 
Figure 4-13 Objects at rest on an equal arm balance in a vacuum condition. 
 
 The buoyancy force is referring to the weight of the air displaced on the object/sample, 
which is given by the density of the media surrounding the object (e.g. standard air of density; 
ρair = 1.2 kg/m3 at 20ºC, 1013.25 mbar and 50 %RH) and the volume displaced (Figure 4-13). 
The buoyancy effect is however, less significant in an air density range of 1.18 to 1.22 kg/m3.  
 
( )[ ]
( )T
TRHP
air +
−−=
15.273
020582.000252.0348444.0ρ
    Equation 4-19 
 
 Figure 4-14 illustrates the influence of buoyancy effect with varying air density in the 
system. In scenario (a) where the system is in standard air of density (ρair = 1.2 kg/m3). The 
                                                 
17 By definition, mass is a measure of the amount of material in a body and immersing it in a liquid does not 
change the amount. 
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weights will balance as shown if the conventional masses18 are equal (W1 = W2). Meanwhile as 
the air becomes less dense (scenario (b)), the larger weight, W2 will appear to be heavier. 
Therefore the apparent weight difference is (V1 - V2) x (1.2 – 1.1) kg. Conversely, if the air 
becomes denser, the larger weight, W2 will appear to be lighter. Subsequently the apparent 
weight difference is equal to (V1 - V2) x (1.2 – 1.3) kg. 
 
 
Note: W = conventional mass (kg); V = volume (m3) 
Figure 4-14 Variation in buoyancy effect with varying air density. Source: National Physical 
Laboratory [170] 
 
Hence, buoyancy correction (BC) to be taken into account is given by: 
 
( ) ( )2.1−⋅−= airholdersample VVBC ρ       Equation 4-20 
 
steels
holder
holder
m
V
.ρ=         Equation 4-21 
where Vholder represents the volume of the sample holder.  
                                                 
18 Conventional mass is the mass that an object would appear to have if weighed at 20ºC in air of density of 1.2 
mg/cm3 against a standard material (e.g. stainless steel) having a density of 8.0 g/cm3. 
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4.4 Dehydration of Crystalline Hydrates 
 
 The dehydration of hydrates abides by the regular features of a topochemical19 thermal 
decomposition reaction, expressed as the following.  
 
A (solid) Æ B (solid) + C (gas) 
  
 The reaction involves the destruction of a crystal lattice and the formation of a new 
lattice which may sometimes differ markedly from the primary lattice in its structural 
characteristics. The most important early review by Garner in 1956 [171] has strengthened the 
theoretical importance of the interface model for dehydration in crystals through consideration 
of the relationships between reactant and product phases. Subsequent reviews include Young 
[172] who summarised aspects of the dehydration literature up to about 1965; Makatun and 
Shchegrov’s review [173] which drew attention to the types and strengths of bonds that retain 
water in crystalline hydrate, and Lyakhov and Boldyrev’s review [174] which summarised the 
factors that influence experimentally measured dehydration kinetics. In recent years, Galwey 
reviewed the research concerned with characterising dehydration mechanisms [175], and 
examined all relevant features of dehydration phenomena [16]. 
 
 
4.4.1 Dehydration Mechanisms of Hydrate 
 
 There are primarily three types of process and the kinetic characteristics of solid state 
reactions [176]; interface advance, chain type and diffusion limited. These behaviours are not 
necessarily mutually exclusive and might occur simultaneously (or orderly) during a water 
elimination process. Chain type reaction however has yet to find its application in dehydration 
process; therefore it is not discussed in this thesis. Figure 4-15 illustrates the processes 
participating in the dehydration of crystalline solids, by which Galwey [175] generalised the 
sequence of water elimination as the following: 
                                                 
19 Topochemical reaction results in significant structural modifications to the host (i.e. breakage of bonds) when 
there is an introduction of a guest species or a departure of a species within the host. As explained in IUPAC 
Compendium of Chemical Terminology (1997). 
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1. Water mobility within the crystalline reactant. 
2. Diffusive migration of water to crystal edge or reaction interface, hence the vacancy of 
intersite increases. 
3. Desorption as the water volatilises at the crystal edge or interface. 
4. Chemical reactions between diffused water and solid. 
5. Recrystallisation of solid reactant to product structure. 
6. Water vapour adsorption/desorption on products solid. 
7. Intranuclear diffusive escape of water and loss beyond crystal. 
 
 
Figure 4-15 Schematic representation of interface structure for general dehydration 
reactions. Source: [175] 
 
During the interface advance mechanism, it is known that the dehydration of solids may 
proceed with two or more distinct controlling steps; chemical changes and a phase 
transformation [177]. The chemical change may be self-inhibiting and its initial occurrence 
may be limited to a thin surface layer that may exhibit an orange peel texture20 and the other 
'superficial skin' properties. The continuation of the chemical reaction necessitates the 
recrystallisation of product phase. These two processes may proceed separately, perhaps some 
distance apart, within the reactant particle, which will be discussed in the following section.  
                                                 
20 Orange peel texture refers to a specific circular textural feature on a crystal surface, which is strongly 
reminiscent of the outer layer of an orange peel. 
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According to Byrn et al. [5], the breaking of hydrogen bonds with the water molecules 
is the first step in the dehydration reaction. Once the first water molecule at the surface is 
released, the loss of the subsequent water molecules then sets up a thermodynamic gradient 
along the channel. On the other hand, Febles et al. [83] observed two types of water molecules 
moving with different dynamics within the lattice. The water molecules covering the surface of 
the pore lattice remained hydrogen-bonded most of the time thus preventing the pore from 
collapsing. Meanwhile the clusters of water molecules distributed along the pore provide a 
wetting path that causes the hydrate water to reversibly fill the pore, depending on the exterior 
water vapour pressure. Airaksinen et al. [178] has warned of the tendency of the channel type 
hydrates to dehydrate more rapidly than isolated site hydrates when they were treated 
isothermally at moderate temperatures, for example: ampicilin trihydrate. Thus, the 
dehydration kinetics of channel hydrates is expected to be more sensitive to changes in 
morphology than isolated site and ion-associated hydrates.   
 
Another simplified representation (Figure 4-16) depicts the formation of polymorphic 
anhydrates and/or intermediate labile phase following the dehydration of a hydrated structure. 
Catastrophic ‘hard’ dehydration conditions [179] tend to yield an amorphous material, which 
in turn might evolve into a variety of anhydrates by means of a nucleation and growth 
mechanism. This kind of destructive-reconstructive mechanism is more likely to loose the 
structural information of the initial hydrated material. In 1911, Partington [180] proposed an 
amorphous intermediate step during the dehydration of salt hydrate, and for many years since, 
it was thought that nucleation and growth of the stable crystalline phase occur rapidly. 
However, since 1930, other researchers have demonstrated that under vacuum conditions, 
certain salt hydrates formed an intermediate amorphous phase, but recrystallised slowly and 
some appeared only after prolonged heating [181]. Conversely, smooth dehydration conditions 
allow a cooperative departure of water molecules, with a subsequent structural reorganisation 
step which leads to formation of the nearest possible crystalline packing, with part of the initial 
structural information being preserved [99]. 
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Figure 4-16 Schematic diagram of formation of new polymorphs following different dehydration 
chemistry. Source: [16; 99] 
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* Includes interface advance, nucleation and growth 
Figure 4-17 Properties and rate determining steps of dehydration. Adapted from [16]. 
 
 
4.4.2 Dependence of Dehydration Rate on Solid State Reactions 
 
 The dehydration rate of hydrates depends on a wide range of both internal and external 
factors. General features of solid state reactions such as: self-cooling, formation of labile phase 
(or intermediate hydrate) and impedance layering associated with vapour pressures of water 
and organic solvent21 have an influence on the dehydration behaviour and kinetics [174]. 
 
4.4.2.1 Self-cooling effect of solids 
 
Most crystal hydrates, particularly inorganic hydrates, loose water in a markedly 
endothermic process. Upon dehydration in a vacuum incubator, the heat exchange between the 
sample and incubator occurs by radiation; therefore the operating temperature set might not be 
the same as the temperature at which the water elimination takes place. Such a discrepancy is 
known as the ‘self-cooling’ effect. Calculations based on the classical black-body radiation 
                                                 
21 It is well established that organic solvents facilitate the dehydration process. Likewise, water vapour possesses 
similar effect to desolvation rate of organic solvates. 
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theory were proposed to compensate for this effect. The Smith and Topley equation determines 
the sample’s temperature by inclusion of physical characteristics of the sample: 
 
[ ]44121038.1 TTA
dt
dm ′−×⋅=⎟⎠
⎞⎜⎝
⎛− −λ       Equation 4-22 
λ heat of reaction (kJ/kg) 
(-dm/dt) mass rate of reaction (kg/s) 
A external surface area of the sample (m2) 
T, T’ temperature of the thermostat and sample, respectively (K) 
 
Another analogous equation, used by Cooper and Garner, includes the assumption of Planck's 
law22.  
 
[ ]440 TTh ′−Δ⋅=Δ⋅⋅δλ        Equation 4-23 
δ reaction rate (kg/m2.s) 
∆0 initial surface area of which radiation takes place (m2) 
∆ surface area of separation at specific time (m2) 
h Planck’s constant (6.626 x10-34 m2.kg/s) 
 
4.4.2.2 Gaseous atmosphere 
 
Hydrates are strongly associated with a gaseous environment and their stability cannot 
be specified without the knowledge of partial pressure or relative humidity of water at each 
temperature of interest. Drying and dehydration at atmospheric conditions can occur for three 
different types of vapour or gaseous streams; inert gases, water vapour (%RH) and organic 
solvent vapours (%P/P0). In an inert environment, Lyakhov and Boldyrev [174] observed no 
distinct effect on the rate of dehydration until pressure exceeded 4 mmHg, where diffusion 
control has begun. 
 
 Though water may be uniformly and strongly bound within channels, they still exhibit 
an onset of dehydration at relatively low temperatures or when being stored at low relative 
humidity. However, most dehydration experiments when undertaken at very low relative 
humidities, may not be very realistic or revealing in their behaviour. As mechanisms change, 
                                                 
22 Planck's law of black body radiation describes the intensity radiated by a blackbody at temperature T as a 
function of frequency (or wavelength). 
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dehydration characteristics also change. Although a majority of the crystal hydrate decrease 
gradually in drying rate at increasing water vapour pressure (%RH), an abnormal change of the 
dehydration rate of crystalline hydrates with an increase of water vapour pressure was 
discovered by Topley and Smith in 1931.  
 
 
The Smith and Topley Effect 
 
 In contrast to the expected monotonous decrease with increasing %RH, the dehydration 
rate, described by the Smith and Topley effect in Figure 4-18, begins to increase upon reaching 
a certain critical pressure. The dehydration rate then passes through a maximum vapour 
pressure at point C before eventually diminishes to zero rate at the equilibrium dissociation 
pressure. 
 
 Volmer and Seydel [182] proposed the mechanism of product recrystallisation in the 
presence of water vapour, illustrated in the top diagram of Figure 4-18. This mechanism 
implies that the initial product of dehydration is a highly disordered material (amorphous 
phase), which is unstable but yet retains the structural features of the reactant lattice (Region 
A-B). As the water vapour pressure increases, the available water facilitates the structural 
reorganisation. The growth of a crystalline product and the subsequent formation of additional 
channels, cracks and pores between product grains allow rapid escape of the hydrate water 
from the reaction zone. As a result, the rate of dehydration increases (Region B-C). When it 
passes through a maximum vapour pressure, the reverse reaction (i.e. rehydration) becomes 
significant, hence explaining the gradual decline of the dehydration rate (Region C-D). 
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Figure 4-18 Smith-Topley effect: schematic diagram of variation in dehydration rate with 
prevailing water vapour pressure and the corresponding mechanism. Adapted from [176]. 
 
 
Effect of Dehydration on Superficial Textural Development 
  
 For surfaces without any active imperfection, as depicted in Figure 4-19, exposure to 
water vapour is able to enhance the subsequent textural development, even though they may 
display different patterns of change of intranuclear surface: ‘orange peel’ texturing of 
internuclear or a remarkable rise in nucleation density [171]. The properties of such a layer 
appear not to be strongly influenced by the crystallographic orientation of the face because of 
the "real" reorganised structure of the boundary layer. No considerable strain is associated with 
the interface and the nucleus are regarded as a texture specifically generated to temporarily 
retain sufficient water vapour to promote the recrystallisation, which is the essential feature of 
interface advance mechanism. The reorganisation of such superficial ‘orange peel’ layer which 
takes place upon re-exposure to water vapour appears to be a general phenomenon feature for 
several salt hydrates which exhibit reversible dehydration/hydration [183; 184]. 
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Figure 4-19 Schematic representation of surface texture changes on crystals without active 
imperfection during low water vapour pressure condition. Adapted from [171; 185]. 
 
 
4.4.3 Dependence of Dehydration Rate on Structural Factors 
 
A widely accepted concept for the dehydration process is that the chemical 
transformation occurs within an interfacial zone of locally heightened reactivity, as 
demonstrated previously (Figure 4-19). This interfacial zone has been regarded as a constantly 
advancing chemical perturbation front, but the material comprising of both the reactant and 
product would undergoes only minor displacement with concurrent changes in bonding. Apart 
from that, Byrn et al. [5] have identified that dehydration temperature and reaction time depend 
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on the extent of the crystal defects. The threshold temperature23  is closely related to the 
structural effects of the crystal hydrates (e.g. tunnel area, crystal packing, crystal defects and 
the hydrogen-bond energy), and has to be taken into account for the dehydration process. The 
lattice defect levels varied with the intensity of the mechanical pretreatment, e.g. milled lactose 
monohydrate, meanwhile are able to promote the hydrate removal of a material [186].  
 
4.4.3.1 Crystal defects 
 
 Since 1950s, the relationship between disorder and the reactivity of crystals became a 
subject of research in a number of laboratories, particularly Professor Vladimir V. Boldyrev, 
who suggested that it is the displacements of protons, ions, and electrons in the lattice that give 
rise to the rupture of chemical bonds and, eventually leads to the decomposition of the reactant 
[187]. The presence of defects influences strongly the rate-limiting stage of the reaction. 
Therefore, since then the main methods of investigation are essentially based on studying the 
effect of lattice disorder. 
 
Every crystal must have at least one imperfection, that is, its surface. A crystal surface 
is often visualised as being a smooth sheet of atoms whose pattern is the same as that on a 
parallel plane inside the crystal [188]. Depending on the surface structure, the various defects 
have different coordinates, for example free adatoms on the surface, kinks, vacancies and 
atoms in surface layer [189], depicted in Figure 4-20. These surface defects are formed due to 
thermal activation, serving as preferred binding and reaction sites for either chemically or 
physically adsorbed molecules. The dynamical behaviour and stability of such defect sites may 
influence the surface reaction kinetics. Other than the surface defects, there are also three 
general crystal defects, namely: 
 
1. Point defects - atoms missing or in irregular places in the lattice (i.e. lattice vacancies, 
substitutional and interstitial impurities, self-interstitials). 
2. Linear defects - also known as dislocation, groups of atoms in irregular positions (e.g. 
screw and edge dislocations). 
3. Planar defects - interfaces between homogeneous regions of the material (e.g. grain 
boundaries, stacking faults, external surfaces). 
                                                 
23 the temperature at which 2% of the water is lost. 
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2
1
3
4 1:  free adatom
2:  kink atom
3:  mono-vacancy
4:  surface atom
 
Note: atoms in deeper layer shown in darker shading. 
Figure 4-20 Ball model of atomic configurations on a FCC (100) surface. Adapted from [189]. 
 
 Figure 4-21 illustrates the surface texture changes occurred during the dehydration of a 
solid with defects. The recrystallisation of the dehydrated product in this case is a consequence 
of water loss at surface exposed following crack propagation through stress relief in the 
vicinity of the phase transition. Nucleation at first occurs within these zones of structural 
distortion, and is promoted by the local water vapour retention. Nucleus growth is therefore an 
autocatalytic reaction dependent on sufficient availability of the volatile product at the 
interface. 
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Figure 4-21 Schematic representation of surface texture changes on crystals with active 
imperfections during vacuum dehydration process. Adapted from [171; 185]. 
 
4.4.3.2 Types of water arrangement in hydrate 
 
Water molecules in hydrates may be classified according to the number of nearest 
water neighbours [81] or hydrogen bonding with the oxygen and nitrogen atoms within the 
crystals [190]. The water neighbours are denoted as type d (proton donor) or a (proton 
acceptor). For instance, in a tetrahedral arrangement, one water molecule can be hydrogen 
bonded to four different molecules. There are nine possibilities of molecular arrangements, 
from an isolated water molecule up to four water neighbours. 
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Gillon et al. [190] however proposed eight types of molecular arrangement for water 
molecules within organic hydrates, following a thorough search of the Cambridge Structural 
Database (CSD). The classification is mainly based on the interaction/ role of water molecule 
with its surroundings. The arrangements include: simple arrangement which water acts as a 
donor or acceptor and forming merely one hydrogen bond; arrangements which water forms 
two hydrogen bonds, and subsequently three and four, the maximum hydrogen bonding 
capacity. Their study nonetheless is limited; as they only consider the hydrogen bonds for 
oxygen and nitrogen atom as proton acceptors, while OH- and NH- groups as the only proton 
donors. 
 
 
Water network/cluster in hydrate 
 
The water networks in hydrates are associated with hydrogen bonding when numerous 
types of water molecules repeat in the similar structure. Wells [81] put forward the concept of 
finite and infinite types of water networks. In the former category, pairs of water molecules 
hydrogen bonded together are referred to as dimer (e.g. MgS2O3.6H2O), whilst group of three 
as trimer (e.g. CaCO3.6H2O), and eventually till octamer (e.g. Cu(UO2PO4)2.8H2O). Water 
networks of infinite size are seldom encountered and being grouped into chains and sheets. An 
exemplary study of this area is outlined in Wells [81], and the various water network shown 
may be used as basis of classification to relate the kinetic aspect of drying behaviour for 
crystalline hydrates.  
 
 Infantes and Motherwell [64] conducted a comprehensive study on the classification of 
water clusters in organic crystals, based on the Cambridge Structures Database (CSD). Discrete 
rings and chains, infinite chains and tapes, and layer structures were employed to describe the 
patterns of water clusters, denoted as D-, R-, C-, T- and L-patterns. Discrete and chained 
clusters with 4-membered water rings, and taped clusters with 5-, 4, 6-membered rings were 
identified as the predominant groups.  
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Geometry of water channel in hydrate 
 
The geometry of a channel is associated with the shape, size and number of tunnels 
within the crystalline hydrates. The narrowest lattice pore known has an inner diameter of 3.0 
Å, which is only slightly larger than the diameter of the water molecule, 2.8 Å [83]. Perrier and 
Byrn [191] have highlighted the importance of the cross sectional area of the water channel in 
relationship to the dehydration behaviour of hydrates. In their studies of water tunnels in 
theophylline monohydrate, the water chain of some channel hydrates (e.g. theophylline 
monohydrate) displayed a zigzag pattern, of which their cross-sectional areas might not 
accurately reflect the actual size of the channel. As depicted in Figure 4-22a, theophylline 
molecules are in direct contact with water molecules in the narrow hydrate water channel.  
 
In contrast, caffeine 4/5 hydrate (Figure 4-22b) exhibits larger cross sectional tunnel 
areas, hence it has vacancies suitable to accommodate non-stoichiometric water molecules. 
The tunnel enables the water molecules to readily effloresce in the a-crystallographic direction 
[67]. The size of the tunnel may also facilitate the diffusion of intact water molecules along the 
channel and the replacement of water molecules by D2O molecules via hydrogen/deuterium 
(H/D) exchange. This finding hence agrees with [138], who concluded that crystalline solids 
like caffeine 4/5 hydrate should be relatively easy to dry due to the extensive distribution of 
water within the capillaries and the large water tunnels. 
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Distances, X and Y, denote the shortest distances between opposite atoms (in 3D) forming the channel. 
Figure 4-22 Crystal structure of (a) theophylline monohydrate and (b) caffeine 4/5 hydrate. Adapted 
from [67]. 
 
 
4.4.4 Dependence of Dehydration Rate on Particle Size and Morphology 
 
As the crystals become smaller in size, the increasingly important issue for product 
development is how to effectively dry these small particles. Due to their larger surface area, 
they will have both a much greater affinity for moisture and a much enhanced tendency to 
agglomerate upon drying. For smaller particle sizes (less than 10 μm), the crystallite size may 
not be the primary particle size, and hence the drying and dehydration rate may be determined 
by the size of the agglomerated material. It is known that the primary influence on dehydration 
rate is the differences in particle size (and agglomeration), with morphology of the solid 
representing a secondary influence.  
 
In the drying context, solids with larger particle sizes require a longer growth 
(crystallisation) time but they are easier to be filtered, hence the product purity goes up (Table 
4-1). Conversely, drying of any internal moisture at the final stage requires a longer residence 
(a) 
(b) 
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time, leading to a substantial increase in the volume, holdup and bed depth of the dryer. The 
effect of crystal habits and agglomeration on dehydration will be discussed in detail in Chapter 
8. 
 
Table 4-1: Typical effects of particle size on equipment design parameters. 
Particle size 30 μm 100 μm 300 μm 
Growth time 5 minutes 15 minutes 45 minutes 
Crystalliser size 1.0 m3 1.4 m3 2.1 m3 
Impurity in cake 0.2 % 0.1 % 0.05 % 
Cake moisture* 20 %w/w 10 %w/w 5 %w/w 
Cake handling properties Difficult and sticky Moderate Easy and free flowing 
Dryer diameter 4.0 m 2.83 m 2.0 m 
Residence time 20 minutes 40 minutes 60 minutes 
Bed depth 0.25 m 1.0 m 3.0 m 
*Cake moisture in dry basis. 
Adapted from [192]. 
 
4.4.4.1 Thermodynamic aspects of a dehydration process 
 
Dehydration is a strongly endothermic process which may be reversible. The presence 
of water molecules influences the intermolecular interactions (in terms of its internal energy 
and enthalpy) and the level of crystalline disorder. As a result of hydration of solids, changes in 
shape and symmetry of the unit cell will alter the entropy of the solid. These changes then 
influence the free energy, chemical potential and thermodynamic activity (interrelated to 
fugacity) of the solid. The stability of a hydrate relative to the anhydrate (or lower hydrate) 
depends upon the water activity in the vapour phase (also relative humidity). This 
thermodynamic description of hydrate equilibria is a vital link to the stability of hydrated forms 
and also explains the inherent differences between hydrates and polymorphs [193].  
 
In liquid water, the energy of attraction between water molecules (hydrogen bond 
enthalpy) is about 23.3 kJ/mol. The Gibbs free energy change (ΔG) presents the balance 
between the increases in bond strength (ΔH) and consequent entropy loss (ΔS) on hydrogen 
bond formation (i.e. ΔG = ΔH-TΔS) and may be used to describe the balance between 
formation and breakage of hydrogen bonds. Several estimates give the equivalent Gibbs free 
energy change (ΔG) for the formation of water's hydrogen bonds at about 2 kJ/mol at 25°C 
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(Silverstein et al., 2000), the difference in value from that of the bond’s attractive energy being, 
due to the loss in entropy (i.e. increased order) on forming the bonds. A summary of this 
relationship is outlined in Figure 4-23.  
 
Water molecule(s) in crystal structure
Interaction between molecules within solid
Internal energy Disorder due to thermal motions & spatial locations
EntropyInternal energy + PV = Enthalpy
Free energy = Enthalpy – T.Entropy
Partial molar free energy = Chemical potential
Thermodynamic activity
Solubility = thermodynamic activity of solid/ 
activity coefficient of dissolved solute
Thermodynamic activity α rate of reaction
A.k (Cs – C) = J.A = dm/dt = Dissolution rate
Stabilty = 1 / rate of decomposition
Bioavailability & product performance
Note:
A = area of the solid exposed to dissolution medium (m2)
Ky = mass transfer coefficient (m/s)
Cs = solubility of solid (g/100 g solvent)
C = concentration dissolved (g/100 g solvent)
J = intrinsic dissolution rate (g/s)
dm/dt = dissolution rate of solute (g/s)  
Figure 4-23 Effect of hydration on the physical and pharmaceutical properties of a drug. Adapted 
from [193]. 
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4.5 Dehydration Kinetics 
 
 The purpose of various kinetic studies is to gain an insight into the controlling factors 
and mechanisms of the chemical changes occuring in the reactant. Kinetic measurements for 
dehydration reactions are often empirical and are sensitive to experimental conditions due to 
the influence of reversibility and of endothermicity. Generally, a set of measured values 
(fractional reaction, time, temperature) are first determined isothermally or under a controlled 
temperature change. Having these data, the solid state kinetic model would provide the most 
acceptable fit for the reaction and the magnitudes of the Arrhenius parameters [16]. 
Subsequently, any other relevant experimental measurements can be combined with the solid 
state kinetic model to formulate a reaction mechanism, which includes characterisation of the 
reaction geometry and/or the controlling interface step. 
 
 
Polanyi-Wigner Theory 
 
 The Polanyi–Wigner equation is used to describe the rate of a thermal desorption 
process (dehydration) at an active interface of a homogeneous surface. It is represented based 
on transition state theory by Young [172] as follow: 
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dt
dx exp1expexp0    Equation 4-24 
(dx/dt) rate of interface advance (m/s) 
x0 incremental forward advance distance for unit reaction (m) 
k Boltzmann’s constant (1.38065 x10-23 J/K) 
T temperature (K) 
h Planck’s constant (6.626 x10-34 m2.kg/s) 
S, G, H thermodynamic symbols (entropy, Gibbs energy, enthalpy) referring to the  precursor 
activation of the transition state (J or J/K) 
R gas constant (8.31447 J/K.mol) 
 
 The Polanyi–Wigner equation was originally accepted as providing a unifying 
theoretical model capable of describing the rate of dehydration. However, this representation of 
dehydration kinetics has found fewer applications in the recent literature, due to the fact that 
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mechanisms of chemical processes within the active reactant-product contact zone are much 
more complicated than the simple dissociation processes originally envisaged [16; 171; 194].  
 
 
4.5.1 Kinetic Models for Solid State Reactions 
 
 Many models have been developed to account for the dehydration kinetics of 
crystalline hydrates. These all assume certain geometries and rely on some consistency of the 
system as the process proceeds. Often these models are indistinguishable for a given system 
due to experimental variation and because many structural change during dehydration. The 
kinetic analysis is achieved by simply fitting the experimental data into solid state kinetic 
models. Though this approach cannot deduce the reaction mechanism, it still provides a useful 
understanding to the possible mechanisms. The dehydration of a solid is regarded as a first 
order process which is limited by either the rate of mass transfer or the equilibrium between the 
solid and gas phase, based on the fundamental relationship, where; 
 
DFKR ±=  
 
R rate of volatiles being removed 
K constant dependent on solid surface area and type of drying equipment 
DF drying force for removal of volatiles from the solid, which is equivalent to the actual 
concentration-equilibrium concentration 
 
Isothermal solid state reaction models 
 
 The solid state kinetic models quoted in many reviews [195; 196] are expressed by the 
general integrated rate equation: 
 
( ) tkg ⋅=α          Equation 4-25 
 
By which; k as the rate constant, t reaction time and g(α) is a function of the reaction 
mechanism (Figure 4-24). Another general term in solid state reactions is the values of the 
Arrhenius parameters, namely activation energy, Ea and the frequency factor (pre-exponential 
factor), A.   
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Figure 4-24 Reduced time plots for thermal decomposition reactions of solids, as (a) sigmoid rate; 
(b) acceleratory rate; (c) deceleratory rate; and (d) shorter induction period with defected surface. 
Source: [176; 197] 
 
 
 Table 4-2 summarise the common kinetic equations for solid state reactions. These 
models differ in terms of the geometry considered, assumptions made on the underlying 
process, and rate controlling mechanism. The mechanistic representations of these models have 
been applied in the interpretation of dehydration reactions, and experimental evidence is 
available to prove their existence [198].  
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Table 4-2: Common kinetic equations for solid state reactions  
g(α) Symbol m value* Rate-controlling process (Mechanism) 
Acceleratory rate equations 
n
1α  - - Power law 
αln  - - Exponential law 
Deceleratory rate equations 
Based on diffusion mechanism 
α2 D1 0.62 One-dimensional diffusion ( ) ( ) ααα +−⋅− 1ln1  D2 0.57 Two-dimensional diffusion 
( )[ ]23111 α−−  D3 0.54 Three-dimensional diffusion 
(Jander) 
( ) ( ) 321321 αα −−⋅−  D4 0.57 Three-dimensional diffusion 
(Ginstling-Brounshtein) 
Based on order with respect of α ( )α−− 1ln  F1 1.00 First-order reaction 
( ) 11 −−α  F2 N/A Second-order reaction 
( ) 21 −−α  F3 N/A Third-order reaction 
Based on geometric models 
α R1 1.24 
Zero-order 
(Polany-Wigner equation) 
( )[ ]21112 α−−⋅  R2 1.11 Two-dimensional phase boundary reaction 
( )[ ]31113 α−−⋅  R3 1.07 Three-dimensional phase boundary reaction 
Sigmoid rate equations 
( )[ ] 211ln α−−  A2 2.00 Two-dimensional growth of nuclei 
( )[ ] 311ln α−−  A3 3.00 Three-dimensional growth of nuclei 
( )[ ] 411ln α−−  A4 N/A 
Constant random formation of nuclei and 
three-dimensional, growth, boundary control 
(Avrami-Erofe’ev equation) 
( )⎥⎦⎤⎢⎣⎡ −αα 1ln  P1 N/A Prout-Tompkins equation 
* m: Hancock-Sharp constant 24 
Source: [176; 197-199] 
 
                                                 
24 Hancock-Sharp constant refers to the slopes of theoretical reduced time plots in the α range of 0.15 to 0.50. The 
constant varies according to the reaction mechanism and geometry of the system.  
Source: Hancock, J.D. and Sharp, J.H. (1972) Journal of the American Ceramic Society, 55(2): p74. 
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 Since dehydration curves are best represented by series of equations over the time, 
Griesser and Burger [198] employed a biphasic first-order model to describe the entire 
dehydration process: 
 
( ){ } ( ){ }ibia ttkttk eBeA −⋅−−⋅− ⋅+⋅=−α1       Equation 4-26 
1-α Fraction amount of hydrate (0-1) 
ti Lag time period until start of reaction (s) 
A, B Intercept of terminal part and initial part, respectively 
ka, kb Slope of terminal part and initial part, respectively 
 
 
4.5.2  Dehydration Kinetic Parameters 
 
Activation Energy of a Dehydration Process 
 
 Activation energy, or symbolised as Ea (kJ/mol) is a key parameter in the data 
interpretation for chemical kinetics. It has been regarded as the energy barrier to bond 
redistribution as the rate limiting step, undergoing systematic changes during the progress of a 
particular reaction. This is because the parameter possesses theoretical values which relates 
through the Arrhenius equation, temperature coefficient of reaction rate to the height of energy 
barrier opposing reaction.  
  
 
Drying Constant for a Dehydration Process 
 
 The drying rate constant (k) is a phenomenological property representative of important 
transport properties (e.g. moisture diffusivity, thermal conductivity, interface heat and mass 
transfer coefficients). It is the most suitable quantity for design, optimisation purposes, and 
also any situation in which large number of iterative model calculations are needed. This 
suitability is due to the fact that the drying constant embodies all the transport properties into a 
simple exponential function, under constant drying conditions, where the material layer is thin 
enough or the air velocity is high [200]. 
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 In general, the changes in kinetic characteristics resulting from modifications to 
experimental conditions are easily demonstrated by comparative experiments using reactant 
particles of different sizes or other adjustment of the procedural variables. It is obvious that 
individual magnitudes of the kinetic parameters have not been demonstrated to provide 
valuable information for many and diverse solid state decompositions. Consequently, many 
reports of kinetic studies appear as isolated, with limited mechanistic conclusions that do not 
contribute to the organic development of a coherent and systematic scientific understanding. 
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CHAPTER 5 MATERIAL AND PREPARATION 
 
 Commercial carbamazepine (CBZ) (Sigma-Aldrich Ltd., Gillingham, UK) was selected 
as a model compound, due to its ability to form a stoichiometric channel hydrate and exhibit 
polymorphism. Carbamazepine has four crystalline anhydrous polymorphs, one dihydrate, 
several organic solvates, including mono-acetone solvate and an amorphous form. 
 
 
5.1 Carbamazepine (CBZ) 
 
 Carbamazepine (C15H12N2O, MW = 236.269 g/mol) is a potent antiepileptic drug (AED) 
used for treating acute mania used since 1970’s and its clinical efficacy has been widened as a 
mood stabilising drug from late 1980’s. Being used routinely in the treatment of epilepsy, 
bipolar disorder, schizophrenia and trigeminal neuralgia, carbamazepine acts as a suppressor 
for the neurons which trigger the seizure attack [201].  
 
 Carbamazepine is synthesised by reacting 5H-dibenz(b,f)azepine and phosgene, which 
forms 5-chlorcarboxy-5H-dibenz-(b,f)azepine. It then reacts with ammonia to give the desired 
carbamazepine (Figure 5-1). An alternative method of synthesis involves the direct reaction of 
5H-dibenz(b,f)azepine with potassium cyanate [202]. These methods are described in U.S. 
Patent No. 2,948,718 25.  
 
N
H
N
H
N
C
NH2
O
1. COCl2
2. NH3 KOCN
 
Figure 5-1 Synthesis routes of Carbamazepine. 
                                                 
25 United States Patent and Trademark Office, www.uspto.gov. US Patent No. 2948718, Issue Date August 9, 
1960. 
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 Carbamazepine, also known as Amizepin, Carbamazepen, 5H-dibenz(b,f)azepine-5-
carboxamide and 5-carbamoyl-5H-dibenz(b,f)azepine, has been marketed under various brand 
names, e.g. Calepsin, Carbatrol, Epitol, Tegretol etc. over the last 30 years. Carbamazepine 
tablet forms have been linked to a notorious history of bioinequivalence and clinical failures, 
as carbamazepine drug is a Class II drug of which its bioavailability is limited by poor 
solubility and dissolution rate in gastrointestinal (GI) tract [201]. Consequently, the oral 
absorption of the carbamazepine drug is slow, erratic and unpredictable in humans owing to its 
extremely low water solubility (0.4 mg/mL) [203] and slow dissolution rate [204].  
 
 The extended-release formulations of carbamazepine have been developed in recent 
years to decrease daily concentration fluctuations in blood serum by smoothing out blood 
levels of the drug and to improve dosing convenience. They are typically designed to provide 
carbamazepine at a therapeutic range of 4 μg/ml to 12 μg/ml over a period of time. 
Carbamazepine’s concentration in blood levels of greater than 12 μg/ml are found to result in 
undesirable side effects, i.e. neuromuscular disturbance, cardiovascular and gastrointestinal 
effects [205]. 
 
 In addition, carbamazepine crystals have poor compaction properties, and are therefore 
not suitable for direct tableting. It is however being marketed in solid dosage form where a 
direct tableting method is usually used for commercial production [201]. In addition, though 
practically insoluble in water, carbamazepine drug often rapidly transform to the hydrated form 
once immersed in water and/or exposed to humidity in storage [55].  
 
 
5.1.1 Carbamazepine Anhydrate Polymorphs 
 
 The carbamazepine anhydrous polymorphs, namely triclinic (P 1 ), trigonal (R 3 ), P-
monoclinic (P21/c), C-monoclinic (C2/c) and the amorphous form have been widely 
characterised and studied [73; 206-214]. The earliest X-ray analysis of carbamazepine 
polymorph dates back to 1975 [215] and the crystallographic data for the four known 
anhydrous polymorphs are listed in Table 5-1. 
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triclinic (P1) trigonal (R3) P-monoclinic (P21/c) C-monoclinic (C2/c)  
Figure 5-2 Molecular arrangement of carbamazepine polymorphs (white, red, purple and grey 
sticks denote hydrogen, oxygen, nitrogen and carbon respectively). Source: [210; 211; 216; 217]. 
 
 
Table 5-1: Crystallographic data for carbamazepine polymorphs 
Crystal system Triclinic Trigonal P-monoclinic C-monoclinic 
Space group P 1  R 3  P21/c C2/c 
Unit cell lengths a = 5.171 Å 
b = 20.574 Å 
c = 22.245 Å 
a =b= 35.454 Å 
c = 5.253 Å 
a = 7.529 Å 
b = 11.148 Å 
c = 15.470 Å 
a = 26.609 Å 
b = 6.9269 Å 
c = 13.957 Å 
Unit cell angles α = 84.124º 
β = 88.008º 
γ = 85.187º 
α = β = γ = 90º α = γ = 90º 
β = 116.17º 
α = γ = 90º 
β = 109.70º 
Molecules per 
unit cell, Z26 
8 18 4 8 
Volume of cell 
(Å3) 
2344.824 5718.321 1165.343 2421.926 
Calculated 
density (g/cm3) 
1.34 1.24 - 
1.296 (158 K) 
1.268 (298 K) 
Measured 
density (g/cm3) 
1.31 1.235 1.343 - 
 
Crystal habit 
Needle with flat 
cross section 
Needle with 
hexagonal cross 
section 
Prism 
(or bead-like) 
Plate 
References [209; 211; 218] [217] [216; 219] [210] 
 
 
                                                 
26 Z is referred to as the number of molecules in the crystallographic unit cell, the word ‘molecule’ however 
should more strictly be the formula unit, for instance this would include both the metal-containing moiety and the 
water molecule in a specific compound. Z value is different compared to Z’, referred to as the number of 
molecules per asymmetric unit (Cambridge Crystallographic Data Centre).  
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5.1.2 Naming system of carbamazepine polymorphs 
 
 There is a vast variation in the polymorph nomenclature of carbamazepine anhydrates, 
where different naming systems have been adopted since 1968 [42]. There were Greek symbol 
system [92; 220-222], Roman numeral system according to the citing of reported crystal 
structures [223-226], according to the sequence of cell parameters determination [210; 211; 
227-230], according to their descending melting points [207; 213; 231] and other naming 
systems, such as Form C1, C2 and C3 [232]. To avoid any confusion, the carbamazepine 
anhydrates, relevant to this work, are being referenced to their Bravais lattices [70; 209], since 
the two monoclinic modifications can be distinguished as a P-lattice and a C-lattice. 
 
Table 5-2: Summary of polymorph nomenclature system employed in literature. 
Triclinic Trigonal P-monoclinic C-monoclinic Reference 
Triclinic Trigonal Monoclinic  [209] 
Triclinic Trigonal P-monoclinic C-monoclinic [70] 
  Monoclinic  [216; 219] 
Polymorph I  Polymorph III  [233] 
Form I Form II Form III  [222; 234] 
Form I  Form III  
[42; 208; 233; 235; 
236] [9; 237; 238] 
Form I  Form III Form II [207; 213; 231] 
Form I Form II, IV Form III  [239] 
Form I Form II Form III Form IV [210; 211; 227-230] 
Form III Form II Form I  [223-226] 
Polymorph γ Polymorph α Polymorph β  [218; 220-222] 
 Polymorph α Polymorph β  [217; 240] 
  Polymorph β  [241] 
Polymorph α  Polymorph β  [242; 243] 
Form C3 Form C2 Form C1  [232] 
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5.1.3 Metastability of Carbamazepine Polymorphic Anhydrates 
 
 P-monoclinic anhydrate was reported as the most stable and least soluble form at 
315.15 K and below [225; 244], followed by triclinic > C-monoclinic) > trigonal [211; 222]. 
Apart from the C-monoclinic form, the order of the relative stability at room temperature 
coincides with work conducted by Ceolin and colleagues, which listed as P-monoclinic > 
triclinic > trigonal, based on their densities and unit cells calculation. Cruz Cabeza and 
colleagues however have predicted computationally that both C-monoclinic and P-monoclinic 
polymorphs have similar free energies at 0K [209; 229; 230].  
 
 Various studies of physicochemical properties of triclinic and P-monoclinic have been 
reported, however there are some discrepancies among findings of these studies, including the 
relationship between physicochemical properties and the bioavailability of carbamazepine 
polymorphs [245]. Triclinic and P-monoclinic, C-monoclinic and P-monoclinic are identified 
as the enantiotropic pairs [207; 211; 235], which the less stable one will transform into the 
more thermodynamically stable state above the transition temperature. However, Grzesiak et al. 
[211] suggested that triclinic and C-monoclinic are monotropically related, but 
enantiotropically related according to Krahn and Mielck [207]. The trigonal structure 
meanwhile is monotropically related to triclinic, having an exothermic heat of transition at 
120-130ºC [221; 223; 224].  
 
 Nevertheless, since all reported polymorphs posses similar strong hydrogen bonding 
patterns and molecular conformations related to the dimer formation in the dictating geometry 
[246], and small changes in torsional angles of the carboxamide group [210], there are merely 
minute differences in the calculated relative free energy, that is 8.38 kJ/mol [229] and also the 
experimentally determined enthalpy of melting: 0.69 kcal/mol [211] between the most and 
least stable form (P-monoclinic and trigonal, respectively). Most importantly, this means that 
the four polymorphs of carbamazepine are close enough in free energy and/or impurity effects 
can easily cause crossovers in stability during crystallisation, and consequently thermodynamic 
and kinetic factors can be controlled to determine which phase crystallises first at the nanoscale. 
 
 A thermodynamic perspective is commonly employed to explain the polymorphic 
transitions, based on their relative stabilities. The ‘rule of stages’, postulated by Wilhelm 
Ostwald [41], suggested that a single crystallite from a disordered phase, for instance 
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carbamazepine amorphous phase, forms through a cascade of several less stable intermediate 
states before transforming to the final thermodynamically stable crystal: P-monoclinic for 
example. It has been observed that the metastable trigonal form was favoured in those 
crystallising conditions of having relatively high concentrations and proceeding at a relatively 
rapid rate of crystallisation [222]. It has been reported that the quench-cooled melt of P-
monoclinic form in liquid nitrogen will generate the amorphous phase (Tg at 52-56ºC), which 
tends to recrystallise at 100ºC, followed by an endotherm corresponding to the formation of 
trigonal form as observed during differential scanning calorimetry analysis [10; 73]. The 
amorphous form, on the other hand, is highly unstable and readily crystallises at ambient 
conditions [73]. 
 
 
5.1.4 Preparation of Carbamazepine Anhydrates 
 
 Reference standards of the polymorphic forms are often required to enable direct 
comparison of their X-ray powder diffraction (XRPD) patterns obtained through dehydration 
studies. Harvesting from a concentrated solution may give rise to a metastable form as opposed 
to a stable form from steady crystallisation through precipitation and solvent evaporation [247]. 
Apart from a high degree of supersaturation, kinetically controlled crystallisation also involves 
rapid evaporation and/or rapid cooling from solution/melt. Shown in Figure 5-3 are the 
solubility curves for the stable carbamazepine anhydrate, P-monoclinic in two organic solvents 
used in this work. Lee et al. [248] have also demonstrated the solubility curves of this form for 
another 11 types of solvents, including ethyl acetate, isopropyl alcohol, acetone, acetonitrile, 
chloroform etc. 
 
 140
0
10
20
30
40
50
60
270 280 290 300 310 320 330 340 350 360
Temperature (K)
M
ol
e 
fr
ac
tio
n 
so
lu
bi
lit
y,
 X
1 (
10
3 ) Methanol
Ethanol
 
Figure 5-3 Solubility of carbamazepine in methanol and ethanol solvent. Determined from [249]. 
 
 
5.1.4.1 Crystallisation of Carbamazepine Anhydrates 
 
 The P-monoclinic form of carbamazepine, known to be the most stable form at room 
temperature, was normally used as purchased. It can be recrystallised from solvents of high 
dielectric constant, for instance aliphatic alcohols [207; 217]. Another technique involving 
recrystallisation from aqueous solutions at different pH values (pH = 1, 7 and 11) is able to 
improve the physicomechanical property of carbamazepine sample created, due to the pH 
induced differences in morphological structures produced [250]. 
 
 The triclinic form is recognised to be enantiotropically related to P-monoclinic, and 
was prepared by heating and holding the commercial form at 150ºC to 185ºC for more than 10 
min, which induces a complete phase transformation [209; 211; 213; 218]. The triclinic form 
can be also obtained upon crystallisation from solvents of low dielectric constant [217]. 
Competition slurries in isopropyl benzene, also known as cumene were employed to establish 
the transition temperature during crystallisation for the enantiotropically related triclinic and P-
monoclinic forms, which was found to be between 79ºC and 82ºC [244]. The transition 
temperature between these two forms can be estimated via two routes [235], namely: van’t 
Hoff solubility plot and theoretical solubility equations, based on the ratio of the two 
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solubilities. The transition temperature based on the solubility in 2-propanol solution has been 
determined as 71ºC [235]. 
 
 The trigonal form crystallises from certain solvents including toluene and n-tridecane 
[70; 234]. Having solvent inclusion within the voids of the trigonal form stabilises the crystal 
structure [234]. However, the trigonal form was originally obtained through crystallisation 
from tetrahydrofuran by Lowes et al. in 1987 [217] for crystal structure determination. This 
work was followed by Fabbiani and colleagues [251] who used the same crystallisation 
technique in 2007. Presence of solvent inclusions was not reported and studied in those initial 
studies. Apart from that, the trigonal form was also crystallised from supersaturated ethanol 
solution at 0ºC [211]. In fact, according to Florence et al., crystallisation of the trigonal form 
can be achieved from a large variety of solvents, in particular conditions of supersaturation and 
rapid cooling, even though rapid crystallisation does not produce well-defined single crystals 
for structure determination [222].  
 
 Attempts to make a reference standard for C-monoclinic by crystallisation from 
solution were unsuccessful in most reported studies, except for crystallisation from ethanol 
solution in an ice bath [213]. In a recent study using an automated parallel crystallisation 
process, it is concluded that the C-monoclinic form could not be reproduced by solvent 
crystallisation alone [222], and normally it involves slow evaporation from a polymer-
containing solution (hydroxypropyl cellulose) [210; 211; 227]. 
 
 
5.1.5 Experimental Section for Preparation of Carbamazepine Anhydrates 
 
 The P-monoclinic form was re-crystallised from the commercial carbamazepine 
powder (Figure 5-4a) in ethanol solution (16.5 mg/mL), via solvent evaporation technique. The 
triclinic form was obtained by simply heating the P-monoclinic crystals at 150ºC in an oven for 
over 3 hours. Attempts to crystallise the C-monoclinic using previously reported method [213] 
were unsuccessful. Meanwhile, the unstable trigonal form was also crystallised from 
supersaturated ethanol solution (48 mg/mL) with rapid cooling from an 80ºC water bath to 
room temperature, prior to further cooling at 5ºC for 5 hours. However, a mixture of trigonal 
and P-monoclinic crystals (Figure 5-5a) would often appear, highlighting the instability of the 
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trigonal form. In all attempts, no well-defined single crystals were obtained (Figure 5-5b), due 
to the rapid crystallisation method used. 0.96 g carbamazepine anhydrate dissolved in 20 mL 
ethanol at 80ºC.  
 
 
Figure 5-4 Microscopy images of (a) commercial carbamazepine anhydrate, (b) and (c) as the re-
crystallised anhydrates (P-monoclinic) of different facets. 
 
 
Figure 5-5 SEM micrographs of (a) mixture of trigonal and P-monoclinic crystals, and (b) trigonal 
crystal.  
 
 
5.2 Carbamazepine Dihydrate 
 
 Carbamazepine dihydrate is practically insoluble in water with solubility of 0.11 
mg/mL at 25ºC [252]. Each layer of the crystal lattice of the dihydrate contains four water 
molecules which form channels along the C-axis [70]. These channels enable the hydrate water 
to be easily removed, leading to the formation of metastable carbamazepine anhydrate 
polymorphs [73; 207; 213]. 
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Figure 5-6 Molecular structure of carbamazepine dihydrate (white, red, purple and grey sticks 
denote hydrogen, oxygen, nitrogen and carbon respectively). 
 
 
Figure 5-7 Visualised channel of hydrate water, along the stacking of the carbamazepine 
molecules. 
 
 There is no evidence thus far that supports the existence of true polymorphs of 
carbamazepine dihydrate, except for McMahon et al. [208], who managed to form two types of 
carbamazepine dihydrates from triclinic and P-monoclinic anhydrates, which might exhibit 
alternative molecular organisation. The dihydrates exhibited slightly different thermochemical 
behaviour, even though no distinct structural variations could be detected in the XRPD patterns 
or vibrational spectroscopic data.  
 
 In the earlier years, the dihydrate’s structure has been reported in the literature [253] to 
be a disordered orthorhombic (space group Abam) structure, with the carbamezapine molecule 
assumed to have a spurious symmetry plane arising from rotational disorder of the amide group 
(Table 5-3). The appearance of disorder is exacerbated by the similarity of the diffracting 
powers of oxygen and amine, as present in the amide grouping. 
 
 
b
a 
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Table 5-3: Crystallographic data for dihydrate forms of carbamazepine 
Parameter 
Dihydrate 
P-monoclinic 
Dihydrate 
Orthorhombic 
Space group P21/c Cmca (Abam) 
Unit cell lengths a = 10.066 Å 
b = 28.719 Å 
c = 4.831 Å 
a = 19.834 Å 
b = 4.945 Å 
c = 28.826 Å 
Unit cell angles α = γ = 90º 
β = 103.45º 
α = β = γ = 90º 
 
Molecules per unit cell 4 8 
Volume of cell (106 pm3) 1358.268 2827.23 
Calculated density (g/cm3) 1.28 1.28 
Reference [70] [220; 253]  
 
 
5.2.1 Stability of Carbamazepine Dihydrate 
 
 “Slurry experiments” have become very common in the pharmaceutical industry to 
assess the relative stability of polymorphs. As the relative thermodynamic stability of 
polymorphs varies with temperature and pressure [254], changing solvent compositions does 
not alter their relative thermodynamic stability. Therefore, maintaining mixtures of polymorphs 
in solvents long enough eventually results in isolation of one stable form [255], regardless the 
composition of solvents or solvent mixture [256]. 
  
 In an anhydrate/hydrate system in mixtures of water and an organic solvent, the water 
activity plays a crucial role. For a given temperature, there exists an equilibrium water activity 
value, at which the solubilities, and thus the stabilities, of the anhydrous and hydrate forms are 
identical [256-259]. Any deviation from the equilibrium water activity will result in phase 
transformation, either from anhydrate to hydrate or in the opposite direction. Many studies 
have been conducted to observe the transition of carbamazepine anhydrate to the dehydrate 
form using inline spectroscopy techniques [208] and particle vision measurement (Lasentec 
PVM®) [260], in order to construct the transition point plots based on temperature as such in 
Figure 5-8.  
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Figure 5-8 Transition points of carbamazepine anhydrate and dihydrate in ethanol-water mixture. 
Adapted from [257]. 
 
 
Dehydration stability of Carbamazepine dihydrate 
 
 It has been demonstrated that under different drying conditions, with the control of 
relative humidity, elevated pressure and temperature, carbamazepine dihydrate may degrade 
and/or recrystallise into the different polymorphs [73; 207; 212]. The presence of high water 
vapour partial pressures has favoured the retention of hydrate water and facilitated the 
nucleation of anhydrate phase, hence the dihydrate often converts into the triclinic anhydrate at 
higher ≥11.13 %RH at 44ºC [73; 92; 261]. 
 
 On the other hand, the stable P-monoclinic anhydrate would appear when dehydrating 
at elevated pressure (102 psi = 689.5 kPa) and high temperature (85ºC) [212]. Under a closed 
environment conditions where liberated hydrate water cannot readily escape from the sample, 
for example in a sealed DSC pan with a pinhole, it was demonstrated that P-monoclinic was 
formed following the dehydration process [208].  
 
 The least stable trigonal anhydrate however could not be detected and characterised 
fully under a dehydration condition, due to its fast transformation to the next metastable form 
[70]. Meanwhile, previously reported formation pathways of C-monoclinic include 
dehydration of carbamazepine dihydrate over phosphorus pentoxide in vacuo [207] and at 
ambient condition [70]; freeze drying of fresh carbamazepine dihydrate [231]; spray drying of 
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carbamazepine anhydrate dissolved in methanol solution [262; 263]. Apart from that, 
dehydration under extremely low or zero water vapour pressure (~ 0 %RH) would produce 
inherently unstable amorphous form [73; 92; 261].  
 
 
5.2.2 Crystallisation of Carbamazepine Dihydrate 
 
 Carbamazepine dihydrate crystals are commonly prepared from three methods; 
crystallisation from a mixture of water and ethanol solution, suspension of fine anhydrate 
powder or anhydrate crystals in water, or exposure to relative humidity of 100 %RH.  
  
 Laine et al. [55] observed the formation of about 1 μm thick and flexible fibres in the 
earliest stages of growth, before the fibres thickened and straightening out to form needle-like 
crystals with a diameter of 10 μm or less. Though carbamazepine is poorly soluble in water, 
the concentration of the solution is sufficient to maintain the one-dimentional growth of the 
dihydrate crystals through a suspension method. The anhydrate crystal was believed to act as 
the nucleation sites for the whiskers of dihydrate [55]. 
 
 Among the four polymorphic anhydrates, P-monoclinic consists of only four molecules 
per unit cell [264], with significant hexagonal voids being present due to the three dimers 
forming a triangular structure. These hexagonal voids might facilitate the inclusion of water 
molecules into the crystal lattice and subsequently accelerate relatively the transformation to a 
dihydrate, compared to other polymorphs. 
 
 Other novel crystallisation techniques include precipitation of carbamazepine dihydrate 
crystals from confined spaces of non-ionic microemulsions [242; 265]. Microemulsions are 
nanosized droplets made from isotropic mixtures of oil, water and surfactant, characterised by 
thermodynamic stability and high surface areas for improved solubility [266]. Crystallisation 
from bicontinuous and oil in water microemulsions resulted in plate- and needle-like 
morphology of carbamazepine dihydrate crystals, respectively [242]. 
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5.2.3 Experimental Section for Preparation of Carbamazepine Dihydrate 
 
 Commercial carbamazepine anhydrate (C15H12N2O) was used as received (Sigma-
Aldrich Ltd., Gillingham, UK). Carbamazepine dihydrate was prepared via two routes; 
crystallisation from organic solvent aqueous solution and suspension in deionised water, to 
yield loose crystals and agglomerates respectively (procedures were summarised in Table 5-4). 
 
 
Method 1: Wet crystallisation of carbamazepine dihydrate 
 
 This method involved having the carbamazepine anhydrate powders dissolved in the 
solution mixture (0.1 g/mL with 30%v/v water) with reflux heating from an 80ºC water bath 
[207], as illustrated in Error! Reference source not found.. The solution was allowed to cool 
down to 25ºC under fume cupboard over 4 hours. Crystals were then harvested by filtration 
and dried at room temperature (20ºC ± 2ºC) in a the fume cupboard for 3 hours. This 
preparation method generated two different crystal habits as depicted in Figure 5-9. Habit 1 
referred to plate shape (aspect ratio l/d ~1.6) and Habit 2 denoted the needle shape (aspect ratio 
l/d >10), obtained from ethanol and methanol aqueous solution respectively. The crystals were 
kept in sealed glass vials before storage at controlled humidity (74 %RH) to maintain the 
hydrates’ integrity. 
 
 
Method 2: ‘Forced’ hydration method of carbamazepine dihydate 
 
 Carbamazepine anhydrate was immersed in deionised water (0.015 g/mL) at room 
temperature. The suspension was mediated by a stirring action at 100 rpm for 24 hours to form 
the acicular shaped carbamazepine dihydrate crystals. The carbamazepine dihydrate was sieved 
into six particle size distributions (sieve fractions); 75-180 μm, 180-250 μm, 250-500 μm, 500-
710 μm, 710-1400 μm and >1400 μm, using a series of ASTM standard sieves (Endecotts Ltd., 
London, UK). During the sieving process, the partially dried dihydrate formed agglomerates 
(Figure 5-10). The size of the primary particle within these agglomerates was determined via 
microscopy technique and was almost identical at an average length of 13.08 μm (± 3.31 μm). 
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All carbamazepine dihydrates were kept in sealed glass vials and stored at appropriate 
controlled humidities to maintain the sample’s integrity. 
Table 5-4: Preparation methods for carbamazepine dihydrate adopted in this work. 
Wet crystallisation ‘Forced’ hydration 
 0.1 g/mL in aqueous solution (30:70 %v/v 
of water and alcohol mixture). 
 0.015 g/mL in water. 
 Dissolve carbamazepine in a mixture of 
water and alcohol, via reflux heating in an 
80ºC water bath. 
 Dispersion of carbamazepine powder in 
water at 25ºC. The slurry was stirred at 
100 rpm for 24 hours. 
 Cool down to 25ºC for 4 hours, and 
separate the crystals from solution using 
filter paper.  
 Filter the resultant slurry via suction 
method. 
 Dried in fume cupboard for 3 hours.  Dried in fume cupboard for 3 hours. 
 Two different crystal habits from ethanol 
and methanol aqueous solutions. 
 Sieved into six particle size distributions. 
Dihydrate sample: 
 Plate shape (crystallised from ethanol 
aqueous solution) aspect ratio ~1.6. 
 Needle shape (crystallised from methanol 
aqueous solution) aspect ratio >10. 
Dihydrate sample: 
 75-180 μm, 180-250 μm, 250-500 μm, 
500-710 μm, 710-1400 μm, > 1400 μm. 
 Average length of 13.08 ± 3.31 μm, and 
aspect ratio >10. 
 
 
 
Figure 5-9 Microscopy images of carbamazepine dihydrate crystals of (a) plate, and (b) needle 
habits. 
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Figure 5-10 Microscopy images of carbamazepine dihydrate agglomerates of different sieve 
fractions: (a) 75-180μm, (b) 180-250μm, (c) 250-500μm, (d) 500-710μm, and (e) 710-1400μm. 
 
 
Theoretical water content of Carbamazepine dihydrate 
 
 For a stoichiometric carbamazepine dihydrate with two water molecules (MW for H2O 
= 18 g/mol), the total fractional moisture content, XA is determined as 0.1524. Therefore any 
moisture content values reported above 0.1524 are considered as the excess unbound water, i.e. 
physisorbed or condensed water. 
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5.3 Carbamazepine Acetone Solvate 
 
 Apart from its ability to form a stoichiometric hydrate, carbamazepine also form eight 
different solvates [222; 228; 230; 267; 268]; acetone, acetic acid, dimethyl sulphoxide 
(DMSO), 1,4-dioxane, N,N-dimethyl acetamide (DMA), N,N-dimethyl formamide (DMF), N-
methylpyrrolidone, nitromethane, furfural, formamide, formic acid and trifluoroacetic acid. 
The structure of the acetone solvate was first solved in 1983 [269]. It classifies into the P 1  
space group and contains one molecule in the asymmetric unit cell, as shown in Figure 5-11 
and Table 5-5. 
 
 
Figure 5-11 Molecular structure of carbamazepine mono-acetone solvate (white, red, purple and 
grey sticks denote hydrogen, oxygen, nitrogen and carbon respectively). 
 
Table 5-5: Crystallographic data for carbamazepine acetone solvate 
Parameter Acetone solvate (Triclinic crystal system) 
Space group P 1  
Unit cell lengths a = 7.3985 Å ;  b = 8.9054 Å ;  c = 11.873 Å 
Unit cell angles α = 95.809º ;  β = 93.401º ;  γ = 101.362º 
Molecules per unit cell 2 
Volume of cell (106 pm3) 760.479 
Melting point (ºC) 189 
Reference [228] 
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5.3.1 Stability of Carbamazepine Acetone Solvate 
  
 As opposed to widely adopted slurries experiments, Burnett et al. [268] employed 
Dynamic Vapour Sorption (DVS) to determine the solvation behavior of carbamazepine over a 
range of temperatures and acetone vapour pressures. It is known that both the solvation-
desolvation processes formed from the liquid or vapour phase are thermodynamically 
equivalent. As long as the solvate formation measured by vapour sorption techniques is 
performed under equilibrium conditions, similar transitions should be observed to those which 
occur in the liquid-phase. 
 
 Figure 5-12 shows an example of the acetone sorption and desorption isotherms at 25ºC, 
where solvation occurs above 85% P/P0 during the sorption phase, but it is not desolvated until 
below 10% P/P0 during the desorption phase. It has been concluded that the solvation transition 
point increased from 62.5% P/P0 at 10°C to 97.8% P/P0 at 30°C [268]. 
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Figure 5-12 Acetone vapour sorption and desorption isotherms on amorphous carbamazepine at 
25ºC. Adapted from [268]. 
 
 
 152
5.3.2 Experimental Section for Preparation of Carbamazepine Acetone 
Solvate 
 
 Acetone solvate crystals were precipitated from an acetone solution (concentration 
below the solubility curve as in Figure 5-13 by slow evaporation at room temperature. Based 
on different precipitation rates, different crystal sizes of acetone solvate can be generated; 
Figure 5-14a and Figure 5-14b pertain at a slower rate, while Figure 5-14c a faster evaporation 
rate. 
 
 
Figure 5-13 Solubility curves of carbamazepine in acetone solvent. Adapted from [248]. 
 
 
Figure 5-14 Microscopy images of carbamazepine mono-acetone solvate crystals. 
 
 
 153
Theoretical solvent content for Carbamazepine acetone solvate 
 
 For a stoichiometric carbamazepine acetone solvate with one acetone molecule (MW 
for C3H6O = 58.08 g/mol), the total solvent content, XA is determined as 0.2458. 
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Mass
Mass
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5.4 Conclusions 
 
 Model compounds of carbamazepine dihydrate and mono-acetone solvate were 
prepared for the dehydration/desolvation studies. The dihydrate samples were prepared in 
different crystal habits and sieve fractions, using the wet crystallisation and ‘forced’ hydration 
method, respectively. Detailed physical and chemical properties of all samples, including the 
polymorphic anhydrates have been reviewed extensively.  
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CHAPTER 6 EXPERIMENTAL DETERMINATION OF 
DEHYDRATION STABILITY 
 
6.1 Introduction to Instrumentation 
 
“There is need of a method for investigating the truth about things” 
 
Rules For The Direction of The Mind 
René Descartes (1596-1650) 
 
 The methods for the characterisation of hydrates and their phase transformations (e.g. 
dehydration and polymorphism) are often being classified as energetic (thermal and 
spectroscopic) and structural, or molecular level and particulate level [76]. The commonly 
employed methods are microscopy techniques, gravimetric analysis, thermal methods, 
spectroscopy techniques and crystallography studies. Table 6-1 summarises the techniques 
available for characterisation and study of the solid state forms, including the data type 
obtained, information gained and any shortcoming of those techniques.  
 
Table 6-1: Analytical techniques to investigate and characterise the solid state forms 
Instrument/ 
technique 
Measurement Information (●) / Shortcoming (○) 
Molecular level properties 
• Chemical identification 
• Molecular structure information 
• Rapid measurements 
• Information about solvent and solvates 
• Quantitation possible 
Fourier transform 
infrared spectroscopy 
(FT-IR),  
Diffuse reflectance IR 
fourier transform 
spectroscopy 
(DRIFT),  
Attenuated total 
reflectance 
spectroscopy (ATR) 
Intramolecular 
vibrations (dipole 
moment changes) 
o Sample preparation artefacts possible 
o Interference from excipients and humidity 
o Subtle differences 
o Difficult to differentiate in mid infrared (MIR) 
region 
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• Complimentary to IR spectroscopy 
• Chemical identification 
• Molecular structure information 
• No sample preparation, rapid measurements 
• Ability to penetrate through containers 
• Water is Raman inactive 
• Relatively insensitive to particle size 
• Quantitation possible 
Raman 
spectroscopy 
Intra-molecular 
vibrations 
(polarisability 
changes) 
o Interference from excipients 
o Local sample heating 
o Fluorescence effect 
o Consider sample volume 
o Not all materials are good Raman scatterers 
• Chemical and physical information 
• No sample preparation, rapid measurements 
• Ability to penetrate through containers 
• Ability to show different states of water 
• Quantitation possible 
Near Infrared (NIR) 
spectroscopy 
Overtones and 
combinations of 
molecular vibrations 
(dipole moment 
changes) 
o Influenced by water and particle size, low 
intensity 
o Subtle differences, broad bands and overlapping 
regions 
o Poor fingerprint 
• Chemical information (directly probes atom 
positions) 
• Phase characterisation, crystal structure 
determination 
• Minimal sample preparation 
• Insensitive to particle size 
• Quantitation possible 
Solid state Nuclear 
Magnetic Resonance 
(ssNMR) 
Magnetic resonance 
o Heating of the sample by fast spinning (up to the 
order of hundreds of thousands of cycles per 
second) 
o Experimental artefacts 
o Slow data acquisition 
o Environmental effects difficult to study 
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Particulate level properties 
Single crystal X-ray 
diffraction, 
Powder X-ray 
Diffraction (XRPD) 
Diffractogram from 
single crystal and 
powder sample 
• Crystal structure (“golden standard”), phase 
identification 
• Crystallinity (%) measurement 
• Quantification possible 
• Temperature and humidity controlled chambers 
available 
  o Influenced by particle size and orientation 
o Difficulty of preparing high quality single crystal 
o Interference from crystalline excipients 
• Crystal structure information 
• Additional information from molecular rotations 
in gaseous phase 
• No sample preparation required (ATR 
measurements), rapid measurements 
• Quantitation possible 
Terahertz Pulsed 
Spectroscopy (TPS) 
Intermolecular 
vibrations and 
molecular flexing 
(dipole moment 
changes) 
o Influenced by water vapour 
o Diffuse reflectance set-up not currently available 
o Difficulties in data interpretation (not well 
understood) 
• Morphology (shape/habit, size, dispersion colour) 
• Surface examination (optical constants/ interfacial 
angles, birefringence) 
• Qualitative information on crystallinity 
• Melting, transition and eutectic point 
determination 
• Study dehydration, crystallisation 
Optical Microscopy/ 
Hot-Stage Microscopy 
(HSM), Scanning 
Electron Microscopy 
(SEM), Atomic Force 
Microscope (AFM) 
Microscopy under the 
influence of light or 
electron radiation 
o Interference from excipients 
o Small scanning area 
o Limited quantitative information 
• Fast, very sensitive, automation 
• Thermodynamic information (melting point, heat 
capacity, heats of fusion/transition) 
• Quantitative information about relative stability 
and energies involved with phase change 
• Glass transition temperature determination 
Differential Scanning 
Calorimetry (DSC) 
Heat flow versus 
temperature 
o Quantification limited due to kinetic effects 
o Impurities modify melting points 
Thermogravimetric 
Analysis (TGA) 
Change of mass 
versus temperature 
• Fast, very sensitive, automation 
• Study low temperature solvate and hydrate phase 
transitions 
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• Release and stability testing 
• Quantification  
o No information on the nature of transition 
o No structural information 
o Interference from water containing excipients 
Bulk level properties 
• Quantification  of amorphous phase 
• Formation and loss of hydrates 
• Good sensitivity 
Microcalorimetry Heat flow versus time
o No direct structural information 
o Difficult to determine nature of thermal events 
o Not good for kinetic studies 
• Detection and quantification  of polymorphs and 
amorphous phase 
• Sensitive to low energy differences 
Solution calorimetry Heat flow during 
dissolution 
o Interference from other crystalline forms 
o Solubility problem 
• Hygroscopicity behaviour 
• Hydrate formation and stability 
• Crystallisation of amorphous phase 
• Detects low levels of amorphous phase 
• Gives equilibrium and kinetic data 
DVS Moisture 
sorption/ desorption 
isotherms 
Change of mass 
versus %RH 
o Interference from amorphous excipients 
o Hysteresis possible 
• Total water content in sample Karl Fischer (KF) 
titrimetry 
Amount of water (%) 
 o No separation between unbound and hydrate water 
• Relative stability of polymorphs, based on Burger 
rule (more unstable form at 0ºC should have lower 
density) 
Density (pycnometry, 
flotation, indirectly 
using unit cell 
constants) 
Mass per unit volume 
o Exceptions to the rule possible 
• Solubility versus temperature transition point 
• Saturation solubility - analysis of insoluble 
• Solvent-mediated transition – stable form 
Solubility Amount dissolved in 
different solvents and 
temperatures 
o Characteristic data needed 
o Influence impurities 
o Influence of change during measurement 
Source: [69; 72; 270; 271] 
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 Khankari and Grant [193] also developed a brief methodology when working with 
hydrates (Figure 6-1). The first step involves verification of hydrates, of which the formation 
of hydrate will be observed from crystallisation from a number of solvent-water mixtures and 
moisture sorption studies. The resultant solid phases that indicate significant change in the 
humidity profile are characterised by a combination of methods (i) for phase identification and 
(ii) to reveal composition and stoichiometry. If the substance is a hydrate, a series of physical 
properties will be evaluated and compared among the different numbers of hydrate and 
anhydrous forms of the substance. Drug composition within the excipient will then be studied 
if only there is a distinct difference of physical properties amongst the hydrates and anhydrate. 
Last step requires constant monitoring of the substance in single crystal form to ensure the 
stability of the hydrates. 
 
 
Figure 6-1 “Decision tree” for characterising pharmaceutical hydrates. Adapted from [193]. 
 
 
6.2 Gravimetric Technique for Dehydration Studies 
 
 Since the first gravimetric adsorption measuring instruments - hygrometers, described 
by Nicholas of Cues in 1450, until the electronic beam microbalance by Emich in 1912 [105], 
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means for isotherm measurement have evolved to the electro-dynamically recording 
microbalances developed by Leo Cahn and the Cahn Corporation in the 1950’s. 
 
 
6.2.1 Dynamic Vapour Sorption (DVS) 
  
 Dynamic Vapour Sorption (DVS) gravimetric instruments (Surface Measurement 
Systems Ltd., London, UK) provides rapid but accurate measurements of gravimetric moisture 
and organic vapour uptake and loss in solid materials at specific temperature and pressure. The 
gravimetric moisture or solvent uptake of the sample is determined as a function of time at 
fixed relative humidity27 or partial pressures28. 
 
 Apart from hydration and solvation of solids, other phenomena of solid state reactions 
and phase transitions that can be studied using DVS gravimetric instruments include; surface 
adsorption, bulk sorption, deliquescence, hysteresis of sorption and desorption isotherms, solid 
state reactions (e.g. crystallisation of amorphous phase), determination of glass transition 
temperatures and moisture induced transformations. 
 
Table 6-2: Summary of DVS equipments used in this work 
Commercial/ 
customised model 
Vapour/  
Gas induced 
Temperature/ 
Pressure 
Capacity /Resolution 
DVS-1000 Moisture/inert 
5-50°C / 
atmospheric 
1.5g / 0.1µg 
DVS Advantage 
Organic 
vapour/inert 
5-60°C / 
atmospheric 
1.5g / 0.1µg 
DVS Vacuum Air/inert 5-85°C / 10-3 Torr 1.5g / 0.1µg 
Source: [272] 
 
 In this work, DVS gravimetric instruments (Table 6-2) were employed to simulate 
various atmospheric and vacuum pressure conditions for dehydration studies, using sample size 
                                                 
27 Relative humidity refers to the partial pressure of water vapour. 
28 Partial pressure refers to organic solvent vapour in this work (a measure of thermodynamic activity of the 
solvent molecules in gas form). 
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of 30.0 mg ±2.0 mg. The isothermal drying and dehydration rates of carbamazepine dihydrate 
were measured with Cahn D-200 recording microbalance (Thermo Fisher Scientific Inc., 
Waltham, MA, US) at a balance resolution of ± 0.1 µg and a drift of less than 2 μg per day. 
The partial pressure in the atmospheric flow DVS system is regulated between 0 %P/P0 to 98 
%P/P0 (± 1 %P/P0) and the system temperature is controlled between 5ºC and 60ºC (± 0.5ºC). 
The dry laboratory air is separated into two streams of gases prior entering into the DVS 
system (Figure 6-2). One of them is directed through the humidifier continuously into the 
temperature controlled system at a volumetric flow capacity of 50 to 500 sccm29. The DVS is 
enclosed in a temperature controlled incubator which is controlled via CAL 3300 auto-tune 
temperature controller. Temperature and humidity probes are inserted at both sample and 
reference chambers to measure and record the readings at all times (the smallest time interval – 
data measuring at every one second and data recording at every two seconds). 
 
 
Figure 6-2 Schematic diagram of DVS Advantage instrument (also applicable to DVS-1000). 
 
 
                                                 
29 Abbreviation for “standard cubic centimeter per minute”, the given volumetric flow rate at standard temperature 
and pressure (STP). 
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Vapour pressure of solvent in DVS flow system 
 
 Raoult’s law states that the vapour pressure of a solvent above an ideal solution is equal 
to the vapour pressure of the pure solvent at the same temperature, i.e. the mole fraction of the 
solvent present. As the equilibrated vapour pressures of solvents are proportional to their 
vapour pressures, the relationship in the liquid and vapour phases can be expressed by the 
following equations. 
 
satiii Pxp ,=          Equation 6-1 
atmii Pyp =          Equation 6-2 
pi equilibrated vapour pressure (kPa) 
xi molar fraction of component i in liquid phase (mol/mol) 
yi molar fraction of component i in vapour phase (mol/mol) 
Pi, sat saturated vapour pressure of a pure component i (kPa) 
Patm atmospheric pressure (kPa) 
 
 In the DVS Advantage system, the vapour pressure of solvent at operating temperature 
was determined by the extended modified Antoine equation (Equation 6-3). The Antoine 
constants employed are listed in Table 6-3. Saturated vapour pressure for each solvent was 
calculated, and the corresponding satiP ,  at varying temperature. 
 
( ) 654
3
2
1, lnln
C
sati TCTCCT
CCP ++++=      Equation 6-3 
Pi, sat saturated vapour pressure of a pure component i (kPa) 
Ci extended Antoine coefficients (i=1, 2, 3..and 6) 
T temperature (K) 
 
Table 6-3: Constants of each solvent vapour for the extended modified Antoine equation 
Solvent C1 C2 C3 C4 C5 C6 
Acetone 69.006 -5599.6 0 -7.0985 6.2273 x10-6 2 
Ethyl Acetate 66.824 -6227.6 0 -6.4100 1.7914 x10-17 6 
Ethanol 74.475 -7164.3 0 -7.3270 3.134 x10-6 2 
Methanol 81.768 -6876 0 -8.7078 7.1926 x10-6 2 
Source: Surface Measurement System Ltd., UK. 
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 The vacuum DVS system operates within the absolute pressure range of 10-3 to 760 
Torr (± 10-5 Torr) from 20ºC to 85ºC. The vacuum conditions are achieved using a standard 
rotary pump, and controlled by adjusting the butterfly valve. The pressure in the DVS chamber 
is monitored by three pressure transducers (Figure 6-3a). Vacuum DVS was designed to 
operate at both static and dynamic operational modes, as illustrated in Figure 6-3b. In the static 
mode, there is no mass transfer within the system once the pressure set point was achieved. 
Meanwhile in the dynamic mode, dry laboratory air or inert gas such as nitrogen can be 
induced into the system at user selected flow rate (e.g. 50 sccm, 100 sccm and 200 sccm) 
whilst the system pressure is maintained via the use of a downstreak butterfly valve operating 
on the vacuum line.  
 
 
Figure 6-3 Schematic diagram of (a) DVS Vacuum instrument and (b) operating modes of the 
flow controller. 
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6.3 Thermoanalytical Technique for Sample Characterisation 
 
6.3.1 Thermogravimetric Analysis (TGA) 
 
 Thermogravimetric analysis (TGA) determines the thermal stability of a solid material 
and its fraction of volatile components (e.g. water and solvent of crystallisation in this work) 
by monitoring the weight change between the sample and reference pan when the sample is 
heated, either isothermally or non-isothermally at a specific heating rate. The measurement is 
conducted in an inert atmosphere, under nitrogen purge rate of 50 sccm/min. Both of the 
sample and reference holders are assumed to be free from buoyancy effects, though calibration 
is still required to compensate for the differential thermal expansion of the balance arms. Q500 
TGA by TA Instruments Ltd, UK was used in this work to primarily determine the amount of 
physically bound water and/or lattice water, as differentiated by the rate of their removal. 
 
 Non-isothermal TGA profiles, depicted in Figure 6-4, confirmed the water and solvent 
content of the prepared carbamazepine samples in this work. The initial mass, denoted as 100% 
was the total sample mass prior to TGA analysis. The mass loss values correspond to the 
stoichiometric mass change (13.22% at wet basis) for a carbamazepine dihydrate during 
dehydration; meanwhile the stoichiometric mass change for a carbamazepine mono-acetone 
solvate is 19.73% on a wet basis.  
 
 However, there was a substantial mass loss (about 55%mass) for the dihydrate 
agglomerate with larger particle size (Figure 6-4d), even though no higher hydration state has 
ever been reported for carbamazepine. Therefore, it has been concluded that there has been 
inclusion of physically bound moisture in the large dihydrate agglomerates, and that the initial 
sample mass consisted of both bound water and unbound water. In this instance, it was proven 
that non-isothermal TGA was unable to differentiate the states of water from the mass loss 
profile. 
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Figure 6-4 TGA profile of carbamazepine dihydrate and solvate samples at heating rate of 
10ºC/min; revealing the mass loss of bound water (a, c), bound solvent (b), and both bound and 
unbound water (d) 
 
 
6.3.2 Differential Scanning Calorimetry (DSC) 
 
 Differential scanning calorimetry (DSC) is the preferred thermoanalytical method for 
characterisation of pharmaceutics as it provides detailed information on both the physical and 
energetic properties of a substance. These include quantitative data of exothermic, endothermic 
and heat capacity changes as a function of temperature and time (e.g. desolvation, dehydration 
etc.). It is also widely used in industrial settings as a quality control instrument due to its 
applicability in evaluating sample purity.  
 
 A power compensation DSC measures the power input for a sample cell and compares 
that to an empty reference cell such that both are maintained closely throughout the experiment 
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at the same temperature. The basic principle underlying this technique is that, when the sample 
undergoes a physical transformation such as phase transitions, more (or less) heat, associated 
with endothermic (or exothermic) process, will be supplied to the sample pan compared to the 
reference one.  
 
 Figure 6-5 illustrates that the heat flows into both sample and reference pan via an 
electrically heated constant thermoelectric disk and the heat is proportional to the difference in 
output of the two thermocouple junctions. The pan may be open, pin-hole, covered or sealed, 
and the reference pan is normally filled with an inert material (e.g. alumina or air). There are 
two types of DSC; power compensated DSC (two furnaces) and heat flux DSC (single furnace) 
which were used in this work.  
 
Sample
Constant heating disk
Reference
Heating block
Chromel wire
Alumel wire
Chromel disk
 
*Alumel (aluminium-nickel) refers as negative wire, while chromel (nickel-chromium) is the positive 
wire in K-type thermocouple. 
Figure 6-5 Schematic diagram of heat flux differential scanning calorimetry. Adapted from [273]. 
 
 An endotherm or exothermic peak can be described by the onset temperature, where the 
transition starts to deviate from the baseline (Figure 6-6). The extrapolated onset melting 
temperature is taken at the intersection of the extrapolated baseline prior to the transition with 
the extrapolated leading edge of the transition. Meanwhile, the peak temperature is normally 
defined as the reaction temperature, as in melting temperature for a melting endotherm. 
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Figure 6-6 Differential scanning calorimetry scan of a drug substance (endothermic transitions 
downward). Adapted from [273]. 
 
 The heating and cooling rates also have a noticeable influence on the enthalpies and 
their temperature range, as demonstrated by Taylor and York’s [274] studies of trehalose 
dihydrate, where by DSC was less sensitive in detecting the lost water from the enthalpy of 
dehydration at a slower scanning rate. Nonetheless, DSC itself does not show unequivocally 
the existence of a solvate, unless combined with data from TGA, nuclear magnetic resonance 
(NMR) etc. Byrn et al. [5] suggested that analysis of solvates should be conducted using either 
an open pan or a pan with a pin-prick for DSC to avoid unusual and variable results. An open 
pan analysis will reproduce the conditions at which TGA is performed. However, for less 
stable hydrates, the endotherm of dehydration may be so broad that the combined methods of 
DSC/TGA are difficult to detect accurately. At this stage, X-ray diffraction is the ultimate 
technique for demonstration of the hydrate formation. 
 
 Amongst the anhydrate polymorphs, the enantiotropic pair of P-monoclinic and 
triclinic are widely studied due to their stability [70; 207; 208; 212; 213]. Figure 6-7 depicts 
the endothermal peak, referring to the polymorphic transition from P-monoclinic to triclinic. 
The onset melting temperature ranges of DSC for these two polymorphs are 174-176ºC for P-
monoclinic and 189-191ºC for triclinic form [235], which coincide with the results of Krahn & 
Mielck [207].  
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Figure 6-7 DSC profile of carbamazepine anhydrate (P-monoclinic form) prepared in this work. 
 
 Figure 6-8 demonstrates the broad and early onset dehydration of carbamazepine 
dihydrate, with the crystal form dehydrated within temperature range of 58ºC to 61ºC (418.3 ± 
5.0 J/g) and the agglomerate form between 65ºC and 73ºC (400.2 ± 8.5 J/g). It can be deduced 
from this rather low dehydration temperature that hydrate water molecules are probably not 
strongly involved in the crystal lattice, nor encaged in voids within the crystal lattice. The 
dehydrated agglomerate shows an endothermal transition from P-monoclinic to triclinic form 
at 149-150ºC (shown as hump no. 3 in Figure 6-8), before the melting peak of the triclinic form 
around 189-191ºC. Based on those DSC profiles, it is shown that dehydration of the dihydrate 
crystals leads to the formation of triclinic anhydrate, while the dihydrate agglomerates would 
dehydrate into the stable P-monoclinic anhydrate, before converting to the triclinic form at the 
transition temperature. 
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Note: 
(1) & (2) heat of vapourisation, due to dehydration of hydrate water. 
(3) & (4) heat of transition from P-monoclinic to triclinic, denoted as enantiotropically related. 
(5) heat of melting of triclinic form. 
Figure 6-8 DSC profiles of carbamazepine dihydrate in crystal form and agglomerated form, 
prepared in this work. 
 
 Similar to the dihydrate form, an early onset desolvation (heat of vapourisation at 160.7 
± 5.8 J/g) was observed for carbamazepine acetone solvate (referring to hump no. 1 in Figure 
6-9). The desolvation process ceases around 78-79ºC, slightly higher than the boiling 
temperature of pure acetone. As the temperature increases, an endothermal peak appeared at 
173-175ºC (65.0 ± 0.5 J/g), followed by an exothermic event at 179-180ºC (40.5 ± 0.8 J/g), 
which was either a crystallisation or monotropically related phase transformation. Eventually it 
reaches the melting point of the triclinic anhydrate at 189-191ºC. The similar trends of endo-
exo-endo thermal events were obtained for the desolvated form (shown as humps no. 2, 3 and 4 
in Figure 6-9 and at temperatures between 173ºC and 185ºC). These are clearly different than 
the DSC profile of a P-monoclinic anhydrate. This data therefore hints about the formation of 
metastable polymorph following a desolvation process.  
 
Ramp 10°C/min to 210°C 
Endothermic 
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Note: 
(1) heat of vapourisation, due to desolvation of acetone molecules. 
(2) heat of melting  of trigonal. 
(3) heat of transition for monotropically related polymorphs. 
(4) heat of transition for enantiotropically related polymorphs. 
(5) heat of melting of triclinic form. 
Figure 6-9 DSC profiles of carbamazepine acetone solvate and the desolvated form. 
 
 
6.3.3 Hot Stage Microscopy (HSM) 
 
 Hot stage microscopy (HSM) is used to analyse the morphology changes of hydrates 
upon dehydration at high temperature and to prepare anhydrate samples (e.g. polymorphs of 
carbamazepine). Observable physical changes of the hydrate crystals can thus be matched with 
the DSC and TGA traces, at the same heating rates.  HSM consists of a TMS 90 temperature 
controller (Linkam Scientific Instruments Ltd., Surrey, UK), a THM 600 stage holder (Linkam 
Scientific Instruments Ltd., Surrey, UK) for the sample and an Olympus BH2 brightfield 
microscope (Olympus Corporation, Tokyo, Japan). The temperature controller is able to 
increase the temperature up to 400ºC at the fastest ramping rate of 99ºC/min. The sample 
chamber is air tight and inert gas such as nitrogen can be introduced into the system throughout 
the heating or cooling processes. 
Ramp 10°C/min to 210°C 
Endothermic 
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 Phase transformations can be clearly observed, as shown in Figure 6-10 and Figure 
6-11. The carbamazepine anhydrate P-monoclinic turned opaque in Figure 6-10f and the 
process completes by 162ºC, in agreement with the heat of transition to triclinic form 
determined from DSC. The phase transition was observed to be commencing in the vicinity of 
the defects. Similar to the anhydrate, carbamazepine dihydrate also gradually became opaque 
from the temperature range 35ºC to 90ºC. The broad temperature range demonstrates the 
expected large endotherm of dehydration. Dehydration seemed to be proceeding rather 
homogeneously in the single crystal sample. 
 
 
Figure 6-10 Optical microscopy images showing the evolution of a carbamazepine P-monoclinic 
anhydrate crystal to the triclinic anhydrate upon heating, with transition temperatures between 160.5ºC 
and 162ºC. 
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Figure 6-11 Optical microscopy images showing the evolution of a carbamazepine dihydrate crystal 
losing its water of crystallisation. 
 
 
6.4 Spectroscopy Techniques for Pharmaceutical Hydrates 
 
 Spectroscopy has become a vital technique in the physical characterisation of 
pharmaceutical solids. Infrared (IR) or near infrared (NIR), more recently Raman and solid 
state nuclear magnetic resonance (ssNMR) have proven to be especially successful. Recent 
reviews [275; 276] summarised each vibrational technique based upon a unique phenomenon; 
IR is associated to energy absorption, Raman is related to inelastic scattering, whilst ssNMR 
involves energy absorption in the presence of magnetic field. Information, extracted through 
light absorption, emission or scattering and optical rotation, include energies of electronic, 
vibrational, rotational states, structure and symmetry of molecules, and also dynamic 
information. 
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Figure 6-12 Categories for types of spectroscopy technique at different wavelength and frequency. 
 
 Water in crystalline hydrates often has a 6º of vibrational freedom: two stretching 
(symmetric and asymmetric), one bending, three vibrational (hindered rotation) and three 
hindered translational degrees of freedom [60]. The shift in OH stretching frequency, detected 
by vibrational spectroscopy, can be used to evaluate the interaction energy between water and 
other molecules. Specifically, lower frequency of OH stretch implies a higher degree of water 
hydrogen bonding.  
 
 
Figure 6-13 Vibrational modes (a) symmetric stretch; (b) asymmetric stretch; (c) bending, and 
librational modes (d) wag; (e) twist; (f) rock for water molecule. 
  
 NIR spectroscopy detects the overtone absorption of the vibrating bonds, like O-H, N-
H, C-H and S-H bonds [89]. However, the strong O-H bands dominate and other vibrations 
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cannot be easily observed. Meanwhile Raman spectroscopy is a structure-rich approach that 
provides an excellent method for probing solid state hydrogen bonding interactions between 
molecules, including polymorphs and solvates (including hydrates) [277; 278]. The low Raman 
activity of water vibrations will not mask a wide Raman spectrum range. 
 
 
6.4.1 Raman Spectroscopy Coupled with DVS System 
 
 An Ocean Optics QE65000 spectrometer (Ocean Optics Inc., Dunedin, US) coupled 
with Hamamatsu S7031-1006 charge-coupled device (Hamamatsu Co., Bridgewater, US) was 
integrated into DVS system for the dehydration/desolvation studies. This set-up enabled 
qualitative in situ and real-time collection of the Raman spectra and gravimetric measurement 
at the same time during a dehydration or desolvation event. The fibre optic laser beam at 785 
nm was positioned into the sample tube, in which the laser light was focused on the solid 
sample placed on the quartz sample pan (Figure 6-14).  
 
 Backscattered Raman light was then being transmitted back to the spectrometer for 
analysis in the Ocean Optics Spectrasuite programme (Ocean Optics Inc., Dunedin, US) via a 
fibre optic probe. The spectroscopic acquisition conditions were optimised for each spectrum 
that was captured, the Raman excitation time was 8 seconds for three spectral accumulations. 
An external triggering of the spectrometer was accomplished with DVS video capturing 
method. This approach was to ensure that the sample was visually recorded followed by three 
Raman scans after each stage.  
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Figure 6-14 Experimental set-up of Raman spectroscopy coupled with DVS system. 
 
 The Raman spectra are able to differentiate between carbamazepine dihydrate, acetone 
solvate and anhydrate, based on the differences in peak positions and intensities, as shown in 
Figure 6-16 and Figure 6-17. Peak positions were assigned to specific molecular vibrations by 
reference to published literature [279; 280] and are summarised in Table 6-4. Regions where 
clear spectral differences between the pseudopolymorphs and anhydrate were identified as 
350-450 cm-1, 650-810 cm-1 and 1000-1260 cm-1. Several changes in the collected spectra were 
observed during the dehydration and desolvation, with the absolute and relative intensities of a 
number of characteristic peaks changing. 
 
 However, no distinct difference can be observed for polymorphic transition or presence 
of the amorphous form. The main reason is due to the excitation wavelength of the laser used 
not giving a sufficiently strong Raman spectrum for this specific sample morphology. Fourier 
Transform (FT) Raman spectroscopy with a wavelength of 1064 nm offers a better opportunity 
to discern the differences between carbamazepine polymorphs [208; 214; 231]. Moreover, it 
has been demonstrated that IR spectroscopy is more sensitive in detecting polymorphism, than 
Raman spectroscopy, due to the high intensity of IR bands on the CONH2 group (Figure 6-15), 
which the strong Raman bands are not associated with. Instead Raman bands react strongly to 
the motions of aromatic rings and central ring [214]. 
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Table 6-4: Assignment of Raman bands to molecular vibrations for carbamazepine anhydrate, 
dihydrate and acetone solvate 
Anhydrate 
Raman band (cm-1) 
Dihydrate 
Raman band (cm-1) 
Approximate description of 
vibration mode 
366w, 389m  384m  Lattice vibration 
- 445w Lattice vibration 
694s sh - δ aromatic, in-plane/C-H wag cis 
803m 787w ν(C-C) 
1245m 1255m ν (C-N) amide III 1º amide 
Anhydrate 
Raman band (cm-1) 
Acetone solvate 
Raman band (cm-1) 
Approximate description of 
vibration mode 
- 447w Lattice vibration 
694m sh, 716s  694m, 722s δ aromatic, in-plane/C-H wag cis 
- 770m ν(C-N-C) 3◦ amide 
797m  792m, 808m ν(C-C) 
- 1034s sh δ(C-H) aromatic, in-plane 
1150m 1156s ν(C-C) ring/ (C-N-C) asymmetric 
Note: ν: stretch, δ: bend, w: weak, m: medium, s: strong, sh: shoulder. 
 
Water (1) bound to amide C=O group.
Water (2) bound to amide N-H group.
Acetone bound to amide N-H group.
(1)(2)
(a) carbamazepine dihydrate (b) carbamazepine acetone solvate
 
Figure 6-15 Molecular arrangements of (a) carbamazepine dihydrate and (b) acetone solvate. 
 
 Tian et al. [281] investigated the influence of sample characteristics on identification 
and quantification of a mixture of carbamazepine hydrate and anhydrate by Raman 
spectroscopy and X-ray powder diffraction (XRPD). They concluded that Raman spectroscopy 
is more reliable as a quantification method than XRPD because it eliminates the influences of 
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different particle size, morphology and special distribution of the two solid state forms. 
Nonetheless, if the Raman laser spot i.e. diameter of 200 μm were focused partly on the 
unchanged regions or an uncovered portion where there is no growth occurring, then no 
measurable differences could be detected. 
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Figure 6-16 Raman spectra for dehydration of carbamazepine dihydrate crystal from this work, at 0 %RH, 200 sccm and 40ºC.
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Figure 6-17 Raman spectra for desolvation of carbamazepine acetone powder from this work, at 30 %RH, 200 sccm and 30ºC.
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6.5 X-ray Powder Diffraction (XRPD) 
 
“Every crystalline substance gives a pattern; the same substance always gives the same 
pattern; and in a mixture of substances each produces its pattern independently of the others.”  
        A. W. Hull in 1919 [282] 
 
 X-ray powder diffraction (XRPD) is perhaps the most definitive and non destructive 
analytical technique method of detecting and quantifying molecular order in any system. As 
each powder diffraction pattern is a unique characteristic of a particular crystalline substance, 
XRPD is capable of identifying unknown substances in polycrystalline or powdered solid 
samples, by comparing the diffraction data against a database maintained by the International 
Centre for Diffraction Data (ICDD). It may also be used to correlate the physicochemical 
structure of pharmaceutical solids to observed stability and drug release profiles. Previously, it 
has been unable to compete with Fourier transform spectroscopy methods in terms of 
measurement time and accuracy. Moreover, the detection limit of XRPD has shown 
considerable variation (e.g. 5-10% in amorphous content [283; 284]). Nonetheless, recent 
refinements in hardware and software have significantly increased the technique's speed, 
accuracy and versatility.  
 
 
6.5.1 Theoretical Consideration of X-ray Diffraction 
 
 When an intense beam of X-rays (monochromatic X-rays30 in the range of 0.01-100Å) 
interacts with an atom, they induce an electronic cloud movement as does any electromagnetic 
wave [285]. In addition to adsorption and other phenomena, these charges also re-radiate 
waves with the same frequency, known as Rayleigh scattering waves, which interfere with 
each other either constructively or destructively31. The intensities32 and spatial distributions of 
the scattered X-rays form a specific diffraction pattern on the detector, which is uniquely 
determined by the structure of the sample and also forms the basis of the diffraction analysis. 
                                                 
30 Monochromatic X-ray denotes single wavelength X-ray, produced using a monochromator. 
31 Overlapping waves either sum up to produce stronger peaks or subtract from each other to a lower degree. 
32 Intensity is a measure of the time-averaged energy flux, whilst intensity of a beam is defined as the energy 
flowing through a 1m x 1m area in one second. 
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 Figure 6-18 shows two parallel incident rays hit on two atomic planes of crystal, e.g., 
atoms, ions, and molecules, at angle θ and separated by the distance d. The possible d-spacing 
defined by the Miller indices h, k, l are determined by the properties of the unit cell, as 
discussed in Chapter 2. However, the intensities of the reflections are determined by the 
distribution of the electrons in the unit cell. The highest electron density is found around atoms. 
Therefore, the intensities depend on the types of atom and their respective location within the 
unit cell. Planes with high electron density will reflect strongly, meanwhile planes with low 
electron density will give weak intensities. 
 
dA (Å)
2θA (º)
Atomic planes
λ (Å)
Incident beam Scattered beam
Atomic planes
λ (Å)
Incident beam Scattered beam
(b)
(a)
2θB (º)
2θB (º)
2θA (º)
dB (Å)
 
Note: Units used are shown in parenthesis. 
Figure 6-18 X-ray scattering from a crystal lattice, with case (b) having a higher wavelength (λ), 
longer spacing (dB) and larger scattering angle (2θB). 
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6.5.2 Bragg's Law 
 
 In 1913 W.L. Bragg derived the first mathematical explanation of the actual positions 
of the X-ray diffraction spots, which describes X-ray diffraction as a process similar to 
reflection from planes of atoms in the crystal [286]. When the incident X-rays hit the crystal 
planes at an incident angle θ, as illustrated in Figure 6-18, X-rays are scattered with a reflection 
angle of θ. The incident and diffracted rays are in the same plane as the normal to the crystal 
planes. The observed diffraction peak, according to the Bragg's condition, can be expressed in 
this simple equation: 
 
θλ sin2 ⋅= dn         Equation 6-4 
n an integer number 
λ wavelength of x-rays, and moving electrons, protons and neutrons (nm) 
d spacing between the planes in the atomic lattice (d-spacing) (Å) 
θ angle between the incident ray and the scattering planes (º) 
 
 The first-order reflection (n=1) refers to the fundamental energy, meanwhile the 
subsequent second- or third-order reflections are from the harmonic energies, two or three 
times the fundamental energy [285].  
 
 Bragg’s Law was derived using the reflection geometry and applying trigonometry. The 
lower beam always travel the extra distance (AB + BC) in order to continue travelling parallel 
and adjacent to the top beam (Figure 6-19). The extra distance is defined as an integral (n) 
multiple of the wavelength (λ) for the phases of the two beams to be the same. The right 
triangle of ABZ shows that d as the hypotenuse. Thus, d and θ can relate to the extra distance 
(AB + BC) as: 
 
θsin⋅= dAB  
 
Since BCABn +=λ and BCAB = , 
ABn 2=λ  
Therefore, θλ sin2 ⋅= dn  
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Figure 6-19 Derivation of Bragg's Law 
 
 It is also noteworthy that the location of the surface does not change the derivation of 
Bragg's Law. By varying the angle θ, the Bragg's Law conditions are satisfied by different d-
spacings in polycrystalline materials. Hence, θ decreases as d increases and vice verse. Plotting 
the angular positions and intensities of the resultant diffracted peaks of radiation produces a 
pattern, which is characteristic of the sample. Where a mixture of different phases is present, 
the resultant diffractogram is formed by addition of the individual patterns. 
 
 
6.5.3 Features of XRPD 
 
 Unlike the single crystal X-ray diffraction, X-ray powder diffraction (XRPD) technique 
requires less tedious sample preparation, a set of complete diffractions can be obtained and the 
phase transformation as a function of temperature, pressure etc. can be observed. In XRPD, the 
sample consists of many smooth plane surface crystallites with random orientations and the 
sample has to be grinded down to particle size of about 2 μm to 5 μm (in cross section). Ideally 
a random distribution of all possible h, k, l planes is required as only those crystallites having 
the reflecting planes (h, k, l) parallel to the specimen surface will contribute to the reflected 
intensities.  
 
 XRPD in this work was performed using an X’Pert PRO diffractometer (PANalytical, 
Almelo, The Netherlands) with Nickel-filtered Cu K-α radiation (λ = 1.5418Å) at accelerating 
voltage of 40 kV and 40 mA with a X’Celerator RTMS (Real Time Multiple Strip) detector. 
Samples were packed into flat sample holder prior to scanning over an angular range of 5º to 
40º (2θ) using a step size of 0.016º (2θ) at a count time of 2 seconds. The manual slit settings 
employed were 0.04 rad soller slit, ½º anti-scatter slit and ¼º divergence slit at the incident 
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beam. The XRPD data was subsequently analysed with X’Pert High Score software, having the 
structures confirmed with the International Centre for Diffraction Data database (Newtown 
Square, PA). 
 
6.5.3.1 Source of X-ray radiation 
 
 X-rays were discovered through a high tension electrical discharges experiment in an 
evacuated glass tube by Prof. W.C. Röntgen in 1895 [287]. Till now, laboratory X-rays are still 
produced in a sealed tube source, with a vacuum pressure of less than 0.013 Pa to prevent any 
discharge in the residual gas [20]. There are three main components for X-rays generation; a 
source of electrons, a means of accelerating the electrons at high speeds, and a target anode to 
receive the impact of the electrons and interact with them.  
 
 Filament tungsten is generally employed as cathode to thermally generate the electrons, 
known as thermionic emission. Tungsten is used as cathode due to the fact that it has the 
highest melting temperature of all the non-alloyed metals, and the highest tensile strength at 
temperatures over 1650ºC [288]. The electrons accelerate towards the anode (copper -Cu in 
most cases, others include Mo, Cr, Fe, Co, Ag and W [287]) due to the high voltage differential 
between cathode and anode, as depicted in Figure 6-20. Once the electrons strike on the anode, 
X-rays are emitted. Since only about 1% of the collisions are converted into X-rays, whilst the 
rest are thermal energy (UV radiation) and limited visible light, therefore a coolant is 
constantly supplied to the copper block to prevent over-heating. The X-rays subsequently exit 
the tube through thin beryllium windows. Beryllium is used due to the low atomic weight (4) 
which minimises the absorption of the X-rays. 
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Figure 6-20 Schematic diagram of an X-ray generator. 
 
 The emission spectrum of the generated X-rays is a superposition of; a broad band of 
continuous Bremsstrahlung radiation (also known as white radiation) and characteristic 
radiation, which is composed of discrete peaks: Cu K-α at 1.542Å and Cu K-β at 1.392Å. 
Characteristic radiation is generated when an incident electron has sufficient energy to dislodge 
an electron from one of the inner electron shells of the target Cu atom, and radiation will be 
released once an electron from a shell of higher energy drops into that vacant place [20].  
 
 However, no characteristic radiation will be produced until the voltage level reaches 
over the threshold value of the metal anode, for example about 8.5kV for Cu (Figure 6-21). 
The typical operating voltage is set at about four times the threshold value, and an increase in 
the voltage supply might increase the intensity but will not alter the wavelength of the 
characteristic peaks [20]. In order to simplify the XRPD patterns, only one characteristic peak 
(Cu K-α) will be selected as this will reduce the number of recorded diffractions. Therefore, 
the Cu K-β radiation is often being reduced with a nickel filter, as it will contaminate the 
powder diffraction pattern from Cu K-α. The optimum thickness of the nickel filter however is 
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a compromise between reducing the unwanted Cu K-β intensity and reducing the desired Cu 
K-α [287]. Besides, a monochromator is used to cut out both white radiation and the unwanted 
characteristic radiation, as denoted in the shaded area of Figure 6-21. 
 
 
Figure 6-21 X-ray spectra produced by three different accelerating voltages (8kV, 25kV and 50 kV) 
from a Cu anode. Source: [287]. 
 
6.5.3.2 Goniometer of XRPD 
 
 The mechanical assembly of the sample holder, detector arm and associated gearing 
(e.g. slit system) is referred to as the goniometer. Figure 6-22 shows a typical Bragg Brentano 
theta-theta setup, viewed from the top and the sample is stationary in the horizontal position. 
The distance from the X-ray tube to the sample is the same as from the sample to the detector. 
Meanwhile the X-ray tube and the detector both move simultaneously over the angular range 
theta (θº).  
 
 As the line source emits radiation in all directions, a series of slit systems are employed 
to enhance the focusing and to improve the signal-to-noise ratio of the diffraction scan. The 
simplest collimation can be achieved by a divergence slit, which controls the in-plane 
divergence of X-ray beam as shown in Figure 6-22. A soller slit on the other hand controls the 
axial divergence of X-ray beam. A soller slit is made from a set of closely spaced parallel thin 
metal plates, where it is fitted into the incident and diffracted beam path parallel to the 
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diffraction plane [289]. In addition, the openings of the anti-scatter slit and receiving slit can be 
manipulated to improve the intensities of the diffracted peaks. 
 
 
Figure 6-22 Schematic diagram of a diffractometer slit system in a Bragg Brentano theta-theta setup. 
 
6.5.3.3 Detector of XRPD 
 
 In general, there are two types of detectors; line detector and area detector, as depicted 
in Figure 6-23. Line detector supports the spatial resolution in one direction only, for example 
the position sensitive device (PSD), meanwhile area detector facilitates resolution in two 
dimensions, such as in a charge coupled device (CCD) and image plate device (IPD) [290]. 
Both line and area detectors, however, can measure the diffracted intensity at multiple points at 
once and a single measurement often results in the diffraction pattern resolved in one or two 
dimensions, respectively. 
 
 
Note: Light trace extended from the center of optical diffractogram is the shade from primary beam 
trap.Bragg angle is zero at the center, and increases along any line, shown in the right diagram. 
Figure 6-23 Schematic diagram explaining the differences between point, line and area detectors, 
used in powder diffractometry. 
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 Comparable to the position sensitive detector (PSD), the real time multiple strip 
detector (RTMS) of PANalytical XRD instrument employs the principle used in a standard 
solid state detector. A solid state detector is made of a single crystal consisting of a sandwich 
of intrinsic silicon between a p-type and an n-type semiconductors (a p-i-n diode) [291]. The 
RTMS technology offers direct detection of the diffracted X-rays, with the ability to process 
high count rates and without any delayed responses (e.g. gas ionization). The X'Celerator 
detector (PANalytical B.V., Almelo, The Netherlands) therefore is able to reduce the 
measurement times by as much as 100-fold, while at the same time significantly improve 
detection limits without compromising data quality. 
 
 
Figure 6-24 Schematic diagram of data collection using Real Time Multiple Strip (RTMS) detector. 
 
 
6.5.4 Limitations of XRPD 
 
6.5.4.1 Detection limit 
  
 Conventional X-ray powder diffraction can be used to quantify non-crystalline 
materials (i.e. amorphous phase) down to levels of 5% [283; 284; 292]. PANalytical B.V. 
(Almelo, The Netherlands) however claimed that their XRPD instrument, which is employed 
in this work, is able to detect down to about 0.5% of crystalline material and less than 1% of 
amorphous content, as summarised in Table 6-5. Besides, XRPD is more precise than NIR 
spectra in terms of detecting the small amounts of crystalline lactose. 
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Table 6-5: Comparative data for X-ray diffraction, near infra-red spectroscopy and differential 
scanning calorimetry 
 
0-100% crystal content 
1-10% 
crystal content 
1-9% 
amorphous content 
 XRD NIR DSC XRD NIR XRD NIR 
R2 0.9981 0.9975 0.9611 0.999 0.9904 0.9994 0.9939 
Detection 
Limit (%) 
   0.50 0.82 0.99 0.22 
Source: PANalytical B.V., The Netherlands. 
 
6.5.4.2 Penetration depth 
 
 Penetration depth is defined as the length at which the X-ray beam has fallen by a 
factor 1/e. It is a measure of how far the beam can penetrate into a sample, where 99% of the 
information recorded in a diffraction pattern originates from. Penetration depth can be 
determined using Mass Absorption calculator (MAC), which is primarily used to calculate the 
mass absorption coefficient of any element, compound or mixture for a given wavelength. 
Specific information are required, such as anode material, radiation wavelength (Cu K-α), 
chemical formula (MW), density, packing (powdered sample between values of 0.5 to 1) and 
angle of incident. 
 
 The depth of penetration becomes commensurably deeper with higher incident angles. 
Meanwhile more densely packed powder and/or sample with high density have a shallower 
penetration depth. It has been demonstrated that X-rays in a typical XRPD experimental setup 
only have a small mean penetration depth (e.g. about 30μm for Cu K-α radiation) which 
implies that only a thin sample layer is analysed and this might lead to poor particle statistics 
[281]. However, based on PANalytical X'Pert PRO instrument, for a carbamazepine sample 
with packing factor of 1 has its penetration depth ranging from ~150μm at 5º 2θ up to 
~1200μm at 40º 2θ. 
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Figure 6-25 Calculated penetration depths of the Cu K-α beam on carbamazepine samples. 
 
 In addition, a range of other sample properties such as particle size, packing and sample 
thickness are known to affect the observed diffraction pattern. Shown in Figure 6-26, the 
dehydrated carbamazepine sample consists of a mixture of triclinic and P-monoclinic forms. It 
has been demonstrated in this work that dehydration under such conditions (shown in Figure 
6-26) would lead to formation of triclinic form. However, P-monoclinic appears to be 
predominantly formed inside the packed powder bed, as illustrated in Figure 6-27.  
 
 This observation arises due to two reasons; the re-crystallisation of the anhydrate phase 
was kinetically hindered, where the formation of anhydrate at the bottom of powder bed was 
not influenced greatly by the drying environment. Secondly, the particle size effect. It is known 
that for a large crystal size, unrepresentative particles are analysed at the top layer of the 
powder bed, and XRD pattern only provide information about the composition of these large 
particles instead of the overall sample composition. 
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Note:  
Dihydrate sample was packed into a flat sample holder, and kept throughout the dehydration process. 
Dehydration under atmospheric condition at 40ºCand 40 %RH. 
Figure 6-26 XRPD patterns of the dehydration of carbamazepine dihydrate into a mixture of 
polymorphic anhydrates.  
 
 
Figure 6-27 Penetration depth effect on unevenly distributed carbamazepine mixtures. 
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6.5.4.3 Crystal statistic effect 
 
 The crystal statistic effect refers to the different intensity ratios of the diffraction peaks 
than the true diffraction peaks, due to large particle size and sample preparation method. Figure 
6-28 depicts the comparison between good and poor statistics, where the good statistics have 
all the diffraction peaks produced by a similar number of crystallites. On the contrary, the false 
diffraction peaks are produced by different numbers of crystallites. In severe cases, these 
effects also influence the shape of the peaks [293]. In order to obtain a good crystal statistics, a 
large number of crystallites should contribute to the diffraction process, and this can be 
achieved by grinding samples to reduce the average particle size.  
 
 
Figure 6-28 Crystal statistic effect (a) good statistics, reflecting true pattern of the sample, and (b) 
poor statistics, referring to false pattern. 
 
6.5.4.4 Preferred orientation effect 
 
 The conventional theory of XRPD assumes random distribution of the orientations 
among the infinite amount of crystallites, in excess of 106 to 107 particles [290]. This number is 
not easily achievable and most of the time, preferred orientation effects prevail. Preferred 
orientation can be induced by surface flattening process during sample preparation, especially 
in the flat sample holder for Bragg Brentano theta-theta setup XRPD.  
 
 In addition, the external shape (habit) of the crystallites plays a crucial role in achieving, 
or not, randomness of their orientations and reducing the preferred orientation effect. Ideally, 
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an equidimensional crystal habit with 2 μm to 5 μm of particle size is desirable. Equally, the 
particle size should not be too small because damage to the crystal structure will produce broad 
peaks, making it difficult to identify or quantify the actual phases present in the sample. 
 
 
6.6 Mercury Porosimetry 
 
 Mercury porosimetry provides a wide range of valuable information, including the pore 
size distribution, the total pore volume or porosity, the skeletal and apparent density33, and the 
specific pore area of a sample. Knowledge of pore structure is important to predict material 
behaviour under different environmental conditions. Porosity also strongly influences the 
physical properties of materials, such as durability, mechanical strength, permeability, 
adsorption properties etc. 
 
 Mercury porosimetry is primarily used to determine the meso- and macroporosity of 
solids (Figure 6-29), ranging from 3 nm to 200 μm based on the International Union of Pure 
and Applied Chemistry (IUPAC) classification [100]. Micropores constitute the range of 
porosity in physisorption processes, whereas meso- and macropores act as transport systems 
filling through a process analogous to capillary condensation [294].  
 
 
Figure 6-29 Pore size detection limits of gas adsorption and mercury porosimetry. 
 
 Pore structure of a solid consists of an irregular network, with constrictions, cavities, 
junctions and so on [295]. There are two main topologies of pores: closed pores and open pores, 
as shown in Figure 6-30. Closed pores are completely isolated from the external surface, with 
                                                 
33 Density: (1) true density = excluding pores and inter-particle voids. (2) apparent density = including closed and 
inaccessible pores. (3) bulk/envelope density = all including pores and inter-particle voids. 
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no access of external fluids. Meanwhile open pores are linked to the external surface and are 
accessible to fluids, depending on the pore size and properties of the fluid [296]. Mercury is 
used almost exclusively as the liquid of choice for intrusion porosimetry because it is non-
wetting towards most substances, except for metals (i.e. gold, aluminum) and has a very low 
compressibility (40.2 x 10-12 Pa-1 at 20ºC and 101 kPa [297]). 
 
Closed pore Blind pores Cross-linked pores Through pores
Closed pore Open pore  
Figure 6-30 Schematic representation of pores. Adapted from [296]. 
 
 
6.6.1 Theoretical Consideration for Mercury Porosimetry 
 
 The concept of using mercury penetration was first suggested by Smetana in 1842 [298] 
to highlight the porous nature of wood. This study was then followed by Dr. E. W. Washburn 
in 1921 [299], who proposed a method to obtain a pore size distribution from pressure-volume 
data for mercury penetration into a porous body. Loisy made the similar suggestion of using 
the pressure-volume data in 1941 [300]. However, it was not until 1945 that the actual 
application through an intrusion-based, pore-measuring instrument was described by Ritter and 
Drake [301]. This publication forms the basis of all subsequent developments in mercury 
porosimetry. The technique was then introduced in the field of pharmaceutical technology by 
Higuchi and his associates in 1965 [302], where they determined the porosity of granules over 
a small pressure range of 20-150 kPa.    
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6.6.2 Washburn Equation 
 
 Washburn has pointed out the fact that surface tension opposes the entrance into a small 
pore of any non-wetting fluid (angle of contact greater than 90º), which is the phenomenon of 
capillary depression. However, this opposition can be overcome by application of external 
pressure and the pressure required is a measure of the pore size, expressed in the Washburn's 
equation [299]: 
 
d
P θγ cos4−=Δ         Equation 6-5 
ΔP applied pressure (Pa) 
γ surface tension of mercury (485.5 mN/m) 
θ contact angle (141.3º) 
d pore diameter (m) 
 
 A key assumption in the Washburn equation is the pore shape, assuming a cylindrical 
pore geometry. Figure 6-31 shows the irregular shaped ‘real’ pore and the cylindrical pore. The 
volume of the cylindrical pore is equal to the ‘real’ pore, however the measured pore diameter 
and the calculated surface area will deviate from the actual values [295].  
 
 
Figure 6-31 A pore with irregular shape (1) and the same pore determined from the mercury 
porosimetry (2).  
 
 Based on the previous assumption, the Washburn equation is modified using the 
Young-Laplace equation, such that the difference in pressure across the surface can be 
expressed as following: 
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P γ         Equation 6-6 
 
with r1 and r2 refer to the principal meniscus curvature radii, γ as surface tension and for 
spherical surfaces, r1 = r2. In real porous media, the final term is generally considered as the 
curvature of meniscus C:  
 
CP ⋅= γ          Equation 6-7 
 
 As surface tension is a function of the curvature C, C therefore depends on the angle of 
contact between mercury and the solid and on the pore geometry (cylindrical capillaries in this 
case), as depicted in Figure 6-32. Combining both Equation 6-4 and Equation 6-5 will become 
the Washburn equation. 
 
r
C θcos2=          Equation 6-8 
 
 
Figure 6-32 Capillary action of a wetting and non-wetting liquid relative to the walls of capillary. 
 
 
6.6.3 Features of Mercury Porosimetry 
 
 Measurements of mercury porosimetry are based on the ratio between the pressure and 
the volume of mercury during intrusion and extrusion, as depicted in Figure 6-33. The shape 
and width of the resulting hysteresis envelope depend on the pore characteristics of the 
material. During the intrusion process, mercury is forced to move into the sample cup at a 
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controlled increasing pressure applied by the oil (Figure 6-34). At the initial period, mercury 
only surrounds the sample, does not enter the cracks and crevices in the surface nor into pores 
in the material, due to the very low residual pressure at sub-ambient condition. As the pressure 
increases, the volume of mercury penetrated is detected by means of capacitive system, based 
on the variation in length of mercury column in a capillary. 
 
 
Figure 6-33 Typical intrusion-extrusion curve of mercury porosimetry. 
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Figure 6-34 Cross section of a penetrometer with 50% of the stem capacity has been used. 
  
 Mercury porosimetry analysis in this work was conducted with AutoPore IV 9500 
Series Porosimeter (Micromeretic Instrument Co., Norcross, GA). The analysis was 
determined at low (from 10 psi to 30 psi = 68.95 kPa to 206.84 kPa) and high (from 31 psi to 
33,000 psi = 213.74 kPa to 227.53 MPa) pressure ranges, with data resolution ± 0.1 μL for the 
mercury intrusion and extrusion volumes. The pressure was incrementally increased up to the 
highest pressure and 10 seconds was allowed to elapse before the volume of intruded mercury 
was recorded at each pressure.  
 
 Two penetrometers with different cup volume were used: Pen 0725 (3.7611 mL) and 
Pen 0949 (4.0162 mL). Both penetrometers however have the same stem cell capacity of 1.1 
mL and maximum head pressure of 4.45 psia. Prior to the mercury porosimetry analysis, all 
samples were conditioned in DVS system under 50 %RH at 25ºC for one day, in order to 
remove any excess adsorbed water. 
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6.6.3.1 Convergence volume 
 
 When a sample is made of fine powders or granules, there is an additional step in the 
interpretation and reduction of the experimental data. Figure 6-35 illustrates the intrusion 
mechanism of agglomerated dihydrate, in comparison to the plots of cumulative and 
differential pore volume data vs. pore diameter. 
 
Point A to B 
 Initially, the mercury envelope forms around the bulk mass of material, but not around 
the individual particles. The bulk volume or envelope volume of the entire sample mass, in this 
instance, is displaced. The void between the granules/ agglomerates is known as the 
convergence volume. 
 
Point B 
 Only when pressure is increased will mercury invade the inter-particle space (also 
known as interstitial void volume) and envelope individual particles. The intrusion pressure at 
B also refers to the breakthrough pressure, where inter-particle void filling begins. The 
indication of breakthrough is an abrupt increase in the slope of the intrusion curve (high rate of 
intrusion) and a notable decrease in the intrusion rate when filling is completed.  
 
Point B-C-D 
 A further increase in pressure from Point B will force mercury into the voids within the 
individual particles. For porous particles, mercury porosimetry analysis shows two penetration 
regions: low-pressure penetration (Point B to C) which is relevant to the inter-particle porosity, 
and the high-pressure penetration (Point C to D) which denotes the particle porosity. However, 
only pores with access to the surface can be filled and any blind pores will remain unfilled.  
 
Point D 
 The pressure at which the intrusion process is completed depends on the size and shape 
of the particles. Further increases in pressure from Point D can cause temporary or even 
permanent structural changes in the sample material [303]. 
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Figure 6-35 Mercury intrusion mechanism of agglomerates from this work. 
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6.6.3.2 Mercury porosimetry hysteresis 
 
 Hysteresis between the intrusion and extrusion is observed in essentially all samples 
examined using mercury porosimetry. There are three primarily theories to explain this 
phenomenon: contact angle hysteresis, ink bottle theory and percolation-connectivity model.  
 
Contact angle hysteresis 
 
 Traditionally, this difference in advancing and receding contact angle has been referred 
to as contact angle hysteresis. Studies including Lowell et al. [304] who elaborated on the 
theory of contact angle hysteresis thermodynamically; Schwartz and Garoff [305] who 
extended the concept to heterogeneous surface, and examined the effects of a particular 
geometry of surface heterogeneity on the contact angle behaviour; and Salmas et al. [306] who 
combined the effect of pore structure networking and mercury contact angle to explain the 
occurrence of hysteresis. Nonetheless, the application of contact angle hysteresis is 
questionable, especially surface roughness of the sample and/or impurities on the mercury or 
solid surface could certainly change the value of the contact angle [296]. 
 
Ink bottle theory 
 
 Depicted in Figure 6-30, pores are rarely uniform in shape. In fact, most of the entrance 
openings (also known as ‘throat’) to a pore is smaller than the actual cavity, and mercury 
enters the pore cavity at a pressure determined by the ‘throat’. During extrusion the mercury 
network would then break at the narrower connections of ‘throat’ between pores, leaving a 
large amount of mercury trapped inside the sample. This leads to significant under-estimation 
of pore sizes particularly in materials with a broad pore size distribution [307]. 
 
 As the ratio of inner pore size and throat size increases, more mercury will be remained 
in the pore structure [296]. In a recent study to improve the analysis of porous inorganic 
materials with ink bottle characteristic, some of the pores were first impregnated with Wood’s 
metal 34  before mercury intrusion [307]. These combined techniques allow the selective 
                                                 
34 Wood’s metal is a fusible alloy, which has properties similar to mercury above its melting point (70ºC) and can 
be intruded in a controlled, size-sensitive manner. 
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consideration of certain pore types, and provide more detailed information about a pore system, 
rather than a simple pore size distribution. 
 
Percolation-connectivity model 
 
 Percolation-connectivity model is an extension of the ink-bottle theory which takes into 
account the connection effects between the pores. Large internal voids, which are surrounded 
by smaller pores, will not be filled unless the intrusion pressure is sufficient to fill a continuous 
pathway towards that pore. However, during the extrusion process, the reverse process occurs, 
resulting in mercury entrapment in some of the pores or network of pores which no longer have 
a continuous path towards the material surface [296]. 
 
 
6.6.4 Limitations of Mercury Porosimetry 
 
 There are a number of limitations of mercury porosimetry; (1) sample destructive 
technique; (2) measurement of the largest entrance towards a pore, but not the actual inner pore 
size; (3) representation of a distribution of constrictions in a pore network, excluding of closed 
pore volume; (4) smallest pore size achievable is only 3 nm of pore diameter at intrusion 
pressure 60,000 psia (413.69 MPa); (5) largest measurable pore size is limited by the height of 
sample due to the minimum head pressure (1 cm sample height equivalent to 1 mm pore 
diameter measured) etc.  
 
 Problems arisen from the instrument and type of sample used include (1) pre-treatment 
of samples, as the solvent or chemicals adsorbed might induce air pockets and contaminate the 
intruded mercury; (2) creation of artificial pores due to sample preparation into the 
penetrometer cell; (3) possible compressibility effects; (4) deformation or breakage of 
agglomerates during the first pressurisation run, associated with the mercury filling rate [295]. 
 
 In order to fully characterise the different ranges of porosity or pore shapes, 
complementary experimental techniques and methods of calculation can be used. For example, 
combination of adsorption of N2 (77 K), mercury porosimetry and method developed by 
Spitzer et al. [308] allows the determination of a global size distribution of porosity [294]. 
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Even by non-destructive image analysis techniques based on X-ray tomography methods can 
provide complementary information.  
 
 X-ray tomography can be employed to quantify of the interior microstructure, including 
cross-linked and closed pore network, with spatial resolution up to 2 μm or even down to 0.3 
μm using a synchrotron radiation source. Considerable technical progress even led to the 
development of 3D reconstruction methods with a spatial resolution of better than 30 nm [307]. 
In recent years, there are also tomography methods being developed by Jones et al. [309], to 
provide full quantitative characterisation of the pore network (i.e. pore shape information, pore 
size distribution for the macropores and their interconnect lengths).  
  
 In addition, indirect analysis methods, among them, sorption isotherms, thermo-
porosimetry [310], nuclear magnetic resonance spin relaxation techniques, small-angle neuron 
or X-ray scattering or a combination of methods [307; 311], each of which has its specific 
advantages and drawbacks, are also possible. 
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CHAPTER 7 CRYSTAL PROPERTIES ON DEHYDRATION 
BEHAVIOUR 
 
7.1 Introduction 
 
“O amazement of things – even the least particle!” 
Walt Whitman, In Leaves of Grass (1897) 
 
 Particle science and technology is crucial as 75% of chemical manufacturing processes 
involve fine particles at some point. Proper design and handling of these particles (and other 
solid forms) is a must from the early stages of process development, and the choice of process 
route gives options to change the particle size for any individual unit operation.  
 
 Different particle formation methods will give different initial particle sizes, and the 
following processes of size enlargement (by agglomeration or granulation) or size reduction 
(by comminution or attrition) can modify the particle properties. For example in Figure 7-1, the 
product specification in this case requires a particle size of about 100 μm. If there is no 
difficulty in processing this particular size in the intermediate steps, smaller particles are 
normally crystallised from the beginning as often be easier than trying to change the particle 
size by agglomeration (Route A), or at times wet agglomeration which by passing the drying 
stage (Route C). The small particles though may not be effective in filtration and washing, 
hence entrainment of solvent tends to be high [192], but they have favourable downstream 
processing characteristics, such as good flow and compression properties. 
 
 On the other hand, the more conservative approach via Route B involves crystallising 
slightly larger particle size to allow for downstream attrition. However, the downside is that a 
substantially larger crystalliser with longer processing time is required. Meanwhile, Route D 
shows an alternative approach where the wet solid is extruded into pellets and dried on a band 
dryer. This is a very common processing route in industry for fine particles, especially for 
those unusually sticky solids [127; 132]. All the examples in Figure 7-1 involve a drying stage, 
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which has been shown as an imperative unit operation in the particle formation process, to 
achieve the required particle sizes. Apart from the particle size, drying stage also determines 
the consistency of the product quality and stability of drug compounds, while minimising the 
loss of product functionality through these processes. 
 
 
Figure 7-1 Plot of mean particle size through a process for alternative process route. Adapted from 
[192]. 
 
 
7.2 Experimental Section for Preparation and Characterisation of 
Carbamazepine Dihydrate 
 Carbamazepine dihydrate were prepared via wet crystallisation and ‘forced’ hydration 
technique, previously explained in Section 5.2.3.  
 
Carbamazepine dihydrate crystals 
  
 The wet crystallisation technique generated two different crystal habits. Habit 1 refers 
to plate shape (aspect ratio l/d ~1.6) and habit 2 denotes the needle shape (aspect ratio l/d >10), 
obtained from ethanol and methanol aqueous solution respectively.  
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Carbamazepine dihydrate agglomerates 
  
 The dihydrate from ‘forced’ hydration method was sieved into six particle size 
distributions; 75-180 μm, 180-250 μm, 250-500 μm, 500-710 μm, 710-1400 μm and >1400 μm. 
All carbamazepine dihydrates were kept in sealed glass vials and stored at controlled humidity 
(74 %RH and 25ºC) to maintain the sample’s integrity. 
 
Dynamic Vapour Sorption (DVS) 
 
 The atmospheric flow DVS (Surface Measurement Systems Ltd., London, UK) 
gravimetric instrument was employed to measure the dehydration rate of carbamazepine 
dihydrate, with a balance resolution ± 0.1 µg and a drift of less than 2 μg per day. The DVS 
system is maintained at 0 %P/P0 (± 1 %P/P0), supplied by the laboratory compressed air at a 
fixed air volumetric flow rate of 100 sccm. Temperature in the incubator is controlled 20ºC (± 
0.5ºC). Sample size of 30.0 mg ± 2.0 mg was used and the weight changes were measured at a 
data saving rate of every 20 seconds. 
 
X-ray Powder Diffraction (XRPD) 
 
 XRPD analysis was performed on the dihydrate crystals, using an X’Pert PRO 
diffractometer (PANalytical, Almelo, The Netherlands) with nickel-filtered Cu-Kα radiation (λ 
= 1.541 Å) at acceleration voltage of 40 kV and 40 mA. Samples were first ground gently with 
pestle and mortar to about 5 μm size. They were then packed into an aluminium flat sample 
holder and scanned over an angular range of 5º to 40º (2θ) using a step size of 0.016º (2θ) with 
count time of 2 seconds. All measurements were taken on a spinner stage, rotating at 1 
resolution per second, to eliminate any preferred orientation effect. 
 
 XRPD data were then compared with the International Centre for Diffraction Data 
(Newtown Square, PA, US) powder diffraction database, and the simulated powder patterns 
from the Cambridge Structural Database (Cambridge, UK), using the X'Pert HighScore 
(PANalytical, Almelo, The Netherlands) phase identification software. 
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Mercury Porosimetry Analysis  
 
 Mercury porosimetry analysis was conducted with AutoPore IV 9500 Series 
Porosimeter (Micromeretic Instrument Co., Norcross, GA). The analysis was conducted at low 
and high pressure ranges. The pressure was incrementally increased up to 33,000 psia and 10 
seconds was allowed to elapse before the volume of intruded mercury was recorded at each 
pressure. Prior to the mercury porosimetry analysis, all samples were conditioned in Dynamic 
Vapour Sorption system under 50 %RH at 25ºC for one day, in order to remove any excess 
adsorbed water. 
 
Scanning Electron Microscopy (SEM) 
 
 TM-1000 Tabletop Microscope (Hitachi Ltd., Tokyo, Japan) was used to observe 
morphological changes of carbamazepine crystals. Samples were mounted onto conductive 
doubled-sided tape attached to aluminium specimen stub and were gold-coated in a sputter 
coater prior to analysis. SEM micrographs, up to 2000x magnification, were taken at a 15 kV 
beam acceleration voltage.   
 
 
7.3 Crystal Habit 
 
 Most organic crystalline forms exhibit anisotropic structural properties, leading to the 
formation of different crystal habits. Crystal habit35 is a manifestation of thermodynamic and 
kinetic factors determining the relative growth or inhibition of the development of the different 
crystal faces that ultimately define the shape of crystal. The habit is dependent on the intrinsic 
crystal properties, for instance inter-planar spacing and attachment energies, and also 
influenced by external factors such as the type of solvent, degree of supersaturation and 
temperature. 
 
  
                                                 
35 ‘Habit’, derived from Latin and Old French word for mode of growth, is used to describe the outward 
appearance of a crystal that consists of a group of symmetry related faces, known as forms. 
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 The US Pharmacopeia monograph 776 (Rockville, Maryland, US) has adopted six 
general shape descriptions (Figure 7-2), such as plate shape for flat and tabular crystals that 
have similar breadth and width, but are thicker than flakes. There is equant shaped crystals, 
which are equidimensional, as found in cubes or spheres.  Other shapes include: columnar 
shape for elongated and prismatic crystals; needle for acicular, thin and highly elongated 
crystals; and lath shape for elongated, thin and blade-like crystals. 
 
 
Figure 7-2: Schematic diagram of the six basic crystal shapes. 
 
 
 In the pharmaceutical industry, the habit of a crystal is known to have influence on the 
development of formulation and unit operations including flow, blending, granulation and 
compaction [312]. The poor dissolution characteristic of water-insoluble drugs (i.e. 
carbamazepine) is a major challenge but it can be improved by several methods; particle size 
reduction to increase the surface area, solubilisation in surfactant systems, formation of water-
soluble complexes, drug derivatisation into strong electrolyte salt forms that usually have 
higher dissolution rate, and manipulation of solid state of drug substance, such as habit 
modification by changing the crystallising conditions or introducing additives/impurities in the 
growth media [252; 313].  
 
 For example, needle-like crystals are often found to considerably complicate processes, 
like formulation and tabletting for a solid dosage form [314]. Though needle-shaped crystals 
are more prone to mechanical attrition and exhibit poor flow and mechanical characteristics, 
they lead to a significant increase in the specific surface area thus improve the dissolution 
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behaviour and chemical reactions. In some cases, they even have better aerodynamic properties 
as inhaled particles, than spherical shaped crystals [315]. In other industries, like ZnO 
nanowires for solar cells, crystal shapes are engineered to be as needle-like as possible [27].  
 
 
7.3.1 Crystal Growth Mechanism 
 
 Crystal formation is a multi-metric process, involving three essential stages: nucleation, 
growth and cessation of growth. Most crystals contain dislocations (crystal defects) which 
cause steps to be formed on the faces and promote growth.  Laine et al. [55] and Katzhendler 
et al. [316] observed the crystal growth of carbamazepine dihydrate, generated by whisker 
mechanism via axial screw dislocation growth. Screw dislocation obviates the necessity for 
surface nucleation [18], hence under a supersaturated environment, a crystal is growing 
through the self-perpetuating steps which provide the facile spiral growth fronts, [317; 318] as 
depicted Figure 7-3. 
 
 
Figure 7-3 Development of a spiral growth starting from a single screw dislocation. Adapted from [18]. 
 
 The whiskers often contain one or more screw dislocations parallel to their axes. 
Therefore the emergent steps at the whisker tip provide the energetically favoured sites for 
growth to continue indefinitely below the critical two-dimensional nucleation level (Figure 
7-4), whereas the slower growing crystalline side walls36 are suppressed, making up the major 
part of the crystal surface [319].  
 
                                                 
36 The slower growing surfaces are morphologically important facets. 
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Solid line: growth rate.  
Blue dotted line: growth rate if two-dimensional (2D) nucleation continues to be dominant below its 
applicable supersaturation range.  
Red dotted line:  growth rate if spiral growth was the persistent mechanism above its applicable 
supersaturation range. 
Figure 7-4: Growth mechanisms for a flat (F) face, as a function of supersaturation. 
 
 The needle-like crystals of carbamazepine dihydrate have high surface area per unit 
volume, with the ratio of length to diameter (l/d) obtained in the range of 5 ≤ l/d ≈ 1000, and 
the diameter varies from 20 nm to 100 μm [55]. The largest crystal face of the plate shaped 
habit was (100) and the longer axis was coincident with the (001) direction.  
 
 According to Laine et al. [55], the whisker growth was characterised by the extremely 
fast growth rate of 10-6 to 10-4 m/s along the c-axis, illustrated in Figure 7-5. This direction of 
growth was expected to be the fastest because it has the strongest intermolecular interactions: 
carbamazepine molecules form centrosymmetric dimers by hydrogen bonding between 
carboxamide groups (Figure 7-5a). Another significant interactions viewed along the a-axis 
(Figure 7-5b) are the channels of hydrogen-bonded water molecules and π–π interactions 
between the aromatic regions of carbamazepine molecules [252]. At times, irregular shaped of 
dihydrate crystals were formed from supersaturated solution, as in Figure 7-6a and Figure 7-6b. 
Structural defects and impurities were believed as one of the reasons for these uncontrolled 
whisker formations.  
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Figure 7-5 Carbamazepine dihydrate crystal lattice (a) viewed down the c-axis and (b) viewed 
down the a-axis. 
 
                        
Figure 7-6 Three major types of whisker growth mechanism: (a) thickened base (b) growth from 
hollows on surface and (c) along surface of mother crystal. 
 
 
7.3.2 Influence of Crystal Habit on XRPD Pattern 
 
7.3.2.1 Preferred orientation effect of carbamazepine dihydrate 
 
 During the sample preparation for XRPD measurement, it is imperative to reduce the 
particle size of those plate and needle-like habits of the dihydrate, in order to achieve random 
orientations. The packing orientation of plate shaped crystals in the flat sample holder of Bragg 
Brentano theta-theta setup favoured the diffraction of the elongated crystal plane (100), which 
was shown as an intensed peak at 8.86 º2θ in Figure 7-7a. This preferred orientation effect can 
be reduced by grinding the dihydrate crystals into smaller particle size distribution. As the 
particle size reduces, reflections of other characteristic planes gradually appear on the 
diffraction patterns, as demonstrated from Figure 7-7b to Figure 7-7d. In particular, the 
(a) (b) (c) 
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diffracted peak of the crystal surface at the side – plane (040) – was clearly observed at 12.18 
º2θ. 
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*Particle size of the dihydrate plate crystals reduces from (a) to (d). 
Figure 7-7 Preferred orientation effects on plate shape carbamazepine dihydrate from this 
work. 
 
 
7.3.2.2 Twinning effect on carbamazepine dihydrate crystals 
 
 As the loose crystals of carbamazepine dihydrate were well-defined and similar in 
particle size; they were therefore easily ground to a more homogenous average particle size. 
Diffraction pattern of the agglomerated dihydrate, however, exhibits different intensity ratio 
than the true diffraction patterns (Figure 7-8). The differences appeared across 18º to 25º2θ, 
affecting lattice planes like; (220) at 18.96 º2θ, (021) at 19.51 º2θ, (15 1 ) at 24.19 º2θ, (131) at 
24.36 º2θ and (080) at 24.75 º2θ. It was initially thought that such observation was due to the 
crystal statistic effect from sample preparation method; especially some of the primary 
particles of agglomerate were in clumps, hence a huge variation in the size and number of 
crystallites (Figure 7-9).  
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Figure 7-8 XRPD patterns of (a) carbamazepine dihydrate crystals, and (b) carbamazepine 
dihydrate agglomerates prepared in this work. 
 
 
Figure 7-9 SEM image of carbamazepine dihydrate agglomerate, showing a variation of size and 
number of crystallites. 
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 Another possible cause for this observation was reported in [70; 256], which was due to 
the twinning of dihydrate crystals. Sometimes during crystal growth, two or more inter-grown 
crystals are added to the face of an already existing crystal in a symmetrical fashion – known 
as twinned crystals (Figure 7-10).  They have two different lattice orientations which can be 
indexed on a single lattice, hence making their structural solution and refinement difficult 
[320]. Such symmetrical disorder on a molecular level often produces indisputably a new 
structure. In the case of carbamazepine dihydrate, the reflection in the mirror plane (twinning 
plane: (100) in Figure 7-11) is perpendicular to the a-axis, perfectly emulating the 
orthorhombic symmetry [70; 253] which is often mistakenly identified in the single crystal X-
ray diffraction analysis.  
 
 
Figure 7-10 Twin plane (100) of carbamazepine dihydrate monoclinic system, with the mirror 
planes parallel to one another. 
 
 
Figure 7-11 Projection of the twinning plane (1 0 0) on the molecular packing of carbamazepine 
dihydrate. 
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7.3.3 Effect of Crystal Habit on Dehydration Kinetics 
 
 Figure 7-12 depicts the dehydration pattern of carbamazepine dihydrate crystals of two 
habits, with both exhibiting the exponential decay characteristic. Under the same drying 
condition, needle shaped crystals dehydrate more rapidly than the plate shaped crystals 
(denoted as habit 2 and habit 1, respectively).  
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Figure 7-12 Effect of crystal habit variation on dehydration profile of carbamazepine dihydrate 
prepared in this work, at 20ºC and 0%RH. 
 
 SEM micrographs in Figure 7-13 show that the ends of the hydrate water channel were 
not on the largest exposed area – lattice plane (100), but in fact they were perpendicular with 
that plane. Therefore, having a larger (100) surface would not necessarily dehydrate faster.  
 
 As the hydrate is dehydrating, defects are often formed on the surface of the crystal due 
to the stress relief, hence promoting the removal of the remaining hydrate water and then 
acting as the centres for nucleus formation [321]. This supports our observation where 
equidistant repeating channels were formed along plane (100) and parallel to plane (040) 
during/after the dehydration, suggesting that plane (040) might play a significant part in the 
removal of hydrate water. Based on that, habit 2 (needle shaped crystals) therefore would have 
higher surface area per mass ratio for faster dehydration process, than the habit 1 (plate shaped 
crystals). 
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Figure 7-13 Scanning electron microscopy images of carbamazepine dihydrate crystal (habit 1). 
 
 
7.4 Spherical Agglomeration 
 
 For crystalline materials, the primary particles 37  are single crystal domains. It is 
important to note that even for a particle that looks like a single, nonporous, non-agglomerated 
crystal, it may in fact be made up of several single crystal domains. Since an agglomerate is a 
cluster of primary particles that are strongly bound through a region that is not planar or 
involves some voids, there are significantly imperfect contacts between those crystals.  
 
 Figure 7-14 represents most of the different processes, involving size enlargement and 
size reduction phenomena during agglomeration. Nucleation refers to the production of micro-
agglomerates, which occurs when the primary particles collide and adhere to each other [322]. 
As more primary particles are available, they tend to either form more nuclei or grow into 
larger agglomerates. At times, they may even break apart at structurally weaker areas due to 
impact and/or abrasion action.  
 
                                                 
37 Primary particle is the lowest level of structure which possesses the highest degree of crystal lattice or structural 
homogeneity, the highest density and the lowest void fraction. 
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Figure 7-14 Size change mechanisms in agglomeration processes. 
 
 
7.4.1 Binding Mechanism and Solvent Inclusion in Agglomerates 
 
 Forces contributing to agglomeration process are of two types: natural (or physical) and 
applied (or mechanical) forces. The natural forces cause the particles to temporarily or 
permanently stick together and are based on a number of binding mechanisms (Figure 7-15), 
such as: the adhesional and cohesional forces in bridging bonds which are not freely moveable; 
the molecular and electrostatic attractions between solid particles; interlocking effects between 
particles depending on the particle shape; and very importantly, the interfacial and capillary 
forces due to the presence of a liquid phase. Application of external forces however can 
contribute to the enhancement of inherently present binding mechanisms [322; 323]. 
 
 Acicular or needle-like shaped crystals provide special challenges in the secondary 
processing operations (e.g. suspension-type crystallisation and granulation) in the 
pharmaceutical industry, due to their tendency to form cake or agglomerates with resultant 
inclusion of liquid solvent. The inclusion of liquid solvent not only decreases the purity of the 
drug formulation, but this liquid solvent, released during the drying process, can participate in 
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various undesirable physical and chemical material transformations [92]. Even if the drug 
substances are poorly soluble in the liquid solvent, the presence of any dissolved solute may 
facilitate the formation of crystalline bridges between the particles during drying process [324]. 
Any resulting morphological transformations may have a detrimental effect on the final solid 
properties, including thermal and mechanical properties, which could potentially reduce the 
bioavailability or the storage envelope of such drug substances. 
 
 Liquid bridge forms when a film of mobile liquid on a particle surface is in contact with 
other particles or surfaces. The maximum amount of water held thus depends on the surface 
area of particles and the fraction of pores in a given volume of agglomerate, known as porosity 
[325]. Under normal atmospheric conditions, an absolutely dry particulate solid hardly exists 
due to surface adsorption from the surrounding moisture. Moreover, it is also not feasible to 
remove all the unbound water during the manufacturing of solid state products, as the energy 
and time required for a falling-rate drying (especially for the remaining 1-2 %wt of moisture 
content) are substantially higher than those at a constant rate period. In fact, the water 
molecules of adsorption layers form quickly on the solid surfaces with increasing relative 
humidity (pendular regime in Figure 7-15), and participate in the development of strength by 
enhancing molecular forces (i.e. van der Waals).  
 
 The moisture saturation of the solids enters the funicular regime when liquid bridges 
begin to form at the contact points between particles (Figure 7-15). A further increase in liquid 
saturation produces a transitional situation where liquid bridges and void spaces that are filled 
with liquid coexist, known as the capillary regime. The theoretically highest saturation (100%) 
is reached when all voids within a bulk mass or agglomerate are filled. The liquid droplets at 
this saturation are shaped by the surface tension, and may hold the solid particles together 
(liquid drop regime in Figure 7-15).  
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Figure 7-15 Pictorial representation of the binding mechanisms of agglomeration. 
 
 Though agglomerates of different sizes and surface chemistry are known to retain 
different amounts of liquid solvent and whilst the agglomeration mechanisms of acicular 
crystals have been widely studied [92; 201; 204; 252], the role of these trapped water 
molecules on the stability (physical and chemical) of the drug substances is not well 
understood.  In the following section, the influence of unbound water on the stability of an 
agglomerated hydrate was investigated. The study enables us to understand and elucidate the 
transport mechanisms of both unbound water and hydrate water (water of crystallisation) 
prevalent during the drying process. Subsequently, this knowledge allows us to map out the 
stability region of agglomerated hydrates reported here as well highlighting the effect of 
agglomerate structure on this stability performance. 
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7.4.2 Bound and Unbound Water in Agglomerates 
 
 In order to determine the amount of water in the agglomerated form, carbamazepine 
dihydrate in different sieve fractions: 75-180 μm, 180-250 μm, 250-500 μm, 500-710 μm, 710-
1400 μm and >1400 μm (up to about 1800 μm), were subjected to isothermal drying condition 
at 0 %RH and at temperature 30ºC. The results were presented in Figure 7-16. 
 
 The smaller carbamazepine dihydrate agglomerates contain fewer crystals and, as 
expected, dehydrate faster due to higher surface area for mass ratios (Figure 7-16). However, 
as the agglomerate size goes up to 710 μm and above, the drying of unbound water and 
dehydration of bound water proceed via two-step mechanism. It was demonstrated by the 
smooth and linear drying rate, prior to an inflection point at XA of 0.1524 for the change in 
gradient which refers to the slower diffusion of bound water. This also implies that drying and 
dehydration processes do not occur simultaneously in those >710 μm agglomerates. This 
observation agrees with the work of Suraya and Suryanarayanan [92], although their dihydrate 
primary particles were relatively larger (about 100 μm) and contained ~30 %wt of unbound 
water.  
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Figure 7-16 Dehydration profile of carbamazepine dihydrate agglomerates of different particle sizes 
at 0 %RH and 30ºC. 
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 All agglomerates below 710 μm were found to retain a negligible amount of unbound 
water: <0.02 %wt (mass of unbound water per unit mass of dry solid). Based on the established 
condensation behaviour of water in soils and saturation regime map for granules [324; 326], 
these agglomerates in this size distribution were well within the pendular regime. Whereas for 
the agglomerates between 710-1400 μm, the saturation state just fell within the funicular 
regime, with higher unbound water content of 12.1 % (±1.5 %wt). Surprisingly, agglomerates 
>1400m retained a significant amount of unbound water: 57.2 % (±2.0 %wt), also within the 
funicular regime. 
 
 
7.4.3 Pore Size Distribution of Agglomerates 
 
 Larger agglomerates (>710 μm) were demonstrated to posses high water holding 
capacity, which directly associated with the pore size distribution in those agglomerates. In the 
mercury porosimetry experiments, there are both intra- and inter-agglomerate contributions to 
the sample porosity. Intra-agglomerate porosity refers to the microscopic pore space created by 
the geometrical packing of individual crystals. Meanwhile, inter-agglomerate porosity is from 
those pore spaces due to arrangement of crystal agglomerates [327]. 
 
 Here we analysed only the porosity data which related to the intra-agglomerate porosity 
using the intrusion data from 30 psia to 33,000 psia. Therefore, the intra-agglomerate intrusion 
volume (mL/g) and pore area (m2/g) were used as comparison. From the results in Table 7-1, 
there was a substantial increment by about 34% in pore volume and 93% in pore area, as the 
particle size distribution reached >1400 μm. These values coincide with the characteristics of 
high unbound water retention in the agglomerates. 
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Table 7-1: Mercury porosimetry analysis for carbamazepine dihydrate agglomerates 
Size distribution Total intra-agglomerate  
pore volume (mL/g) 
Total intra-agglomerate  
pore area (m2/g) 
180-250μm 0.783 7.049 
250-500μm 0.815 7.032 
500-710μm 0.822 8.465 
710-1400μm 0.918 10.023 
>1400μm 1.051 13.623 
 
 From the pore size distribution plot presented in Figure 7-17, it is clearly shown that 
only macroporosity (pore size above 50 nm) exists in the carbamazepine dihydrate 
agglomerates. Smaller agglomerates (below 1400 μm) display a unimodal pore size 
distribution, ranging between 0.83 to 1.33 μm, however those above 1400 μm agglomerates 
exhibit a bimodal distribution characteristics, with a higher number of larger pores (2.53 to 
3.28 μm diameter).  
 
 All of our carbamazepine dihydrate samples below 710 μm size were observed to be 
more fragile than the larger closed packed agglomerates. Therefore deformation of the pore 
structures within agglomerates might occur when the mercury intrudes, especially at the high 
pressure range analysis. Moreover, due to their complex and heterogeneous structures, the pore 
space between the acicular crystals in the agglomerate was spatially disordered; consequently 
the pore size distribution values were used for comparison purpose only.  
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Figure 7-17 Pore size distribution obtained from Hg porosimetry for carbamazepine dihydrate 
agglomerates of different particle size distributions. 
 
 According to IUPAC, the shape of hysteresis can be classified into four types, based on 
experimental observations and the application of classical principles of pore filling (e.g. 
contact angle hysteresis, the ink bottle theory and the percolation-connectivity model) [100; 
296]. Hysteresis data in this study was determined from the discrepancy of the amount of 
mercury retained in the pores during intrusion and extrusion.  
 
 For carbamazepine dihydrate agglomerates which retained excess unbound water (>710 
μm of particle size distribution) exhibit the characteristic of Hysteresis Type 1 [100], depicted 
as the diagram H1 inserted in Figure 7-18. Previously mentioned in Section 3.5.2 and Figure 
3-10, this type of hysteresis is often associated with spheroidal agglomerates, having capillary 
condensation in its pore structure. This is hence in agreement with the large holding capacity of 
unbound water (~56% by mass) found in this kind of agglomerate.  
 
 The remaining particle sizes however portray the characteristic of Hysteresis Type 2 
(H2), shown in Figure 7-19. The pore structure is difficult to interpret, owing to the differences 
in condensation and evaporation mechanisms [100]. Nonetheless, not well-defined size and 
shape of pores are primarily found in those agglomerates. Arguably, all of our dihydrate 
samples below 710 μm size were loosely packed and therefore deformation of pore structure 
might occur when the mercury intrudes at the high pressure range. 
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Figure 7-18 Hysteresis between intrusion and extrusion pore volume of carbamazepine agglomerate 
of particle size above 1400μm. 
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Figure 7-19 Hysteresis between intrusion and extrusion pore volume of carbamazepine agglomerate 
of particle size 180-250μm. 
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7.4.4 Particle Packing Morphology of Agglomerates 
 
 Microscopic observations, as shown previously in Figure 5-10, reveal that the 
agglomerates came in various macroscopic shapes; spherical and oblong. Figure 7-20 here 
illustrates the packing morphology of carbamazepine dihydrate agglomerates for two different 
and extreme particle size distributions; >1400 µm (Figure 7-20a-b) and 75-180µm (Figure 
7-20c-d). The densely packed >1400 µm agglomerates were in spherical shape and have larger 
pores occasionally observed on the surface. The shape of 75-180 µm size agglomerates 
however was mostly oblong with irregular outlines and the agglomerate packing was 
characterised by a rigid and open structure.  
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Figure 7-20 Morphology of carbamazepine dihydrate agglomerates of different particle size: (a-b) 
>1400μm and (c-d) 75-180μm. 
 
 The crystal morphology was measured by SEM, and the average size of the primary 
particle crystal size within these agglomerates was estimated by counting at least 50 crystals 
from the SEM images. The average size was similar, with the average length of the primary 
crystals in >1400 µm agglomerates at 13.36 ± 4.23 µm, meanwhile the primary crystal size of 
75-180 µm agglomerates was at 13.66 ± 8.50 µm. All the crystals have an aspect ratio of >10 
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and a crystal diameter within the range of 0.8 to 1.8 µm. Therefore, the primary crystal size can 
be disregarded as the dominant factor that causes solvent inclusion. Instead, it has been 
suggested that it is the differences in packing and pore structure of these agglomerates which 
influence the amount of solvent inclusion. 
 
 The particle structures of an agglomerate are often divided into several levels; from 
lower to higher level structures, the strength of bonding decreases, the void fraction within the 
agglomerate increases, and the degree of structural complexity increases. Small primary 
particles are often held together by relatively strong forces to form medium-size aggregates 
which are bound by moderate forces to form larger agglomerates [328]. The cores of the large 
agglomerates are dense and almost all fused together.  
 
 It is well established that the densest packing of infinite straight cylinders is hexagonal 
which is equivalent to the planar packing hexagonally of discs [329]. The least dense packing 
for the same system will result in a fully random distribution of the same straight cylinders in 
space. Though in the case of carbamazepine dihydrate agglomerates, the cylinders are not 
infinite in length but have length to diameter ratio of >10. Nevertheless, the same general 
observations for fibre packing could be expected to hold true [330].  
 
 It is can be clearly observed from the SEM images in Figure 7-20, that the 
agglomerates adopt two quite different particle packing morphologies. In the smaller 
agglomerates, the acicular crystals adopt a highly random orientation, whilst it is clear that the 
larger agglomerates adopt a much more lamellar structure which is somewhat nematic in form.  
Studies by Novellani et al.[331] confirm that the random 3D packing of cylindrical fibres 
results in a higher internal void space compared to similar 2D fibre packing. That result is 
intuitively sensible, though in this work it was found the converse, suggesting that either one or 
both of the agglomerates do not exhibit fully random 2D or 3D structures.  
 
 The porosity results presented in Figure 7-17 also show a single pore size distribution 
for the smaller agglomerates and a bimodal pore size distribution for the larger agglomerates. 
The former result is consistent with a 3D random acicular particle network in the case of the 
smaller agglomerates. The presence of a bimodal pore size distribution in these larger 
agglomerates suggests that the acicular fibres in these agglomerates are not randomly 
distributed in either 2D or 3D. 
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7.4.5 Retention Mechanism of Unbound Water in Agglomerates. 
 
 The substantial holding capacity of unbound water in large agglomerates (1400-~1800 
μm) might due to the ‘forced’ hydration preparation method, and the slow migration of water 
to the agglomerate surface. Based on the two-step dehydration kinetics shown in Figure 7-16, it 
is sufficient to exclude the possibility of solvent inclusion within the layers of crystals, 
depicted in Figure 7-21. Only large crystals (i.e. >70 μm for hexamine crystals [332]) with 
relatively fast growth rate would increase the inclusion potential of crystallising solvent, 
through cavities and growth layers on surfaces [333-335].  
 
 
Figure 7-21 Development of crystallising solvent inclusion by the interaction of growth layers. 
Adapted from [335]. 
 
 The packing transition, which results in closed and dense agglomerate structure in this 
work, is shown in Figure 7-22. Since the hydration method (Stage A) involves total immersion 
of the poorly soluble crystallised dihydrate in water, it is highly probable that there exists a 
hydrophobic interaction between the crystals [88]. This concept relates to the entropy nature of 
hydrophobic molecules to form agglomerates in an aqueous medium, for instance; separation 
of oil and water [87]. The water molecules prefer to form the stronger hydrogen bond network, 
resulting in the segregation and effective mutual attraction of the hydrophobic carbamazepine 
dihydrate crystals.  
 
 The significant effect of hydrophobic particle surfaces in total immersion of water was 
evidently shown in previous literature [336; 337], in which the hydrophobic free energy is 
proportional to the surface area for interaction between hydrophobic solutes and water 
molecules [87]. As the acicular shape of carbamazepine dihydrate was able to provide the high 
surface coverage for effective contact area between each other, consequently there was an 
increasing likelihood for agglomeration to occur, as depicted in Stage B (Figure 7-22). 
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Figure 7-22 Proposed moisture-induced packing transition stages of agglomerated acicular 
carbamazepine dihydrate crystals in particle size 1400-~1800μm. 
  
 As the resultant dihydrate was being filtered via suction, there are two preparation 
scenarios; those particles having crystal surfaces saturated with high amount of unbound water 
molecules, and those with just a slight moisture excess. The former case would allow a certain 
degree of “surface plasticity” – a term proposed by Newitt and Conway-Jones [324], where by 
this excess unbound water was able to hold the primary particle by the effect of cohesion due 
to capillary forces (Stage C). Meanwhile in the latter case, the primary particles were just 
sufficiently moist to form a “pendular bond” at point of contact. During the pre-drying step: 
Stage D, the slow evaporation of excess water at room temperature would form the crystalline 
bridges and therefore shape into this densely packed structure, resulting in inclusion of the 
remaining unbound water molecules within the agglomerates.  
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7.4.6 Role of Unbound Water in Agglomerates 
 
 It has been recognised that the carbamazepine dihydrate is stable above 52 %RH 
(absolute humidity, Hc as 0.01024 kg water/kg air) at 25ºC [92]. Once the dihydrate was exposed 
to an environmental humidity below that critical humidity, loss of hydrate water will 
commence. To investigate the role of unbound water on the stability of carbamazepine 
dihydrate, agglomerates with particle size >1400μm were subjected to drying conditions under 
different relative humidities (10-80 %RH) and over a range of temperatures (25-50ºC). An 
example of humidity-controlled drying experiment at 30ºC is presented in Figure 7-23.  
  
 Carbamazepine dihydrate agglomerates were first exposed to a high humidity 
environment, for instance: at 80 %RH (Figure 7-23). The loss of unbound water would begin 
and become plateau after ~11 hours, no further water removal was observed, even at a longer 
time scale. Since 80 %RH was well above the Hc of carbamazepine dihydrate, the humidity of 
the system was subsequently brought down to 0 %RH at the 800th minute (illustrated by the 
dotted line) in order to instigate the dehydration of carbamazepine dihydrate. The amount of 
water removed under the 0%RH period correlates to the stoichiometric dihydrate, XA = 0.1524.  
 
 As the starting humidity decreases to 30 %RH, only the removal of unbound water took 
place and all samples reached the equilibrium state where the remaining water content 
corresponds to XA. However, at 20 %RH, dehydration process commenced once the removal 
of unbound water was completed, represented by the inflection point in Figure 7-23. In order to 
pin-point the condition where dehydration would commence – critical humidity (between 20 
%RH and 30 %RH for this example at 30ºC), drying experiments were conducted at a 2 %RH 
increment, for instance 22 %RH, 24 %RH, 26 %RH and so on. In all cases of large 
agglomerates, the critical humidities found were substantially lower than those without 
unbound water. It could thus be concluded that these agglomerated carbamazepine dihydrate 
managed to retain the dihydrate’s integrity even at lower humidity than the previously reported 
52 %RH [92].  
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Figure 7-23 Dehydration profile of carbamazepine dihydrate agglomerates (>1400μm) under 
different levels of humidity at 30ºC. Only the removal of unbound water was observed for drying 
conditions above 30 %RH, while removal of both unbound and bound water. 
 
 The critical humidity, HC (kg water/kg air) of agglomerated dihydrate over a range of 
temperatures (Figure 7-24), were compared to the critical value of those crystal forms without 
inclusion of unbound water [92; 220]. Absolute humidity values were calculated from the 
following equations [338]. 
 
sp
pRH ×= 100
        Equation 7-1 
 
( )pPMW
pMW
H
air
OH
−
×= 2
        Equation 7-2  
 
With p is the calculated partial pressure in mmHg; ps is the corresponding vapour pressure 
(mmHg) at DVS temperature (dry-bulb); and P as the atmospheric pressure at 760.0 mmHg. 
 
 This has shown clearly that in the case of the large agglomerates generated here, 
agglomeration and inclusion of unbound water are not only able to impede the dehydration 
process, but also have been able to maintain the stability of the dihydrate form at a much lower 
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environmental moisture concentrations (e.g. 0.0039 kg water/kg air at 25ºC). The relationship of 
these two functions: absolute humidity and temperature clearly defines the boundary between 
the regions for dihydrate or anhydrate form stability.  
 
 
▲ and ● denote the HC for loose crystal forms by Surana et al. (2003) and  Dugue et al. (1991), 
respectively. 
Figure 7-24 Critical absolute humidity values for agglomerated carbamazepine dihydrate with 
unbound water (>1400 μm) and without unbound water (< 710 μm). 
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7.5 Conclusions 
 
 Within the experimental range considered, we have demonstrated that crystal properties 
(i.e. habits and agglomeration) have notable influence on the drying and dehydration 
behaviours of carbamazepine dihydrate. Equidistant repeating channels were observed along 
dihydrate plane (100) and parallel to plane (040), forming through stress relief of the 
dehydration process. It is concluded that the defects were able to facilitate the removal of 
hydrate water, with the needle habit of carbamazepine dihydrate dehydrating faster than the 
plate habit. 
 
 As the agglomerated dihydrates exceed a critical particle size (>710 μm), they tend to 
retain an excess amount of physically adsorbed water, up to a significant 57.2 %wt and exhibit 
closed pore structure. These large agglomerates (particle diameter 1400-~1800 μm), occur 
within the funicular regime of moisture saturation, are significantly more stable than those 
agglomerates without inclusion of unbound water, of which the dihydrate’s integrity can be 
retained even at low critical humidity of 20 %RH (0.0039 kg water/kg air) at 25ºC. Mercury 
porosimetry further confirmed that total intra-agglomerate intrusion volume for the largest 
agglomerates was 34% higher than those smaller agglomerates.  
 
 This work demonstrates that in developing a drying strategy for active pharmaceutical 
ingredients (APIs) which are capable of forming hydrates, agglomeration effects as shown here 
can be potentially controlled and exploited to increase the stability of the desired hydrated 
products. In particular for wet spherical agglomeration technique which has been accepted as 
an attractive method for agglomerating fine particles dispersed in liquid [339]. Further studies 
using other hydrates with different morphology are required to confirm the generality of the 
conclusions reported here. 
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CHAPTER 8 KINETIC ANALYSIS OF DRYING AND 
DEHYDRATION OF CARBAMAZEPINE DIHYDRATE 
 
8.1 Introduction 
 
“All great truths are simple in final analysis, and easily understood;  
if they are not, they are not great truths.” 
Napoleon Hill (1883-1970) Author 
 
 
 The processing stresses (e.g. mechanical and thermal) imposed on drug substances 
during drying operation may lead to the liberation of the water of crystallisation, affecting 
various solid state properties. Despite the frequent occurrence of channel hydrates, their 
complex dehydration behaviour still provides number of important industrial challenges, which 
forms the rationale for the dehydration studies reported here. In this Chapter, a gravimetric 
technique (Dynamic Vapour Sorption) was employed to delineate the drying 38  and 
dehydration39 behaviours of carbamazepine dihydrate. The effects of various drying conditions 
(i.e. temperature, vacuum pressure, air flow rate, relative humidity) on the dehydration kinetics 
were investigated. 
 
 
                                                 
38 ‘Drying’ here refers to removal of unbound (physically adsorbed) water. 
39 ‘Dehydration’ refers to removal of bound water (water of crystallisation). 
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8.2 Effects of Temperature on Drying and Dehydration Behaviour 
 Dehydration profiles obtained from the DVS instrument were presented as plots of 
moisture content (dry basis) XA against drying time. 
 
8.2.1 Carbamazepine Dihydrate Crystals 
  
 Figure 8-1 shows that higher temperature has markedly shortened the dehydration time. 
Isothermal and atmospheric dehydration of carbamazepine dihydrate crystals follows an 
exponential decay trend, governed by a falling rate mode. The total moisture content removed 
from the carbamazepine dihydrate crystals corresponded to the stoichiometric amount of 
hydrate water (XA = 0.15 kg/kg), showing that no significant unbound water, or none of the 
unbound water was included in the sample. 
 
 Within the studied temperature range (20ºC to 60ºC), the dehydration end point 
decreases with increasing temperature. Dehydration was observed even at such low 
temperatures as 20ºC (0 %RH), indicating that relative humidity has a significant effect in 
inducing the removal of hydrate water. Due to the unique lattice channel arrangement, the 
vapour pressure in the solid establishes a concentration gradient that drives hydrate water to the 
surface where it is desorbed to the surroundings [169]. As the highest dehydration temperature 
is well below the melting point of carbamazepine (189ºC) [235], heat transfer only intensifies 
at the air-sample interface, therefore the rate of hydrate water desorbed from the crystal surface 
to the surroundings is the rate limiting step for the atmospheric dehydration process.  
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Figure 8-1 Effect of temperature variation on dehydration of carbamazepine dihydrate crystals. 
  
 The dehydration rates dXA/dt (minute-1) were subsequently determined by computing 
the time derivative of the moisture content curve. A dehydration rate curve (or known as 
Krischer curve), as shown in Figure 8-2 is often used as the basis for the characteristic curve 
scaling method [340].  A constant drying phase was not observed from the Krischer curve of 
the dihydrate crystals. This time-dependent dehydration rate implies that the dehydration 
process is an internal diffusion controlled process. 
 
 Since the Krischer curve was obtained by differentiation of the moisture content curve, 
hence it usually has a significant amount of noise, especially at lower moisture content (the 
remaining 10 %wt of moisture content), lower dehydration rate and longer drying times. These 
observations could stem from the very small changes in the recorded moisture content, which 
might be of the same order of magnitude as the vibration of the weighing device.  
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Figure 8-2 Krischer curve for carbamazepine dihydrate crystals at different temperatures. 
 
 
8.2.2 Carbamazepine Dihydrate Agglomerates 
 
 Physically adsorbed water (or surface water) in the <710 μm agglomerated forms fall 
within the pendular regime [341], as reported in Chapter 7. The primary particle sizes of the 
dihydrate crystals within these agglomerates are similar. Not surprisingly, the particle size 
shows a strong influence on the dehydration kinetics in a zero humidity environment (Figure 
8-3). It was found out that the dehydration time reduces with smaller particle size distribution 
and increasing temperature.  
 
 The smaller agglomerate sizes dehydrate faster than the larger ones, due to the fact that 
smaller particle size distribution has greater surface area-to-volume ratio for heat and mass 
transfer, hence promoting the evaporation rate of the diffused hydrate water. However, higher 
temperature only expediates the dehydration rates up to a certain extent, where the dehydration 
end points for all three agglomerates were similar at temperature 50ºC. Note that for 
agglomerate size 180-250 μm in Figure 8-3a, the total moisture content is slightly less than the 
stoichiometric value of 0.1524 kg/kg at high temperatures (40ºC and 50ºC). This is merely due 
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to the immediate release of hydrate water once the samples were placed into the heated DVS 
system and before the gravimetric measurement commenced.  
 
 Meanwhile, the larger agglomerates (>710 μm), shown in Figure 8-4 tend to retain an 
excess amount of unbound water (well within the funicular regime of saturation). The drying 
and dehydration processes do not occur simultaneously in these >710 μm agglomerates, as 
demonstrated earlier in Chapter 7. The two-step drying and dehydration mechanism, depicted 
in Figure 8-4, was characterised by a linear but faster drying rate, prior to an inflection point at 
the dihydrate stoichiometric water content (~0.15 kg/kg) for a change in gradient to the slower 
dehydration of bound water. Even though both drying and dehydration rates were promoted by 
the increasing temperature, the differences in the gradient became smaller, till both rates were 
indistinguishable (710-1400 μm at 50ºC). 
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Figure 8-3 Effect of particle size on dehydration profile of carbamazepine dihydrate agglomerates 
at 0 %RH. 
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Figure 8-4 Effect of particle size on drying and dehydration profiles of carbamazepine dihydrate 
agglomerates at 0 %RH. 
 
 An example of the Krischer curve at 30ºC is shown in Figure 8-5. The curve displays 
two distinct stages for bound and unbound water, illustrating the three classical drying phases 
(i.e. induction period, constant rate and falling rate) [138], particularly for the removal of the 
unbound water. It is clear that the agglomerates not only dehydrate more rapidly than the 
crystal forms but also progress at different controlling mechanism, that is, boundary layer 
controlled reaction. 
 
 The constant drying phase observed in Figure 8-5 is clearly shown for an appreciable 
period. This is due to the constant saturation of water on the sample surface, indicating that the 
rate of water diffusion onto the surface is larger than the rate of water evaporate from the 
surface. Therefore, it is concluded that dehydration of agglomerates was governed by boundary 
layer controlled mechanism and influenced by external limitations. The falling rate phase 
commenced when the water vapour pressure was insufficient to keep the surface saturated with 
water vapour [93]. At this stage, the drying rate was governed by the internal moisture 
diffusion of carbamazepine dihydrate and the influence of external variables (i.e. heat and mass 
transfer coefficients) diminished. 
 
Unbound water 
Bound water 
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Figure 8-5 Krischer curve for carbamazepine dihydrate agglomerates of different particle sizes at 
30ºC. 
 
 
8.3 Effects of Vacuum Pressure on Drying and Dehydration 
Behaviour 
 
8.3.1 Carbamazepine Dihydrate Crystals Under Vacuum 
  
 Similarly, dehydration under reduced pressure condition has markedly promoted the 
hydrate water removal process. Figure 8-6 shows that the dehydration end points of 
carbamazepine dihydrate crystals at 10-3 Torr (0.13 Pa) and 50 Torr (6.67 kPa) of absolute 
pressure were shortened by almost 5 times and 3 times, respectively at 20ºC, in comparison to 
those under atmospheric condition (20ºC, 0 %RH). At higher temperatures (i.e. 50ºC) however, 
there was no further enhancement for vacuum drying where the dehydration end point was 
similar to those at elevated temperature in atmospheric condition (Figure 8-1). This effect 
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might be due to the rate limiting diffusion of hydrate water onto the crystal surface, of which 
the dominating falling rate period was clearly reflected in the Krischer curve in Figure 8-7. 
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Figure 8-6 Effect of vacuum pressure and temperature variation on dehydration of carbamazepine 
dihydrate crystals. 
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Figure 8-7 Krischer curve of vacuum dehydration of carbamazepine dihydrate crystals. 
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8.3.2 Carbamazepine Dihydrate Agglomerates Under Vacuum 
 
 Although dehydration under vacuum pressure (Figure 8-8) proceeds at a faster rate, the 
drying rate is not expected to have any significant effect on the liquid-phase distribution within 
the porous structure, hence the controlling mechanism. This is because in both conditions (i.e. 
atmospheric and vacuum pressure), the characteristic time of reaching the equilibrium 
meniscus shape due to capillary forces is much shorter than that of meniscus motion due to 
evaporation [342]. Krischer curve in Figure 8-9 still shows the three classical drying phases, 
but at higher drying rates than those at atmospheric condition.  
 
 Given that the sample size used in this work was 30.0 mg ±2.0 mg, and the weight 
change for a complete dehydration was about 3.97 mg (13.22 %w/w of hydrate water). For an 
operating temperature range between 20 to 60ºC and absolute pressure from 10-3 Torr to 100 
Torr, the buoyancy correction only resulted in an error of less than 0.408 %. Therefore, it can 
be concluded that the buoyancy effect is negligible in this work. 
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Figure 8-8 Effect of vacuum pressure on dehydration of carbamazepine dihydrate agglomerates at 
30ºC. 
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Figure 8-9 Krischer curve of vacuum dehydration of carbamazepine dihydrate agglomerates at 100 
Torr and 30ºC. 
 
 
8.4 Effects of Drying Air Flow Rates on Dehydration Behaviour 
 
 The drying air flows at a reduced speed (99% or slower than the free stream velocity40) 
near the surface of sample, a region known as the boundary layer. Initially, the boundary layer 
has the air flowing in parallel path (laminar region). Further down the flow path, the air flow 
pattern often becomes turbulent. Apart from wall friction, fluid properties etc., the distance 
when the transition from laminar to turbulent occurs is dependent on the velocity, where higher 
velocities lead to faster transition [343]. The transfer of energy within the boundary layer is 
approximately equal to the square root of velocity if within a laminar region, and proportional 
to the velocity up to the 4/5 power if within the turbulent region. Since the boundary layer is of 
key importance in the drying of wet materials, velocity of the air will be regarded as critical 
variable in controlling the drying kinetics of those agglomerated dihydrates. 
 
                                                 
40 Free stream velocity is the velocity far away from any object or boundaries in the part of the flow that is not 
disturbed by any object or boundaries. 
Unbound water Bound water 
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 The study on the effects of volumetric air flow rates on the dehydration behaviour of 
carbamazepine dihydrate was conducted in DVS Advantage. The induced air flow at 0 %RH 
was varied within 50 sccm and 700 sccm, measured by Agilent ADM 2000 flow meter 
(Agilent Technologies Inc., Santa Clara, US) at the downstream of the DVS system (Figure 
6-2).  
 
 Figure 8-10 depicts the effects of volumetric air flow rate on the dehydration of 
carbamazepine dihydrate crystals. The dehydration end point was almost identical for each 
flow rates, and the change in drying rates was negligible. These results were in agreement with 
the proposition that the major controlling resistance for the crystal form was in fact the internal 
diffusion rate of hydrate water, not the boundary layer. Therefore, external variables, such as 
air flow have no significant contributing factor in the dehydration process. 
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Figure 8-10  Effects of volumetric air flow rates on dehydration of carbamazepine dihydrate crystals 
at 30ºC. 
 
 On the contrary, the effects of volumetric air flow on the agglomerates were clearly 
demonstrated in Figure 8-11. Dehydration rate of carbamazepine dihydrate agglomerates 
increases with higher volumetric air flow rates, even as high as 700 sccm. Faster dehydration 
rate was the result of evaporation of the diffused hydrate water as the headspace was 
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continually exchanged with air flow. However, there are noticeable incremental step changes 
in the dehydration rate as the volumetric flow rate reached 100 sccm, 300 sccm and 500 sccm. 
The step change might correspond to the air velocity transition, which influences the flow 
pattern across the sample – heat and mass transfer enhancement. 
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Figure 8-11 Effects of volumetric air flow rates on dehydration of carbamazepine dihydrate 
agglomerates (250-500 μm) at 30ºC. 
 
 
8.4.1 Conversion of Localised Volumetric Air Flow Rate 
 
 The volumetric air flow rate of the DVS instrument is denoted in sccm (standard cubic 
centimetre per minute) at standard temperature and pressure (273.15 K and 100.00 kPa), based 
on the current International Union of Pure and Applied Chemistry (IUPAC) standard. The 
physical properties of air change with the surrounding temperature and pressure, which also 
differ in the volumetric unit given by the instrument. Hence, in order to determine the air 
velocity transition of carbamazepine dihydrate agglomerates and mass transfer characteristic of 
the DVS Advantage, the standard volumetric flow rate was converted into localised volumetric 
flow rate at the each specific experimental condition.  
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 The step-by-step calculations are shown in Figure 8-12. The dimension of the DVS 
system – the circular tube was taken into account. The air flow is entering from the side, 
providing a tangential convective mass transfer effect to the sample. Under such arrangement, 
the diameter of the smaller entrance (0.013 m) is the hydraulic diameter. The expansion effect 
from the entrance was negligible due to the laminar flow entry. The velocity, u obtained and 
kinematic fluid viscosity, ν at each experimental condition was used to determine the Reynolds 
number, Re: 
 
μ
ρ hdu ⋅⋅=Re υ
hdu ⋅=
       Equation 8-1 
 
 
Figure 8-12 Determination of Reynolds number for mass transfer calculation and the representation 
of tangential convective drying in DVS Advantage. 
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8.4.2 Determination of Mass Transfer Coefficient 
 
 Sherwood number (Sh) is the dimensionless concentration gradient at the surface, and it 
is used to determine the mass transfer coefficient (Ky), as Sh is a function of Reynolds number 
Re and Schmidt number Sc, at specific boundary condition. 
 
( )Scf
D
LK
Sh
AB
y Re,=⋅=        Equation 8-2 
ABD
Sc υ=
          Equation 8-3 
  
 The widely used empirical formula of binary diffusion coefficient, DAB (m2/s) of 
Equation 8-4 was employed, which gives a constant value of ScH2O-air = 0.61 at 1 atm and 
below temperature 373 K. 
 
685.1
0
051097.1
2 ⎟⎠
⎞⎜⎝
⎛⎟⎠
⎞⎜⎝
⎛×= −− TTP
PD airOH
     Equation 8-4 
 
for 273 K < T < 373 K at P0 = 101.325 kPa; T0 = 256 K. 
 
 The air flow rate into the system was simplified as an external flow over a spherical 
shaped DVS pan. In such a flow boundary, it has been assumed that there is no constraint 
imposed by the adjacent surfaces (i.e. the internal circular tube wall). Hence the temperature, 
concentration and velocity of the moving fluid outside of the convective mass transfer 
boundary are negligible. Equation 8-5 by Ranz and Marshall [344] was selected. In the limit of 
Re Æ 0, Sh in the equation will eventually reduce to 2. The Sh value corresponds to the heat 
transfer by conduction from a spherical surface to a stationary, infinite medium around the 
surface, which also implies the natural convection phenomena [140].  
 
For an external flow over a sphere, a correlation was proposed by Ranz and Marshall [344], 
 
3
1
2
1
Re6.00.2 ScSh +=        Equation 8-5 
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 Figure 8-13 illustrates the relationship of mass transfer coefficient, Ky and Re with the 
volumetric air flow rates at varying temperatures. As expected, the Ky increases with higher 
temperature. However there is a decrease in the local Re with increasing temperature. This is 
due to an increase in kinematic air viscosity ν with temperature, which is associated to the 
thermal effect of critical Re [345]. 
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Figure 8-13 Calculated transport parameters of DVS system over a range of operating temperature 
(20ºC-60ºC). 
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8.4.3 Air Velocity Transition Regimes 
 
 Although all the flow rates induced into the DVS system were well within the laminar 
region (Re <2300), the effect of air velocity transition was observed in the dehydration rates. 
Based on the flow patterns shown in Figure 8-14, there are three different flow pattern regimes 
under the laminar region, meanwhile a turbulent vortex and three-dimensional wake flow 
would only be observed if the Re falls between 150 and 3x105. The three flow pattern 
transitions fit nicely in Figure 8-15, where Regime (a) represents those flow conditions at 50 
sccm and below; Regime (b) for 100 sccm until 400 sccm; and finally Regime (c) as the flow 
characteristic for air flow rates at 500 sccm and above.  
 
 
Figure 8-14 Air velocity transition regimes for flow across the DVS sample pan. Adapted from 
[142]. 
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Figure 8-15 Effect of flow regimes transition on dehydration rate of carbamazepine dihydrate. 
 
 
8.5 Effects of Relative Humidity on Dehydration Behaviour 
 
 The dehydration of carbamazepine dihydrate displays a very pronounce dependency on 
the surrounding vapour pressure, in regard to the relative humidity. It was observed that there 
is no appreciable mass change when carbamazepine dihydrate was exposed to >50 %RH at 
room temperature. This indicates that there is none or negligible amount of surface water 
adsorbed on the dihydrate crystals, or within the dihydrate agglomerates. This therefore 
coincides with Surana et al. [92], where 52 %RH was recognised as critical relative humidity 
of carbamazepine dihydrate at 25ºC. Once the dihydrate was brought in an atmosphere of 
humidity below the critical relative humidity, departure of hydrate water from crystal lattice 
will commence.  
 
 Overall, the increasing humidity has mitigated the dehydration rates of dihydrate 
crystals (Figure 8-16) and agglomerates (Figure 8-17), especially when the relative humidity 
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reaches 30 %RH. At this high humidity, the dehydration rate exhibits sigmoidal characteristic, 
governed by growth of anhydrate nuclei as the dehydration progresses [261]. The saturated 
amount of water molecules in the bulk has reduced the driving force, inhibiting the effective 
mass transfer at the air-sample interface.  
 
 This inhibitory effect from the surrounding moisture is clearly shown in Figure 8-18. 
The decreasing trend in dehydration rate constants with increasing humidity is in contrast with 
the dehydration rate trend described by the Smith and Topley effect [346], as mentioned in 
Chapter 4. There is no maximum point where the dehydration rate constant increases upon 
reaching a certain relative humidity. 
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Figure 8-16 Effect of water vapour pressures (%RH) on dehydration of carbamazepine dihydrate 
crystals at 40ºC. 
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Figure 8-17 Effect of water vapour pressures (%RH) on dehydration of carbamazepine dihydrate 
agglomerates (particle size 250-500 µm) at 40ºC. 
 
 
* Error bars shown were from three repeats of the dehydration experiments. 
Figure 8-18 Dehydration rate constants of carbamazepine dihydrate under varying relative humidity. 
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8.6 Dehydration Kinetic Analysis 
 
 Conventional solid state kinetic studies involve non-isothermal processes, which are 
more intricate due to the non-isotropic nature of the solids. In this work, dehydration studies 
were conducted under isothermal conditions in the DVS instruments. In the first instance, 
fractional mass (α) of the dehydration and desolvation was calculated and plotted against the 
operating period (Figure 8-19).  
 
 Based on the shape of time reduced plot and selection from a rich array of solid state 
kinetic models in Table 4-2, deceleratory first order reaction was identified as the 
representation for dehydration of carbamazepine dihydrate crystals and agglomerates, which is 
in agreement with Young and Suryanarayanan [347]. Meanwhile a two-dimensional growth 
type sigmoidal rate equation determined the dehydration rates of both carbamazepine 
dihydrates under elevated humidity (30 %RH and above). The removal of unbound water 
however obeyed a simple linear deceleratory zero order reaction. 
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Figure 8-19 Kinetic analysis for dehydration reaction. 
 
 The data were then fitted with Equation 8-6, which is an integral form of the first order 
equation and Equation 8-7 for the two-dimensional growth rate, to determine the isothermal 
rate coefficient (k), commonly used to predict a material’s stability. The solid state reaction 
equations were summarised in Table 4-2. 
 
( ) kt=−− α1ln         Equation 8-6 
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( )[ ] kt=−− 211ln α         Equation 8-7 
  
 Activation energies, Ea (kJ/mol) in Table 8-1 were determined from the slope of the 
Arrhenius plots of drying/dehydration rate constant at different temperatures. Ea here was 
referred to the energy barrier or threshold that must be surmounted to instigate the drying and 
dehydration processes. Though it was empirically determined, Ea is an important experimental 
parameter which provides the temperature dependence of the transformation (dehydration) rate, 
and is useful in understanding its mechanism. These values differed from those in literature; 
68.8 kJ/mol [261] and 88 kJ/mol [92] determined under atmospheric condition and 0 %RH. 
The discrepancy could be due to structural factors, e.g. particle size used by the previous 
authors was well below 100 μm, nature of the surface defects due to different preparation 
methods, and dehydration conditions employed. Other contributing factors are lattice defect 
and packing structure of the agglomerates [341].  
 
Table 8-1: Kinetic analysis for dehydration of carbamazepine dihydrate at atmospheric and vacuum 
conditions 
Activation energy of dehydration, Ea (kJ/mol) Crystal properties of 
carbamazepine  dihydrate Atmospheric Vacuum (100 Torr)* 
Agglomerate 180-250 µm 
Agglomerate 250-500 µm 
Agglomerate 500-710 µm 
Agglomerate 710-1400 µm 
 - Unbound water 
Agglomerate >1400 µm 
 - Unbound water 
Crystal habit 1 
61.4 ± 1.3 
77.1 ± 5.5 
79.9 ± 4.1 
103.9 ± 2.4 
32.3 ± 0.3 
107.5 ± 1.8 
35.0 ± 0.2 
74.6 ± 0.3 
62.2 ± 1.5 
57.7 ± 2.2 
55.0 ± 2.4 
40.2 ± 1.0 
9.2 ± 0.2 
61.6 ± 0.5 
9.4 ± 0.2 
35.0 ± 0.2 (10-3 Torr) 
* Vacuum dehydration at 100 Torr, otherwise stated. 
 
 Not surprisingly, the rapid dehydration rate of those smaller particles was reflected in 
lower activation energy. This may be rationalised by the larger specific surface area for 
effective mass transfer and the shorter hydrate channel to overcome. Moreover the controlling 
dehydration mechanim of agglomerates was greatly influenced by external conditions (i.e. 
drying temperature – which is used for activation energy calculation). Since unbound water is 
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physically adsorbed on the crystal surface and behaves like pure water, the drying Ea values 
should be similar to the enthalpy of vapourisation of water, which is about 43.3 kJ/mol. The 
slightly lower drying Ea values from this work (32.3 – 35.0 kJ/mol) were due to the fact that 
zero humidity and flow conditions assisted the removal of unbound water. 
 
 
8.7 Conclusions 
 
 Understanding the complex dehydration behaviour of pharmaceutical channel type 
hydrates is clearly important for various scientific and practical reasons, primarily to determine 
the allowable conditions for pharmaceutics manufacturing, packaging and transport purposes. 
In this dehydration studies, we have demonstrated that increasing temperature, lower vacuum 
pressure, higher air flow rate and dry environment accelerate the dehydration rate of 
carbamazepine dihydrate. The results shown here were in agreement with the proposition that 
the major controlling resistance for the crystal form was in fact the internal diffusion rate of 
hydrate water. Thus, external variables such as air flows have no significant contributing factor 
in the dehydration kinetics, or at least provide the enhancement to a certain extent only.  
 
 Within the studied temperature range (20ºC to 60ºC), increasing temperature only 
expediates the dehydration rates up to 50ºC, where at that point, no further enhancement was 
observed from the influence of lower vacuum pressure and smaller agglomerate size. 
Dehydration of the dihydrate commences even at low temperature of 20ºC (0 %RH), indicating 
that relative humidity imposes a significant effect in inducing the removal of hydrate water. 
Increasing humidity however mitigates the dehydration rates, in particular when reaching a 30 
%RH environment at which the dehydration of dihydrate sample exhibits a sigmoidal 
characteristic. 
 
 In addition, agglomerated forms dehydrate more rapidly than the crystal forms, and 
proceed at a different controlling mode: boundary layer controlled type. Dehydration behaviour 
of these agglomerates hence was greatly influenced by the drying conditions and showed 
strong dependency upon the heat and mass transfer characteristics. Under varying volumetric 
flow rate conditions, there are noticeable incremental step changes in the dehydration rate of 
agglomerates, at 100 sccm, 300 sccm and 500 sccm which correspond to the transitions of air 
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velocity and the flow pattern across the sample holder. The drying and dehydration processes 
were demonstrated as a two-step mechanism, where removal of unbound water occurred first, 
accounting to the lower activation energy, followed by dehydration of hydrate water. 
 The kinetic analysis presented here can be used as a good starting point for elucidating 
the drying and dehydration mechanism. This work has certainly provided an insight to those 
environmental factors and crystal properties affecting the dehydration behaviour of 
carbamazepine dihydrate. 
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CHAPTER 9 SOLID STATE PHASE TRANSFORMATION DURING 
DEHYDRATION PROCESS 
 
9.1 Introduction to Phase Transformation 
 
“Nothing is, everything is becoming.” 
Heraclitus of Ephesus (535-475 BC), Greek philosopher. 
 
 A system starts to transform when it is no longer stable and the system departs from the 
equilibrium. The stability of a system can be determined by its thermodynamic characteristics, 
such as Gibbs free energy. At constant temperature and pressure, a closed system has the 
lowest Gibbs free energy, which is at its most stable state (represented by position A in Figure 
9-1). Any displacement, no matter small or large changes the position of block, however it will 
eventually fall back to the minimum free energy state. The displacements involved may be 
from external factors, such as temperature and pressure of the system.  
 
 The block can remain at the unstable state, B (Figure 9-1) if it is perfectly balanced. 
However the slightlest displacement would cause the maximum free energy to decrease and 
take the block to other positions, such as a metastable state at position C. Any small 
displacement at C’ positions will bring the block back to the metastable state, meanwhile only 
with large displacement, the block will return to the most stable state at A.  
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Figure 9-1 Relation between stable, unstable and metastable states, represented by a rectangular 
block in a series of positions. Source: [348; 349]. 
 
 In addition to temperature, pressure and composition, crystal defects such as vacancies, 
interstitials, dislocations and interphase interfaces also alter the material’s stability 
considerably. Any perturbations (e.g. mechanical, thermal, electromagnetic) can introduce 
stress into the lattice. Low level stresses are accommodated by the lattice and local strains 
develop. However, as the local strain fields increase, they can couple and create larger domains 
of strain until the lattice undergoes a global transformation to the new phase [350]. In 
particular for the transformation of an unstable system, the differences between the new and 
old phases are so great both structurally and energetically, that the system undergoes extensive 
atomic re-arrangement in order to instigate the necessary structural and compositional changes 
[349]. 
 
 Although there are many interesting reports in the literature of solid state 
transformations during processing, they are primarily very specific in nature. Thus far, there 
has been only a limited attempt in pharmaceutical sciences to establish a general mechanistic 
framework within which to rationalise such processing-induced changes.  
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 In the solid state pathway, phase transformations occur without any intervening 
transient liquid or vapour phases. Jena and Chaturvedi [349] categorised two microscopic 
modes of transformations (i.e. heterogeneous or homogeneous), based on the effect on the 
microstructure and stems from Gibbs [351]. The latter occur over the entire volume of system 
simultaneously, and it is associated with very small changes in enthalpy, entropy and volume 
during the phase transformation. This type of second-order transformation does not relate to 
the dehydration studies, as it does not involve formation of distinct new phases.  
 
 The heterogeneous phase transformations, on the other hand, are initiated by the 
appearance of microscopically small volumes of the product phase at identifiable locations 
within the parent phase. Such an initiation process is known as nucleation, and the migration of 
the interface between the nuclei of product phase and the untransformed parent phase is called 
growth. The rates of both nucleation and growth are strongly dependent on the temperature of 
the system.  
 
 There is also a mechanistic based classification scheme for phase transformation 
mechanisms [352]. However, from a practical point of view, it is difficult to apply as detailed 
experimental investigations and cumbersome theoretical considerations are required. Apart 
from the assumed details of the reaction mechanism, Ågren [353] proposed that other practical 
consequences, such as the rate of transformation (i.e. rapid or slow), change in composition etc. 
should be taken in consideration, in search for a experimental facts based and better 
classification for phase transformation.  
 
 
9.2 Phase Transformation of Carbamazepine Dihydrate 
 
 Since a major recall of carbamazepine tablets in 1988 [354], caused by unplanned 
anhydrous to dihydrate conversion, the phase transformations of carbamazepine have been 
studied extensively. In particular, solution mediated phase conversion from the anhydrate P-
monoclinic to dihydrate, using X-ray powder diffraction technique [241], chromatography 
method [9], fluorescence spectroscopy in aqueous suspension [264], spectroscopic monitoring 
of a simulated intestinal fluid [355]; in ethanol-water mixture [356-358], focused beam 
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reflectance measurement [260] and conventional visuallisation techniques (i.e. light 
microscopy) [11].  
 
 It has been discussed in Chapter 5 that under different operating conditions, that is, with 
the control of relative humidity, elevated pressure and temperature, carbamazepine dihydrate 
recrystallise into a range of polymorphic anhydrates [73; 92; 207; 212; 261]. Nevertheless, the 
previous studies were conducted in extreme drying conditions (elevated temperature/pressure), 
and mostly inaccessible in normal processing conditions. Therefore, there still remains a need 
for a comprehensive understanding of how the dehydration conditions affect the stability of the 
carbamazepine anhydrates formed, and whether the phase transition is a thermodynamically 
driven or kinetically favoured process.  
 
 With such an integrated knowledge of transformation mechanisms and polymorphism, 
we could anticipate and prevent solid state phase transformations during manufacturing, thus 
helping to ensure the consistent quality of the drug substance. Hence, the purpose of this study 
is to describe and investigate the formation of polymorphic carbamazepine anhydrates and 
their transformation mechanisms by X-ray diffraction method under a range of controlled 
drying conditions, e.g. vacuum pressure, temperature and surrounding vapours.  
 
 The phase transformation studies were performed under a variety of conditions in an 
attempt to identify the critical experimental variables that influence the observed kinetics, as 
reported in Chapter 8. The dehydration environments of interest here included reduced 
pressure (10-3 to 102 Torr) and atmospheric pressure (760 Torr), with a range of water vapour 
(5% to 60 %RH) and organic solvent vapours: ethanol, methanol, acetone and ethyl acetate (5 
% to 90 %P/P0). All experiments were conducted within controlled temperature range of 30ºC 
to 50ºC. The dihydrate crystals (~ 2 g) were packed into the XRPD sample holder prior to the 
dehydration studies in the DVS instruments. The results are schematically summarised in 
Figure 9-2. The organic solvent vapour-mediated phase transformations (Routes A, D and E) 
are to be discussed in detail in Chapter 10 instead. 
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Figure 9-2 Summary of the dehydration-induced phase transformation of carbamazepine dihydrate 
in this work.  
 
 The phase transformation pathway of the carbamazepine dihydrate to its polymorphic 
anhydrates was clearly influenced by the degree of drying imposed on the samples, the stability 
of which increases with lower impact drying conditions. These polymorphic anhydrates were 
subsequently confirmed as trigonal, triclinic, C-monoclinic and P-monoclinic forms using the 
XRPD analysis (Figure 9-3). The characteristic peaks in the XRPD pattern remained 
throughout the studies, only exhibiting reductions in level of crystallinity of the dehydrated 
samples.  
 
 Planes: (100) at 8.86 º2θ and (040) at 12.18 º2θ, in the XRPD pattern in Figure 9-3a, 
appear to be the two strongest peaks of the dihydrate crystal. The fact is that in the structure of 
carbamazepine dihydrate, water molecules are located along the c- crystallographic axis 
(Figure 9-4). Owing to the size of structural channels, dehydration is more likely to be 
progressively evacuated along this c- direction. 
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XRPD peak lists of this work matched to those reported in literature and Miller indexes were assigned 
to the respective peaks (Harris et al., 2005; Grzesiak et al., 2003; Lang et al., 2002; Reboul et al., 1981; 
Lowes et al., 1987).  
Figure 9-3 X-ray powder diffraction profiles of (a) carbamazepine dihydrate; (b) anhydrate 
trigonal; (c) triclinic; (d) C-monoclinic; and (e) P-monoclinic.  
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Figure 9-4 Crystal structure of carbamazepine dihydrate (space group of P21/c), observed along 
the c-axis. (Harris et al., 2005) 
 
 
9.3 Phase Transformation under Vacuum Pressure 
 
 The series of XRPD patterns shown in Figure 9-5 illustrate the progressive phase 
transformation from dihydrate to anhydrate, during vacuum pressure (10-3 Torr) dehydration. A 
decrease in intensity and broadening of the characteristic peaks were observed once the 
departure of hydrate water molecules commenced (Figure 9-5b to Figure 9-5d). Further periods 
of low pressure dehydration resulted in the appearance of an amorphous halo in the powder 
patterns (Figure 9-5e to Figure 9-5g) indicative of destruction of the initial lattice structure. 
This strongly suggests that vacuum dehydration reduces the crystal quality significantly.  
 
 The resultant disordered form, being the higher energy state relative to its crystalline 
counterpart, and due to a greater molecular mobility and thermodynamic escaping tendency, 
was susceptible to crystallisation via a solid state mechanism. The lattice gradually underwent 
structural rearrangement to a mixture of the energetically feasible crystalline packing (C-
monoclinic as major component and P-monoclinic as minor component), as shown in Figure 
9-5h. This observation strongly suggested that formation of dehydrated product was driven by 
kinetic factors, favouring the nucleation of the metastable C-monoclinic phase based on the 
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CBZ-CBZ 
2
2R (8) dimer motif [222]. The presence of the minor component: P-monoclinic was 
however observed as a characteristic peak at 10.2 º2θ only. 
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Blue marker denotes characteristic peaks of dihydrate; red marker represents peaks of C-monoclinic; 
green marker refers as peak of P-monoclinic. 
Figure 9-5 X-ray powder diffraction patterns of vacuum pressure dehydration of carbamazepine 
dihydrate crystals, conducted at 40ºC and 10-3 Torr. 
 
 Extreme dehydration conditions often result in defects on crystals, which consist of a 
disordered assembly of fine crystals (up to 100 nm in cross section) or amorphous form to 
compensate for the structural stresses imposed [73; 359]. The crystal structure can be disrupted 
to various degrees of disorder from lattice defects such as molecular level dislocations to 
amorphous regions where the disorder is more extensive. In this case, surface defects: 
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equidistant repeating channels evidently appeared on the plane (100) during the dehydration 
process (Figure 9-6a). Based on the micro-scale of these channels, they did not reflect the 
actual hydrate channels which should be distanced at a few angstroms. However, these defects 
serve to facilitate the removal of the remaining hydrate water and act as the nucleation sites for 
the anhydrate whiskers to crystallise (Figure 9-6b). The distribution of these nuclei was not 
random, as the crystalline structures formed on regions where the dislocations were. 
 
 
Figure 9-6 SEM images of (a) channel-like defects on plane (100) of carbamazepine dihydrate 
during dehydration and (b) formation of needle-like crystals after reduced pressure dehydration. 
 
 Garner and Jennings in 1954 [321] suggested that as the hydrate water is removed, the 
defects formed on the surface of the crystal would then diffuse into its volume and accumulate 
at dislocations. Supporting this observation, MacDonald [360] noted that reversible reactions, 
such as dehydration begin at the exterior of a crystal, and water molecules evaporating from 
the surface at the points where they are least strongly bound to the crystals, for instance, point 
defects, impurities, dislocations etc., would form vacancies which subsequently facilitate the 
formation of nuclei. After the barrier to nucleation has been overcome, the nuclei formed 
would grow to microscopic crystals during a stage referred to as crystal growth. The 
morphology of C-monoclinic, however, was reported as plate-like crystals [210]. 
 
 The rate of solid state phase transformation under low pressure nonetheless was 
hindered as the C-monoclinic anhydrate only gradually emerged after an appreciable period, 
and in this case, it took one day. This phenomena is known as time dependence nucleation 
[321], of which the appearance of nucleus is determined by the number of nuclei previously 
formed on the crystal surface.  
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 Similar dehydration mechanisms were observed for carbamazepine dihydrate 
agglomerates. Shown in Figure 9-7b, the crystal lattice collapsed almost instantly after 30 
minutes of vacuum drying. The amorphous halo lasted for a short while, before the stable P-
monoclinic phase appeared in Figure 9-7d. There was no formation of the metastable C-
monoclinic and this will be discussed in details in Section 9.4. 
 
 
Blue marker denotes characteristic peaks of dihydrate; green marker represents peaks of P-monoclinic. 
Figure 9-7 X-ray powder diffraction patterns of vacuum pressure dehydration of carbamazepine 
dihydrate agglomerates, conducted at 40ºC and 10-3 Torr. 
 
 
Figure 9-8 SEM images of carbamazepine dihydrate agglomerate (>1400 μm) (a) before 
dehydration and (b) after dehydration. 
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9.3.1 Effect of Temperature on Nucleation Phenomena 
 
 Even though homogenous nucleation is difficult or near impossible to achieve in large 
volumes, Classical Nucleation Theory (CNT) remains as the first approximation in describing 
nucleation kinetics [18; 361; 362]. In CNT, the thermodynamic driving force for nucleation is 
given by the difference in the free energies of the liquid and the crystalline phases. The 
temperature dependence of the kinetic factor and the thermodynamic driving force for 
nucleation have opposite signs in Equation 9-1. Nucleation is thermodynamically favoured at 
low temperatures, referring to a higher degree of supercooling, meanwhile crystal growth is 
favoured at higher temperatures or greater mobility [363]. Therefore, nucleation occurs by the 
balance in the temperature dependence of these two factors. 
 
( ) ( ) ( )dTTSdT
T
TT
Tm
T
Tm
T
∫∫ Δ−=⎥⎦⎤⎢⎣⎡ ∂
Δ∂=Δ μμ       Equation 9-1 
 
μΔ  difference in the chemical potential between crystalline and the liquid phase (J) 
( )TSΔ  difference in the molar entropies between the crystal and super-cooled melt (J/mol.K) 
Tm temperature of super-cooled melt (K) 
T temperature (K) 
 
 However, as solids are anisotropic (structurally inhomogeneous), the free energy of 
formation of a nucleus is location dependent. Nuclei would appear preferentially at those 
locations where free energy is less, i.e. defects. The nucleation rate N&  can be expressed as: 
 
( )kTGkTGNN t **0 expexp Δ−⎟⎠⎞⎜⎝⎛ Δ−= &&      Equation 9-2 
 
0N&  pre-exponential factor (no. of critical nuclei/m
3.s) 
*
tGΔ  activation free energy for diffusion across the interface (J/mol) 
*GΔ  free energy of formation (J/mol) 
k nucleation rate constant (J/mol.K) 
T transformation temperature (K) 
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 The first factor: ⎟⎠
⎞⎜⎝
⎛ Δ−
kT
Gt
*
exp  approaches zero at absolute zero, and increases 
rapidly with increasing temperature. Meanwhile the second factor: ( )kTG*exp Δ−  which is 
related to the equilibrium temperature, will increase rapidly as the transformation temperature 
departs from the equilibrium temperature [349]. These suggest that nucleation is strongly 
dependent on the temperature, clearly demonstrated in the vacuum dehydration of 
carbamazepine dihydrate at a much lower temperature, that is, at 20ºC (Figure 9-9). 
 
 Even after 12 days of vacuum drying at 10-3 Torr, only three distinguishable 
characteristic peaks of C-monoclinic were observed: plane ( )220  at 12.84 º2θ, ( )111  at 14.01 
º2θ, and ( )211  at 17.69 º2θ (Figure 9-10b), meanwhile the remaining crystalline peaks were 
barely discernable. 
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Blue marker denotes characteristic peaks of dihydrate. 
Figure 9-9 X-ray powder diffraction patterns of low pressure dehydration of carbamazepine 
dihydrate crystals, conducted at 20ºC and 10-3 Torr. 
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Figure 9-10 Comparison of X-ray powder diffraction patterns between (a) carbamazepine C-
monoclinic (ICDD reference pattern [211]) and (b) dehydrated sample after 12 days of vacuum drying. 
 
 
9.3.2 Effect of Induced Air Flow on Nucleation 
 
 Dehydration of carbamazepine dihydrate crystal at 100 Torr of absolute pressure 
however did not go through a transient amorphous phase, but transformed into a mixture of 
triclinic and C-monoclinic anhydrate phases (Figure 9-11). It was observed later in Section 9.4 
that the humidified air flow (humidity 40 %RH) induced the formation of triclinic in the 
presence of water vapour at atmospheric condition. 
 
 Figure 9-12 demonstrates that even the slightest change in the vacuum drying condition, 
i.e. inducing a small volumetric air flow rate at 50 sccm was able to alter the phase 
transformation mechanism, varying from the amorphous state, and thus determine the end-
products. It is clear that from the work presented here, nucleation and crystallisation from an 
amorphous state is a complicated phenomenon and more than one factor may impact the rates 
of these two events. Therefore, an increased understanding of the relative contributions of 
molecular mobility and processing conditions are important to control the crystalline forms and 
possibly to increase the usage of amorphous solids in the oral dosage forms. 
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Blue marker denotes characteristic peaks of dihydrate; red marker represents peaks of C-monoclinic; 
yellow marker represents peaks of triclinic. 
Figure 9-11 X-ray powder diffraction patterns of low pressure dehydration of carbamazepine 
dihydrate crystals, conducted at 40ºC and 100 Torr with air flow 50 sccm. 
 
 
Red marker represents peaks of C-monoclinic; yellow marker represents peaks of triclinic. 
Figure 9-12 X-ray powder diffraction patterns of low pressure dehydration of carbamazepine 
dihydrate crystals at 40ºC and (a) 10-3 Torr; (b) 100 Torr at 200 sccm; (c) 100 Torr at 50 sccm. 
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9.4 Water Vapour-mediated Phase Transformation 
 
 As reported by Li et al. [73], carbamazepine dihydrate can collapse into the amorphous 
form under conditions of 0 %RH dehydration. The relative humidity provided in the DVS 
system was kept below the critical relative humidity, RHC of carbamazepine dihydrate at the 
specific temperature. For instance, 70 %RH at 22ºC [220]. Once the relative humidity exceeds 
the RHC at the corresponding temperature, the liberation of hydrate water will not occur.  
 
 The gradual disappearance of carbamazepine dihydrate, illustrated in Figure 9-13, was 
accompanied by the appearance of the crystalline anhydrate phase, as opposed to the 
dehydration mechanism which occurs under vacuum conditions. There is no evidence of any 
disorganised phase observed under this atmospheric dehydration (5 % to 60 %RH). The water 
vapour is thought to have facilitated the nucleation of the anhydrate phase by providing the 
molecular mobility to high energy regions of defects caused by the departure of hydrate water. 
It has been demonstrated in the dehydration of inorganic hydrates, such as manganous oxalate 
hemihydrate and copper sulphate pentahydrate [321; 364], that water vapour was able to 
catalyse the ionic movement of the disordered crystallites, causing the recrystallisation process. 
 
 In addition, the dehydration under humidified conditions proceeds at a slower rate and a 
less destructive mode than that at 10-3 Torr pressure or 0 %RH. As a result, a steady transition 
to the more stable triclinic anhydrate ensued. The triclinic form was obtained in every case in 
the relative humidity range from 5 % to 60 %RH, and within the temperature range of 20ºC to 
50ºC. 
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Blue marker denotes characteristic peaks of dihydrate; yellow marker represents peaks of triclinic. 
Figure 9-13 X-ray powder diffraction patterns of atmospheric dehydration of carbamazepine 
dihydrate crystals, conducted at 40ºC and 40 %RH. 
 
  Though formation of triclinic form was observed via water vapour-mediated 
dehydration route in previous studies [73; 261], the preparation method of original 
carbamazepine dihydrate was different. In those cases, the hydration technique involve the 
dispersion of carbamazepine anhydrate in deionised water for ~24 hours, prior to filtration and 
pre-drying of the ‘wet’ carbamazepine dihydrate (~16.8 %wt). The inclusion of physically 
bound water and residual of the unconverted carbamazepine anhydrate often result in the 
formation of a mixture of triclinic and P-monoclinic forms [92], or P-monoclinic form, as in 
this work (Figure 9-14).  
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Blue marker denotes characteristic peaks of dihydrate; green marker represents peaks of P-monoclinic. 
Figure 9-14 X-ray powder diffraction patterns of atmospheric dehydration of carbamazepine 
dihydrate agglomerates, conducted at 40ºC and 40 %RH. 
 
 
9.5 Organic Solvent Vapour-mediated Phase Transformation 
 
 It has been observed that methanol and ethanol vapours were not only able to accelerate 
the dehydration process, but also to facilitate the phase transition to the stable phase – P-
monoclinic anhydrate. This observation was reported in previous studies, though in those 
polymorphic phase transformation cases, where the metastable forms were suspended (or 
dissolved) in organic solvent solution in order for the transformation to take place [30; 365; 
366].  
 
 Under such elevated organic solvent partial pressures, the departure of hydrate water 
was initiated once the solvent vapour adsorbed and partially dissolved on the crystal surface 
[365; 367]. As the remaining hydrate water was being removed, the stable P-monoclinic would 
gradually appear through the entire dehydrated phase. The simultaneous existence of dihydate 
and P-monoclinic between Figure 9-15b and Figure 9-15c reveals that dehydration proceeds 
probably by means of a progressive and smooth mechanism, without disruption of the initial 
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crystal lattice which occurred in a vacuum condition. For ethanol and methanol partial 
pressures considered in this work (5% to 90% P/P0), the dehydrated product was always the 
stable P-monoclinic form. The detailed explainations on the evolution of crystal packings at 
varying partial pressures of organic solvents (i.e. methanol, ethanol, acetone and ethyl acetate) 
are presented in Chapter 10. 
 
 
Blue marker denotes characteristic peaks of dihydrate; green marker represents peaks of P-monoclinic. 
Figure 9-15 X-ray powder diffraction patterns of organic solvent vapour-mediated dehydration of 
carbamazepine dihydrate crystals, conducted at 20ºC and 90% P/P0 MeOH.  
 
 
9.6 Dehydration-induced Phase Transformation Mechanism 
 
 By monitoring both water content (DVS instrument) and solid phase composition 
(XRD measurement), it was able to identify the steps and mechanisms that control the 
dehydration process here. Several studies [179; 368; 369] have proposed models for the 
dehydration mechanism of molecular crystals. There are two types of mechanisms according to 
the process of removal of water molecules that are reported in this thesis: catastrophic, and 
smooth and controlled dehydration mechanisms. The eventual process of reorganisation is 
either through a nucleation and growth process or cooperative. The mechanisms were 
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associated with the formation of unstable amorphous phase and the accessibility of solvent in 
the drying environment, as illustrated in Figure 9-16.  
 
 The catastrophic dehydration under vacuum resulted in the collapse of the crystal 
structure upon liberation of the hydrate water molecules, and proceeds at a faster rate than 
normal atmospheric dehydration. The nucleation of the crystalline anhydrate phase is 
nevertheless kinetically hindered at such low pressures, due to the lack of a solute (water 
vapour or solvent molecules) to provide the necessary molecular mobility. Owing to its 
instability, it must evolve rapidly toward the closest energy minimum, and transforms into one 
of the three metastable forms of anhydrate. As a result, the solid state phase transformation to 
the metastable C-monoclinic progresses by red coloured route in Figure 9-16.  
  
 The transformation to C-monoclinic seemed to follow the ‘rule of stages’, propounded 
by Ostwald [41]. It is stated that an unstable system does not necessarily transform directly into 
the most stable state, but into another transient state whose formation from the original is 
accompanied by the smallest loss of free energy. This exemplified the importance of kinetics 
over thermodynamics when a non-equilibrium system (amorphous phase) was encountered.  
 
 
Figure 9-16 Phase transformation from carbamazepine dihydrate to the polymorphic anhydrate 
forms. 
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 Dehydration under a humidified environment mediates a smooth phase transition from 
the dihydrate to anhydrate, due to the retarding effect from the higher concentration of water 
vapours at the air-sample interface. The slower ‘relaxation’ period allowed the structure 
rearrangement to the next metastable polymorph: triclinic (demonstrated as green coloured 
route).   
 
 The presence of an interacting solvent vapour however promoted the dehydration 
kinetics. In addition, the substantial lattice spacing of hydrate water on plane (100) is exposed 
to the penetration of solvent molecules, which are readily mixed with the hydrate water 
molecules. It is therefore reasonable to suggest that channel hydrates, with accessible lattice 
spacings are more vulnerable to organic solvent vapour-mediated dehydration. The soluble 
organic solvent vapour always converts the dehydrated carbamazepine to the most stable 
anhydrate P-monoclinic, via a surface dissolution mechanism, as depicted by blue coloured 
route. 
  
 The dehydration work reported here has emphasised the fact that a simple 
thermodynamic prediction of dehydrated crystal structures is not practical as it will 
overestimate the tendency to polymorphism. The low relative free energy between the 
carbamazepine polymorphs [222] also contributes towards the occurrence of polymorphism 
after the dehydration process. Therefore the subtle differences in the dehydration conditions 
studied here could easily induce the nucleation of the other metastable polymorphs.  
 
 
9.7 Surface Induced Nucleation by Organic Solvent Vapours 
 
 It has been demonstrated here that the solution mediated phase transformation of 
carbamazepine is affected by the processing (i.e. grinding) and storage conditions of the 
starting material [10]. The dihydrate crystals used in this work were not modified by any 
pretreatment steps, therefore difference in the surface characteristics of the dehydrated crystals 
could be examined clearly. 
 
 Surface defects in the form of equidistant repeating channels (Figure 9-17a) were 
observed during the dehydration process. Further dehydration resulted in an increase of the 
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proportion of these channels, but the global shape of the initial particle was preserved. These 
defects serve to facilitate water transport and act as the nucleation sites for the metastable 
polymorphs. The whiskers of C-monoclinic (Figure 9-17b) and triclinic (Figure 9-17e), 
following vacuum pressure and water vapour-mediated dehydration, were distinctively obvious 
on the crystal surface. The formation of whiskers under water vapour-mediated condition can 
be attributed to the high local supersaturations during the phase change which in turn are 
caused by the low solubility of the carbamazepine in water.  
 
 Only a negligible amount of small needle crystals were found on those crystal surfaces 
underwent ethanol vapour-mediated dehydration (Figure 9-17c). This implies the important 
structural similarities exist between the initial and end product: from a dihydrate (P21/c, 
monoclinic system) to the anhydrate (P21/c, monoclinic system). Hence, the structural 
similarity allows cooperative departure of hydrate water, followed by internal rearrangement 
without going through macroscopic strains. Meanwhile, etching patterns resulted from the 
reaction with acetone vapour were observed in Figure 9-17d. Other studies [370] have shown 
that the formation of whiskers on the parent crystal surface often occurs in those far-from 
equilibrium conditions which are controlled by kinetic factors (i.e. vacuum pressure). 
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(a) Equidistant repeating channels 
      formed during dehydration
(b) C-monoclinic (major component) crystals 
  after vacuum dehydration
(e) Triclinic crystals after water vapour-
      mediated dehydration
100 μm
50 μm
30 μm
50 μm
50 μm
(c) Surface defects after ethanol 
      vapour-mediated dehydration
(d) Surface etching after acetone 
      vapour-mediated dehydration
 
Figure 9-17 Processing-induced nucleation on surface defects of plane (100) of carbamazepine 
dihydrate crystals. 
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9.8 Transitions between Polymorphic Anhydrates 
 
 Once the metastable polymorphs (triclinic and C-monoclinic) are formed, they have 
exhibited sufficient chemical and physical stability for at least six months under the storage 
conditions, and no further conversion to the most stable polymorph P-monoclinic was 
observed using the XRPD. The next logical step in understanding the system was therefore to 
study the interconversion between the various metastable forms. Most often, such phase 
transformations can be initiated thermally, by solution-mediated means, or even by applying 
pressure [50]. In this work, the organic solvent vapour method was employed, since or solvents 
have been able to convert the dihydrate into the stable P-monoclinic. 
  
 The metastable polymorphs (triclinic and C-monoclinic) generated from the 
dehydration work, crystallised trigonal form and the commercial P-monoclinic crystal were 
exposed to 90 %P/P0 ethanol and methanol vapours for 12 hours at 30ºC in the DVS 
instrument. The sorption of solvent vapour was recorded and is presented in Figure 9-18. The 
samples were then analysed with XRPD to identify the polymorphs formed. A small amount of 
solvent sorption was observed in Figure 9-18, especially for trigonal and C-monoclinic forms 
which show a peak initially. 
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Figure 9-18 Solvent vapour uptake at 90 %P/P0 ethanol partial pressure. 
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 Carbamazepine is an excellent example of crystal polymorphism in which its 
conformation and strong hydrogen-bonding scheme remains constant for all the polymorphs 
[211]. The polymorph differences among crystal forms lie solely in the packing of the 
carboxamide dimer units, which are described by the pattern of weak C-H···O interactions. 
According to the nuclear magnetic resonance (13C NMR) spectra [70], all polymorphs have one 
complete formula unit in the crystallographic asymmetric unit; except for the triclinic form 
which has four inequivalent molecules. 
  
 Only the amorphous form, trigonal, C-monoclinic, and P-monoclinic polymorphs were 
able to transform to the stable P-monoclinic, while triclinic remained as it is. The triclinic and 
P-monoclinic forms are enantiotropically related [207; 211; 235], with a transition temperature 
around 162ºC being reported in differential scanning calorimetry. Such transformation was not 
successful at ambient condition, and could only be induced by either thermal reaction or 
pressure. Moreover, Ceolin et al. [209] also demonstrated that the triclinic form was stable 
within the temperature range 132ºC and 190ºC in a topological pressure-temperature diagram.  
 
 The four polymorphs were also subjected to the dehydration conditions used in this 
work, and other conditions generally employed for polymorphic interconversion. The results 
presented here have brought a further insight about the stability hierarchy of carbamazepine 
polymorphs at room temperature.  
 
 
 281
9.9 Conclusions 
 
 It has been demonstrated that the phase transformation of carbamazepine dihydrate 
during a dehydration process is strongly related to the role of solvent vapour (water, ethanol 
and methanol) in the drying environment. The XRPD results shown here have shed some light 
on the sequential nature of the solid state reaction and establish the dehydration mechanism (i.e. 
smooth or catastrophic), including nature of the intermediate phase. The formation of the 
metastable polymorphs is kinetically favoured and is closely related to the extent of 
dehydration condition imposed and the accessibility of the surrounding vapours.  
 
 Vacuum dehydration has led to the disruption of crystal structure and the subsequent 
formation of the disordered phase (amorphous form). The amorphous phase proved to be 
somewhat resistant to nucleation and crystallisation under the influence of low temperature and 
high vacuum. The metastable C-monoclinic polymorph was observed as a major component to 
nucleate preferentially on surface defects; forming equidistant repeating channels on plane 
(100). 
 
 The ‘relaxation’ period during/after the solvent vapour-mediated dehydration process 
however initiated the structural rearrangements by passing the disordered phase and facilitated 
the polymorph transformations. All metastable polymorphs formed in this work were stable in 
storage for at least six months. Apart from the triclinic form, the organic solvent vapour-
mediated method (e.g. ethanol and methanol) was able to transform the metastable polymorphs 
to the most stable P-monoclinic. Methanol and ethanol solvent vapours-mediated method was 
proven to be an efficient technique for obtaining the most stable anhydrous form. Since no 
suspension and/or complete dissolution of the metastable form in the solution is required, there 
is no complication in the crystallisation kinetics, preservation of the initial particle shape and 
size, or additional unit operations (i.e. filtration and drying) to obtain the stable form. 
 
 The diversity of dehydration mechanisms found here constitute an extension of the 
possible pathways for the preparation of polymorphs with desired physical properties. The 
knowledge and understanding can then be utilised to our advantages in the drug formulation 
and/or manufacturing process. 
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CHAPTER 10 SOLUTE-SOLVENT INTERACTION DURING 
DEHYDRATION AND DESOLVATION PROCESSES 
 
10.1 Introduction 
 
 With the increasing number of crystalline forms identified as solvates, there is a 
necessity to characterise these pseudopolymorphs accurately [54; 254] and to understand the 
relationships between these forms in terms of transformation pathways to the unsolvated 
counterparts and relative stabilities as a function of their processing environment. Such studies 
include the analysis of desolvation mechanisms, possible recrystallisation behaviours, and 
solid-solid transformations occurring in a humid atmosphere, or even in the presence of a 
solvent [371]. 
 
 Previous studies have shown that the crystallising solvent directly affects the 
crystallisation products formed [8; 255; 372-374]. In a recent example of solvent-dependent 
polymorphic transformation, Gu et al. [366] have shown that the balance of solubility and 
strength of hydrogen bonding interactions between the solute and solvent molecules 
determines the solid state transition kinetics.  
 
 Cardew and Davey [31] have previously developed a two-step model for the solvent-
mediated transformation, which involves the dissolution of metastable phase and growth of 
nuclei of the stable form. In their work, a mechanistic insight of the solid state transformation 
was obtained by measuring the supersaturation profile rather than the conversion data. It was 
subsequently demonstrated through examples, such as dyestuffs and paclobutrazol [375], that 
the transition kinetics can be well described in terms of the relative rates of dissolution and 
growth of the metastable and stable phases.  
 
 A similar concept was used by Threlfall [376] in an attempt to provide the 
thermodynamic and kinetic insight of the role of solvent in solid state transformations. It has 
been shown that in some cases of crystallisation, the choice of solvent may just be a secondary 
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effect, compared to the potential effects of concentration attainable in that solvent at a certain 
temperature.  That is, enhanced solubility may be far more important than any specific solvate-
solid state chemistry which might occur. Considering the delicate interplay that 
thermodynamic, kinetic, and molecular recognition factors have on a dehydration/desolvation 
processes, it is not surprising that there is a lack of a clear understanding in the factors that 
control phase transformation events and the role that solvents specifically play. The work 
presented here seeks (1) to investigate the effects of organic solvent vapours on the 
dehydration of carbamazepine dihydrate, and (2) to propose an interpretation of the associated 
mechanisms on the basis of structural data. 
 
 
10.2  Role of Solvent Vapour on Dehydration Behaviour 
 
 Organic solvents are characterised by several properties that make them suitable for 
dissolving and for acting as a reaction media for various types of solutes. These properties 
include physical (i.e. vapour pressure, boiling point, dielectric constant) and chemical (i.e. 
hydrogen-bond propensity, dipole moment) quantities [377]. Four different types of solvents 
were employed in the solvent vapour-mediated dehydration studies described here. The 
solvents were chosen based on their polarity; dipolar aprotic solvents (i.e. acetone and ethyl 
acetate) and polar protic solvents (i.e. ethanol and methanol). 
 
 The selected solvents are known as drying agents, which are able to interact strongly 
with water. Naturally a hydrate would behave differently in an environment filled with these 
solvent vapours. It will be shown in this Chapter that dehydration kinetics of carbamazepine 
dihydrate were significantly expedited by the presence of acetone, ethyl acetate, ethanol and 
methanol vapours, compared to that dehydration rate under zero humidity condition.  
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10.2.1 Dehydration Kinetics 
 
 In Chapter 8, it was observed that the dehydration kinetics of carbamazepine dihydrate 
display a very pronounced dependency on the surrounding vapour pressure. These results have 
shown that the presence of water vapour alters and mitigates the dehydration rate. The 
dehydration rate decreases with increasing air relative humidity, exhibiting sigmoidal kinetic 
characteristics at 30 %RH and above. 
 
 
Acetone vapour-mediated dehydration behaviour 
 
 Figure 10-1 shows the dehydration profiles of carbamazepine dihydrate crystals under 
varying acetone partial pressures at 30ºC. At lower partial pressures (<20 %P/P0), though the 
dehydration kinetics have a similar exponential decay trend as in zero humidity conditions, the 
dehydration end point at 10 %P/P0 was 3 times faster than that at 0 %P/P0. It is postulated here 
that the hydrogen-bonding ability of acetone is an important factor contributing to the faster 
dehydration rate. It is also due to the fact that acetone is an effective drying agent, its high 
volatility and readiness to mix with water molecules. 
 
 As we progress to the higher partial pressures (from 20 % to 50 %P/P0), a small uptake 
of acetone molecules was observed. Once the sample reaches an equilibrium mass, the partial 
pressure was reduced to 0 %P/P0 (marked as point ‘Z’ at 400 minutes in Figure 10-1). The 
maximum amount of acetone desorbed here was < 0.014 kg/kg d.b. (~1 %w/w) of solvent 
content at 50 %P/P0. This quantity is consistent with acetone which is retained in a surface 
adsorbed state. 
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* ‘Z’ refers to the point when the acetone partial pressures were reduced to 0 %P/P0.  
Figure 10-1 Dehydration profile of carbamazepine dihydrate crystals under acetone partial 
pressures (10 %-50 %P/P0) at 30ºC. 
 
 The acetone vapour however started showing a different effect on the dehydration 
kinetics when the partial pressure reaches above 60 %P/P0 (Figure 10-2). Initially, there was a 
steep dehydration curve but before the dehydration could reach completion, significant 
sorption of acetone molecules occurred. The solvent content then gradually increased until it 
reaches a plateau. The higher the partial pressure, the more acetone molecules retained by the 
sample.  
 
 The carbamazepine sample reveals a unique characteristic at 90 %P/P0, where the 
equilibrium solvent content approaches the stoichiometric value for a mono-acetone solvate 
(XA = 0.2458 kg/kg d.b.). As for 80 %P/P0 condition, the inclusion of acetone molecules 
appeared to keep increasing, and an acetone solvate was eventually formed (as confirmed by 
XRPD in the subsequent Figure 10-6). Obviously the acetone solvate is the thermodynamically 
stable phase in acetone solvent, and as is shown here, even in an acetone-laden vapour 
environment (≥ 80 %P/P0). The transition point for a carbamazepine dihydrate to a mono-
acetone solvate was found to be lower than the solvation point from a P-monoclinic anhydrate 
(97.8 %P/P0 at 30ºC) [268]. 
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Figure 10-2 Dehydration profile of carbamazepine dihydrate crystals under elevated acetone partial 
pressures at 30ºC. 
 
 It may be postulated that the main driving force for the exchange of solvent observed 
here was due to the high partial pressure of acetone around the crystal. In such acetone-laden 
environment ((≥ 80 %P/P0), the vapour pressure of the water molecules located in the crystal 
lattice becomes higher, and could easily overcome the weak hydrogen-bond. Due to the fact 
that these hydrophilic lattice channels are not that large to accommodate the acetone molecule 
(molecular diameter of 6.3 Å [378], compared to water molecule at 2.75 Å [94]), the solvation 
mechanism was probably not fully topotactic 41 . It could be envisaged that the acetone 
molecules somehow penetrated within the crystal and stabilised the lattice by forming 
hydrogen-bonds with the carbamazepine molecules. 
 
 By comparing the adsorption free energies of the first three layers of acetone adsorption, 
there is no strong dipolar or hydrogen bonding interactions between the second and the third 
layer, the third layer hence should be randomly thermalised as in the liquid phase [379-382]. 
As a result, the thickness of the acetone vapour-solid interface is generally not more than two 
layers.  
                                                 
41 Topotactic reaction refers to a reversible or irreversible reaction that involves the introduction of a guest species 
into a host structure, and that results in significant structural modifications to the host, for example, the breakage 
of bonds. (IUPAC) 
 287
Ethyl acetate vapour-mediated dehydration behaviour 
 
 Another dipolar aprotic solvent; ethyl acetate, similar to acetone also enhances the 
dehydration rate, comparing to the zero humidity rate (Figure 10-3). However even at a low 
partial pressure – 10 %P/P0, there was 0.6 %w/w of solvent remained on the carbamazepine 
crystals. More ethyl acetate molecules were adsorbed/retained in the solids as the concentration 
of ethyl acetate in the environment increases till 90 %P/P0.  
 
 Inclusion of ethyl acetate in the channel lattices could happen as the highest 
equilibrium solvent content recorded at 90 %P/P0 was 0.040 kg/kg d.b. (= 3.48 %w/w), 
substantially more than the typical amount for a surface adsorption (i.e. <1 %w/w). Similar to 
acetone system, ethyl acetate molecules also hold up to about 6.64 Å (1.4 layers of surface 
thickness) on a vapour-liquid interface [383]. Secondly, the molecular size of ethyl acetate is 
4.95 Å [384], which is much smaller than acetone molecules and thus could be easily 
accommodated within the channel lattices during the dehydration process.  
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Figure 10-3 Dehydration of carbamazepine dihydrate crystals under ethyl acetate partial pressures 
at 30ºC. 
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Ethanol and methanol vapours-mediated dehydration behaviour 
 
 Both polar protic solvents; ethanol and methanol vapours were also found to promote 
dehydration rather than exert an inhibitory effect (Figure 10-4 and Figure 10-5). Although both 
ethanol and methanol solvents do not contribute in any solvate formation, there seems to be a 
substantial amount of temporary solvent uptake (or inclusion) at elevated partial pressures. For 
instance, at 90 %P/P0 ethanol vapour, and from 60 %P/P0 methanol vapour onwards. 
Interestingly, the solvent molecules were eventually removed by the end of a dehydration 
process.  
  
0.00
0.04
0.08
0.12
0.16
0.20
0 50 100 150 200 250 300 350 400
0%P/Po
10%P/Po
20%P/Po
30%P/Po
40%P/Po
50%P/Po
60%P/Po
70%P/Po
80%P/Po
90%P/Po
M
oi
st
ur
e/
 s
ol
ve
nt
 c
on
te
nt
, X
A
(k
g/
kg
)
 
Figure 10-4 Dehydration of carbamazepine dihydrate crystals under ethanol partial pressures at 
30ºC. 
 
 Figure 10-5 shows that there is a strong tendency of the methanol molecules for being 
(ad)sorbed at the interface and/or into the crystal. Being one of the smallest possible molecule 
with amphiphilic character, methanol is fundamentally interesting from a chemical physics 
perspective as it is an analogue to water in which a methyl group replaces a single proton [385; 
386]. This minor substitution allows for a rather significant difference between these two 
hydrogen-bonding liquids (water and methanol). 
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Figure 10-5 Dehydration of carbamazepine dihydrate crystals under methanol partial pressures at 
30ºC. 
  
  Although bulk-phase thermodynamics of mass transport are well understood in terms 
of equilibrium constants, for instance Henry’s Law coefficients, the solvent uptake is however 
more difficult to obtain, in particular when the factors controlling uptake kinetics are not well 
understood. The gravimetric results shown here have demonstrated that dehydration rate was 
influenced by the solvent’s polarity, hence the hydrogen bonding ability. All solvents studied 
here were able to promote the dehydration kinetic of carbamazepine dihydrate.  
 
 Dipolar aprotic (i.e. acetone and ethyl acetate) solvent vapours however induce solvent 
adsorption and inclusion at elevated partial pressures. Polar protic (i.e. ethanol and methanol) 
solvent vapours, on the other hand, were merely able to have the effect of temporary solvent 
inclusion during the dehydration process. Due to the existence of the lattice channels running 
along the c-axis of carbamazepine dihydrate in which the water molecules were located 
initially, then a solvent exchange process could possibly occur. Moreover, small solvent 
molecules are excellent candidates for filling small cavities in crystal structures through the 
formation of hydrogen bonds, apart from the water molecules. The molecular diameter (DM) 
for the solvent molecules used in this work, in an increasing order, are: water (2.75 Å) < 
methanol (4.1 Å) < ethyl acetate (4.95 Å) < ethanol (5.2 Å) < acetone (6.3 Å) [94; 378; 387]. 
 290
Nonetheless, in comparing the amounts of solvent absorbed, it seems that the molecular size is 
not the major contributory cause in the solvent inclusion effect. 
 
 Once the solvent vapour-laden environment reaches the deliquescense partial pressure 
(DPP) of the solid at a specific temperature, the dissolving solvent vapour condenses on the 
crystal surface, forming a thin-layer of solution. Although complete deliquescence of 
carbamazepine (fully dissolved solid) was not expected to occur in this work, partial 
dissolution might take place on the crystal surfaces [388]. The DPP of solid is dependent on 
the particle size (noticeable effect for particles size <60 nm) [389; 390], crystal morphology 
(polymorphic transformation alters the deliquescence properties due to different solubilities) 
[391] etc. This could then relate to the interaction between the solvent molecules and 
carbamazepine, which will be discussed in Section 10.2.3. 
 
 
10.2.2 Solvent Vapour-mediated Phase Transformation of 
Carbamazepine Dihydrate 
 
 In order to investigate the events associated with high solvent uptake and the evolution 
of crystal packings during dehydration at elevated partial pressures, XRPD study was 
performed.  
 
 
Dipolar aprotic solvent-mediated phase transformation 
 
 Figure 10-6 shows the XRPD peaks of carbamazepine dihydrate crystals at 60 %P/P0 
and 80 %P/P0 of acetone partial pressures, based on the gravimetric data shown previously. At 
60 %P/P0, the XRPD patterns in Figure 10-6b showed no presence of carbamazepine acetone 
solvate, even though there was an appreciable amount of solvent uptake. An additional peak 
was observed at 5.05 º2θ, along with the decreasing peaks of dihydrate. The peak at 5.05 º2θ, 
shown in the shaded area, was referring to the plane (110) of the least stable trigonal form. The 
characteristic peak was distinct and recognisable. No other carbamazepine 
polymorphs/hydrate/solvate has a peak at this angle. Clearly, the local chemical environment 
of the solute-solvent system had influences on the outcomes of the least stable anhydate form. 
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 Trigonal form however disappeared as soon as the mass uptake of acetone solvent 
gradually increased and was replaced by formation of the stable P-monoclinic. In addition, 
there was no broadening of peaks or reduction in crystallinity during the phase transition from 
a dihydrate to P-monoclinic anhydrate. Both diffraction patterns of dihydrate and P-monoclinic 
form were preserved at 60 %P/P0, indicating a cooperative and non-destructive dehydration 
mechanism, without complete destruction of the long range order of carbamazepine molecules. 
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Figure 10-6 Acetone vapour-mediated dehydration of carbamazepine dihydrate crystals at 30ºC, 
with X-ray diffraction profiles at (a) 80 %P/P0 and (b) 60 %P/P0. 
  
 As for the XRPD pattern at 80 %P/P0 (Figure 10-6a), it can be observed that the 
dihydrate’s characteristic peaks, especially planes: (100) at 8.86 º2θ and (040) at 12.18 º2θ 
diminished as the mass uptake of acetone molecules began. The characteristic peaks of trigonal 
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form appeared too, at 5.05 º2θ and 8.75 º2θ, referring to plane (110) and (300), respectively. 
As the trigonal peaks disappeared with time, the following XRPD patterns showed full 
transition to an acetone solvate after 20 hours of experiment. 
 
 XRPD pattern at ‘4’ in Figure 10-6a was then compared to the trigonal form, 
crystallised from method in [211], and the acetone solvate, presented in Figure 10-7. Though it 
was a mixture of trigonal form and acetone solvate, the trigonal peaks were evident. Trigonal 
phase was maintained throughout the sorption curve and during the transition from dihydrate to 
acetone solvate.  
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Pink marker represents peaks of trigonal; purple marker represents peaks of acetone solvate. 
Figure 10-7 X-ray powder diffraction patterns of carbamazepine (a) trigonal form; (b) acetone 
solvate; (c) after 5 hours at 80 %P/P0 (denoted as ‘4’ in Figure 10-8). 
 
 Evaluation of the crystal structures here has shown that acetone vapour-mediated 
dehydration occurs according to a cooperative mechanism. Starting from single crystals of 
dihydrate, the phase transformation went through an intermediate metastable phase – trigonal 
form before converting into the stable P-monoclinic (60 %P/P0), or the acetone solvate if the 
environment was above its critical partial pressure (80 %P/P0). 
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 Likewise for ethyl acetate vapour-mediated dehydration (Figure 10-8), the 
characteristic peak of metastable trigonal form was observed at 5.05 º2θ, along with the 
decreasing peaks of dihydrate. In this instance, however, the trigonal form did not disappear 
but progressively formed, and was stable at the end of the dehydration process (marked as ‘5’ 
in Figure 10-8). This is very interesting, since the metastable trigonal form is known to be very 
difficult to crystallise from solution, and yet here we have demonstrated for the first time a new 
way to generate the trigonal form via vapour-mediated dehydration.  
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Figure 10-8 Ethyl acetate vapour-mediated dehydration of carbamazepine dihydrate crystals at 30ºC, 
with X-ray diffraction profile at 80 %P/P0. 
  
 
Polar protic solvent-mediated phase transformation 
 
 As mentioned earlier in Chapter 9, ethanol- and methanol-mediated dehydration (80 
%P/P0) exhibit a cooperative and non-destructive dehydration mechanism. There was no 
broadening of peaks or reduced crystallinity during the phase transformation from a dihydrate 
to the P-monoclinic anhydrate (Figure 10-9 and Figure 10-10). Unlike the dehydration with 
acetone vapour, the metastable polymorph was not observed under these two conditions. 
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Figure 10-9 Ethanol vapour-mediated dehydration of carbamazepine dihydrate crystals at 30ºC, 
with X-ray diffraction profile at 80 %P/P0. 
 
 Based on the gravimetric data in Figure 10-10, it was suggested that there were 
incorporation of methanol molecules and possible lattice expansion at high partial pressure. 
Therefore, peak shifts in the XRPD patterns of carbamazepine were initially suspected. 
However, the XRPD patterns in Figure 10-10 show no crystallographic abnormalities from the 
reference patterns of dihydrate and P-monoclinic. 
 
 An unfortunate liability of solvent inclusion in the lattice channels is that small 
methanol molecules tend to be disordered, or maybe exhibit a liquid-like disorder. Therefore, 
XRPD alone cannot detect the crystallographic arrangement of this type of disordered solvent 
molecules, in this work. Advanced technique such as solid state nuclear magnetic resonance 
(NMR) is able to distinguish many atoms within a molecule and to determine the differences 
between polymorphs/pseudopolymorphs, arising from the changes in molecular geometry (i.e. 
intramolecular) and packing (i.e. intermolecular) [392]. 
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Figure 10-10 Methanol vapour-mediated dehydration of carbamazepine dihydrate crystals at 30ºC, 
with X-ray diffraction profile at 80 %P/P0. 
 
 
10.2.3 Solvent-solute Interaction 
 
 In a solvent vapour-mediated method, the conditions permit the attainment of an 
equilibrium between the solid, the product (i.e. solvate), and the solvent vapour. The solute, 
carbamazepine sample in this case, was in contact not only with the air and the solvent vapour, 
but also with the solvent.  
 
 It has been shown that a solvent-mediated polymorphic transformation depends on the 
solubility of the solute in that particular solvent [393], and specific solvent properties 
(polarisability and hydrogen bond propensity) [366; 394]. Both criteria were thought to be 
crucial in solvent vapour-mediated dehydration too, affecting the dehydration rate as well as 
the relative nucleation rate of the anhydrate phase. 
 
 
10.2.3.1 Solvent solubility of Carbamazepine 
 
 The solubility of carbamazepine P-monoclinic in each particular solvent (at T = 25ºC) 
is: 10.5 mg/mL in ethyl acetate < 13.5 mg/mL in acetone < 17.5 mg/mL in ethanol < 100 
mg/mL in methanol [249; 395]. The high solubilities of carbamazepine in those organic 
solvents are due to the ability of the organic solvent molecules to disrupt the N-H···O hydrogen 
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bonds and the C-H···O weak interactions of the carboxamide dimer units existing in the solid 
state of carbamazepine [211]. The influence of solubility on the nucleation rates can be 
explained by the classical nucleation theory (CNT) [18], mentioned in Chapter 9. CNT predicts 
that under constant supersaturation, the rate of nucleation of the anhydrate phase is faster in 
systems with higher solubilities, due to the higher probability of intermolecular collisions. 
 
 Since carbamazepine is reported to be more soluble in methanol than the other three 
solvents, one would have expected that methanol vapour-mediated dehydration rate would 
therefore be the fastest among all.  Nonetheless, the dehydration rate is not always higher in the 
presence of solvent giving a higher solubility. Increase in the dehydration rate with increasing 
solubility was not observed experimentally in this work. Therefore no correlation between 
solvent solubility and dehydration kinetics can be established. Moreover, drying rate constants 
above 40 %P/P0 are not comparable as sorption of solvent molecules began (Figure 10-1 to 
Figure 10-5) and the water removal process proceeds at a more complex mechanism. In order 
to understand the system, the knowledge of the specific solute-solvent interactions is needed.  
 
 
10.2.3.2 Hydrogen bond propensity 
 
 Linear solvation energy relationships (LSER) has been proposed and used to model 
equilibrium solvation processes in many areas of chemistry [377; 396; 397]. In most of these 
studies the LSERs are based on solvatochromic42 scales of solvent strength, including α as the 
scale of hydrogen bond donor (HBD) acidity of the solvent, β is the scale of hydrogen bond 
acceptor (HBA) basicity or electron pair donation ability to form a  coordinative bond, and π* 
is a measure of the dipolarity/polarisability parameter. The balance between hydrogen bond 
donors to acceptors of the solvents was reflected by the ratio of hydrogen-bond propensities: 
HBD/HBA. Among the solvents used in this work, acetone is associated with HBA type of 
solvent, meanwhile  methanol and ethanol belong to HBD type solvent [398]. Their solvent 
property parameters are shown in Table 10-1. 
 
 
 
                                                 
42 Solvatochromism refers to the change in position and sometimes intensity of an electronic absorption or 
emission band, accompanying a change in the polarity of the medium (IUPAC 1994). 
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Table 10-1: Property parameters of organic solvents at 25ºC 
Solvent 
Hydrogen bond 
donor propensity 
(HBD), α 
Hydrogen bond 
acceptor propensity 
(HBA), β 
Dipolarity/ 
polarisability π* 
Acetone 0.08 0.43 0.71 
Ethyl Acetate 0.00 0.45 0.55 
Ethanol 0.86 0.75 0.54 
Methanol 0.98 0.66 0.60 
Source: [377] 
 
 From a crystallisation event, it has been shown that solvents that primarily accept 
hydrogen bonds (HBD/HBA ≈ 0) preferentially crystallised the metastable trigonal form, 
whereas solvents that accept and donate donate hydrogen bonds concomitantly crystallised the 
P-monoclinic and trigonal forms [394].  
 
 Figure 10-11 shows an example of the HBA solvent; ethyl acetate used in their 
crystallisation work, performed at an initial supersaturation of 2.0 (C/S)P-monoclinic at 25ºC. Ethyl 
acetate solvent exhibits the most discriminating power for inhibiting the nucleation of P-
monoclinic form and preferentially nucleating the trigonal form. The amount of the stable P-
monoclinic form crystallised could be altered with the supersaturation profile, of which lower 
supersaturation gave higher percentage of P-monoclinic form in the solid phase [394]. Hence 
in order to obtain the P-monoclinic (> 95 %w/w), longer crystallisation time is required at a 
low supersaturation. In Kelly and coworkers’ report [394], the percentage of polymorph in the 
solid phase (%w/w) was quantified by using XRPD and a standard curve based on the known 
quantities of both polymorphs. 
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Figure 10-11 Schematic representating of the carbamazepine supersaturation-time profile and solid 
phase composition in hydrogen-bond accepting (HBA) solvent. Adapted from [394]. 
 
 Considering the supersaturation effect of ethyl acetate in a crystallisation event, the 
XRPD patterns of dehydrated carbamazepine sample from each ethyl acetate partial pressure 
are shown in Figure 10-12. Clearly, the four selected characteristic peaks of trigonal form were 
observed at 5.05 º2θ, 8.75 º2θ, 13.40 º2θ and 20.30 º2θ, referring to plane (110), (300), (410) 
and (440), respectively. The crystallinity of the trigonal form increases with higher 
concentration of ethyl acetate environment. All the trigonal form attained were pure trigonal 
form – within the detection limit of XRPD, except at 10 %P/P0 (Figure 10-12a) where a 
mixture of the trigonal and P-monoclinic forms was obtained. The work presented here implies 
that ethyl acetate solvent, which primarily interacts by accepting hydrogen bonds, is able to 
promote the formation of a metastable trigonal form through solid-vapour interface.  
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Figure 10-12 XRPD profile of carbamazepine anhydrate obtained at the end of dehydration under 
varying ethyl acetate partial pressures at 30ºC. 
 
 The weak CH···O interactions in the carbamazepine crystal structure serve as an 
important secondary interactions [210; 211], and in many instances this type of interaction has 
been documented to play a dominant role in determining crystal packing and molecular 
conformation [399-401]. The CH···O interaction is known to be critical in stabilising the P-
monoclinic structure, closely linked through the centrosymmetric dimers. However, a HBA 
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type solvent can easily disrupt the CH···O interaction [394], therefore it can destabilise the 
carbamazepine crystal structure, and prevent the stacking pattern and molecular motif 
necessary for nucleation of P-monoclinic. This interaction is less likely to affect the remaining 
three polymorphs. 
 
 It can be concluded that specific intermolecular interactions can have a profound effects 
on the selective nucleation of carbamazepine polymorphs during a dehydration process, as 
demonstrated through the first reported phase transition through the example of dihydrate-
trigonal-acetone solvate and dihydrate-trigonal. The balance between hydrogen bond donors to 
acceptors of solvents with carbamazepine molecules was crucial in determining the molecular 
motif required for the formation of the stable P-monoclinic and should be thoroughly 
considered when evaluating dehydration outcomes. 
 
 
10.3 Role of Water Vapour on Desolvation Behaviour 
 
 Desolvation of an acetone carbamazepine solvate is briefly discussed in this section. 
The primary interest was observing the desolvation kinetics under varying humidified 
conditions. Shown in Figure 10-13, water vapour seems to provide an enhancement for the 
desolvation kinetics. This result was in contrast to the case of carbamazepine dihydrate where 
the dehydration kinetics was retarded in a water vapour environment. The decreasing trend in 
desolvation rate with increasing relative humidity was observed throughout the temperature 
range between 30ºC to 50ºC. The isothermal desolvation process, however, exhibits a 
sigmoidal characteristic, indicating a more complex mechanism, than the exponential decay 
trend of dehydration process. 
 
 
10.3.1 Kinetics Analysis 
 
  One of the most widely accepted mechanisms invoked to describe the desolvation of 
solvates is the ‘reaction interface theory’ [16; 402]. The reaction interface theory states that 
desolvation is initiated at surface defect sites, leading to nucleation and growth of the 
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anhydrate phase. At these defect sites, the lattice is strained and the neighboring molecules are 
more energetic. Therefore, desolvation and recrystallisation of anhydrate commence within the 
reaction interface which then propagates inwards. The rate limiting step of this reaction is the 
formation and growth of the finite quantities of carbamazepine anhydrate nuclei, during the 
departure of acetone molecules. Once the nuclei were formed, the desolvation and nucleation 
growth occur simultaneously. Hence, the sigmoidal characteristic, as shown in Figure 10-13 
The advancement of this phase transition may be anisotropic, or even favour certain 
crystallographic directions [171].  
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Figure 10-13 Desolvation of carbamazepine acetone solvate crystals under different relative 
humidities. 
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10.3.2 Avrami-Erofe’ev Kinetic Model 
 
 Sigmoidal-shaped kinetic curves are a common feature for many solid state reactions. 
Finney and Finke [195] reported a historical tabulation of the Avrami-Erofe’ev equation 
(Equation 10-1) and its more than 13 variants (n) [185; 196; 403-406].  
 
( ) ( )nkt−=−α1ln         Equation 10-1 
 
 The fractional desolvation (α) plot of carbamazepine acetone solvate (crystal form) was 
fitted into the two-dimensional Avrami-Erofe’ev growth and nucleation model (Equation 10-2). 
The acetone solvate in powder form, however, have a steeper desolvation rate and hence obeys 
the three-dimensional growth and nucleation model (Equation 10-3). The differenced in these 
reaction models for the same material could be related to the effect of particle size and crystal 
habit. 
 
( )[ ] kt=−− 211ln α          Equation 10-2 
  
( )[ ] kt=−− 411ln α         Equation 10-3 
 
 The desolvation activation energy, Ea (kJ/mol) was determined using the rate constants 
and Arrhenius equation, as depicted in Figure 10-14. Ea for carbamazepine acetone solvate at 0 
%RH were 125.2 ± 4.3 kJ/mol and 52.6 ± 0.1 kJ/mol for both crystal and powder forms, 
respectively. Previously reported value was 81.9 kJ/mol [268], and it was stated that the 
slightly lower value obtained for desolvation of acetone solvate was due to the decreased 
hydrogen bonding with the carbamazepine for acetone compared to water molecules in 
dehydration process. The discrepancy in Ea value was primarily due to the solvate preparation 
method: powder or crystal forms. In short, crystal form and/or larger size would have higher Ea 
value. 
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Figure 10-14 Kinetic analysis for desolvation reaction. 
 
  
 Desolvation Ea at varying relative humidity (5 % to 30 %RH) were then calculated for 
the acetone solvate crystals (Figure 10-15). As expected, the desolvation Ea decreases when the 
relative humidity increases. The value at 30 %RH was, however, similar to that reported by 
Burnett et al. [268].  
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Figure 10-15 Activation energy of desolvation for carbamazepine acetone solvate crystals at 
different relative humidities. 
 
 XRPD analysis was also conducted for water vapour-mediated desolvation at 20 %RH 
and 30ºC, and is shown in Figure 10-16. There was neither formation of metastable 
polymorphs nor labile amorphous state, instead, the acetone solvate transformed to the stable 
P-monoclinic form gradually.  
 
 The initially period (Point ‘1’ to ‘2’ in the gravimetric plot of Figure 10-16) shows only 
the desolvation process, indicated by the reduction in characteristic peaks of acetone solvate. 
P-monoclinic only appeared from the steep desolvation curve, and the XRPD patterns 
coincided with the ‘reaction interface theory’, mentioned earlier. The formation of the P-
monoclinic nuclei occurred from Point ‘2’ onwards. Once these nuclei were formed, the 
desolvation and recrystallisation proceeded simultaneously, at a faster rate. All carbamazepine 
crystals were converted to P-monoclinic at the end of desolvation process, denoted by Point ‘4’. 
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Purple marker denotes characteristic peaks of acetone solvate; green marker represents peaks of P-
monoclinic. 
Figure 10-16 Water vapour-mediated phase transformation of carbamazepine acetone solvate at 20 
%RH and 30ºC. 
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10.4  Conclusions 
 
 In summary, the dehydration/desolvation work presented in this Chapter has been able 
to demonstrate the significant effects of the presence of organic solvent vapours have on the 
dehydration/desolvation kinetics and related solid state phase transformations. The organic 
solvent vapours (acetone, ethyl acetate, ethanol and methanol) were found to promote 
dehydration rather than exert an inhibitory effect. A surprising but important observation was 
that elevated partial pressure (>50 %P/P0) resulted in partial dissolution of carbamazepine 
crystals and/or inclusion of solvent molecules (i.e. acetone, ethyl acetate and methanol) within 
the lattice channels, further complicating the interpretation of mechanism involved. 
 
 In the case of elevated acetone vapour pressures, it was the first transformation report, 
to our best knowledge, that a dihydrate dehydrates into an intermediate trigonal form, before 
transforming towards the acetone solvate, or to the P-monoclinic at lower acetone partial 
pressures (≤ 60 %P/P0).  Likewise and interestingly, ethyl acetate vapour promotes the 
formation of metastable trigonal form, which is very difficult to crystallise from solution. It has 
been shown that, the solvent vapour-mediated dehydration was unlike the solvent-mediated 
transformation, as the solvent-solute interaction was far more significant than the effects of 
solubility in that particular solvent. The balance between hydrogen bond donors to acceptors of 
the solvents gave some insight to the nucleation and crystallisation behaviors of carbamazepine.  
 
 On the other hand, water vapour was able to provide an enhancing effect on the 
desolvation kinetics of carbamazepine acetone solvate. The sigmoidal shaped desolvation 
kinetics followed the Avrami-Erofe’ev model, and the desolvation mechanism involved the 
occurrence of the rate-limiting heterogeneous nucleation at defect sites follow by propagation 
inwards and throughout the solid. All solvent vapour-mediated transformations, be it a 
dehydration or desolvation processes, occur according to a cooperative mechanism, without 
any formation of an amorphous phase. 
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CHAPTER 11 CONCLUSIONS AND FUTURE WORK 
  
 Hydrates form an integral part of many pharmaceutical dosage forms. Carbamazepine 
dihydrate was selected as the model compound because it is an excellent example of crystal 
polymorphism (four known polymorphic anhydrates) and it has a low dehydration temperature 
due to the unique structural arrangement of a channel hydrate. The results presented in this 
thesis show that dehydration of carbamazepine dihydrate under varying drying environment 
may adversely affect the kinetics, and even the physical and chemical properties of the 
carbamazepine solid. Understanding the complex dehydration behaviour of pharmaceutical 
channel hydrates is clearly important for various scientific and practical reasons. This thesis 
aims to provide a basis for developing a drying strategy for active pharmaceutical ingredients 
which are capable of forming channel hydrates. 
 
 
11.1 Overall Summary 
 
 Within the experimental range considered in this thesis, it is evident that crystal related 
properties (i.e. crystal habits and agglomeration) have notable influences on the drying and 
dehydration kinetics of carbamazepine dihydrate. This dihydrate, when crystallised from a 
mixture of ethanol and water solution, exhibits different dehydration behaviour and proceeds at 
a distinct controlling mechanism, than the dihydrate prepared from suspension in water. The 
dehydration results have revealed that an increased temperature (up to 60ºC), lower vacuum 
pressure (down to 10-3 Torr of absolute pressure), higher air flow rate (up to 700 sccm) and dry 
environment (< 5 %RH) provide an enhancing effect on the dehydration rate. The dehydration 
kinetics, on the whole, were largely affected by the temperature and vacuum pressure. 
 
 The surface defects on plane (100), formed through stress relief of the dehydration 
process, were able to facilitate the removal of hydrate water along a preferred crystallographic 
direction (along c-axis). The unique equidistant repeating channels enable the needle habit of 
carbamazepine dihydrate to dehydrate faster than the plate habit. The dehydration results 
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shown here are in agreement with the proposition that the major controlling resistance for the 
crystal form is the internal diffusion rate of hydrate water. Consequently, external variables 
such as air flow rates are not a significant contributing factor in the dehydration kinetics of 
loose crystals, or at least promote the kinetics to a limited extent only. For instance, increasing 
temperature only expediates the dehydration rates up to 50ºC, where at that point, no further 
enhancement was observed from the influence of lower vacuum pressure and smaller 
agglomerate size. Relative humidity (i.e. 0 %RH) was found to be imposing a significant effect 
in inducing the removal of hydrate water even at low temperature of 20ºC. Increasing humidity 
however mitigates the dehydration rates, in particular when reaching a 30 %RH environment. 
 
 The agglomerated forms of carbamazepine dihydrate meanwhile dehydrate more 
rapidly than the loose crystal forms, governed by boundary layer-internal diffusion type 
mechanism. Drying and dehydration behaviours of these agglomerates hence are greatly 
influenced by the drying conditions and show a strong dependency on the heat and mass 
transfer characteristics, especially during the transitions of air velocity and the flow pattern 
across the sample holder. As the agglomerated dihydrates exceed a critical particle size, they 
tend to retain an excess amount of physically adsorbed water, up to a significant 57.2 %wt and 
exhibit closed pore structure. The drying and dehydration processes were demonstrated to be a 
two-step mechanism, where removal of unbound water occurred first, followed by dehydration 
of hydrate water. Dynamic Vapour Sorption (DVS) was proven to be a suitable gravimetric 
method to differentiate the differing states of water, as the drying of unbound water yielded a 
steeper mass loss gradient, than the dehydration of bound water. 
 
 This thesis also presents the first report of the agglomeration effects on dehydration 
stability of carbamazepine dihydrate. The large agglomerates (particle diameter 1400-
~1800μm), having a funicular regime of moisture saturation, are significantly more stable than 
those agglomerates without inclusion of unbound water. The dihydrate’s integrity was 
demonstrated to be retained even at low critical humidity of 20 %RH (0.0039 kg water/kg air) at 
25ºC. The agglomerated effects shown here therefore can be potentially controlled and 
exploited to increase the stability of the desired hydrated products. In general, the dehydration 
work here has given an insight to those environmental factors and crystal properties affecting 
the dehydration behaviour of carbamazepine dihydrate. The kinetic analysis hence provides a 
good starting point for elucidating the drying and dehydration mechanism.  
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 X-ray powder diffraction (XRPD) results and Dynamic Vapour Sorption (DVS) data 
shown here have shed some light on the sequential nature of the solid state phase 
transformation processes, and established two dehydration mechanisms, namely smooth or 
catastrophic mechanisms. The presence of metastable polymorphs and lower crystallinity 
phase of carbamazepine were detected during the dehydration studies. Vacuum dehydration 
has led to the disruption of crystal structure and the subsequent formation of the disordered 
phase (amorphous form). The amorphous phase proved to be somewhat resistant to nucleation 
and crystallisation under the influence of low temperature and high vacuum pressure. The 
metastable C-monoclinic polymorph preferentially nucleated on the surface defects: 
equidistant repeating channels on plane (100). The ‘relaxation’ period during/after the water 
vapour-mediated dehydration process however initiated the structural rearrangements by 
passing the disordered phase and facilitated the nucleation of metastable triclinic. The 
formation of the metastable polymorphs (C-monoclinic and triclinic) is kinetically favoured 
and closely related to the extent of dehydration condition imposed. All metastable polymorphs 
prepared in this work were stable in storage for at least six months.  
 
 It is noteworthy that the thesis also presents the first report of phase transformation of 
carbamazepine dihydrate, in the presence of an interacting solvent vapour (i.e. acetone, ethyl 
acetate, ethanol and methanol), at varying partial pressures. Unlike the conventional solution-
mediated phase transformation, no suspension and/or complete dissolution of the dihydrate 
form is required, therefore there is no complication in differentiating the dissolution rates and 
crystallisation kinetics; maintaining the initial particle shape and size, or requiring any 
additional stages (i.e. filtration and drying) to obtain the end products.  
 
 In short, all organic solvent vapours, employed in this work, were found to promote 
dehydration rather than to exert an inhibitory effect. An important remark is that at elevated 
partial pressure (>50 %P/P0) conditions, there were partial dissolution of carbamazepine 
crystals and/or inclusion of solvent molecules within the lattice channels, further complicating 
the interpretation of intrinsic solid state mechanism involved. It is clear in vapour phase that 
the strength of solvent-solute interaction is far more significant than the effects of solvent 
solubility. The balance between hydrogen bond donors to acceptors of the solvents is crucial to 
the nucleation and crystallisation behaviors of carbamazepine. For the first time, a dihydrate 
was reported to dehydrate into an intermediate trigonal form, before transforming towards a 
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stable acetone solvate at elevated acetone partial pressures (≥ 70 %P/P0), or to the metastable 
trigonal form at ethyl acetate partial pressures (20-90 %P/P0).   
   
 Water vapour, on the other hand, was able to promote the desolvation kinetics of 
carbamazepine acetone solvate. The sigmoidal shaped desolvation kinetics followed the 
Avrami-Erofe’ev model, where the desolvation commenced with the rate-limiting 
heterogeneous nucleation at defect sites follow by propagation inwards and throughout the 
entire solid. All solvent vapour-mediated transformations, be it a dehydration or desolvation 
processes, occur according to a cooperative mechanism, without any formation of an 
amorphous phase. 
 
 In conclusion, the work presented in this thesis has led to the development of an 
understanding of the dehydration behaviour of carbamazepine dihydrate and the effects of 
drying conditions on the important solid state properties. These findings have contributed to 
the field of process-induced polymorphism by exploring the role of surrounding vapours in 
assisting the dehydration process and facilitating the nucleation event of polymorphic 
anhydrates. This seems to be an area that has growing importance given the continual interest 
in predicting and controlling polymorphism during pharmaceutical processing. The diversity of 
the dehydration mechanisms found here constitute an extension of the possible pathways for 
the preparation of polymorphs with desired physical properties. The knowledge gained can 
then be utilised to our advantage in the drug development and/or manufacturing processes.  
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11.2  Future Work 
 
 Probing deeper, there are some future extensions to the work in this thesis that would 
help strengthen the knowledge of the dehydration stability of channel type hydrate. Some 
points of interest which need a further research are as follows: 
 
 
Unbound water distribution in agglomerates 
 
 Non-destructive imaging techniques like X-ray micro-computed tomography (µCT) is 
proposed for future work in order to visualise and quantify the interior microstructure of the 
random acicular particle network. This technique has been used widely, especially in a recent 
work by Hapgood et al. [336], which they investigated the agglomeration and distribution of 
the granulating fluid of a highly hydrophobic fine powder. Therefore, moisture distrbution and 
movement within the solids would make a step change in the understanding of the transport 
processes occurring within the solids during the drying process. 
 
 
Kinetic analysis of a single crystal of carbamazepine dihydrate 
 
 The present investigation on this internal diffusion dominant process can be made 
confirmed through further experimentation on single crystal, using an ultra-sensitive balance, 
for example: quartz crystal microbalance (QCM). In a preliminary study, we have succeeded in 
crystallising lactose alpha-monohydrate (another commonly used hydrated excipient) on the 
QCM sensor, and reasonable fundamental frequency shift was obtained.  
 
 
Relative stability of carbamazepine polymorphs. 
 
 There has been disagreement regarding to the relative stability between the 
carbamazepine polymorphs in literature. In order to obtain the important thermodynamic 
features (i.e. monotropy and enantiotropy) of these polymorphs, solubility and/or vapour 
pressure measurements are proposed as future work. Mao et al. [407] developed a model to 
 313
estimate the solubility ratio of two polymorphic forms, based on the calculation of free energy 
differences between the two forms at any temperature. The free energy is determined from 
temperature, the enthalpy of fusion for monotropic systems, the temperature of the solid–solid 
transition point, and the enthalpy of transition for enantiotropic systems. Vapour pressure data 
meanwhile can also be used to examine the thermodynamic relationship, since the heat of 
sublimation can be equated to the lattice energy of a crystalline state [408]. 
 
 
Inter-conversion of polymorphic anhydrates 
 
 Since carbamazepine has the potential to exist in four different crystalline forms and an 
amorphous form, it is crucial to extensively explore and fully gather information on the inter-
conversion phenomena of those forms. Preliminary results on the solvent vapour-mediated 
polymorphic transformation have been shown in Chapter 9. Future studies, however, will 
include other processing conditions (as such in Figure 11-1), the measurement of the 
dissolution rate during phase transformation and calculation of the chemical potential of 
polymorphs. This information might establish a correlation between the amount of surface 
dissolution and the relative stability of both initial and converted polymorphs. 
 
Trigonal
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Monoclinic
P21/c
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Monoclinic
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P-1
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Figure 11-1 Polymorphic interconversion observed in this work. 
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Localised fluctuations during dehydration 
 
 A majority of studies concerned with molecular crystalline systems (including the work 
presented here) typically characterise the equilibrium properties of polymorphs, rather than 
definitively ascertaining the molecular level events leading to the transformations. Another 
interesting aspect for future investigation is to characterise the localised fluctuations in crystal 
structures at the molecular level, which is extremely difficult from an experimental standpoint. 
Sophisticated molecular simulations, however, are able to provide approaches that could 
potentially address to this problem and to determine the molecular pathways of the 
polymorphic transformations. Clearly such an advanced modeling tool will help elevate drying 
research to the next level of sophistication.  
 
 In addition, a fundamental understanding of the factors that determine whether the 
solvent molecules in the bulk will adsorb on the surface or be accommodated within the 
channel lattice is still lacking. Molecular dynamics computer simulations would certainly 
provide some insights and explore the molecular-level details during the solvent inclusion 
process. 
  
 
Surface-induced nucleation 
 
 A more detailed investigation of the surface defects, forming through stress relief, at 
different drying conditions could be delivered by atomic force microscopy (AFM) and white-
light interferometer (also known as optical profilometry – OP). AFM is known as a powerful 
surface mapping technique which allows quantitative determination of the topographical 
features of dehydrating/dehydrated carbamazepine dihydrate.  
 
 On the other hand, OP, a non-contact method which can map the vertical (Z axis) 
topography of the crystal surface at a resolution as high as 0.1 nm, is commonly used to 
examine surface topography with very high precision, in particular the measurement of surface 
roughness over a time scale. This OP technique can be employed to understand how the crystal 
surface’s geometry (i.e. roughness and texture) can impact the dehydration behaviour of 
hydrates, having considering the influences of different drying environments. Figure 11-2 
shows the preliminary study of surface roughness on the plane (100) of carbamazepine crystals, 
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using a Wyko NT9100 Optical Profiler (Veeco UK Ltd., Cambridge, UK). A substantial 
increment in the average surface roughness was observed after vacuum dehydration, which 
corresponded to the formations of equidistant repeating surface defects and anhydrous 
whiskers. 
 
 
Figure 11-2 Optical profilometry images of carbamazepine crystal surfaces (a) before dehydration, 
and (b) after vacuum dehydration at 40ºC. 
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